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ABSTRACT 
Obesity and poor quality diet are major interrelated risk factors for cardiovascular disease 
(CVD) and mortality, which are well established in middle-aged populations. However, 
there is controversy on the effects of obesity on CVD and mortality in the elderly. Since 
body composition changes with age (visceral fat increases and muscle mass decreases) it 
may be important to also account for muscle mass in the elderly. However, few studies 
have examined the combined effects of adiposity and sarcopenia (low muscle mass) on 
CVD risk and mortality in the elderly. There is also a paucity of data on the associations 
between dietary patterns and CVD risk and mortality in older age. This thesis uses the 
British Regional Heart Study, a population based prospective cohort of men, to investigate 
the impact of body composition (obesity and sarcopenia) and dietary patterns on the risk of 
cardiovascular endpoints and all-cause mortality in older age (60-79 years). The main 
findings are that sarcopenic men (defined using mid-arm muscle circumference) and obese 
men (defined using waist circumference) had a significantly increased risk of CVD 
mortality and all-cause mortality. Men with both sarcopenia and obesity showed the highest 
all-cause mortality risk, and also an increased CVD mortality risk although non-significant. 
Adherence to an a priori defined dietary pattern (the Elderly Dietary Index, a modified 
Mediterranean-style diet) was associated with a lower risk of CVD mortality and all-cause 
mortality. Adherence to a ‘high fat/low fibre’ diet, identified by principal component 
analysis, was associated with an increased risk of all-cause mortality but not CVD 
mortality. Adherence to a ‘high sugar’ diet was associated with an increased risk of 
coronary heart disease (CHD) events and CVD events. Body composition and dietary 
patterns are therefore important risk factors for CVD and all-cause mortality which persist 
in older age.   
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ICD-9   International Classification of diseases - ninth revision  
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Exposures 
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BMI    Body mass index 
CRP    C-reactive protein 
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SBP   Systolic blood pressure 
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Statistical terms 
CI    Confidence interval 
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SD   Standard deviation 
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CHAPTER 1 Introduction 
1.1. Introduction and rationale for thesis 
1.1.1.  Cardiovascular disease in an ageing population 
The population in the United Kingdom (UK) is ageing due to a steady increase in life 
expectancy over time. Since the 1930s, the number of people aged over 65 years in the UK 
has more than doubled1 and by 2012, 23.0% of the population were aged over 60, a 
proportion which is predicted to increase to 29.6% by 20502. The elderly are particularly at 
risk of non-communicable diseases and the key to healthy ageing is the prevention of 
diseases and disability3. Death rates from cardiovascular disease (CVD) have been falling 
in the UK since the early 1970s but CVD remains the main cause of mortality, accounting 
for nearly a third of all deaths in both men and women, and is a major contributor to 
morbidity and disability4.  CVD is largely preventable, and much focus of prevention 
efforts has turned to promoting healthy lifestyle behaviours5;6. Diet and adiposity are 
recognised by the World Health Organization (WHO) as two major interrelated and 
modifiable determinants of CVD7 and much emphasis of recent CVD prevention efforts 
have therefore been on promoting healthy eating and the prevention of obesity5;6;8.  
 
Whilst the major aetiological factors for CVD and mortality are well established (as 
summarised in Chapter 2, section 2.3.1), however, most research on its causes and 
prevention has focused on exposures in middle-aged populations (adults <60 years). The 
determinants of CVD and the scope for CVD prevention in later life (aged 60 years and 
above) remain uncertain. The effects of two major modifiable risk factors for CVD (obesity 
and diet) in middle age are known, but whether their effects persist in older adults is 
unclear. This is important as the risks of CVD are particularly high in older people so even 
small reductions in risk later in life can have considerable scope for health benefits4;9. 
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1.1.2.  Body composition and CVD 
Overweight and obesity, abnormal or excessive fat accumulation, are major risk factors for 
cardiovascular morbidity and mortality in adult populations and the prevalence in middle-
aged and older adults is continuing to rise over time10;11. Obesity prevalence, also increases 
with age; 85% of men and 75% of women aged 65-74 years are overweight or obese12, 
making it an important public health problem in an ageing population. However, the impact 
of being overweight and of obesity in the elderly on CVD and mortality remain 
controversial. There is considerable debate in the literature regarding the ideal body 
composition in the elderly, with many studies showing that being overweight or obese, as 
defined by body mass index (BMI), does not appear to be harmful and may even be 
associated with lower, rather than higher, mortality13;14. Important changes in body 
composition occur with age including a relative increase in fat tissue and a gradual decline 
in muscle mass3. Since BMI combines both fat mass and muscle mass, which have 
opposing effects on the risk of morbidity and mortality, the validity of the use of BMI in 
the elderly may be limited15;16. It may therefore be important to consider alternative 
measures of adiposity, and also muscle mass, when assessing CVD risk in the elderly. 
Sarcopenia has been defined as the age-associated loss of skeletal muscle mass and has 
been associated with metabolic impairment, CVD risk factors, physical disability and 
mortality17. Paradoxically, sarcopenia is often associated with obesity18-21. Recently, the 
concept of sarcopenic obesity has emerged which refers to sarcopenia coupled with high 
levels of adipose tissue18;22. Thus sarcopenia with obesity may synergistically increase their 
effect on metabolic disorders, CVD and mortality. However, it is unclear what the 
determinants of the combination of high adiposity and low muscle mass are in the elderly, 
and also what are the associated risks of cardiovascular morbidity and mortality.  
 
1.1.3.  Diet and CVD 
Similarly, the importance of diet in the prevention of chronic disease morbidity and 
mortality has been well established in middle-aged populations, and may be particularly 
important in the elderly, who are at high risk of CVD and other chronic diseases, but there 
is a paucity of data on optimal dietary patterns in the elderly. Studies investigating diet and 
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CVD and mortality have previously focused on individual foods or nutrients23, with 
particularly strong evidence that the intake of salt24 and saturated fats25 are positively 
associated with CVD risk and that the intake of fruits and vegetables are inversely 
associated with CVD risk26;27. However, recently attention has turned to investigating 
overall dietary patterns and health outcomes28. Dietary patterns can be assessed using both 
a priori methods (hypothesis oriented or theoretically defined approaches which are a 
priori in nature, since they use available scientific evidence to generate predefined dietary 
scores or indexes based on dietary recommendations or guidelines) and a posteriori method 
(data-driven or exploratory approaches which are a posteriori in nature, since dietary 
patterns are derived from the available data, based on statistical methods such as principal 
component analysis or cluster analysis)29;30. To date, dietary patterns and the risk of CVD 
and mortality have largely been studied in middle-aged populations, many of which have 
focused on the ‘Mediterranean diet’31;32. However, only a limited number of studies have 
investigated the effect of diet on cardiovascular risk factors in older populations33. Fewer 
still have identified usual patterns of diet protective against CVD and mortality, which can 
be translated to the average older UK population. 
 
This thesis will focus on addressing several important questions on the role of body 
composition (adiposity and in particular low muscle mass) and dietary patterns on CVD 
and mortality in older age (over 60 years). These questions have important public health 
implications for recommendations on the ideal body composition and dietary patterns of 
older adults and thus for the prevention of CVD and mortality.  
 
1.2. Thesis objectives 
The overall aim of this thesis is therefore to investigate the impact of measures of body 
composition (adiposity and muscle mass) and dietary patterns on the risk of cardiovascular 
endpoints (coronary heart disease [CHD] events; CVD events; CVD mortality) and all-
cause mortality in older men. The specific objectives of the thesis are to: 
Chapter 1 Introduction 
 
22 
 
1. Examine the associations between various body composition measures (adiposity 
and in particular low muscle mass) and cardiovascular risk factors in older age (60-
79 years). 
2. Examine the associations between adiposity, muscle mass and the risk of CVD and 
mortality in older age. 
3. Examine the associations between a priori dietary patterns (using predefined diet 
scores) and cardiovascular risk factors (including the influence of social 
circumstances) and the risk of CVD and mortality in older age.  
4. Examine the associations between a posteriori dietary patterns (derived from 
principal component analysis) and cardiovascular risk factors, and the risk of CVD 
and mortality in older age. 
 
1.3. Overview of methodology  
This epidemiological research is a statistical analysis of data collected for the British 
Regional Heart Study (BRHS), an established prospective cohort study of cardiovascular 
disease. The BRHS comprises 7735 middle-aged British men drawn from one general 
practice in each of 24 towns representing all major British geographic regions34. The men 
were initially recruited between 1978 and 1980, aged 40-59 years. Since recruitment, 
participants have been followed up for over 30 years, by postal questionnaire and through 
the National Health Service Central Register and reports from general practitioners for 
cardiovascular mortality and morbidity. After 20 years of follow-up, between 1998-2000, 
study participants were re-examined, including a physical examination, blood 
measurements and the completion of questionnaires35. Study participants have continued to 
be followed up from that point to the present day. A more detailed description of the BRHS 
can be found in Chapter 3.  
 
The BRHS is a suitable cohort for studying the objectives of this thesis as it provides 
detailed assessment of a range of body composition measures (including adiposity and 
muscle mass), dietary data from a food frequency questionnaire and comprehensive 
information on cardiovascular risk factors of the study participants at the 20 year re-
Chapter 1 Introduction 
 
23 
 
examination. The BRHS is also a population-based study comprising a socioeconomically 
and geographically representative sample of British men. The BRHS also provides regular 
and objective measurements on CHD events, CVD events and mortality, with very high 
rates of follow-up. This will enable the investigation of measures of body composition and 
dietary patterns in relation to CVD and mortality in older men. However, the study sample 
is made up predominantly of white Europeans men and does not include women or ethnic 
minority groups. 
 
This thesis has used data specifically from the 20 year BRHS re-examination of 4252 men, 
aged 60-79 years, with follow-up data on cardiovascular outcomes and mortality until 2010. 
The four main outcomes assessed in this thesis were CHD events (defined as non-fatal MI 
or fatal CHD, excluding angina); CVD events (defined as non-fatal MI, non-fatal stroke or 
fatal CVD); CVD mortality and all-cause mortality. All statistical analyses have been 
carried out using Stata versions 12-13 (Stata Corp., College Station, Texas). 
 
1.4. Structure of the thesis 
The structure of the thesis is as follows: Chapter 1 provides an introduction to the 
relationship between body composition, dietary patterns and risk of CVD and mortality and 
outlines the importance of understanding these relationships in older age, and presents 
objectives, methodology overview, structure of the thesis and thesis publications. Chapter 2 
presents the epidemiological and aetiological background to CVD and includes literature 
reviews of the associations between body composition and dietary patterns with CVD and 
mortality in older age. Chapter 3 describes the British Regional Heart Study design and 
methodology, the data used to address the thesis objectives and methods used to analyse 
data. Chapter 4 is the first of five results chapters and examines the associations between 
various measures of adiposity and muscle mass and cardiovascular risk factors in older age, 
using cross-sectional data from the 20 year re-examination. Chapter 5 examines the 
associations between adiposity, muscle mass and risk of CVD and mortality in older age, 
using baseline body composition measurements from the 20 year re-examination (1998-
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2000) and follow-up data on CVD and mortality until 2010. Chapter 6 describes the diet of 
the BRHS cohort and examines the associations between a priori diet quality scores, 
cardiovascular risk factors and the risk of CVD and mortality, use baseline dietary data 
from the FFQ completed at the 20 year re-examination (1998-2000) and follow-up data on 
CVD and mortality until 2010. Chapter 7 further develops the findings from Chapter 6 by 
examining the influence of social circumstances on a priori diet quality scores in older age. 
Chapter 8 examines the associations between a posteriori dietary patterns, cardiovascular 
risk factors and the risk of CVD and mortality using baseline dietary data from the FFQ 
completed at the 20 year re-examination (1998-2000) and follow-up data on CVD and 
mortality until 2010. Each results chapter consists of a brief introduction specific to 
analyses of that chapter, methods (including subjects and methods of data collection and 
statistical analysis), results of analyses presented as tables and graphs, and a discussion 
including a summary of the main findings, comparison with previous literature and 
strengths and limitations. Chapter 9 is the concluding chapter, which brings together the 
key findings of all results chapters, together with implications for public health and future 
epidemiological research. 
 
1.5. Thesis publications 
Four first-author papers36-39 based on the material in this thesis have been published in peer-
reviewed journals to date, together with a review article40 and a book chapter41. These 
publications are listed below. For completeness, a ‘letter to the editor’ written about one of 
these papers42 and our response to this43 are also included. A list of oral and poster 
presentations giving at conferences based on the material in this thesis can also be found in 
Appendix I and Appendix II respectively.  
 
1. Atkins JL, Whincup PH, Morris RW, Wannamethee SG. Low muscle mass in 
older men: the role of lifestyle, diet and cardiovascular risk factors. J Nutr 
Health Aging 2014; 18(1):26-33. 
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2. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee 
SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a 
population-based cohort study of older men. J Am Geriatr Soc. 2014; 62(2):253-
260. 
 Letter to the editor: Safer U, Tasci I, Safer VB. Comment on 
"Sarcopenic obesity and risk of cardiovascular disease and mortality: 
a population-based cohort study of older men". J Am Geriatr Soc 
2014; 62(6): 1208. 
 Response to a letter to the editor: Atkins JL, Whincup PH, Morris 
RW, Wannamethee SG. Response to Safer et al. J Am Geriatr Soc 
2014;62(6):1208-9. 
 
3. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee 
SG. High Diet Quality Is Associated with a Lower Risk of Cardiovascular 
Disease and All-Cause Mortality in Older Men. J Nutr 2014;144(5):673-80. 
 
4. Atkins JL, Ramsay SE, Whincup PH, et al. Diet quality in older age: the 
influence of childhood and adult socio-economic circumstances. Br J Nutr 2015: 
113 (9): 1441–52. 
 
5.  Atkins JL, Wannamethee SG. The Effect of Sarcopenic Obesity on 
Cardiovascular Disease and All-Cause Mortality in Older People. Rev Clin 
Gerontol. 2015; 25 (2) 86-97. 
 
6. Atkins JL, Wannamethee SG. Chapter 13. Diet quality and cardiovascular 
disease prevention. In Bendich A, Deckelbaum RJ (Eds), Preventive Nutrition: 
The Comprehensive Guide for Health Professionals. 5th Edition. Humana Press: 
2015.
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CHAPTER 2 Literature review 
2.1. Introduction 
This chapter presents the epidemiological and aetiological background to cardiovascular 
disease (CVD), and reviews existing studies of the associations between body 
composition and dietary patterns with CVD and mortality in older age. Section 2.2 
describes the epidemiology and pathophysiology of CVD and the importance of CVD in 
older age. Section 2.3 details the literature on the aetiology of CVD, including 
established and emerging risk factors. Section 2.4 explores body composition as a major 
risk factor for CVD, including approaches to measuring body composition and a review 
of the evidence for an association between body composition and risk of CVD and 
mortality in older age. Section 2.5 explores dietary patterns as a major risk factor for 
CVD, including methods of assessing dietary intake and a review of the evidence for an 
association between dietary patterns and risk of CVD and mortality in older age. 
Finally, section 2.6 summarises the issues arising from the literature review and restates 
the purpose of the thesis. 
 
2.2. Overview of cardiovascular disease 
2.2.1. Epidemiology and pathophysiology of CVD 
The epidemiological transition has meant that over time the main cause of death 
worldwide has shifted from communicable to non-communicable diseases (NCDs). Of 
the 57 million deaths which occurred globally in 2008, 63% of these were due to 
NCDs44 and of these, CVD is the largest single cause of death6;45. Death rates from 
CVD have been falling in the UK since the early 1970s but CVD remains the main 
cause of mortality, accounting for nearly 180,000 deaths in 2010; nearly a third of all 
deaths in both men and women4. Nearly half (45%) of all CVD deaths in the UK are 
from coronary heart disease (CHD) and over a quarter (28%) are from stroke4. CHD is 
the single most common cause of death in the UK. The incidence of CHD is higher in 
men than in women and in 2010 just below one in five male deaths and one in eight 
female deaths were due to CHD4. CVD is a major contributor to morbidity and 
disability, with an estimated cost to the UK economy of £29.1 billion in 2004, due to 
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health care costs (60%), productivity losses due to mortality and morbidity (23%) and 
informal care-related costs (17%)46. 
 
The main forms of CVD in the UK are CHD (coronary [ischaemic] heart disease) and 
cerebrovascular disease (particularly stroke). Atherosclerosis is the common underlying 
disease process responsible for almost all CHD (coronary atherosclerosis) and a 
substantial proportion of stroke (carotid atherosclerosis) and develops over many years. 
Atherosclerosis is a complex pathological process characterised by chronic 
inflammation in the artery walls, where fatty materials and cholesterol are deposited 
(forming atherosclerotic plaques), narrowing the arterial lumen, obstructing blood flow 
and making the arteries less pliable4;6;47. These plaques can eventually rupture, 
triggering the formation of a thrombus which, if large enough, may occlude a coronary 
blood vessel or a cerebral blood vessel6.  
 
The clinical manifestations of CHD include angina pectoris, acute myocardial infarction 
(MI) and sudden ischaemic death47-49. Angina pectoris is characterised by chest pain due 
to ischaemia of the myocardium and can be stable or unstable. Stable angina is likely to 
cause regular and predictable symptoms. Unstable angina can cause prolonged chest 
pain even at rest or low levels of activity or can be previously diagnosed angina that has 
become more frequent, longer in duration, or lower in threshold to activity50. Acute MI 
(a ‘heart attack’) can be fatal or non-fatal and is caused by necrosis of myocardial tissue 
due to blockage of a coronary artery. Symptoms include chest pain, which can often 
radiate to the jaw, neck, arms and back, shortness of breath, dizziness, nausea and an 
overwhelming sense of anxiety. MI can also be silent; asymptomatic and only 
diagnosed retrospectively through electrocardiograms51. The World Health Organization 
criteria for myocardial infarction are any two of these three conditions: prolonged chest 
pain, positive electrocardiogram findings and raised cardiac enzyme levels52;53.  
 
The clinical manifestations of cerebrovascular disease include transient ischaemic 
attacks (TIAs) and strokes47;48. A TIA is caused by a temporary disruption in cerebral 
blood flow, with symptoms (including facial weakness, arm weakness and speech 
problems) disappearing within 24 hours. Stroke however, is more severe with 
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permanent symptoms. The current universal definition of stroke, as defined by the 
Stroke Council of the American Heart Association and the American Stroke 
Association, is: “Central nervous system infarction is brain, spinal cord, or retinal cell 
death attributable to ischemia, based on pathological, imaging, or other objective 
evidence of cerebral, spinal cord, or retinal focal ischemic injury in a defined vascular 
distribution and/or clinical evidence of cerebral, spinal cord, or retinal focal ischemic 
injury based on symptoms persisting ≥ 24 hours or until death, and other etiologies 
excluded"54.  
 
2.2.2. The importance of CVD in older age 
The population in the UK is ageing due to a steady increase in life expectancy over 
time. Since the 1930s, the number of people aged over 65 years in the UK has more 
than doubled1 and by 2012, 23.0% of the population were aged over 60, a proportion 
which is predicted to increase to 29.6% by 20502. Older adults are at an increased risk 
of developing non-communicable diseases and the majority of the burden from CVD in 
the UK population occurs at older ages, with 74% of all deaths from diseases of the 
circulatory system, 68% of all deaths from CHD and 83% of all deaths from stroke 
occurring in people older than 75 years4. The risk of CVD increases dramatically with 
age in both men and women9. Comparing CHD incidence between younger and older 
age groups in England shows that between 30-54 years and 75-84 years, rates increases 
more than 10-fold in men and more than 30-fold in women55. The prevalence of CVD 
also increases greatly with age with a much steeper increase in men than in women, 
ranging from 3.3% of men and 4.8% of women aged 16-24 to 53.8% and 31.1% 
respectively aged 85 and over56. The population burden of CVD morbidity and 
disability in older people is also further increased by the increasing survival rates 
following myocardial infarction57.  
 
The burden of CVD in older adults is therefore an important public health problem and 
the UK in particular has significantly greater rates of age-standardised years of lives lost 
from cardiovascular and circulatory disorders than many other comparable high income 
countries58. Even small relative risk reductions in CVD in older adults could 
considerably reduce absolute mortality and cardiovascular morbidity and disability 
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risks. Therefore, it is particularly important to identify and reduce exposure to risk 
factors for CVD incidence in older ages59. 
 
2.3. Aetiology of CVD 
2.3.1. Established risk factors for CVD 
CVD is largely preventable, and well-established major risk factors are raised blood 
pressure (hypertension), high low density lipoprotein cholesterol and cigarette smoking, 
followed by harmful use of alcohol, physical inactivity, raised blood sugar levels, 
overweight/obesity and poor diet quality5;6. These risk factors cause damage to coronary 
and cerebral blood vessels due to atherosclerosis. The World Health Organization 
(WHO) attributes 61% of cardiovascular deaths to the following eight major risk factors 
- alcohol use, tobacco use, high blood pressure, high body mass index, high cholesterol, 
high blood glucose, low fruit and vegetable intake, and physical inactivity7. 
 
Blood pressure: It is estimated that 45% of cardiovascular deaths worldwide can be 
attributed to raised blood pressure7. There is a strong positive association between 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) and risk of 
cardiovascular mortality, seen above the usual SBP of 115 mmHg and DBP of 75 
mmHg60. The association between blood pressure and stroke mortality is stronger than 
for CHD mortality; at ages 40-69 years, each 20 mmHg increase in SBP (or 
approximately 10 mmHg increase in DBP) is associated with more than a two-fold 
increase in stroke mortality and a two-fold increase in CHD mortality. The increased 
risk of cardiovascular mortality associated with hypertension also persists, but is 
attenuated, in older age60. 
 
Cholesterol: Globally, 16% of cardiovascular deaths can be attributed to raised 
cholesterol7. The Prospective Studies Collaboration showed that on average, 1 mmol/L 
lower total cholesterol was associated with about a half the risk of CHD mortality in 
early middle-age (40-49 years) and about a sixth of the risk in old age (70-89 years)61. 
This study also showed a positive association between total cholesterol and stroke 
mortality in early middle age (40–59 years), but total cholesterol was negatively related 
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to stroke mortality in older age (70-89 years). The low density lipoprotein (LDL) and 
high density lipoprotein (HDL) components of total cholesterol have opposing effects 
on CHD mortality - the Prospective Studies Collaboration showed that on average 1 
mmol/L lower non-HDL cholesterol and 0·33 mmol/L higher HDL cholesterol, were 
each associated with about a third lower CHD mortality risk61. However, stroke was not 
significantly associated with non-HDL or HDL cholesterol in this study61. 
 
Dietary fat intake is a major determinant of blood cholesterol levels. A high intake of 
dietary cholesterol increases blood cholesterol and this is mainly determined by the 
intake of saturated fatty acids, where as polyunsaturated fatty acids lower blood 
cholesterol levels62;63. 
 
Cigarette smoking: is estimated to cause almost 10% of cardiovascular disease 
worldwide7 and there is evidence that smoking increases risk of mortality 2 to 3 fold64. 
There is a significant body of evidence from prospective studies on the beneficial 
effects of smoking cessation on CHD mortality and stroke mortality, with a 50-year 
follow-up in the British Doctors Study showing that the age of quitting has a major 
impact on life expectancy, with those who quit between 35 and 44 years of age having 
the same survival rates as those who had never smoked64. Cigarette smoking also 
persists as a strong independent risk factor for cardiovascular events and mortality at 
older ages64-66.  
 
Alcohol: There is also evidence that alcohol consumption is associated with CVD risk. 
Many studies have shown a U-shaped or J-shaped relationship between alcohol 
consumption and risk of CVD, with an increased risk in those who abstain from alcohol 
and those who drink excessively compared to light or moderate drinkers67;68. A meta-
analysis of prospective cohort studies showed that the lowest risk of CHD mortality 
occurred with 1-2 drinks a day, but for stroke mortality the lowest risk was for ≤ 1 drink 
per day68. 
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Physical inactivity: is well established as a risk factor for CVD, with insufficient 
activity described as less than 5 sessions of 30 minutes of moderate activity per week, 
or less than 3 sessions of 20 minutes of vigorous activity per week6. Individuals who are 
insufficiently physically active have a 20% to 30% increase in all-cause mortality risk 
compared to those who engage in at least 30 minutes of moderate intensity physical 
activity most days of the week6. A recent meta-analysis also showed that individuals 
performing a moderate level of leisure time physical activity had a 12% lower risk of 
CHD mortality and those performing a high level of activity had a 27% lower risk69. 
Similarly, a meta-analysis reported that moderate physical activity was associated with 
an 11% lower risk of stoke outcomes and high physical activity was associated with a 
19% lower risk70. Studies have also shown that the association between higher physical 
activity and lower CVD risk persists in older age71;72. 
 
Blood glucose: High blood glucose (hyperglyceamia) increases the risk of 
cardiovascular mortality, with global estimates that 21% of CHD mortality and 13% of 
stroke mortality are attributable to raised blood glucose, including people with and 
without established diabetes7;73. Diabetes specifically, is defined as a fasting plasma 
glucose level of ≥ 7.0 mmol/l, and type 1 and type 2 diabetes mellitus are associated 
with a significantly elevated risk of CVD. The Emerging Risk Factors Collaboration 
carried out a meta-analysis which estimated the hazard ratio (HR) for all vascular 
deaths, comparing diabetes versus no diabetes, as 2.32 (95% CI: 2.11-2.56)74. 
 
Overweight/Obesity: Another important modifiable risk factor for CVD is high 
adiposity, with overweight and obesity showing consistent strong associations with 
CVD risk in middle-aged populations75-79. Some studies suggest that measures of 
central adiposity (waist circumference and waist-to-hip ratio) are stronger predictors of 
cardiovascular risk than BMI (a measure of whole-body adiposity)75;79. Despite the 
well-established associations between obesity and increased cardiovascular risk in 
middle age, the effect of obesity on CVD and mortality in older adults is controversial. 
This evidence for associations between obesity and CVD and mortality in middle-aged 
and older adult populations will be explored in detail in section 2.4. 
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Poor diet quality: is another important behavioural risk factor that is well-established in 
the aetiology of CVD. Various individual aspects of diet have been associated with an 
increased risk of CVD, including high saturated fat intake25, high salt intake24 and low 
fruit and vegetable consumption26;27 and this risk can be reduced by the replacement of 
saturated fats with unsaturated fats, limiting salt intake and increasing fruit and 
vegetable consumption. Recently there has been a shift in focus to overall dietary 
patterns, with the adherence to a Mediterranean-style diet in particular showing 
significant reductions in CVD risk in a recent meta-analysis31. However, despite the 
well-established associations between diet and increased cardiovascular risk in middle 
age, there is a paucity of data on the effects of diet (specifically dietary patterns) on 
CVD in older adults33. This evidence for associations between diet/dietary patterns and 
CVD and mortality in middle-aged and older adult populations will be explored in detail 
in section 2.5. 
 
2.3.2.  Emerging risk factors for CVD 
In addition to the established risk factors for CVD described in section 2.3.1, a range of 
emerging risk factors have developed as being implicated in the aetiology of CVD, 
including markers of inflammation, and endothelial and haemostatic dysfunction since 
they are associated with arterial plaque formation, plaque rupture and thrombosis80;81. 
Prospective studies and meta-analyses have shown that markers of inflammation, 
particularly acute phase proteins (e.g. C-reactive protein [CRP]82) and circulating 
proinflammatory cytokines (e.g. interleukin 6 [IL-6]83) are related to CVD risk. 
Similarly, haemostatic markers (e.g. fibrinogen84, von Willebrand factor [vWF]84;85, and 
tissue plasminogen activator [t-PA]86) and markers of endothelial dysfunction (D-
dimer)84 are associated with an increased CVD risk in adult populations. Emerging risk 
factors may be particularly important in older age as many inflammatory and 
haemostatic markers have shown very high circulating concentrations in older age 
groups, with effects on CVD which persist in this age group87;88. Additionally, some of 
these emerging risk markers are strongly related to other established cardiovascular risk 
factors such as smoking, alcohol intake, physical inactivity, obesity and blood lipids71;89-
92. 
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2.3.3.  Conceptual framework for the influence of risk factors on CVD 
The eight major modifiable risk factors for CVD (hypertension, high LDL cholesterol, 
cigarette smoking, heavy alcohol intake, physical inactivity, raised blood sugar levels, 
overweight/obesity and poor diet quality5;6) mentioned above in section 2.3.1 and the 
emerging risk factors for CVD mentioned in section 2.3.2 can be conceptualised within 
a causal framework. Cigarette smoking, heavy alcohol intake, physical inactivity and 
poor diet quality, can be thought of as behavioural or lifestyle risk factors for CVD, 
with cigarette smoking being the strongest7. These factors may at least in part impact on 
other risk factors that act directly (e.g. blood lipids, blood pressure), as well as having 
direct effects. Physiological risk factors for CVD include overweight/obesity, high 
blood pressure, high LDL and raised blood sugar levels which are known to be causally 
linked to CVD7;10. These causal risk factors can operate via a ‘critical period’ model as 
early as in utero, with fetal undernutrition being associated with an increased risk of 
CHD, or an ‘accumulation of risk’ model throughout the life course93;94. 
 
Emerging risk factors, including inflammatory markers and haemostatic factors, are a 
reflection of the physiological status of an individual and can be strong predictors of 
cardiovascular events80;81. However, whether such factors may be acting as causal risk 
factors for CVD or just risk markers of underlying causal factors has been 
questioned86;95;96. Chronic inflammation has been implicated in the pathogenesis of 
atherosclerosis97 but causality has not been established for many of the inflammatory 
markers implicated. For example, CRP is a strong powerful risk marker for CVD but 
Mendelian randomisation studies have not established CRP as a causal agent for CVD98. 
However, CRP is a downstream marker for interleukin-6 (IL-6) activity, a major 
proinflammatory cytokine which has been causally related to CVD83;99;100. Similarly, 
prospective studies and meta-analyses have shown haemostatic markers such as von 
Willebrand factor ([vWF] a marker of endothelial dysfunction) and fibrin d-dimer (a 
marker of coagulation and fibrinolysis) are associated with increased risk of CHD86;101 
but causality has not been established for these markers. Nevertheless, although markers 
such as CRP, vWF and d-dimer may only be risk markers for CVD risk, they are of 
interest as they may be indicators of the inflammatory and haemostatic pathways. 
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The effects of two particular interrelated risk factors (body composition and dietary 
patterns) on CVD and mortality will now be addressed in detail in sections 2.4 and 2.5 
respectively. 
 
2.4. Body composition, CVD risk and all-cause mortality 
This section will address the effects of two components of body composition (body 
fatness/adiposity and lean mass/muscle mass) on CVD and mortality, and body 
fatness/adiposity will be addressed first. 
 
2.4.1. Assessing and defining adiposity and obesity 
Overweight and obesity are defined by WHO as “abnormal or excessive fat 
accumulation that may impair health”10. There are many available methods of body 
composition assessment used in clinical practice and for epidemiological research to 
measure whole-body or regional adiposity102;103. In epidemiological studies, the most 
commonly used methods to estimate body composition include combinations of weight 
and height, skinfold thickness measurements and body circumferences104. The most 
commonly used measure of obesity is body mass index (BMI), defined as weight (kg) 
divided by height squared (m2), giving the units kg/m2. Underweight is defined as a 
BMI of less than 18.5 kg/m2, a normal healthy weight is defined as a BMI of 18.5-24.9 
kg/m2, and overweight and obesity are defined as BMI cut points of greater than or 
equal to 25 kg/m2 and 30 kg/m2 respectively105;106. BMI is a measure of whole-body 
adiposity, and it was originally known as the Quetelet index since the formula was first 
proposed by Adolphe Quetelet, a Belgian mathematician, in 1832107;108. The term BMI 
was first referred to by Ancel Keys in 1972 in a paper which found that BMI was the 
best proxy for body fat percentage among ratios of weight and height109. However, there 
are serious doubts on the validity of BMI to represent adiposity accurately, since it does 
not distinguish between fat mass and lean mass15;110. 
 
Skinfold anthropometry is also frequently used in body composition assessment, in 
which measurement of subcutaneous fat using skinfold calipers allows adiposity to be 
estimated. Typically, triceps and subscapular skinfold thickness have been used as 
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relative measures of extremity and truncal obesity respectively104. This method has the 
advantages of being quick, and requiring noncomplex portable equipment, but it is 
dependent on the training and skill of the observers so is therefore most suited to 
research settings111. 
 
In recent years there has been more of a focus on the distribution of body fat, with 
measures of central or visceral adiposity being commonly used to define obesity, due to 
the suggestion that these measures are more closely related to CVD. Waist 
circumference (WC) and waist-to-hip ratio (WHR) are two such measures, which can be 
assessed relatively easily with measuring tape and hence are suitable methods for use in 
epidemiological studies. WHO define central obesity using sex-specific cut-points for 
WC (>102 cm for men and >88cm for women) and WHR (≥ 0.90 cm for men and ≥ 
0.85 cm for women)105 112. 
 
Bioelectrical impedance analysis (BIA) is a noninvasive technique which consists of 
passing a low amplitude electrical current through the body and measuring the 
resistance, based on the principle that lean body mass, which consists largely of ions in 
water solution, conducts electricity far better than fat tissue does104;113-115. The measure 
of resistance is then used to estimate lean body mass and (indirectly) fat mass. This 
technique has the advantages of being relatively quick and easy to use, with 
inexpensive, portable equipment but this technique is dependent on the validity of the 
equations used to calculate fat-free mass from the bioelectrical impedance measures114. 
 
Newer body imaging techniques based on electrical resistance and impedance have also 
become available including magnetic resonance imaging (MRI), computerised 
tomography (CT) and dual energy x-ray absorptiometry (DXA). DXA is a technique 
used increasingly to measure fat and fat-free mass. DXA scanners generate X-rays at 
two different energies, making use of the differential attenuation of the energies to 
calculate the bone mineral content and soft tissue composition of the scanned region116. 
DXA has a very low dose of radiation, and hence is a safe but expensive method, which 
is used more often in clinical rather than in research settings.  
Chapter 2 Literature review 
 
 
36 
 
 
2.4.2.  Epidemiology of obesity 
Obesity is an important public health problem and it is well recognised as a major risk 
factor for CVD morbidity and mortality in adult populations75-79, as introduced in 
section 2.3.1, and the evidence for this will be further explored in section 2.4.3. The 
prevalence of obesity continues to increase globally, and this is the case in both middle-
aged and older adult populations. Since 1980, the prevalence of obesity has more than 
doubled worldwide10;11. The prevalence of obesity is also increasing with age; in an 
ageing population this is particularly important in terms of an increased risk of CVD 
morbidity and mortality and hence an added burden on healthcare resources117;118. 
Overweight and obesity are extremely prevalent in older British adults4;12. In 2010, it 
was estimated that 35% of men and 32% of women aged 16 to 24 were overweight or 
obese which rose to 81% of men and 74% of women aged 65 to 744. An increasing 
trend was also seen in the prevalence of central obesity with age, and this was especially 
the case in men. An estimated 13% of men and 18% of women aged 16 to 24 had 
central obesity which compared to 49% of men and 64% of women aged 65 to 744. 
 
2.4.3.  Obesity, CVD risk and all-cause mortality in middle-aged populations 
Obesity is well recognised as a major risk factor for CVD morbidity and mortality in 
adult populations, with many studies showing J or U-shaped associations between BMI-
defined obesity and the aforementioned outcomes75-79;119-121. Collaborative analyses of 
57 prospective cohorts, of men and women aged 35 to 89 year olds, showed a U-shaped 
association between BMI and mortality, with the lowest risk in those with normal BMI 
(22.5-25 kg/m2)76. Above this range, a strong positive association was seen for CVD 
mortality with a 40% increase in risk for each 5 kg/m2 increase in BMI. Measures of 
central obesity have also shown associations with CVD in middle age populations, with 
evidence that they may be stronger predictors of risk than BMI. A meta-analysis of nine 
British cohorts in middle aged populations showed that measures of visceral adiposity 
(WC and WHR) were significantly and positively associated with total and CVD 
mortality, but BMI was not associated with CVD risk79. Stronger evidence has been 
provided by a similar but larger meta-analysis which was carried out in 58 prospective 
cohort studies, across 17 countries78. A slightly greater magnitude of effect was 
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observed for the association between measures of central adiposity, compared to total 
adiposity, with CVD risk; hazard ratios for CVD risk were 1.27 for waist 
circumference, 1.25 for waist-to-hip ratio and 1.23 for BMI, for a 1 standard deviation 
increase in each measure78. Also, the INTERHEART study found that abdominal 
obesity was a much more significant risk factor for MI than BMI, and estimated that 
63% of MIs in Western Europe are due to abdominal obesity (a high waist-to-hip 
ratio)75.  
 
2.4.4.  Body composition, CVD risk and all-cause mortality in older age 
Although strong evidence has shown that obesity and overweight are important 
determinants of the risk of CVD and mortality in middle age, their role in later life is 
controversial13;122. In particular, the relationship between BMI and mortality is less 
clearly defined in older age, with many studies showing that being overweight, as 
defined by BMI, does not appear to be harmful and may even be associated with lower, 
rather than higher, mortality13;14;123. A systematic review and meta-analysis of 26 
studies of healthy men and women, aged 65 years or older, found that BMI in the 
overweight range was not associated with a significantly increased mortality risk, and 
BMI in the moderately obese range was only associated with a modest 10% increase in 
mortality risk14. Similarly, a more recent large meta-analysis of 32 studies, which 
included almost 200,000 individuals aged 65 or older, showed a U-shaped relationship 
between BMI and all-cause mortality124. Overweight was not associated with an 
increased mortality risk, with the lowest risk seen in those with a BMI between 24.0 and 
30.9 kg/m2, and risk only began to increase when BMI exceeded 33 kg/m2 124.  
 
In recently years it has been suggested that measures of adiposity such as WC and 
WHR, which better reflect central adiposity, may be more useful at assessing obesity 
risk than BMI as they are better at predicting CVD and mortality in older subjects 
13;79;122;125-127. A recent meta-analysis of 29 elderly cohorts, which included over 58,000 
men and women aged 65 to 74 years, showed positive associations between WC and all-
cause and cardiovascular mortality risks, which was consistent across BMI 
categories127. Similarly, a recent systematic literature review identified 16 studies which 
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assessed the impact of obesity on mortality in the elderly, and concluded that WC is as 
effective, if not more, than BMI as a risk factor for mortality in older adults128. 
 
Allison et al hypothesised that the frequently observed U-shaped relationships between 
BMI and mortality are due to the opposing effects of fat mass and fat-free mass (both of 
which influence BMI) on mortality15. Using data from the National Health and Nutrition 
Examination Surveys (NHANES I and NHANES II), Allison et al showed that there is a 
positive association between fat mass and mortality but an inverse association between 
fat-free mass and mortality (see Figure 2.1). Ageing is associated with important 
changes to body composition; typically visceral fat increases and there is a substantial 
decreases in fat-free mass (FFM) and muscle mass, meaning that overall body weight 
and BMI may remain relatively unchanged3;13;18;22. Since BMI depends not only on 
adiposity but also on muscle mass, which has opposing effects on mortality, the validity 
of the use of BMI in measuring the impact of obesity in the elderly may therefore be 
limited15;16. The aforementioned studies14;124 which have used BMI to assess obesity in 
the elderly can therefore be criticised on this basis. Therefore to fully understand the 
effects of body composition in the elderly, it may be important to take both fat mass and 
lean mass, assessed independently, into account.  
 
2.4.5. Epidemiology of sarcopenia 
Sarcopenia describes the age-associated loss of skeletal muscle mass and muscle 
function129, and is often associated with visceral obesity18-21. Sarcopenia has a 
multifactorial aetiology, which is not fully understood. However, several underlying 
mechanisms of this age-related muscle loss have been recognised including neuronal 
and hormonal changes, poor nutrition (especially low protein intake), physical inactivity 
and inflammation18;130-133. Given the body composition changes which occur with 
increasing age, sarcopenia often coexists with an increase in fat mass. Recently, a new 
concept of obesity has emerged, ‘sarcopenic obesity’ which refers to the simultaneous 
existence of sarcopenia and high levels of adipose tissue in individuals18;22. Visceral fat 
is a major risk factor in the development of both metabolic disorders (hypertension, 
dyslipidemia and insulin resistance) and CVD. Sarcopenia has also been shown to be 
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associated with CVD risk factors and risk of adverse health outcomes including 
physical disability and mortality19;134-138. Visceral fat and muscle mass are known to be 
related in a pathogenic sense and share common inflammatory pathways18. Therefore it 
is hypothesised that sarcopenia and obesity may act synergistically, so that sarcopenic 
obesity may have a greater effect on metabolic disorders, CVD and mortality than either 
obesity or sarcopenia alone18-22. The interaction between sarcopenia and obesity, with 
rising prevalence in an ageing population, is becoming an important public health issue 
in the older adults18. Sarcopenia is therefore a separate component of body composition 
requiring investigation in relation to CVD and mortality.  
 
2.4.6.  Assessment and definitions of sarcopenia and sarcopenic obesity 
Sarcopenia is the term used to refer to the age-associated loss of skeletal muscle mass 
and function. The name was first coined by Rosenberg in 1989 (with Greek origins of 
‘sarx’ for flesh and ‘penia’ for loss) who suggested that no decline with age is more 
dramatic or potentially more functionally significant than the decline in lean body 
mass139;140. Sarcopenia is associated with increased risks of functional impairment and 
physical disability131;141;142 which account for substantial healthcare costs; in the USA in 
2000 the estimated costs attributable to sarcopenia were $18.5 billion, based on the 
increased risk of physical disability in older adults143. Sarcopenia is common in the 
elderly with prevalence estimated to be between 5% and 13% among 60 to 70 year olds, 
rising to 11% to 50% for those aged over 80 years144. This large amount of variability in 
prevalence estimates is likely to be related to the wide range of measurement methods 
and cut-off points which are used to define sarcopenia144. It is widely accepted that four 
body composition phenotypes exist in older age (normal, sarcopenic, obese and 
sarcopenic obese). However, despite this, to date there is no universally accepted 
operational definition or classification for either sarcopenia or sarcopenic obesity17;138. 
No International Classification of Disease (ICD) codes exist for sarcopenia and there are 
no standard treatment guidelines145. 
 
Many different definitions of sarcopenia have been used in previous literature17;19 based 
on differing measurement methods to assess total or skeletal muscle mass, including 
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body imaging techniques (MRI, CT and DXA), BIA and anthropometric measures18. 
MRI and CT are regarded as the two gold standards methods for muscle mass 
assessment146. However, due to the associated high costs, limited access to equipment in 
some settings and concerns about radiation exposure, the use of whole-body imaging 
methods is usually limited to clinical practice17. Anthropometric measures used to 
assess muscle mass also include measures based on body circumferences, and these are 
quick and simple measures often used in epidemiological research, but do not take 
muscle fat infiltration into account. Mid-upper arm circumference (MUAC) can be 
measured in combination with triceps skinfold thickness, to estimate mid-arm muscle 
circumference (MAMC), which correlates strongly with more accurate dual-energy X-
ray absorptiometry measures of lean mass147;148. Calf circumference is another 
anthropometric measure also positively correlated with muscle mass149. 
 
Baumgartner et al first defined sarcopenia as appendicular skeletal muscle mass (ASM), 
assessed by DXA adjusted for height, two standard deviations below the sex-specific 
reference for a young healthy person131. Another commonly used sarcopenia definition 
was developed by Janssen et al, using BIA to determine skeletal muscle mass141;150. In 
2009, The European Working Group on Sarcopenia in Older People (EWGSOP) 
proposed a clinical definition of sarcopenia for case finding in older individuals. The 
EWGSOP proposed definition includes the presence of both low muscle mass and low 
muscle function (either low strength and/or low physical performance)17. The EWGSOP 
suggested algorithm for sarcopenia suggests using handgrip strength to measure muscle 
strength, and gait speed to measure physical performance17. A systematic review of 
studies which used the EWGSOP definition to define sarcopenia in adults age 50 years 
or over, found substantial prevalence estimates in most geriatric settings, but there was 
wide variation in prevalence estimates; 1 to 29% in community-dwelling populations, 
14 to 33% in long-term care populations and 10% in an acute hospital-care 
population151. A similar definition was proposed by the International Working Group on 
Sarcopenia (IWGS) in 2011, who suggested that diagnosis is based on a low whole-
body or appendicular fat-free mass in combination with poor physical functioning134.  
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The term ‘sarcopenic obesity’ was first coined by Baumgartner et al22 and is it defined 
by a combination of sarcopenia and obesity. However, like sarcopenia, there is no 
universally accepted definition of sarcopenic obesity, so a wide variety of measures of 
obesity (described in section 2.4.1) and muscle mass or function measures (described 
here in section 2.4.6) have previously been used21. However, the lack of agreement on a 
definition for the diagnosis of sarcopenic obesity presents major drawbacks both 
clinically and for research152. Also, although sarcopenia is defined as the age-associated 
loss of muscle over time, most sarcopenia definitions are based on assessment at a 
single time point only. 
 
2.4.7.  Sarcopenia, sarcopenic obesity and cardiovascular risk factors in older age 
Numerous population studies have shown that sarcopenia is cross-sectionally associated 
with established and emerging cardiovascular risk factors137, including insulin 
resistance153, dyslipidemia154, hypertension155, arterial stiffness156 and inflammatory 
markers157-159. In addition, many studies have examined the associations between 
sarcopenic obesity and established cardiovascular risk factors, although not all have 
shown that the sarcopenic obese group have the most adverse metabolic and 
cardiovascular risk profile154;155;160-173. Table 2.1 summarises relevant studies that 
investigate the associations of sarcopenic obesity and cardiovascular risk factors in 
older people.  
 
Several cross-sectional studies carried out in Korean older adults found that sarcopenic 
obese individuals had the worse cardiovascular risk profile; sarcopenic obesity (based 
on skeletal muscle mass assessed by DXA and obesity assessed by CT, DXA, BMI or 
WC) was associated with lower cardiorespiratory fitness, a higher risk of hypertension, 
dyslipidemia and insulin resistance, higher fasting glucose levels, and up to an 8-fold 
increase in metabolic syndrome (MetS) risk compared to non-sarcopenic, non-
obese154;155;160-167. Comparably, sarcopenic obese Taiwanese older adults (defined by 
BIA and BMI) also had the highest risk of MetS. Compared to the non-sarcopenic, non-
obese group, the sarcopenic obese group had a 12-fold increase in risk and the 
sarcopenic group had only a 2-fold increase in risk168. In a large cross-sectional analysis 
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of over 14,000 adults from NHANES III, the sarcopenic obese group (defined by BIA 
and BMI) showed the highest risk of dysglycemia and insulin resistance169. 
 
However, not all studies show that sarcopenic obese individuals have the worst 
cardiovascular risk profiles; some cross-sectional studies have suggested that obese 
older adults may have higher levels of cardiovascular risk factors than sarcopenic obese 
individuals. Older adults from the New Mexico Aging Process Study, aged 60 years or 
over, found that the prevalence of MetS and hypertension was highest in the non-
sarcopenic obese group, followed by the sarcopenic obese group (assessed using DXA 
measurements)170. Studies in postmenopausal women have also shown that sarcopenic 
obese individuals did not show an unfavourable metabolic profile compared to non-
sarcopenic obese individuals171 and that glucose level, lipid profile and blood pressure 
were not significantly different between sarcopenic obese and non-sarcopenic, non-
obese individuals172. 
 
Despite inflammation being strongly associated with both sarcopenia and obesity89;157, 
conflicting results have been found regarding the relationship between inflammatory 
and haemostatic markers and sarcopenic obesity. Cross-sectional analysis of older 
adults from the "Invecchiare in Chianti" (InCHIANTI) study, aged 65 years and older, 
showed that sarcopenic obesity (based on grip strength and WC measurements) was 
associated with higher levels of inflammatory markers including CRP and IL-6173. 
Comparably, sarcopenic obese adult Korean women had the highest CRP levels167. 
However, analysis of baseline data from the Trial of Angiotensin Converting Enzyme 
Inhibition and Novel Cardiovascular Risk Factors study found there were no significant 
interactions between sarcopenia and obesity with CRP, IL-6 or plasminogen activator 
inhibitor174 and another study found that CRP levels were not significantly different 
between sarcopenic obese and non-sarcopenic, non-obese postmenopausal women172.  
 
In summary, many studies suggest that sarcopenia is associated with established and 
emerging cardiovascular risk factors. However, whether sarcopenic obese individuals 
have the worst cardiovascular risk profile seems unclear.  
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2.4.8.  Sarcopenia, sarcopenic obesity and CVD risk in older age 
Section 2.4.7 reviewed the evidence of associations between sarcopenia and sarcopenic 
obesity with cardiovascular risk factors. However, despite the growth of literature in 
this field over the last decade, to date very few studies have examined the prospective 
associations between sarcopenia, and sarcopenic obesity with CVD in older 
people137;152. Table 2.2 summarises relevant studies that investigate the associations of 
sarcopenic obesity with CVD risk and mortality in older people.  
 
Cross-sectional analysis of baseline data from the New Mexico Aging Process Study 
compared CVD prevalence in older adults, aged 60 years and over, between sarcopenic 
obesity groups (defined by ASM and percent body fat from DXA)170. The prevalence of 
CVD in sarcopenic individuals was the highest (18.3%), compared to that of non-
sarcopenic, non-obese individuals (13.7%) and sarcopenic obese (11.5%). However, the 
difference in prevalence across these groups was not significant. A cross-sectional study 
of 1578 male and female participants, aged 65 years or older, from KNHANES found 
that in crude analysis although the sarcopenic obesity group (based on ASM from DXA 
and BMI ≥ 25) showed a slightly higher prevalence of CVD (12.3%) compared to non-
sarcopenic obese (10.0%), this difference was non-significant175. However, in adjusted 
analysis sarcopenia was associated with CVD independent of other well known risk 
factors, renal function and medication (OR: 1.77, 95% CI: 1.08-2.90). Another larger 
cross-sectional study using KNHANES data, analysed the association between 
sarcopenia (defined using ASM) and the prevalence of CVDs in over 7,000 men and 
women aged 50 or over176. The prevalence of CVD was positively associated with 
sarcopenia in men after adjusting for cardiovascular risk factors (Class I sarcopenic, 
OR: 1.82, 95% CI: 1.24-2.67; Class II sarcopenic, OR: 2.35, 95% CI: 1.26-4.40). 
However, no significant association was found in women. Within all of these cross-
sectional studies, the assessment of body composition and cardiovascular risk factors 
was at the same time point so reverse causality is possible. 
 
To my knowledge, only one prospective study has examined the association between 
sarcopenic obesity groups and CVD risk. Stephen et al analysed data from the 
Cardiovascular Health Study, a moderately large prospective study of 3366 community-
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dwelling older men and women (aged 65 years or above) over eight years of follow-
up177. They found that compared to the normal body composition group, the risk of 
CVD events was not significantly elevated in the sarcopenic or sarcopenic obese 
groups, when defined using WC and BIA-measured muscle mass. When sarcopenia and 
obesity was determined by WC and grip strength, CVD risk was not significantly 
increased in the sarcopenic group but was increased by 23% in the sarcopenic obese 
group, with borderline significance (HR: 1.23, 95% CI: 0.99-1.54; adjusted for age, sex, 
ethnicity, income, smoking, alcohol and cognitive function). These results imply that 
muscle strength could be particularly important when assessing the association between 
sarcopenic obesity and CVD risk. 
 
Overall, it seems that findings from these cross-sectional studies and the one available 
prospective study do not provide sufficient evidence to reach a conclusion regarding the 
association between either sarcopenia or sarcopenic obesity with CVD risk.  
 
2.4.9.  Sarcopenia, sarcopenic obesity and all-cause mortality in older age 
In contrast to the limited evidence on sarcopenia and CVD risk, several prospective 
studies have examined the association between sarcopenia and the risk of all-cause 
mortality, and have provided consistent evidence that low muscle mass (defined using 
various measurement methods) is associated with an increased risk of mortality in older 
adults. Simple anthropometric assessments of muscle mass, such as body circumference 
measurements, have been shown to be associated with mortality risk. Data from the 
Longitudinal Aging Study Amsterdam, a population-based cohort of 1,667 older adults, 
aged 65 and above, found that MUAC is more strongly associated with mortality than 
calf circumference, over 15 years of follow-up; the hazard ratio for mortality per 1 
standard deviation lower MUAC was 1.79 (95% CI: 1.48-2.16)178. Similarly, a small 
prospective study of 357 Italian community dwelling older adults, aged over 80 years, 
from The Aging and Longevity Study in the Sirente Geographic Area (ilSIRENTE 
Study), had MAMC measured at baseline and were followed up for 4 years179. 
Participants in the highest tertile of MAMC had a lower risk of mortality compared to 
those in the lowest tertile (adjusted HR: 0.45, 95% CI: 0.23-0.87). Another study in 
1396 older Australians, aged 70 years and older, with low corrected arm muscle area 
(CAMA), derived from a standard formula which takes MUAC and triceps skinfold 
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thickness into account, had almost twice the risk of mortality at 8-year follow-up (HR: 
1.94, 95% CI1.25-3.00)180. 
 
Similarly, estimates of skeletal muscle mass derived from BIA measures have also been 
inversely associated with mortality. In Korean men and women, aged 65 and over, in 
the highest quartile of lean mass and lean mass index (kg/m2) mortality risk was 
reduced by 84% (95% CI: 45-96%) and 69% (95% CI: 12-89%) respectively181 
compared with the lowest quartile. Comparable associations have also been found with 
low muscle mass, measured by DXA. In a prospective cohort of Chilean community 
dwelling adults, it was found that appendicular FFM (from DXA) was a strong predictor 
of mortality182. In 477 adults aged 65 years and over from the Longitudinal Aging Study 
Amsterdam, lower appendicular skeletal muscle mass and lower leg fat mass were also 
strongly associated with an increased mortality risk183. However, these associations 
were not significant in women183. 
 
Strong associations have also been found between sarcopenia (defined using the 
EWGSOP definition which combines measures of muscle mass and muscle function) 
and all-cause mortality. Older participants aged 80 years and over, from the ilSIRENTE 
Study, with the EWGSOP-defined sarcopenia, had 2.32 times the mortality risk than 
that of non-sarcopenic participants (95% CI: 1.01-5.43), over 7 years of follow-up184. A 
similar magnitude of association was observed in an elderly Mexican population, aged 
over 70 years, that also used the EWGSOP definition of sarcopenia185; the risk of 
mortality was 2.39 times higher in sarcopenic compared to non-sarcopenic older adults 
(95% CI: 1.05-5.43) over 3 years of follow-up. 
 
Some studies have suggested that decline in muscle strength is a stronger independent 
predictor of mortality than muscle mass186;187. A cohort of community-dwelling older 
Korean men with sarcopenia, defined using the EWGSOP definition, were at 4 times 
greater risk of mortality than men without sarcopenia. However, when individual 
components of the sarcopenia definition were examined, the associations with muscle 
function (leg muscle strength, and short physical performance battery test score) were 
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stronger than for muscle mass (assessed by ASM/height2, from DXA)188. This 
possibility is also supported by data from the Health, Aging and Body Composition 
(Health ABC) study, which showed that knee extension strength and grip strength were 
strongly inversely associated with mortality, but that muscle size, determined by CT 
area or DXA regional lean mass was not strongly related to mortality189. This strong 
association seen between muscle strength and mortality was independent of muscle 
mass189. 
 
However, only a few prospective studies have specifically examined the association 
between sarcopenic obesity and the all-cause mortality risk in healthy individuals190-194. 
Table 2.2 summarises relevant studies that investigate the associations of sarcopenic 
obesity with mortality and CVD in older people. A small prospective study in a 
population with a specific prevalent disease, 250 patients with gastrointestinal or 
respiratory cancers, found that sarcopenic obese patients had a significantly higher risk 
of mortality compared to those with obesity alone190. An increased all-cause mortality 
risk in sarcopenic obese participants has also been found in a large community-based 
study; a previous report from the BRHS examined anthropometric indexes of body 
composition in relation to mortality over six years of follow-up, including more than 
4,000 older men, aged 60 to 79 years. The results showed that muscle mass (indicated 
by MAMC) was significantly and inversely associated with mortality, and men with a 
high WC (>102cm) and in the lowest quartile of MAMC had a 55% increased risk of 
all-cause mortality compared to those with normal WC and MAMC191.  
 
Mortality risk was assessed in relation to sarcopenia and sarcopenic obesity in 
NHANES III, with over 4,000 participants, aged 60 years or above, followed 
prospectively for 14 years192. Sarcopenic and sarcopenic obese women (based on 
skeletal muscle mass and body fat measurement, from BIA) had a 35% and 29% 
significantly increased risk of mortality respectively compared to women without 
sarcopenia or obesity, after adjustment for age, gender, ethnicity and cardiovascular risk 
factors192. However, the risk of death with sarcopenia and sarcopenic obesity was not 
significant in men in this cohort. The InCHIANTI study classified 934 male and female 
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participants aged 65 years and above into one of six sarcopenic obesity groups, based on 
the presence of absence of sarcopenia (defined using calf skeletal muscle) and whether 
participants were obese, overweight or normal (according to BMI)193. This study 
followed participants for six years prospectively and found no significant difference in 
mortality risk across the six sarcopenic obesity groups.  
 
One prospective study194, with over 30 years of follow-up, has also used a measure of 
muscle strength instead of muscle mass to define sarcopenic obesity in relation to 
mortality risk. In over 6,000 adult men aged 45 to 68 years, there was a significant 
increase in risk of mortality in both men with sarcopenia and in men with sarcopenic 
obesity194. Among men who were of normal BMI (20-24.99 kg/m2), those in the lowest 
grip strength tertile had a 25% increased risk of mortality compared to normal weight 
men in the highest grip strength tertile194. Among men who were overweight (BMI ≥ 25 
kg/m2) those in the lowest grip strength tertile had a 39% increased risk of mortality 
compared to normal weight men in the highest grip strength tertile.  
 
In summary, the association between obesity and sarcopenia, measured either by muscle 
mass or muscle function or a combination of the two, and an increased risk of all-cause 
mortality seems to be fairly well documented in the literature. However, in contrast, 
there is a paucity of prospective studies which have examined the association between 
sarcopenic obesity and all-cause mortality risk. The available evidence on whether the 
presence of sarcopenic obesity increases the risk of all-cause mortality in older adults is 
inconclusive.  
 
2.5. Dietary patterns, CVD risk and all-cause mortality 
2.5.1.  Methods of dietary assessment 
2.5.1.2 Measuring dietary intake 
Diet is a complex exposure and measuring intake accurately and precisely is very 
difficult. Several self-reported measurement methods have been used to assess dietary 
intake in epidemiological studies, but there are associated issues of measurement error 
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including problems surrounding recall bias, social desirability in reporting, and under or 
over reporting of total energy intake104;195;196. One of the most commonly used methods 
for assessing dietary intake is the food frequency questionnaire (FFQ)197. The FFQ 
approach requires participants to report their usual frequency of consumption of a 
number of food or drink items from a list for a specified time period. Information on 
portion size may also be collected. Relative or absolute nutrient intakes can be estimated 
from FFQs using an associated database of all food and drink items included in the 
questionnaire198. Many validated FFQs have been used previously with adaptations for 
different populations and purposes, but the completeness of the food/drink list is crucial 
in the food frequency method. Advantages of the FFQ method include the fact that data 
on usual individual dietary intake is collected, information on total diet is obtained, they 
are low cost to administer and they do not influence eating behaviour199. However, 
disadvantages include the fact that FFQs are cognitively difficult for participants to 
complete, dietary intake is not quantifiably precise and misreporting of intake is 
common199. 
 
Food records or diaries are an alternative dietary assessment method, in which 
participants record everything they ate or drank over a specified period of time, and this 
method can be supplemented by weighing. Theoretically, diet intake is recorded at the 
time of eating and details can be recorded by writing them down, using dictaphones, 
computer recording, photographs, and self-recording scales199;200. 24-hour dietary recall 
is another frequently used method, in which a participant recalls everything they ate or 
drank over the past 24 hours. The recall is typically conducted by interview either face-
to-face or via telephone, and may be paper based or computer assisted. These two 
methods share the advantage of being able to quantify dietary intake, but both have the 
disadvantages of a high investigator cost, intake is often underreported and many days 
are needed to capture an individual’s usual intake199. Food records specifically are not 
prone to recall bias but this method may affect eating behaviour, where as 24-hour 
dietary recall does not affect eating behaviour199. 
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Another more recent method of dietary assessment, which overcomes some of the 
problems surrounding self-reported dietary data collection, is the use of biomarkers. 
Nutritional biomarkers are objectively measured indicators of dietary exposure, which 
have also been used to calibrate the measurement error in self-reported dietary data201. 
However, since nutritional biomarkers are expensive to collect, store and analyse, and 
due to the limited number of valid biomarkers, they are used less frequently in 
population based studies. 
 
In summary, a range of measurement methods can be used to assess dietary intake. For 
the purposes of this thesis, dietary intake has been measured using data already 
collected for the BRHS from a FFQ which was self-completed by participants at the 
twenty year re-examination (see section 3.3.2 for details). 
 
2.5.1.2 Examining dietary patterns 
Historically, studies investigating the associations between diet and risk of morbidity or 
mortality have focused on single foods items and specific dietary nutrients, which have 
been shown to be important in the risk of CVD23;202;203. However, this approach has 
several limitations; it does not take into account the fact that foods are eaten in 
combination, and that interactions and synergies between nutrients are likely to exist. 
Moreover, the effects of single nutrients may be too small to detect and single nutrient 
analysis may be confounded by the effects of overall dietary patterns28;29;195. In recent 
years the focus of nutritional epidemiology has shifted towards examining overall 
dietary patterns in relation to health outcomes28;29. This reflects the complex and 
multidimensional nature of diets consumed in the population, to examine the combined 
effects of the consumption of various foods/nutrients and to reflect ‘real world’ dietary 
preferences. Two main approaches have been developed to assess diet quality: (1) 
Hypothesis oriented or theoretically defined approaches which are a priori in nature, 
since they use available scientific evidence to generate predefined dietary scores or 
indexes based on dietary recommendations or guidelines; and (2) Data-driven or 
exploratory approaches which are a posteriori in nature, since dietary patterns are 
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derived from the available data based on factor analysis, such as principal component 
analysis, or cluster analysis29;30.  
 
2.5.1.3 Defining a priori dietary patterns  
A variety of diverse a priori defined dietary scores and indexes have been developed to 
assess overall diet quality, based on adherence to healthy diet patterns, such as the 
Mediterranean diet, adherence to national or international nutrient or food related 
dietary guidelines or dietary variety-based scores23;195;204-206. Specific scores will be 
described in detail in section 2.5.3, when the evidence for association between such 
scores and risk of CVD and mortality in the elderly will be reviewed.  
 
A priori methods such as diet quality scores or indexes do have some limitations. They 
may be culturally or regionally specific so may not be universally applicable30. Scores 
may also be dependent on the selected underlying dietary guidelines, which are related 
to morbidity and mortality risk generally but not specifically to the risk of a specific 
disease. Adding together equally weighed dietary components implies that each 
component is equally important to CVD risk, which may not be the case. Also, scores 
which dichotomise components do not take into account the full range of consumed 
foods, so using scoring ranges may be preferable to simple cut-offs204. 
 
2.5.1.4 Defining a posteriori dietary patterns  
Many studies have used data-driven or exploratory approaches to assess overall diet 
quality and the two predominant approaches are factor analysis, such as principal 
component analysis, and cluster analysis23;195;207. Factor analysis or principal component 
analysis is a data-reduction technique which identifies foods that are frequently 
consumed together and aggregates food items or groups on the basis of the degree of 
correlation with one another29;30. Cluster analysis derives dietary patterns based on 
differences in dietary intakes between individuals who are separated into mutually 
exclusive groups28;30. In factor analysis, individuals are scored based on their degree of 
adherence to each derived dietary pattern, where as in cluster analysis individuals are 
assigned to one cluster only. Typical dietary patterns derived by such methods tend to 
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identify healthy or prudent and unhealthy or Western style patterns207, and these types 
of dietary patterns have also been found in older European populations208. 
 
Using data-driven approaches to generate dietary patterns has the advantage of not 
making any prior assumptions but uses the existing data to characterise total diet, 
meaning that results can be meaningful, interpretable and can show some 
reproducibility across populations30. However, a posteriori methods of deriving dietary 
patterns, including factor analysis and cluster analysis, do have some considerations. 
Data is limited on the reproducibility and validity of these methods and subjectivity may 
be introduced when grouping dietary variables, making analytic choices about statistical 
methods and in selecting final dietary patterns to use28;30;207. Cluster analysis has low 
statistical power, compared to principal component analysis, and is also highly 
influence by extreme values195;207. It has also been suggested that principal component 
analysis may generate more meaningful and interpretable dietary patterns than cluster 
analysis195;207. 
 
In recent years, a new statistical method of identifying dietary patterns has been 
introduced. Reduced rank regression determines linear functions of predictors (such as 
food groups) by maximizing the explained variation in a set of intermediate response 
variables (such as disease-related nutrients or biomarkers). Reduced rank regression 
combines characteristics of both hypothesis driven approaches, since it used prior 
information for defining response variables, and exploratory approaches, as it uses 
dietary data from the study29;209. 
 
In summary, there are a range of approaches which have been used previously to define 
dietary patterns, each with their advantages and disadvantages. For the purposes of this 
thesis, both a priori (a range of diet scores) and a posteriori methods (principal 
component analysis) will be used to identify dietary patterns in the BRHS cohort (see 
section 3.3.2 for details) and their associations with CVD and mortality in older adults 
will be assessed.  
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2.5.2. The importance of diet in relation to CVD risk and all-cause mortality 
Several aspects of the diet and nutrition are well recognised as a major risk factor for 
CVD morbidity and mortality in middle-aged populations, as introduced in section 
2.3.16;8;23;202;210. Since obesity results when there is an imbalance between energy intake 
and energy expenditure, dietary intake has a major impact on the prevalence of obesity 
in a population6 and preventive nutrition has become a major focus of efforts to prevent 
CVD210. Various individual aspects of diet have been associated with an increased risk 
of CVD, including high saturated fat intake25, high salt intake24 and low fruit and 
vegetable consumption26;27. The Seven Countries Study was the first major study to 
investigate the role of diet in CVD in the early 1960s and showed a strong positive 
association between dietary saturated fat intake and CHD incidence, with a suggestion 
that increased blood cholesterol may act as a key intermediary between the two211;212. 
More recently, a meta-analysis of intervention studies has confirmed the beneficial 
effects of replacing saturated fat acids (SFA) with polyunsaturated fatty acids (PUFA) 
on CHD risk, with an overall pooled risk reduction of 19%25. Also a slightly later 
Cochrane review, also based on analysis of randomised controlled trials suggested that 
reducing saturated fat by reducing and/or modifying dietary fat reduces the risk of 
cardiovascular events by 14%213. 
 
There is also strong evidence from randomised controlled trials (RCTs) of a positive 
association between salt intake and risk of CVD and mortality. A meta-analysis, 
including six trials of both normotensive and hypertensive participants, of interventions 
for reduced dietary salt showed a 23% reduction in the risk of CVD events24. A low 
intake of fruit and vegetables has also long been implicated in the risk of CVD and 
mortality214, with a modelling study estimating that achieving the dietary 
recommendation in the UK would prevent 33,000 deaths a year, mostly due to meeting 
the 5-a-day fruit and vegetable recommendation215. A recent meta-analysis of 
prospective studies found a 4% significant reduction in CVD mortality risk for each 
additional serving of fruit and vegetables per day216. The evidence of an association 
between a higher fruit and vegetable intake and a lower risk of CVD is based 
substantially on observational studies, but RCTs of a Mediterranean style dietary 
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pattern, which have included an important fruit and vegetable component, have also 
supported a potential link26;217 (see Section 2.5.3.1). 
 
In addition, many other aspects of diet have shown evidence of an association with 
CVD risk. An inverse association between fish consumption and CHD mortality has 
been reported218. Also, there is evidence for a positive association between red and 
processed meat intake and the risk of CVD and all-cause mortality219;220, which ties in to 
the association with saturated fat25.  
 
Diet quality is particularly important in the elderly, since this age group are particularly 
vulnerable to malnutrition due to decreased food affordability and availability, lack of 
interest or awareness affecting intake, malabsorption or increased nutrient requirements, 
and unique considerations regarding socioeconomic circumstances and caregiving221;222. 
When these issues are coupled with the increased prevalence of CVD in the elderly, the 
impact of diet in the elderly becomes very important. However to date, dietary patterns 
and the risk of CVD and mortality have largely been studied in middle-aged 
populations, many of which have focused on the Mediterranean diet31;32, which may 
have limited relevance in the UK223. However, evidence on the influence of dietary 
patterns on CVD risk and mortality in older subjects remains limited, especially within 
the UK33. Existing literature on the associations of dietary patterns (defined a priori and 
a posteriori) and risk of CVD and mortality in older adults will be reviewed in section 
2.5.3 and section 2.5.4 respectively. 
 
2.5.3. A priori dietary patterns, CVD risk and all-cause mortality in older age 
2.5.3.1 Mediterranean Diet Score 
A ‘Mediterranean diet’ reflects the dietary patterns characteristic of several olive 
growing countries in the Mediterranean Basin in the early 1960s including Greece, 
southern Italy and Spain224. It was first defined by Ancel Keys in the Seven Countries 
Study who observed lower incidence of CVD in some Mediterranean countries and 
hypothesised this was due to the dietary habits of these populations225. The traditional 
Mediterranean diet is characterised by an abundant consumption of olive oil as the main 
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source of dietary lipids, a high consumption of fruit, vegetables, legumes, cereals and 
nuts, a moderate to low consumption of fish, dairy and wine (consumed with meals), 
and a low consumption of meat and meat products224 (Figure 2.2). The Mediterranean 
Diet Score (MDS) is the most commonly researched predefined dietary pattern and is 
based on adherence to a combination of food items characteristic of a Mediterranean-
style diet. The MDS was first developed by Trichopoulou et al. in 1995226 and was later 
revised to include fish intake227. The MDS ranges from 0 (minimal adherence) to 9 
(maximal adherence). Persons whose consumption of beneficial components 
(vegetables; legumes; fruits and nuts; cereals; fish; monounsaturated/saturated lipids 
ratio) is below the sex-specific median are assigned a value 0 or otherwise a value of 1. 
Persons whose consumption of detrimental components (meat and dairy) is below the 
sex-specific median are assigned a value of 1 or otherwise a value of 0. For ethanol, 
men consuming between 10 and 50g and women consuming between 5 and 25g per day 
score 1. 
 
Since the original MDS was developed, several modified versions have been used228, 
but regardless of the slight variations in scores, the association with CVD has shown 
consistent beneficial results across studies. Numerous prospective cohort studies, based 
in European and North American adult populations, have shown consistent protective 
effects of adherence to a Mediterranean diet on the risk of CVD. A systematic review 
and meta-analysis carried out by Sofi et al. in 2010, which pooled data from 18 cohorts 
(including more than 2 million subjects and 50,000 deaths or incident cases) showed 
that a two point increase in MDS was associated with a 10% reduction in CVD 
incidence and mortality [pooled relative risk (RR): 0.90, 95% confidence interval (CI): 
0.87-0.93]31. This was followed up by Martinez-Gonzalez et al. in 2014, which included 
seven more recent prospective studies, including separate estimates for both men and 
women, and showed highly consistent results. A two point increase in MDS was 
associated with a 13% relative reduction in the incidence of CVD events (pooled RR: 
0.87, 95% CI: 0.85-0.90)217.  
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The strongest evidence of a causal association between adherence to a Mediterranean 
diet and the prevention of CVD comes from two RCTs. The Lyon Diet Heart Study, a 
randomised secondary prevention trial in over 600 French survivors of a first 
myocardial infarction (MI), compared an intervention of a Mediterranean diet to a 
control group receiving standard dietary advice229. Interim analysis after 27 months 
showed a 76% reduction in major coronary events in the Mediterranean diet group229 
and this protective effect was maintained for up to 4 years after the first MI230. In a large 
multicenter randomised primary prevention trial in Spain (PREDIMED), over 7,000 
individuals at high cardiovascular risk were allocated to one of three diets: a 
Mediterranean diet supplemented with mixed nuts, a Mediterranean diet supplemented 
with extra-virgin olive oil and a control group receiving advice to reduce dietary fat231. 
The risk of major cardiovascular events, the primary end point, was reduced by 30% in 
the Mediterranean diet and olive oil group and by 28% in the Mediterranean diet and 
nuts group at 4.8 years of follow-up, at which point the trial was stopped on the basis of 
these results231. The risk of stroke, a secondary end point, was also reduced by 33% in 
the Mediterranean diet and olive oil group and by 46% in the Mediterranean diet and 
nuts group231. A recent review of the evidence of an association between adherence to a 
Mediterranean diet and the risk of CVD used meta-analysis to combine the results from 
these two aforementioned trials229;231, showing a pooled CVD risk reduction of 38% 
after intervention with a Mediterranean diet (RR: 0.62, 95% CI 0.40-0.85)217. 
 
There is also evidence that the beneficial effects of a Mediterranean-style diet in 
reducing the risk of CVD persists in older adult populations. A recent review in elderly 
cohorts (ages 65 years or older) identified 20 studies assessing the relationship between 
the Mediterranean diet and cardiovascular disease, found that such a diet had benefits on 
risk factors for CVD (including lipoprotein levels, endothelium vasodilation, insulin 
resistance, the prevalence of the metabolic syndrome and antioxidant capacity), the 
incidence of MI and cardiovascular mortality32. However, while Mediterranean dietary 
patterns are associated with reduced CVD and mortality in many elderly European and 
US cohorts32, there are a paucity of studies within an older UK population, where the 
prevalence of adherence to Mediterranean style dietary patterns has been shown to be 
low223. One study identified in people, aged 65 years and older, from the British Diet 
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and Nutrition Survey found that the MDS was associated with mortality (highest vs. 
lowest quartile; HR: 0.78, 95% CI: 0.62-0.98)232.  
 
The MDS has also been adapted for use in the elderly, with the Elderly Dietary Index 
(EDI) being developed as a slightly modified version, developed specifically to address 
adherence to nutritional recommendations for older people233. The EDI uses a 4-point 
scoring system for each food component and takes into consideration the U-shaped 
relation between certain food items and the risk of health outcomes, compared to the 
MDS which uses a dichotomous scoring system, based on a cut-off of the median intake 
of foods. It is therefore possible that the MDS may be too crude to apply to an older UK 
population in whom adherence to Mediterranean-style dietary components is low and 
the EDI may therefore be more suited223. The EDI has been shown to be associated with 
CVD risk factors in the older Mediterranean population in which it was developed. 
However, the EDI has not been applied to older populations in other countries, such as 
those in the UK. 
 
2.5.3.2 Healthy Diet Indicator 
The Healthy Diet Indicator (HDI) is another a priori–defined dietary score which was 
developed by Huijbregts et al. and is based on adherence to World Health Organization 
dietary guidelines for the intake of nutrients and food components8;234. The HDI consists 
of nine components (SFA; PUFA; protein; total carbohydrates; monosaccharides and 
disaccharides; dietary fibre; fruit and vegetables; pulses, nuts and seeds; cholesterol), 
each scoring one if the dietary guideline is met and zero otherwise, resulting in a total 
score range from 0 to 9. Further details of the components of the HDI and its scoring 
can be found in Table 2.3. The HDI has been found to be inversely associated with both 
all-cause and cardiovascular mortality risk in older European men from the Seven 
Countries Study, aged 50 to 70 years from Finland, Italy and the Netherlands, over 20 
years of follow-up234. Men in the group with the highest HDI score, compared to the 
group with the lowest score, had a 13% lower risk of all-cause mortality and an 18% 
lower risk in CVD mortality, after adjustment for age, smoking and alcohol 
consumption. An inverse association between the HDI and mortality risk has also been 
seen in data from Healthy Ageing: a Longitudinal study in Europe (HALE)235. 
Participants, aged 70 to 90 years, with an HDI score above the median had a reduced 
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mortality risk compared to those below the median, after adjustments for age, gender, 
behavioural risk factors and chronic disease at baseline (HR: 0.89, 95% CI: 0.81-0.98). 
 
A meta-analysis of 11 prospective cohorts of the Consortium on Health and Ageing: 
Network of cohorts in Europe and the United States (CHANCES) has also confirmed 
the inverse association seen between the HDI score and all-cause mortality risk. Pooled 
data from almost 400,000 participants, aged 60 years and over, found that for every 10-
point increase in HDI score (based on a modified score ranging from 0 [least healthy 
diet] to 70 [healthiest diet]) there was a 10% reduced risk of all-cause mortality (HR: 
0.90, 95% CI: 0.87-0.93)236.  
 
In contrast, two studies not included in this meta-analysis did not show significant 
associations between the HDI and risk of CVD and all-cause mortality. In a British 
population specifically, 972 participants from the British Diet and Nutrition Survey 
aged 65 years and older, no significant association was seen between the healthy diet 
score (a modified version of the HDI for a British population) and all-cause mortality 
during 14 years of follow-up232. Findings from an elderly cohort of 924 Swedish men, 
with a mean age of 71 years, also showed no association between HDI and all-cause 
mortality or CVD mortality over 10 years of follow-up237. However, these two 
aforementioned studies were relatively small in size so may not have had the power to 
exclude the effect size observed in the meta-analysis above. 
 
2.5.3.3 Healthy Eating Index  
The Healthy Eating Index (HEI) was originally proposed by the United States 
Department of Agriculture to measure adherence to Dietary Guidelines for Americans 
and the Food Guide Pyramid238. The HEI is a 10-component system made up of five 
food groups (grains, fruit, vegetable, milk and meat), four nutrients [total fat, SFA, 
cholesterol and sodium] and a measure of diet variety, with a total possible 100-point 
score. McCullough et al. developed a modified version of this score, the Alternative 
Healthy Eating Index (AHEI). The AHEI was designed to assess intake of food groups 
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and macronutrient sources associated with reduced chronic disease risk, and compared 
to the HEI it distinguishes quality within food groups and acknowledges the health 
benefits of unsaturated oils239. The AHEI consists of 9 components with a possible 
score from 2.5 to 87.5. This differs from the Mediterranean Diet Score, which uses 
dichotomous scoring components. Further details of the components of the AHEI and 
its scoring can be found in Table 2.4.  
 
A study in two large American cohorts prospectively compared the AHEI and the HEI, 
and found that the AHEI was better at predicting CVD risk than the original HEI; 38, 
615 men from the Health Professionals’ Follow-up Study (aged 40 to 70 years) and 
67,271 women from the Nurses’ Health Study (aged 30 to 55 years), with AHEI scores 
in the top compared to the bottom quintile had a 39% and a 28% reduction in CVD risk 
respectively240. Similarly, in the Whitehall II cohort study of British adults aged 39 to 
63 years, participants in the top compared to the bottom tertile of AHEI score showed a 
24% lower all-cause mortality risk and a 42% lower CVD mortality risk after 
controlling for potential confounders241. The NIH-AARP Diet and Health Study has 
also found associations between the HEI and the AHEI and outcomes in older people 
aged 51 to 70 years; participants in the highest quintiles of scores were associated with a 
15 to 28% lower risk of all-cause and CVD mortality, with slightly stronger associations 
for the AHEI242. 
 
2.5.3.4 Dietary Approaches to Stop Hypertension diet score 
The Dietary Approaches to Stop Hypertension (DASH) diet is well established in the 
prevention and control of hypertension243. This dietary pattern is rich in fruits, 
vegetables, and low-fat dairy products, includes whole grains, legumes, fish, poultry 
and nuts, and is limited in sugar-sweetened foods, red meat and added fats. RCTS in 
adult populations have shown the DASH dietary pattern to lower both systolic blood 
pressure (SBP) and diastolic blood pressure (DBP), by 5.5 and 3.0 mmHg 
respectively243. As well as decreasing SBP and DBP, RCTs have also shown that DASH 
improved other CVD risk factors. A meta-analysis of RCTs found that an intervention 
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with the DASH diet resulted in significant reductions in total cholesterol (-0·20 mmol/l, 
95 % CI: -0·31, -0·10) and LDL (-0·10 mmol/l, 95 % CI -0·20, -0·01; P= 0·03)244.  
 
In addition to examining cardiovascular risk factors, many studies have also assessed 
the associations between adherence to the DASH dietary pattern and the incidence of 
CVD. A recent systematic review identified six such prospective cohort studies in 
middle-aged populations and pooled analysis showed that a DASH-style diet was 
significantly associated with a lower risk of CVD, coronary heart disease (CHD), stroke 
and heart failure by 20%, 21%, 19% and 29% respectively245. 
 
Similar results have been shown in a limited number of older populations. The NIH-
AARP Diet and Health Study has found associations between DASH diet patterns and 
risk of CVD and all-cause mortality in 492,823 older people aged 51 to 70 years; men in 
the highest quintile of scores had a 17% lower risk of all-cause mortality and a 14% 
lower risk of CVD mortality, with slightly larger risk reductions of 22% for both all-
cause and CVD mortality in women242. However, a prospective study in Chinese older 
adults aged 65 years and over found no significant association between DASH dietary 
score and risk of stroke over 6 years of follow-up246. 
 
2.5.3.5 Other a priori defined dietary patterns 
In addition to some of the most commonly used scores and indexes mentioned above, 
there are other less widely used dietary scores which have been developed, and in some 
cases tailored for specific populations or countries or designed to evaluate prevention 
efforts for specific diseases205. The Diet Quality Index (DQI) is an eight component 
score based on food group and nutrient-based recommendations from the American 
Food and Nutrition Board247. DQI components consist of intake of the following: total 
fat; SFAs; cholesterol; fruit and vegetables; breads, cereal and legumes; protein; 
sodium; calcium. Prospective analyses, based on the American Cancer Society Cancer 
Prevention Study II Nutrition Cohort, a cohort of 115,833 US adults aged 50 to 79 
years, showed that the a higher DQI, which was indicative of a poorer quality diet, was 
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positively associated with all-cause and CVD mortality rates in both women and men248. 
However, in fully adjusted models, only CVD mortality was significantly associated 
with the DQI and only in women (medium/low-quality diet vs. highest-quality diet; RR: 
1.86, 95% CI: 1.19-2.89)248. 
 
Kant et al developed the Recommended Food Score (RFS) based on reported 
consumption of foods recommended by current dietary guidelines, including certain 
fruits, vegetables, cereal products, fish and low-fat dairy products249. Adherence to the 
RFS has shown a significant inverse association with both CVD mortality and all-cause 
mortality; a prospective study in 42,254 women, mean age 61 years, found a 31% 
reduced risk of all-cause mortality and a 33% reduced risk of CHD mortality in women 
of the highest compared to the lowest RFS quartile249. Similar results were found in a 
male Swedish cohort, aged 45 to 79 years; there was a 19% reduced risk of all-cause 
mortality and a 29% reduced risk of CVD mortality in men of a high RFS compared to a 
low RFS249;250. In an older British population specifically, participants aged 65 years 
and older from the British Diet and Nutrition Survey, a high RFS score was 
significantly associated with a reduced risk of all-cause mortality after adjustment for 
behavioural risk factors (highest vs. lowest quartile; HR: 0.67, 95% CI: 0.52-0.86)232. 
 
It has also been suggested that recall of usual dietary behaviours may be less prone to 
recall errors than specific types or amounts of food consumed251. An alternative 
approach to assessing healthy dietary patterns is the dietary behaviour score (DBS)251. 
The DBS is based on the usual consumption related to recommended dietary behaviour, 
including consumption of fruit, vegetables, whole grains, low-fat dairy and low-fat 
meats. In the American Association of Retired Persons Diet and Health Study, 
participants aged 50 to 71 years in the highest quintile of DBS, compared to the lowest 
had ∼23–30% lower risk of CHD mortality251. 
 
In summary, adherence to healthy dietary patterns, identified by diet scores and indexes, 
has tended to show an inverse association with CVD and mortality risk in adult 
populations, but the consistency and magnitude of protective effects has varied across 
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studies. Consistent evidence from prospective studies has provided evidence for an 
inverse association between adherence to a Mediterranean diet and reduced CVD risk in 
the elderly, but the relevance of a Mediterranean diet to an older UK population is 
questionable and needs further exploration. There are a limited number of studies in 
elderly populations on other dietary patterns in relation to CVD and mortality risk, and 
specifically a paucity of studies on diet quality in older British populations. 
 
2.5.4. A posteriori dietary patterns, CVD risk and all-cause mortality in older age 
Dietary patterns can also be assessed using data-driven or exploratory approaches and 
the two predominant approaches are factor analysis, such as principal component 
analysis, and cluster analysis23;195;207, as was described above in Section 2.5.1.4. 
2.5.4.1 Factor analysis, CVD risk and all-cause mortality in older age 
In the Nurses’ Health Study, of 69,017 women aged 38 to 63 years, factor analysis 
identified two major dietary patterns – prudent (characterised by higher intakes of fruits, 
vegetables, legumes, fish, poultry, and whole grains) and Western (characterised by 
higher intakes of red and processed meats, sweets and desserts, French fries, and refined 
grains)252. The prudent diet score was associated with a reduced risk of CHD (quintile 5 
vs. quintile 1 RR: 0.76, 95% CI: 0.60-0.98) and the Western diet was associated with an 
increased risk of CHD (quintile 5 vs. quintile 1 RR: 1.46, 95% CI: 1.07-1.99). Similarly, 
the Dutch European Investigation into Cancer and Nutrition (EPIC) study used principal 
component analysis to identify a prudent pattern (high intakes of fish, high-fibre 
products, raw vegetables and wine) and a Western pattern (high consumption of French 
fries, fast food, low-fibre products, other alcoholic drinks and soft drinks with sugar) 
and found that the prudent pattern was associated with a reduced risk of CHD (HR for 
extreme quartiles: 0.87, 95% CI: 0.75-1.00) and stroke (HR: 0.68, 95% CI: 0.53-0.88), 
but found no association with the Western dietary pattern253. 
 
Observational analysis within the PREDIMED RCT identified two major baseline 
dietary patterns using factor analysis based on 34 predefined food groups - a Western 
dietary pattern (rich in red and processed meats, alcohol, refined grains and whole dairy 
products) and a Mediterranean-type dietary pattern (MDP)254. Higher adherence to the 
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MDP was associated with a lower CVD risk (adjusted HR for fourth vs. first quartile: 
0.52, 95% CI: 0.36- 0.74) but the Western pattern was not significantly associated with 
CVD risk.  
 
Similar results have been shown in older populations, although the number of studies in 
this age group is limited. In the Dutch EPIC cohort, of women aged 60 to 69 years, 
principal component analysis identified three interpretable dietary patterns: 
‘Mediterranean-like’, ‘traditional Dutch dinner’ and ‘healthy traditional Dutch’. Only 
the healthy traditional Dutch dietary pattern was associated with all-cause mortality, 
with a 30% lower risk in those in the highest compared to the lowest tertile255. The 
EPIC-Elderly study also examined survival in relation to dietary patterns, derived by 
principal component analysis, in over 74,000 participants aged 60 years and older 
across ten European countries256. A ‘plant-based’ dietary pattern was identified, which 
showed an inverse association with all-cause mortality, with a one standard deviation 
increment corresponding to a 14% reduction in risk. However, in country-specific 
analysis, the association was absent in the UK. In another older British population, 
participants ages 65 years and above from the National Diet and Nutrition Survey 
identified four interpretable diet patterns using principal component analysis: 
‘Mediterranean–style’, ‘health aware’, ‘traditional’ and ‘sweet and fat’. Only the 
Mediterranean–style dietary pattern was associated with a reduced risk of all-cause 
mortality, with an 18% reduction in risk in those in the highest compared to the lowest 
tertile257. 
 
2.5.4.2 Cluster analysis, CVD risk and all-cause mortality in older age 
In the Whitehall II study, a British prospective cohort of 7731 men and women with a 
mean age of 50 years, cluster analysis identified four dietary patterns at baseline: 
unhealthy (white bread, processed meat, fries, and full-cream milk), sweet (white bread, 
biscuits, cakes, processed meat, and high-fat dairy products), Mediterranean-like (fruit, 
vegetables, rice, pasta, and wine), and healthy (fruit, vegetables, whole-meal bread, low-
fat dairy and little alcohol)258. Compared with the unhealthy cluster, the healthy cluster 
was associated with a reduced risk of CHD mortality (HR: 0.71, 95% CI: 0.51-0.98) 
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after adjustment for confounders. However the other dietary patterns were not 
associated with CHD risk and no dietary patterns were associated with all-cause 
mortality. Cluster analysis was also used in the EPIC-NL study, which identified a 
prudent dietary pattern and a Western pattern, similar to the patterns identified in this 
cohort using principal component analysis mentioned above. Individuals in the prudent 
cluster showed a reduced risk of CHD (HR: 0.91, 95% CI: 0.82-1.00) and stroke (HR: 
0.79, 95% CI: 0.67-0.94) compared to those in the Western cluster253. 
 
In an older population specifically, cluster analysis of data from the Cardiovascular 
Health Study, including 4610 participants aged 65 and over, found that the ‘healthy’ 
diet cluster was inversely associated with mortality, the ‘unhealthy’ cluster was 
positively associated with mortality and the ‘low 4’ cluster (distinguished by higher 
alcohol consumption) was inversely associated with risk of cardiovascular events259. 
Similarly, in the Health ABC study, a prospective cohort of 3,075 participants, aged 70 
to 79, six clusters of dietary patterns were identified260. The ‘high-fat dairy products’ 
and the ‘sweet and desserts’ clusters had a 1.4-fold increased mortality risk compared to 
the ‘healthy foods’ cluster, after adjusting for confounders. Another prospective study in 
community-dwelling older adults in Pennsylvania, mean age of 76 years, identified 
three dietary patterns via cluster analysis: ‘sweets and dairy’, health-conscious’ and 
‘Western’261. However, there were no significant associations between any dietary 
patterns and CVD or mortality. 
 
In summary, the use of factor analysis or cluster analysis typically identifies two major 
types of dietary patterns – prudent (healthy) and Western (unhealthy). There have been 
more studies assessing the association between a posteriori dietary patterns and all-
cause mortality risk, compared to CVD risk. Healthy/prudent dietary patterns have 
tended to show inverse associations with CVD and mortality risk, where as 
unhealthy/Western have either shown positive associations or no significant association 
at all. In the elderly specifically, there are a limited number of studies that have used a 
posteriori methods to define dietary patterns in relation to CVD, particularly, and 
mortality risk, and specifically a paucity of studies in older British populations. 
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2.6. Summary of literature review findings  
CVD is the biggest cause of death and disability worldwide. The importance of CVD 
was highlighted in section 2.2, and this is especially the case in the elderly who are at 
increased risks of CVD and the existence of an ageing population further increase the 
burden from CVD. Section 2.3 outlines both well-established major risk factors and 
other emerging risk factors for CVD. Obesity, and hence diet, are two crucial risk 
factors to consider in the aetiology of CVD. Obesity is a major public health problem as 
prevalence continues to increase over time, and prevalence also increases with age. 
Therefore obesity and diet may be particularly important risk factors for CVD in the 
elderly (as described in section 2.4). However, there are some gaps in the current 
literature regarding their effects in the elderly.  
 
The impact of being overweight and of obesity in the elderly on CVD and mortality are 
controversial, with many studies showing that being overweight or obese, as defined by 
BMI, does not appear to be harmful and may even be associated with lower, rather than 
higher, mortality (as reviewed in section 2.4.4). Since body composition changes with 
age, visceral fat increases and muscle mass decreases, and the two have opposing 
effects on mortality risk, it may also be important to measure muscle mass in relation to 
CVD and mortality risk in the elderly. Sarcopenia has been defined as the age-
associated loss of skeletal muscle mass and has been associated with metabolic 
impairment, CVD risk factors, physical disability and mortality and is also often 
associated with obesity. Recently, a new concept of sarcopenic obesity has emerged in 
older adults, which refers to the sarcopenia coupled with high levels of adipose tissue. 
Thus sarcopenia with obesity may synergistically increase their effect on metabolic 
disorders, CVD and mortality, but the literature in this area is inconclusive. As reviewed 
in section 2.4.7, there is evidence which suggests that sarcopenia is associated with 
established and emerging cardiovascular risk factors in older age. However, whether 
sarcopenic individuals who are also obese have the most adverse cardiovascular risk 
profile is unclear. The literature review on the associations between sarcopenia and 
sarcopenic obesity with the risk of CVD (section 2.4.8) and mortality (section 2.4.9) 
revealed that there is a paucity of prospective studies in the elderly. The effects of 
Chapter 2 Literature review 
 
 
65 
 
sarcopenia and sarcopenic obesity on CVD and mortality in older age therefore remain 
unclear. 
 
Dietary intake is an important established risk factor for CVD and mortality, and has a 
significant impact on the prevalence of obesity in the population. In recent years the 
focus of dietary research has shifted from single nutrients and food items to overall diet 
quality, assessed by hypothesis driven, a priori, approaches which generate diet scores 
and indexes, or data-driven, a posteriori, approaches such as factor analysis and cluster 
analysis (as outlined in section 2.5.1). Epidemiological evidence has shown that 
adherence to healthy dietary patterns, identified from either a priori or a posteriori 
methods, has tended to show an inverse association with risk of CVD and mortality, but 
the magnitude of protective effects has varied across studies. Consistent evidence from 
prospective studies has provided evidence for an inverse association between adherence 
to a Mediterranean diet and reduced CVD risk in the elderly, but whether a 
Mediterranean diet is applicable to an older UK population is questionable. There are a 
limited number of studies in elderly populations on other a priori defined dietary 
patterns in relation to CVD and mortality risk, and specifically a paucity of studies on 
diet quality in older British populations (as reviewed in section 2.5.3). Defining dietary 
patterns a posteriori, either by using factor analysis or cluster analysis, has typically 
identified two major types of dietary patterns – healthy/prudent and unhealthy/Western. 
Healthy/prudent dietary patterns have tended to show inverse associations with CVD 
and mortality risk, where as unhealthy/Western have either shown positive associations 
or no significant association at all. In the elderly specifically, there are a limited number 
of studies that have used a posteriori methods to define dietary patterns in relation to 
CVD, particularly, and mortality risk, and specifically a paucity of studies in older 
British populations (as reviewed in section 2.5.4). It is therefore unclear what the 
optimal dietary patterns are for prevention of CVD and mortality in the elderly, 
especially in British populations. 
 
To date studies have not fully addressed the effect of sarcopenic obesity on the risk of 
CVD and mortality in older adults, or the role of dietary patterns in predicting CVD or 
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mortality risk in older UK population. This thesis will address current gaps in the 
literature on the importance of body composition and dietary patterns in the aetiology of 
CVD and mortality in older adults. Specifically, the review raises several questions 
which this thesis will address, including: 1) How are sarcopenia, and the combination of 
sarcopenia and obesity, associated with cardiovascular risk factors in older age? 2) Do 
sarcopenia, and combined measures of sarcopenia and obesity, increase the risks of 
CVD and mortality in older age? 3) To what extent are a priori diet quality scores 
associated with cardiovascular risk factors and the risk of CVD and mortality in older 
age? and 4) To what extent are a posteriori dietary patterns associated with 
cardiovascular risk factors, and the risk of CVD and mortality in older age?  
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Table 2.1 Summary of studies investigating the association between sarcopenic obesity and cardiovascular risk factors in older 
people  
Author, year Study Study design Population 
Sarcopenic 
obesity 
measurement 
Outcomes Main findings 
Baumgartner, 
2004170  
 
New Mexico Aging 
Process Study 
Cross-sectional 
analysis at 
baseline of a 
prospective 
cohort  
(8y follow-up) 
n = 451 
Men and women 
Aged ≥ 60y 
DXA (ASM; % 
body fat) 
Instrumental 
activities of 
daily living 
disability  
Baseline prevalence of MetS and 
hypertension was highest in non-
sarcopenic obese, followed by SO group. 
Cesari, 
2005174 
Trial of 
Angiotensin 
Converting Enzyme 
Inhibition and 
Novel 
Cardiovascular Risk 
Factors study 
Cross-sectional n = 286 
Participants with a 
high cardiovascular 
risk. 
Men and women. 
Aged > 55y 
DXA 
(appendicular 
lean mass; % 
FM) 
CRP; IL-6; 
PAI-1 
No significant interactions were found 
between sarcopenia and obesity with 
CRP, IL-6 or PAI-1. 
Schrager, 
2007173  
 
InCHIANTI Study Cross-sectional n = 871 
Men and women 
Aged ≥ 65y 
Grip strength; 
WC; BMI ≥ 30 
kg/m2 
Inflammatory 
markers 
SO associated with elevated levels of 
inflammatory markers including CRP and 
IL-6. 
Kim, 2009160  
 
Korean 
Sarcopenic Obesity 
Study 
Cross-sectional n = 526 
Men and women 
Aged ≥ 20y 
DXA (ASM; 
SMI; % body 
fat) 
MetS Women with SO (identified using SMI) 
has a 3-fold increased risk of MetS and 
non-sarcopenic obese had a 2-fold 
increased risk of MetS compared with 
normal subjects. Similar associations 
found in men although not significant. 
Messier 
2009171 
 
 Cross-sectional n = 136 
Healthy overweight 
or obese 
postmenopausal 
women. 
Aged 46-70y 
DXA (ASM); 
CT 
BP; HDL; 
LDL; TC; TG; 
insulin level; 
glucose level 
 
Sarcopenic overweight/obese women did 
not show an unfavourable metabolic 
profile compared to non-sarcopenic 
overweight/obese women. 
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factors in older people 
  
 
Author, year Study Study design Population 
Sarcopenic 
obesity 
measurement 
Outcomes Main findings 
Srikanthan, 
2010169 
NHANES III Cross-sectional n = 14528 
Men and women 
Aged > 20y 
BIA (SMI); 
BMI ≥ 30 
kg/m2 
HOMA-IR; 
glycosylated 
hemoglobin 
level. 
SO group had the highest risk of insulin 
resistance and dysglycemia. 
Lim, 2010161 Korean 
Longitudinal Study 
on Health and 
Aging 
Cross-sectional n = 565 
Men and women 
Aged ≥ 65y 
DXA (ASM); 
CT (VFA) 
MetS SO group at highest risk of insulin 
resistance and MetS, with an 8-fold 
increase in risk of MetS compared to 
non-sarcopenic, non-obese. 
Chung, 
2012162 
 
KNHANES Cross-sectional n = 2943 
Men and women 
Aged ≥ 60y 
DXA (ASM); 
BMI ≥ 25 
kg/m2 
BP; glucose 
tolerance 
indices; lipid 
profiles; 
inflammatory 
markers 
SO group was associated with a higher 
risk of insulin resistance, MetS and CV 
risk factors than any other group. 
Hwang, 
2012163 
KNHANES Cross-sectional n = 2221 
Men and women 
Aged ≥ 60y 
DXA (ASM); 
WC (≥ 90cm 
for men; ≥ 
85cm for 
women) 
Insulin level; 
lipid levels; 
glucose levels 
SO was associated with higher fasting 
glucose level and triglyceride level in 
women, and higher serum insulin level in 
men and women. 
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factors in older people 
 
Author, year Study Study design Population 
Sarcopenic 
obesity 
measurement 
Outcomes Main findings 
Kim, 2013167  
 
Korean 
Sarcopenic Obesity 
Study 
 
Cross-sectional n = 493 
Men and women 
Aged ≥ 20y 
DXA (ASM); 
CT (VFA) 
CRP; HOMA-
IR 
In women, the SO group had higher 
levels of insulin resistance and CRP 
compared to the non-SO group. In men, 
the SO group had higher levels of insulin 
resistance compared to the non-SO 
group. 
Lu, 2013168  Cross-sectional n = 600 
Community 
dwelling Taiwanese 
adults 
Men and women 
Aged 63.6y 
(SD=10.1) 
BIA (skeletal 
muscle mass); 
BMI ≥ 25 
kg/m2 
MetS SO group at highest risk of MetS, with a 
12-fold increase in risk compared to non-
sarcopenic, non-obese. 
 
 
Park, 2013164 
 
KNHANES Cross-sectional n = 6832 
Men and women 
Aged ≥ 19y 
DXA (ASM); 
WC (≥ 90cm 
for men; ≥ 
85cm for 
women) 
BP 
 
 
 
 
 
The odds of hypertension were higher in 
the SO group compared to the obese, 
sarcopenic and normal body composition 
groups. 
Baek, 2014154 
 
KNHANES Cross-sectional n = 3483 
Men and women 
Aged ≥ 65y 
DXA (ASM); 
BMI ≥ 25 
kg/m2 
Lipid levels SO was associated with an increased risk 
of dyslipidemia compared with 
sarcopenia or obesity alone. 
Han, 2014155 KNHANES Cross-sectional n = 4846 
Men and women 
Aged ≥ 60y 
DXA (ASM); 
BMI ≥ 25 
kg/m2 
BP The odds of hypertension were highest in 
the sarcopenic obese group compared to 
all other groups. 
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Table 2.1 Continued. Summary of studies investigating the association between sarcopenic obesity and cardiovascular risk 
factors in older people 
 
ASM, appendicular skeletal muscle mass; BIA, bioelectrical impedance analysis; BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; CT, 
computerised tomography; DXA, dual energy x-ray absorptiometry; FM, fat mass; FFM, fat-free mass; HDL, high density lipoprotein; HOMA-IR, homeostatic 
model assessment insulin resistance; IL-6, interleukin 6; KNHANES, Korea National Health and Nutrition Examination Survey; LDL, low density lipoprotein; 
MetS, metabolic syndrome; NHANES, National Health and Nutrition Examination Survey PAI-1, plasminogen activator inhibitor; SMI, skeletal muscle mass 
index; SO, sarcopenic obesity; TC, total cholesterol; TG, triglyceride; VFA, visceral fat area; WC, waist circumference. 
Adapted from Atkins et al, 201540. 
Author, year Study Study design Population 
Sarcopenic 
obesity 
measurement 
Outcomes Main findings 
Kim, 2014166  Cross-sectional n = 298 
Korean patients 
visiting hospital for 
a regular checkup 
Men and women 
Aged 20-70y 
DXA (SMI); 
CT (VFA) 
Cardiorespirato
ry fitness 
SO strongly associated with 
cardiorespiratory fitness. Lowest 
cardiorespiratory fitness seen in SO 
group. 
Park, 2014165 KNHANES Cross-sectional n = 6832 
Men and women 
Aged ≥ 19y 
DXA (ASM); 
WC (≥ 90cm 
for men; 80cm 
for women) 
MetS 
 
SO was associated with an increased risk 
of MetS in women compared to non-
sarcopenic obese. 
Dos Santos, 
2014172 
 Cross-sectional n = 149 
Postmenopausal 
Brazilian women 
Aged 67.2y 
(SD=6.1) 
DXA 
(appendicular 
FFM; FM) 
BP; glucose 
level; TC; 
HDL; LDL; 
TG; CRP 
No significant difference in BP, glucose 
level, TC, HDL, LDL, T and CRP 
between SO and non-SO groups. 
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Table 2.2 Summary of studies investigating the association between sarcopenic obesity and cardiovascular disease and 
mortality in older people 
 
Author, year Study Study design Population 
Sarcopenic 
obesity 
measurement 
Outcomes Main findings 
Rantanen, 
2000194 
 Prospective cohort  
(30y follow-up) 
n = 6040 
Healthy adults from 
Hawaii 
Men 
Aged 45-68y 
Grip strength; BMI  Mortality Overweight men (BMI ≥ 25 
kg/m2) in the lowest grip 
strength tertile had 1.39 times 
the risk of mortality compared 
to normal weight men in the 
highest tertile. 
Wannamethee, 
2007191 
 
British Regional 
Heart Study 
Prospective cohort  
(6y follow-up) 
n = 4107 
Men 
Aged 60-79y 
MAMC; BIA (FM; 
FFM); WC; WHR  
Mortality A composite measure of WC 
and MAMC most effectively 
predicted mortality. SO, based 
on high WC (>102cm) and 
low MAMC (lowest quartile), 
showed a 55% increase in 
mortality risk compared to 
non-sarcopenic, non-obese. 
Prado, 2008190  Prospective cohort 
(follow-up 
unknown) 
n = 250 
Obese Canadian 
patients with respiratory 
or gastrointestinal 
cancers. 
Men and women 
Aged 35-88y 
CT (muscle cross-
sectional area); 
BMI ≥ 30 kg/m2 
Mortality Patients with SO had a higher 
rate of mortality compared to 
those with obesity alone. 
Cesari, 2009193 
 
 
InCHIANTI 
Study 
 
Prospective cohort  
(6y follow-up) 
n = 934 
Men and women 
Aged ≥ 65y 
CT (calf skeletal 
muscle; calf FM); 
BMI 
Mortality No significant difference 
reported in mortality risk 
across six SO groups. 
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Table 2.2 Continued. Summary of studies investigating the association between sarcopenic obesity and cardiovascular disease 
and mortality in older people 
 
ASM, appendicular skeletal muscle mass; BIA, bioelectrical impedance analysis; BMI, body mass index; CHD, coronary heart disease; CT, computerised 
tomography; CVD, cardiovascular disease; DXA, dual energy x-ray absorptiometry; FM, fat mass; FFM, fat-free mass; KNHANES, Korea National Health and 
Nutrition Examination Survey; MAMC, mid-arm muscle circumference; NHANES, National Health and Nutrition Examination Survey; SO, sarcopenic obesity; 
WC, waist circumference; WHR, waist-to-hip ratio.  
Adapted from Atkins et al, 201540 . 
Author, year Study Study design Population 
Sarcopenic 
obesity 
measurement 
Outcomes Main findings 
Stephen, 
2009177 
Cardiovascular 
Health Study 
Prospective cohort  
 (8y follow-up) 
n = 3366 
Men and women 
Aged ≥ 65y 
BIA (skeletal 
muscle mass); grip 
strength; WC 
CVD; CHD; 
stroke 
SO, based on muscle strength 
but not muscle mass, was 
modestly associated with a 
23% increased risk of CVD. 
Batsis, 2014192 NHANES III 
 
Prospective cohort  
(14y follow-up) 
n = 4652 
Men and women 
Aged ≥ 60y 
BIA (Skeletal 
muscle mass; % 
body fat) 
Mortality Women with SO had a higher 
mortality risk than those 
without sarcopenia or obesity. 
For men, the risk of mortality 
associated with SO was not 
significant. 
Baumgartner, 
2004170  
 
New Mexico 
Aging Process 
Study 
 
Cross-sectional 
analysis at 
baseline of a 
prospective cohort  
(8y follow-up) 
n = 451 
Men and women 
Aged ≥ 60y 
DXA (ASM; % 
body fat) 
Instrumental 
activities of 
daily living 
disability  
At baseline, subjects with SO 
did not show a higher 
prevalence of CVD. 
Chin, 2013175 KNHANES 
 
Cross-sectional n = 1578 
Men and women 
Aged ≥ 65y 
DXA (ASM); BMI 
≥ 25 kg/m2 
CVD SO group showed higher 
prevalence of CVD (12.3%) 
compared to non-sarcopenic 
obese (10.0%), but difference 
was non-significant. 
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Table 2.3 Healthy Diet Indicator components and scoring criteria 
 
 
Component Score = 0 Score = 1 
Saturated fatty acids (% energy) >10 0-10 
Polyunsaturated fatty acids (% energy) <3 and >7 3-7 
Protein (% energy) <10 and >15 10-15 
Total carbohydrates (% energy) <50 and >70 50-70 
Monosaccharides and disaccharides (% energy) >10 0-10 
Dietary fibre (g/day) <27 and >40 27-40 
Cholesterol (mg/d) >300 0-300 
Fruits and vegetables (g/day) <400 >400 
Pulses, nuts, seeds (g/day) <30 >30 
Total score 0 9 
 
Healthy Diet Indictor components and scoring as used by Huijbregts et al234. 
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Table 2.4 Alternative Healthy Eating Index components and scoring criteria 
 
Component Score = 0* Score = 10* 
Vegetables (servings/day) 0 5 
Fruit (servings/day) 0 4 
Nuts and soya protein (servings/day) 0 1 
Ratio of white to red meat 0 4 
Cereal fibre (g/d) 0 15 
Trans fat (% of energy) ≥ 4 ≤ 0.5 
Ratio of PUFA to SFA ≤ 0.1 ≥ 1 
Duration of multivitamin use† < 5 years ≥ 5 years 
Alcohol (servings/day) 
Men: 0 or > 3.5 
Women: 0 or > 2.5 
Men: 1.5-2.5 
Women: 0.5-1.5 
Total score 2.5 87.5 
 
Alternative Healthy Eating Index components and scoring as used by McCullough et al239. 
*Minimum score is 0. Maximum score is 10. Intermediate intakes are scored proportionately between 0 and 
10. 
†For multivitamins, the minimum score is 2.5 and the maximum score is 7.5.  
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Figure 2.1 Hazard ratios for the associations between measures of body composition 
and all-cause mortality 
 
 
Source: Adapted from Allison et al15. Data from NHANES I and NHANES II. Subscapular and triceps 
skinfolds thickness were used as fat mass indicators. Upper arm circumference was used as a fat-free mass 
indicator.
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Figure 2.2 Mediterranean diet pyramid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Adapted from the Supreme Scientific Health Council, Ministry of Health and Welfare Greece262.
                                                
 
 
 
   Red meat 
   Sweets     
           Eggs 
         Poultry 
       Fish & seafood 
           Low-fat dairy products  
                  Olive oil 
Fruits              Vegetables 
Non-refined cereals and products 
(whole grain bread, whole grain pasta, brown rice etc.) 
 
Monthly 
Weekly 
Daily 
Legumes & 
nuts        
Physical activity 
Wine in moderation 
Chapter 3 Methodology 
 
77 
 
CHAPTER 3 Methodology 
3.1. Introduction 
This thesis consists of epidemiological analysis of data from the British Regional Heart 
Study (BRHS), an established prospective cohort study of cardiovascular disease. The 
BRHS was initiated in 1978-80 in men aged 40-59 years drawn from one general 
practice in each of 24 towns across Britain34. Since recruitment, this cohort has been 
followed up for morbidity through general practice records, and for mortality through 
the National Health Service Central Register. A physical examination involved a range 
of physiological measurements, including body composition, and the collection of a 
blood sample was carried out at the start of the study and at follow-up 20 years later35. 
Participants have also completed questionnaires at regular intervals during the follow-
up, which have provided self-reported information on health and disease, lifestyle, 
dietary intake, and personal and socioeconomic circumstances.  
 
This chapter consists of an overview of the BRHS, including the study design and 
methodology (section 3.2), a description of the data used in this thesis, including 
measures of body composition, diet, other relevant cardiovascular risk factors and 
outcomes (section 3.3), strengths of the data source for the intended analysis (section 
3.4) and a brief overview of statistical methods (section 3.5). Specific details of 
statistical analyses for each of the results chapters are described in more detail in each 
of the relevant chapters (Chapters 4 to 8).  
 
3.2. The British Regional Heart Study 
3.2.1. Description of data source 
The British Regional Heart Study (BRHS) is a large, prospective, population-based 
cohort study of cardiovascular disease (CVD), in a socioeconomically and 
geographically representative sample of British men, drawn from a general practice in 
24 towns in Great Britain34. This cohort of 7735 participants was examined at baseline 
in 1978-80, aged 40-59 years. The cohort has been continuously followed up for 
mortality and morbidity from baseline until the present. The main aim of the BRHS was 
to explain the substantial regional variations in mortality from cardiovascular disease in 
Great Britain, by assessing the role of environmental, socioeconomic, and personal risk 
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factors34;263. Over time, as the cohort has aged, there has been an increasing focus on the 
aetiology and prevention of cardiovascular disease in older ages. 
 
3.2.2. Selection procedures  
Towns represented all major geographic regions in Great Britain (England, Scotland 
and Wales) and seven criteria were established for selecting towns34;263: 
1. All standard regions should be represented. 
2. Towns should be discrete entities with populations of 50,000-100,000 at the 
1971 Census. In England one larger town was included (Ipswich). In Scotland, 
some towns below 50,000 were considered to obtain a reasonable number of 
suitable towns. 
3. The choice of towns within regions should reflect the variations in mortality 
from CVD and water hardness. 
4. Towns were to be representative of the region in socioeconomic terms. 
5. Towns with noticeable population movement or with unusual population 
structure were avoided. 
6. The study included some towns that were apparent "outliers" when CVD 
mortality and water hardness were plotted against each other, for example 
Hartlepool, Exeter, and Harrogate. 
7. When similar towns met the above criteria, random selection was made between 
the towns. 
 
Figure 3.1 shows a map of the 24 towns included in the BRHS. Table 3.1 shows 
standardised mortality ratios for CVD in 1969-73 in men aged 35-64 years, the number 
of men examined in each of the 24 towns and the corresponding response rate. 
 
Participants were selected from one general practice in each town to achieve a good 
initial response and subsequent feedback34. Practice selection was selected based on its 
size (practice population >7,500), its representativeness of socioeconomic composition 
and characteristics of the town population and the willingness of the Practice to 
participate. From the age and sex register of each general practice about 400 men aged 
40-59 years were selected randomly, stratified into equal five-year age groups (40-44, 
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45-49, 50-54 and 55-59 years). Men with severe mental or physical disability were 
excluded (6-10% per practice) and the remaining participants were invited to take part. 
Invitations were sent to almost 10,000 men, signed by their GPs, encouraging them to 
attend the cardiovascular health check at a local venue, usually the Practice premises. 
The response rate for those men invited was 78%, with 18 of the 24 towns having a 
response rate of 75% or more (Table 3.1). This resulted in a total of 7735 men being 
recruited into the study, which equates to approximately 300 men from each town34;264. 
 
3.2.3. Baseline examination  
At the start of the study in 1978-80, 7735 men aged 40-59 years attended a physical 
examination carried out in each of the towns. A series of measurements were made by 
three trained nurses, including anthropometric and physiological measurements, 
including height, weight, blood pressure, electrocardiogram, and lung function. In 
addition, a blood sample was collected and the men completed a nurse-administered 
questionnaire on health and lifestyle factors. All baseline examinations were completed 
by 1980. All participants provided written informed consent, obtained in accordance 
with the Declaration of Helsinki. Ethical approval was obtained from all relevant local 
research ethics committees.  
 
3.2.4. Follow-up of participants from baseline 
Since the baseline examination in 1978-80, the cohort has been followed up for 
morbidity outcomes, mortality and by regular postal questionnaires until the 
present35;264, as shown in Figure 3.2. A re-examination was also carried out after 20 
years of follow-up (1998-2000), and after 32 years of follow-up (2010-2012).  
 
3.2.4.1 Mortality 
Information on death was collected through the established “tagging” procedures 
provided by the National Health Service Central Register in Southport for England and 
Wales, and in Edinburgh for Scotland264. The Central Register sent death certificates 
containing identification details, date and place of death and cause of death coded using 
the International Classification of Diseases ninth revision (ICD-9) and subsequently the 
tenth edition (ICD-10). Events were also verified by general practices that provided 
information on deaths as part of a periodic review (see section 3.2.4.2 below). 
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3.2.4.2 Morbidity 
Evidence regarding non-fatal events was obtained by on-going reports from general 
practitioners and by regular reviews of the patients’ medical records264. At 2-yearly 
intervals a standard medical record review form was sent to the general practice (see 
Appendix III for details) requesting confirmation of each man's continuing registration, 
current address, and any new cardiovascular events (including myocardial infarction, 
angina, stroke, transient ischaemic attack and heart failure), new diagnoses of cancer or 
diabetes or cardiovascular treatments (coronary artery bypass graft, coronary 
angioplasty) which have occurred within the last two years. All new non-fatal 
myocardial infarction and stroke events reported by the practices are followed up with 
an enquiry form to the general practitioner or hospital consultant to obtain confirmatory 
evidence that case criteria have been met264;265. Criteria for diagnosis of non-fatal 
myocardial infarction are based on World Health Organization criteria for myocardial 
infarction, including the presence of any two of three of the following: prolonged chest 
pain, positive electrocardiogram findings and raised cardiac enzyme levels52;53. The 
criteria for stroke are based on an acute disturbance of cerebral function of vascular 
origin, producing a neurological deficit lasting for more than 24 hours54;264.  
 
Men who have re-registered with another general practice are traced to the new Practice. 
In addition to the original 24 practices, the study now includes over 850 general 
practices nationwide; follow-up of participants has been maintained for 98% of 
surviving men throughout.  
 
3.2.4.3 Follow-up questionnaires  
Follow-up questionnaire have been sent to participants at regular intervals since the 
initial physical examination and questionnaire, which was completed at baseline in 
1978-80 (see Figure 3.2). The first postal questionnaire after baseline was sent out in 
1983-85, followed by postal questionnaires in 1992 and 1996. At the twenty year re-
examination, in 1998-2000, participants also completed a questionnaire and were sent a 
separate postal food frequency questionnaire (see section 3.3.2). Following this, postal 
questionnaires were also sent out in 2003, 2005 and 2007. In 2010-12, a questionnaire 
was also completed at the 32 year re-examination. 
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3.2.4.4 Twenty year re-examination  
After twenty years of follow-up from baseline, participants (then aged 60-79 years) 
were invited for a re-examination which took place between 1998 and 2000264;266. Of 
the 5565 surviving men, 4252 men (77% of survivors) attended the re-examination at a 
local health centre. Men underwent a physical examination (see Appendix IV for further 
details of the information collected) and completed a general questionnaire, including 
information on lifestyle and medical history (Appendix V)264;266. All men were asked to 
provide a fasting blood sample, which was collected by using the Sarstedt Monovette 
system (Sarstedt, Numbrecht, Germany)267. Participants without diabetes were 
requested to fast for a minimum of 6 hours prior to their appointment time and to drink 
only water. Men attended measurement session at a specified time between 08:00 and 
18:00 hours. Within 6 hours of the blood sample collection time, plasma and serum 
samples were centrifuged, separated and frozen at –20 degrees Celsius and transferred 
to central laboratories for analysis. Between 1998 and 2000, participants also completed 
a separate postal food frequency questionnaire (Appendix VI). Further details of the 
data collected at the re-examination are described in Section 3.3. 
 
3.3. Data used in this thesis 
Data from the BRHS has been used to assess the relationships between measures of 
body composition (adiposity and muscle mass) and dietary patterns with the risk of 
cardiovascular outcome sand mortality. This thesis has primarily used available data 
from the 20 year re-examination, including measurements made at the physical 
examination and data collected via the two questionnaires, and follow-up data on 
mortality and morbidity until June 2010. In addition, some socioeconomic variables 
have been used from earlier questionnaires at 1978-80 (baseline), 1992 and 1996. This 
section will present how data on the major exposure variables (body composition and 
diet), additional risk factors and outcomes variables used in this thesis were collected 
and defined. 
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3.3.1. Body composition measures 
Anthropometric body composition measurements at re-examination in 1998-2000 
included height, weight, waist circumference, hip circumference, subscapular skinfold 
thickness, triceps skinfold thickness and mid-upper arm circumference. Bioelectrical 
impedance analysis (BIA) was also carried out to measure fat mass and fat-free mass. 
Subjects were measured in light clothing without shoes. The number of participants 
with available data for each of the measures of body composition, together with the 
mean measurements in this cohort will be presented in Chapter 4 (Table 4.1). 
 
3.3.1.1 Anthropometric measurements 
Height and Weight: Height and weight were both measured while the participants were 
standing. Height was measured with a Harpenden stadiometer to the last complete 0.1 
cm. Weight was measured with a Soehnle digital electronic scale to the last complete 
0.1 kg. Body mass index (BMI) was calculated for each man in kg/m2. 
 
Waist/Hip circumference: Waist and hip circumferences were measured in duplicate 
with an insertion tape (CMS Ltd, London, United Kingdom) to the last complete 0.1 cm 
and the mean of the two readings was taken. The measurement of waist circumference 
was taken at the midpoint between the iliac crest and the lower ribs measured at the 
sides. Hip circumference was measured at the point of maximum circumference over 
the buttocks. Waist-to-hip ratio was calculated as waist divided by hip circumference 
(cm). Waist circumference and hip circumference were adjusted for observer variation. 
 
A small repeatability study was carried out to examine within-subject variation for BMI, 
waist circumference and waist-to-hip ratio in 110 participants measured by the same 
team of observers on both occasions. The correlations between measurements taken 1 
week apart were 0.99 for BMI, 0.99 for waist circumference and 0.93 for waist-to-hip 
ratio267. The within-subject correlations for waist circumference were similar in non-
obese (BMI <30 kg/m, r = 0.99) and obese men (BMI ≥ 30 kg/m, r = 0.97)267. 
 
Subscapular/Triceps skinfold thickness: Subscapular and triceps skinfold thicknesses 
were measured in duplicate with a Holtain skinfold caliper to the last complete 0.1 mm, 
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on the right side only. Triceps skinfold thickness was measured at the mid-upper arm, 
with the arm pendant. The mean of the two readings was taken. Subscapular skinfold 
and triceps skinfold measurements were adjusted for observer variation. 
 
Mid-upper arm circumference: The mid-upper arm was defined, and the mid-upper arm 
circumference was measured once in the right arm pendant with an insertion tape (CMS 
Ltd, London, United Kingdom) to the last complete 0.1 cm. Mid-arm muscle 
circumference (MAMC) was calculated as: mid-upper arm circumference (cm) - 0.3142 
x triceps skinfold thickness (mm)148. 
 
Weight loss: At re-examination, participants were also asked to report whether their 
weight had changed in the previous three years: no; weight gain; weight loss; 
fluctuation. A dichotomous weight loss variable was created (Yes: weight loss; No: no 
change, gain or fluctuation). 
 
3.3.1.2 Bioelectrical impedance analysis 
Fat mass (FM) and fat-free mass (FFM) were determined by bioelectrical impedance 
analysis (BIA) using a Bodystat 500 arm-leg body composition analyser (Bodystat Ltd, 
Douglas, UK). FFM was calculated using the equation by Deurenberg et al, which was 
validated in people aged over 60 year268: 6710 x height (m2) ÷ resistance (Ω) + 7. FM 
was calculated as body weight - FFM. FM and FFM were also calculated as proportions 
of total body weight (% FM and % FFM). To provide a height-independent body 
composition measure, FM and FFM measures were normalised for height by dividing 
by height (m2) to give fat mass index (FMI) and fat-free mass index (FFMI) in kg/m2.  
  
An alternative estimate of fat-free mass was also applied, using the equation by Janssen 
et al, which was validated in people aged 18-86 years150;269: skeletal muscle mass (kg) = 
[(height (m2) ÷ resistance (Ω) x 0.401) + (1 x 3.825) + (age x -0.071)] + 5.102. Skeletal 
muscle was calculated as proportion of total body weight (% skeletal muscle). Skeletal 
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muscle mass was also normalised for height by dividing by height2 (m) to give the 
skeletal muscle index (SMI) in kg/m2.  
 
3.3.1.3 Defining adiposity and obesity 
The adiposity measures used in this thesis included markers of whole body adiposity 
(BMI and FMI), central adiposity (waist circumference, waist-to-hip ratio and 
subscapular skinfold thickness), and peripheral adiposity (triceps skinfold thickness), as 
introduced in section 2.4.1. Overweight and obesity based on BMI were defined in 
accordance with established World Health Organization cut-points (≥ 25 kg/m2 and ≥ 30 
kg/m2 respectively). Established sex-specific cut-points were used to define obesity for 
waist circumference (>102 cm) and waist-to-hip ratio (≥ 1.00)105. Recent literature 
suggests using ≥ 0.90 as the waist-to-hip ratio cut-point for men270. However, since this 
would have classified 80.0% of participants as obese, a more stringent cut-point of ≥ 
1.00105 was more appropriate for this cohort (classifying 18.7% as obese). 
 
3.3.1.4 Defining muscle mass and sarcopenia 
The markers of muscle mass used within this thesis were MAMC, FFMI and SMI. Key 
issues influencing the definition of sarcopenia were introduced in section 2.4.6; no 
operational definition of sarcopenia has yet been adopted universally17 but the European 
Working Group on Sarcopenia has suggested defining sarcopenia using a combination 
of muscle mass and function (strength and performance). However, in the BRHS cohort 
at the 1998-2000 re-examination, direct measures of muscle function were not available, 
so sarcopenia definitions are based solely on muscle mass. Sarcopenia was defined as a 
level of MAMC, FFMI or SMI below the second quintile of each variable. Sarcopenic 
obesity was defined using various combinations of sarcopenia and obesity, as described 
further in the subsequent results chapters (Chapter 4 and Chapter 5). 
 
Direct measurements of muscle mass such as computerised tomography (CT), magnetic 
resonance imaging (MRI) or dual-energy X-ray absorptiometry (DXA) were not 
available in this cohort. However, the American Heart Association recognises MAMC 
as a proxy marker for muscle mass102 which is strongly correlated with more accurate 
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dual-energy X-ray absorptiometry measures of lean mass147. In addition, the European 
Working Group on Sarcopenia has approved BIA measures as a portable alternative to 
dual-energy X-ray absorptiometry17. The implications of the specific muscle mass 
measurements and definitions of sarcopenia used in this thesis are discussed further 
within the relevant results chapters (Chapter 4 and Chapter 5) and in the chapter on 
implications and conclusions (Chapter 9).  
 
3.3.2. Dietary assessment  
At the same time period as the twenty year re-examination was carried out (1998-2000), 
participants also completed a separate self-administered postal food frequency 
questionnaire (FFQ). The FFQ was developed for use in the World Health 
Organization’s Monitoring Trends and Determinants in Cardiovascular Disease 
Survey271 and later for the Scottish Heart Health Study272. It has been previously 
validated against weighed food intake in British populations273;274. Participants were 
asked to recall their usual intake of 86 different food items. The questionnaire included 
a list of foods, grouped into 12 categories: (1) meat; (2) fish; (3) vegetables - fresh, 
tinned, dried, frozen; (4) fresh fruit; (5) cheese; (6) bread; (7) breakfast cereal; (8) 
biscuits, puddings and sweets; (9) egg; (10) other foods; (11) drinks and juices (non-
alcoholic); (12) fats. The respondent was asked how often he/she usually ate each food 
per week and consumption frequencies were reported in nine categories: 1, 2, 3, 4, 5, 6, 
or 7 days per week, monthly, or rarely/never. Additionally, information was also 
collected on the specific types and quantity of fruit eaten per week, the amount and type 
of milk drank per week, the amount and type of fat used for cooking and for spreading 
on bread, the amount of salt added to food/cooking, the weekly household consumption 
of different types of fats, dairy products and sugar, the amounts of tea/coffee/other hot 
drinks consumed per day and the amount of alcohol drank per week. (See Appendix VI 
for further details of the questions included in the FFQ). 
 
Total macronutrient and micronutrient intakes of all food reported as consumed in the 
FFQ were derived using a validated computer program. The program multiplied the 
food frequency of the food consumed by the standard portion sizes for each food, and 
by the nutrient composition of the food obtained from the UK food composition 
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tables275. This derived data on mean daily total energy intake (kcal/day), as well as 
mean daily intake (g/day) of fat (total, saturated and polyunsaturated), protein, 
carbohydrates (total, starch and sugar) and fibre (cereal and vegetable). Mean daily 
intake of vitamin C, vitamin E, iron and cholesterol (mg/day) were also derived. In 
addition, plasma vitamin C and vitamin E levels were also available from the blood 
sample collected at the re-examination in 1998-2000. Plasma vitamin C and vitamin E 
was measured with high-performance liquid chromatography that included ultraviolet 
and fluorescent detection276;277. For vitamin C, plasma extracts were treated with 
metaphosphoric acid at the point of collection and were then snap-frozen with dry ice. 
Laboratory-blinded split samples were used to ensure quality control throughout the 
study278. 
 
The distribution of total energy intakes was checked for any extreme values. However, 
all were within a range compatible with a normal lifestyle (500-8000 kcal/day in 
men279) so no exclusions were made on this basis. The multivariate nutrient density 
model was used to adjust macronutrients for energy intake; carbohydrates, fats and 
protein were expressed as percentages of energy (% kcal)280. In addition, throughout this 
thesis, all models including dietary patterns as exposure variables, have been adjusted 
for total energy intake (kcal/day)280. The number of participants with available data for 
each of the dietary variables, together with the mean intakes of macronutrients and 
micronutrients in this cohort will be presented in Chapter 6 (Table 6.4). Details of how 
dietary patterns were derived in this cohort, using a priori and a posteriori methods will 
be described in relevant results chapters (Chapters 6, 7 and 8). 
 
3.3.3. Lifestyle variables 
3.3.3.4 Smoking status 
Detailed questions on cigarette smoking habits were obtained from the self-completed 
questionnaire completed at re-examination in 1998-2000. Participants were asked 
whether they had ever smoked cigarettes regularly (at least 1 a day), whether they 
smoke cigarettes at present and, if not, at what age they gave up smoking. From the 
information given, men were classified into four cigarette smoking groups (never 
smoked; long-term ex-smokers, >15 years; recent ex-smokers, ≤ 15 years; current 
smokers)90. 
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3.3.3.5 Alcohol consumption 
In the self-completed questionnaire at re-examination in 1998-2000, participants were 
asked for detailed information on their current frequency of drinking (daily/most days; 
weekends only; occasional; special occasions only; none) and were asked to estimate 
the quantity they drank on the days when they drank alcohol (None; 1-2 drinks; 3-6 
drinks; >6 drinks). Based on these two questions, men were classified into five groups 
according to their reported weekly intake: none (0 drinks/week); occasional (<1 
unit/week); light (1-15 units/week, which included weekend 1-2 units, weekend 3-6 
units and daily 1-2 units); moderate (16-42 units/week, which included daily 3-6 units 
and weekend >6 units); heavy (>42 units/week, which included >6 units daily)281;282. 
One drink was defined as half a pint of beer, a glass of wine, or a single measure of 
spirit (8-10gms). 
 
3.3.3.6 Physical activity 
The self-completed questionnaire at re-examination in 1998-2000, asked participants 
questions relating to their usual patterns of physical activity under the headings of 
regular walking or cycling, recreational activity and sporting (vigorous) activity. 
Regular walking and cycling related to weekday journeys, which included travel to and 
from work. Recreational activity included gardening, pleasure walking, and do-it-
yourself jobs. Sporting activity included running, golf, swimming, tennis, sailing, and 
digging. A physical activity score was derived for each man according to the frequency 
and type (intensity) of physical activity283. Scores were assigned for each type of 
activity and duration on the basis of the intensity and energy demands of the activities 
reported284. The total score for each man is a relative measure of how much physical 
activity has been carried out. Participants were classified into six categories based on 
their physical activity score: inactive (score 0-2), occasional (score 3-5; regular walking 
or recreational activity only), light (score 6-8; more frequent recreational activities or 
vigorous exercise less than once a week), moderate (score 9-12; cycling or very frequent 
recreational activities or sporting activity once a week), moderately-vigorous (score 13-
20; sporting activity at least once a week or frequent cycling, plus frequent recreational 
activities or walking, or frequent sporting activity only), and vigorous score ≥ 21; very 
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frequent sporting exercise or frequent sporting exercise plus other recreational 
activities). This physical activity score has been previously validated at both the 
baseline examination and the re-examination in 1998-2000 against heart rate and lung 
function (FEV1), in men free of pre-existing CHD
283;284. 
 
3.3.4. Socioeconomic circumstances 
Adult socioeconomic position: The longest held occupation of participants was recorded 
at study entry (aged 40-59 years), via a nurse-administered questionnaire in 1978-80 
(Appendix VII). The Registrar General’s Classification of Occupations285 was used to 
classify subjects into six occupational social class categories: I (professional 
occupations e.g. barristers, physicians, engineers), II (intermediate occupations e.g. 
teachers, sales managers), III non-manual (skilled non-manual occupations e.g. clerks, 
shop assistants), III manual (skilled manual occupations e.g. bricklayers, coalminers), 
IV (partly skilled occupations e.g. bus conductors, postmen) and V (unskilled 
occupations e.g. porters, general labourers). Occupational social classes were 
dichotomised into two groups: non-manual (social classes I, II, III non-manual) and 
manual (social classes III manual, IV, V). 
 
In additional to occupational social class, information was collected on other measures 
of socioeconomic position. The 20 years re-examination questionnaire in 1998-2000 
asked participants about car and house ownership, and whether they had central heating 
at home. In addition, the earlier 1996 postal questionnaire provided information on 
education (age at leaving full-time education) and pension (what type of financial 
support participants have or will have on retirement - state only or state plus private 
pension) [Appendix VIII]. The response rate for the 1996 postal questionnaire was 88%. 
 
Childhood socioeconomic position: In the 1992 postal questionnaire, information on 
childhood socioeconomic variables was collected (Appendix IX). Participants were 
asked for their father’s longest held occupation. Registrar General’s Classification of 
Occupations 1931286 was used to classify participants into the following social class 
groups: I (professional occupations e.g. engineers, physicians, clergymen, bankers), II 
Chapter 3 Methodology 
 
89 
 
(intermediate occupations e.g. farmers, coal mine owners/managers,), III (skilled 
occupations e.g. gardeners, farm or factory foremen), IV (partly skilled occupations e.g. 
shepherds, fishermen, miners, quarries) and V (unskilled occupations e.g. masons or 
builders’ labourers, porters, messengers). The 1992 questionnaire also collected 
information on childhood household amenities. Participants were asked if their home 
had a bathroom in the house, hot water supply and family car ownership, up to 10 years 
old. The response rate for the 1992 postal questionnaire was 91%. 
 
Social interaction and family circumstances: The 20 year re-examination questionnaire 
in 1998-2000, asked men how often they saw or spoke to their children, siblings, friends 
and neighbours (every week; every month; every few months; every year; rarely/never; 
does not apply), whether they were living alone (living alone; living with a 
partner/spouse; living with other family members; living with other people), and what 
their marital status was (single; married; widowed; divorced/separated; other).  
 
3.3.5. Physical measurements 
At the physical examination in 1998-2000, blood pressure was measured in duplicate in 
the right arm with a Dinmap 1846SX automated blood pressure monitor (Critikon Inc, 
Tampa, USA) with the participant seated and the arm supported287. Blood pressure was 
adjusted for observer variation288. Forced expiratory volume in 1 second (FEV1) was 
also assessed at the re-examination as part of a spirometric lung function assessment. A 
Vitalograph Compact II instrument was used and this was calibrated using a precision 
syringe at least twice daily289. 
 
3.3.6. Blood measurements 
Concentrations of blood lipids and glucose were measured at the Department of 
Chemical Pathology, Royal Free Hospital, and insulin was measured at the Department 
of Diabetes and Metabolism, University of Newcastle. Serum total cholesterol and high 
density lipoprotein (HDL) cholesterol, and triglycerides were measured using an 
automated analyser Hitachi 747 (Hitachi, Tokyo, Japan)290. Low density lipoprotein 
(LDL) cholesterol was calculated using the Fredrickson-Friedewald equation291. Plasma 
glucose was measured using a glucose oxidase method with a Falcor 600 automated 
Chapter 3 Methodology 
 
90 
 
analyser (A Menarini Diagnostics, Wokingham, United Kingdom). Serum insulin was 
measured using a Drew Hb Gold instrument (Drew Scientific Group Plc, Barrow in 
Furness, UK). Glucose, insulin, triglycerides and LDL cholesterol concentrations were 
adjusted for the period of fasting and the time of day the blood sample was taken290.  
 
A number of emerging cardiovascular risk markers, including haemostatic and 
inflammatory markers, were also measured in citrated blood plasma at the Department 
of Medicine, University of Glasgow283;292. Blood anticoagulated with K2-EDTA (1.5 
mg/ml) was used for the measurement of haematocrit, white blood cell count, and 
platelet count in an automated cell counter and plasma viscosity at 37°C in a semi-
automated capillary viscometer (Coulter Electronics, Luton, UK)293. Blood was also 
anticoagulated with 0.109 mol/L trisodium citrate (9:1 vol:vol) for measurement of 
clottable fibrinogen (Clauss method). Plasma concentrations of tissue plasminogen 
activator (t-PA) antigen and fibrin D-dimer were measured by using enzyme-linked 
immunosorbent assays (Biopool AB, Umea, Sweden), as was von Willebrand factor 
(vWF) antigen (DAKO, High Wycombe, UK). C-reactive protein (CRP) was assayed 
by ultrasensitive nephelometry (Dade Behring, Milton Keynes, UK). Interleukin-6 was 
assayed by a high-sensitivity ELISA (R and D Systems, Oxford, UK). Serum 
homocysteine was measured at the Department of Pharmacology, University of Bergen, 
Norway. A modification of an automated assay was used, based on pre-column 
derivatisation with monobromobimane, followed by reverse phase high performance 
liquid chromatography with fluorescence detection294. 
 
3.3.7. Morbidity 
The self-completed questionnaire at re-examination in 1998-2000 sought information 
from participants on their health status and disability. Participants were asked to rate 
their present state of health as excellent, good, fair or poor. Mobility limitation was 
determined by asking participants whether they had difficulty carrying out any of the 
following activities on their own as a result of a long term health problem: difficulty 
going up/down stairs, difficulty bending/straightening up, difficulty maintaining 
balance, difficulty walking for a quarter of a mile on a level surface .  
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3.3.8. Prevalent disease 
The self-completed questionnaire at re-examination in 1998-2000 sought information 
from participants on their medical history, which provided information on the prevalent 
disease. Participants were asked if a doctor had ever told them that they have had a heart 
attack (coronary thrombosis or myocardial infarction), angina, stroke, diabetes, heart 
failure and cancer. Participants provided a ’yes/no’ response to each question. 
 
3.3.9. Incident disease 
The four main outcome variables assessed in this thesis are incident CHD events, 
incident CVD events, CVD mortality and all-cause mortality. An incident CHD event 
was defined as non-fatal MI or fatal CHD (ICD-9 codes 410-414). An incident CVD 
event was defined as non-fatal MI, non-fatal stroke or fatal CVD (ICD-9 codes 390-
459). CVD mortality was defined as all fatal CVD deaths (ICD-9 codes 390-459). All-
cause mortality was defined as death from any cause. Deaths were ascertained from the 
NHS Central Register (as described in section 3.2.4.1). Non-fatal MIs and non-fatal 
strokes were ascertained from the regular review of general practice records (as 
described in section 3.2.4.2). This thesis uses available followed up data on 
cardiovascular mortality and morbidity from the twenty year re-examination, in 1998-
2000, to June 2010. 
 
3.4.  Strengths of the data source for the intended analysis 
The BRHS is a suitable cohort for studying the objectives set out in this thesis. The 20 
year re-examination in 1998-2000 provides a detailed assessment of both a range of 
body composition measures (including adiposity and muscle mass) and extensive 
dietary data from a food frequency questionnaire, which will be used as the major 
exposure variables. Also, comprehensive information on cardiovascular risk factors was 
collected in 1998-2000. The BRHS also provides continuous follow-up over an 
extended period, with regular and objective measurements on CHD events, CVD events 
and mortality. This will enable the prospective investigation of measures of body 
composition and dietary patterns in relation to the risk of CVD and mortality in older 
men.  
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A major strength of the BRHS is that it is a socioeconomically and geographically 
representative population-based sample of middle-aged men from across Britain264. The 
cohort has benefited from high response rates throughout the follow-up. Data collection 
and recording in the BRHS have been maintained to a very high standard since baseline, 
with near complete follow-up (>98%) for mortality and morbidity35. At the start of the 
study (1978-80), characteristics of participants were compared to non-responders. Men 
who did not participate were younger, more likely to be unmarried, and more likely to 
be less skilled workers compared to study participants295. In the first three years of 
follow-up, non-participants also had a higher total mortality rate, but this declined to 
non-significant levels subsequently. Also, the death rate was similar in participants and 
non-participants for cardiovascular disease, suggesting that any analyses in this thesis 
related to this particular cause of death should not be biased by non-participation. 
 
However, the BRHS has been limited by the restriction of the study population to men 
and the lack of representation from ethnic minority groups, which limits generalizability 
of findings to non-White British populations. The BRHS also avoided inner city 
populations and towns with high mobility, which has had the advantage of enabling the 
cohort to be stable with high response rates.  
 
3.5. Statistical methods 
All statistical analyses were carried out using Stata versions 12-13 (Stata Corp., College 
Station, Texas). Some of the main statistical methods used in this thesis are described 
below. However, specific details of statistical analyses are described in more detail in 
each of the relevant results chapters.  
 
3.5.1. Generalised linear models 
Generalised linear models are used to analyse the relationship between an exposure 
variable and an outcome variable296. Linear regression is used to relate a continuous 
outcome variable (y) to exposure variables (x) as follows: 
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y = β0+ β1x 
β0 is the intercept (the value of y where x = 0) and β1 is the regression coefficient (the 
increase in y for every unit increase in x). 
Linear regression assumes that for any value of x, y is normally distributed and that the 
magnitude of the scatter of the points about the line is the same throughout the length of 
the line. Linear regression has been used to assess the cross-sectional associations at re-
examination in 1998-2000 between continuous measures of body composition or diet in 
relation to cardiovascular risk factors (see chapters 4, 6 and 8). 
 
Logistic regression is used to model the association between a binary outcome variable 
(y) and an exposure variable (x), fitted on a log scale.  
Log (odds) = β0+ β1x 
Logistic regression thus generates the odds of the outcome event in the exposed group, 
the odds of the outcome event in the unexposed group, and the ratio of these two odds: 
Odds = p/1-p    (p = probability of the outcome) 
Odds ratio = Odds in exposed group/Odds in unexposed group 
Logistic regression does not require a linear relationship between the exposure and 
outcome variables since it applies a non-linear log transformation to the predicted odds 
ratios. Logistic regression has been used to assess the cross-sectional associations at re-
examination in 1998-2000 between categorical measures of body composition or diet in 
relation to cardiovascular risk factors (see chapters 4 and 7). 
 
3.5.2. Survival analysis and Cox proportional hazards regression analysis 
Survival analysis is used to investigate the probability of having an event when time to a 
binary event is the main outcomes of interest296. Survival time for each participant is the 
time from a predetermined start point e.g. entry in to the study, until the occurrence of 
the event of interest. For some participants the time to the event of interest may be 
censored, if the event has not occurred at the end of follow-up, they were lost to follow-
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up after a certain date or if they die from a cause other than the event of interest. The 
Kaplan Meier method can be used to calculate the survival probability and to plot 
survival curves, when the exact follow-up time is known. 
 
Cox proportional hazards regression analysis is used to examine the association between 
an exposure variable and a time to event outcome variable, and is the most commonly 
used approach to the regression analysis of survival data. It assumes the ratio of the 
hazards comparing different exposure groups is constant over time, which is known as 
the proportional hazards assumption. This assumption is amenable to testing, on the 
basis of Schoenfeld residuals297. The mathematical form of the Cox proportional 
hazards model is: 
h(t)=h0(t) × exp(β1x1 + β 2x2 +...+ β pxp)    
where h(t) is the hazard at time t, h0(t) is the baseline hazard (the hazard for an 
individual in whom all exposure variables = 0) at time t, and x1 to xp are the p exposure 
variables. 
The hazard ratio comparing exposed and unexposed individuals at time t is: 
HR(t) = h0(t) × exp(β1)/h0(t) = exp(β1)  
Survival analysis and cox proportional hazards regression analysis has been used to 
assess the prospective associations between measures of body composition and dietary 
patterns at re-examination in 1998-2000 with the risk of cardiovascular outcomes and 
mortality over 11 years of follow-up (see Chapters 5, 6 and 8). 
 
3.5.3. Principal component analysis 
Principal component analysis is a multivariate statistical technique which analyses a 
data table representing observations described by several exposure variables. It is a 
method used to find a few combinations of exposure variables, that adequately explain 
the total observed variation, and hence reduces the complexity of the data296. Principal 
component analysis computes new variables called principal components which are 
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obtained as linear combinations of the original variables298. The first principal 
component will explain the greatest variance in the data. The second component is 
computed under the constraint of being orthogonal to the first component and will 
explain the second greatest variance in the data, and so on.  
 
Within nutritional epidemiology, principal component analysis is an exploratory 
approach commonly used to identify a posteriori dietary patterns28 and identifies foods 
frequently consumed together. It aggregates food groups on the basis of the degree to 
which they are correlated with one another, with the aim of identifying food 
items/groups that account for the largest amount of variation in diet between 
individuals29. Principal component analysis is therefore useful for describing the 
intercorrelations between foods299. This thesis has used principal component analysis of 
food groups, derived from the FFQ at re-examination in 1998-2000, to apply a 
posteriori dietary patterns to the BRHS cohort (see Chapter 8). 
 
 
Chapter 3 Methodology 
 
 
96 
 
Table 3.1 Towns included in the British Regional Heart Study 
 
Town 
Standardised mortality ratios 
for cardiovascular disease in 
men aged 35-65 years in 1969-73 
Men examined 
(n) 
Response rate  
(%) 
Ayr 140 301 70 
Bedford 80 303 73 
Burnley 114 286 80 
Carlisle 121 389 85 
Darlington 109 382 82 
Dewsbury 142 326 79 
Dunfermline 118 350 80 
Exeter 90 332 84 
Falkirk 98 308 75 
Gloucester 84 309 73 
Grimbsy 96 318 71 
Guildford 78 335 82 
Harrogate 82 280 77 
Hartlepool 101 334 70 
Ipswich 92 362 85 
Lowestoft 85 324 83 
Maidstone 99 319 72 
Mansfield 95 321 80 
Merthyr Tydfil 135 282 76 
Newcastle-upon-Lyme 115 293 77 
Scunthorpe 109 313 76 
Shrewsbury  95 310 83 
Southport 114 322 80 
Wigan 134 337 77 
Data source: Adapted from Shaper et al, 198134 
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Figure 3.1 Map of 24 British Regional Heart Study towns in Great Britain 
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Figure 3.2 Timeline showing follow-up in the British Regional Heart Study 
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CHAPTER 4 Cross-sectional associations of body composition and cardiovascular 
risk factors in older British men  
4.1. Summary 
Sarcopenia has been defined as the age-associated loss of skeletal muscle mass and has 
been associated with metabolic impairment, cardiovascular disease (CVD) risk factors, 
physical disability and mortality. It has a multifactorial aetiology which is not fully 
understood. Sarcopenia often occurs in combination with obesity (sarcopenic obesity), 
and sarcopenia with obesity may synergistically increase their effect on metabolic 
disorders, CVD and mortality. However, whether sarcopenic obese individuals have the 
most adverse cardiovascular risk profile is unclear. In this chapter, the cross-sectional 
associations between different measures of sarcopenia, obesity, and sarcopenic obesity 
with cardiovascular risk factors were examined. At the 20 year re-examination in 1998-
2000, 4252 men from the British Regional Heart Study (BRHS), aged 60-79 years, 
attended a physical examination (which included body composition assessment), 
provided a fasting blood sample, completed a general questionnaire on their lifestyle 
and medical history, and also a food frequency questionnaire. Cardiovascular risk 
factors were examined by quartiles of mid-arm muscle circumference (MAMC) and fat-
free mass index (FFMI), by waist circumference (WC) groups and by sarcopenic 
obesity groups (defined by combinations of MAMC and WC, or FFMI and fat mass 
index [FMI]). In addition, factors associated with low muscle mass (lowest quartile of 
MAMC/FFMI) were analysed using multivariable logistic regression. Physical 
inactivity and higher levels of insulin resistance, C-reactive protein (CRP), von 
Willebrand Factor (vWF) and fibrinogen were associated with significantly increased 
odds of lower muscle mass (MAMC and FFMI) after adjustment for age, body mass 
index (BMI), behavioural variables and morbidity. Those with a higher percent of 
energy intake from carbohydrates showed lower odds of low MAMC (odds ratio [OR]: 
0.73, 95% CI: 0.55-0.96) and low FFMI (OR: 0.76, 95% CI: 0.58-0.99). With 
participants classified into four sarcopenic obesity groups, the sarcopenic obese group 
(defined using combinations of MAMC and WC, and alternatively FFMI and FMI) had 
significantly higher levels of inflammatory and haemostatic markers (CRP, vWF and 
fibrinogen) than the sarcopenic alone, obese alone or non-sarcopenic, non-obese body 
composition groups. 
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4.2. Introduction 
Ageing is associated with importance changes in body composition; typically visceral 
fat increases and muscle mass decreases, as outlined in Chapter 2 (section 2.4). 
Sarcopenia, the age-associated loss of muscle mass and function, is associated with 
increased risks of metabolic impairment, physical disability, functional impairment and 
mortality137;153-155;157-159. The aetiology of sarcopenia is multifactorial and is not fully 
understood. The risk of sarcopenia is increased by cardiovascular risk factors including 
physical inactivity and current smoking131;138. Diet, as well as being a major 
cardiovascular risk factor, may also be an important determinant of sarcopenia, with 
low intake of protein, total energy, vitamin D, antioxidants and omega-3 
polyunsaturated fatty acids implicated in the development of sarcopenia132;133. Recent 
evidence also suggests cardiovascular and inflammatory biomarkers are important 
contributors to sarcopenia progression157. In addition, there is a suggestion from clinical 
studies that endothelial dysfunction may also be a determinant of sarcopenia300 but this 
has been little studied in the general population. It is important to establish the 
contributions of a wide variety of potential determinants of low muscle mass, as well as 
potential mechanisms linking sarcopenia to adverse outcomes, to inform the 
development of specific prevention and intervention strategies in older people.  
 
Recently, the concept of sarcopenic obesity has emerged which refers to sarcopenia 
coupled with high levels of adipose tissue18-22. The associations between adiposity and 
established and emerging cardiovascular risk markers are well established in the elderly, 
with a previous report from the cohort studied in this thesis (the BRHS) showing that 
adiposity (especially high BMI and high waist circumference) is an established risk 
factor for the metabolic syndrome and insulin resistance in older men267. Visceral fat 
and muscle mass share common metabolic and inflammatory pathways18. Therefore it is 
hypothesised that sarcopenia and obesity may act synergistically, so that sarcopenic 
obesity may have a greater effect on the risks of the metabolic syndrome, CVD and 
mortality than either obesity or sarcopenia alone18;22. However, as reviewed in section 
2.4.7, whether sarcopenic obese individuals have a particularly adverse cardiovascular 
risk profile is unclear. 
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This chapter therefore aims to examine the cross-sectional associations between 
individual and combined measures of low muscle mass (sarcopenia) and obesity with 
established and emerging cardiovascular risk factors, including dietary factors, in older 
men aged 60-79 years. The association of obesity with cardiovascular risk factors has 
been widely studied in the elderly. However, there are gaps in the literature on the 
associations of sarcopenia and combined measures of sarcopenia and obesity with 
cardiovascular risk factors. This chapter will therefore focus particularly on measures of 
muscle mass and composite measures of obesity and low muscle mass in order to 
address these gaps in the literature. 
 
4.3.  Objectives 
To examine the associations between various body composition measures (adiposity 
and in particular low muscle mass) and cardiovascular risk factors in older age (60-79 
years). The specific aims of this chapter are: 
i) To describe the patterns of body composition of a cohort of older men. 
ii) To explore the correlations between different measures of body composition i.e. 
adiposity and muscle mass. 
iii) To explore the relationships of sarcopenia measures with cardiovascular risk 
factors. 
iv) To examine the relationships of obesity with cardiovascular risk factors. 
v) To explore the relationships of combined measures of sarcopenia and obesity 
with cardiovascular risk factors. 
 
4.4.  Methods 
4.4.1. Subjects and methods of data collection 
Cross-sectional data used in this chapter are from the 20 year re-examination of BRHS 
participants, then aged 60-79 years, in 1998-2000. 4252 men (77% of survivors) 
attended a physical examination, provided a fasting blood sample, completed a general 
questionnaire on their lifestyle and medical history, and also a food frequency 
questionnaire (FFQ)264. The physical examination involved body composition 
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measurements (height, weight, waist circumference [WC], hip circumference, 
subscapular skinfold thickness, triceps skinfold thickness and mid-upper arm 
circumference) and bioelectrical impedance analysis (BIA), as described in detail in 
Chapter 3, section 3.3.1. 
 
4.4.2.  Measures of adiposity 
Adiposity measures used in this chapter included markers of whole body adiposity 
(BMI and FMI), central adiposity (WC, waist-to-hip ratio [WHR] and subscapular 
skinfold thickness) and peripheral adiposity (triceps skinfold thickness). Established 
cut-points were used to define overweight and obesity according to BMI (≥ 25 kg/m2 
and ≥ 30 kg/m2 respectively) and sex-specific cut-points were used to define obesity for 
WC (>102 cm) and WHR (≥ 1.00)105. Recent literature suggests using ≥ 0.90 as the 
WHR cut-point for men270. However, since this would have classified 80.0% of 
participants as obese, a more stringent cut-point of ≥ 1.00 was more appropriate for this 
cohort (classifying 18.7% as obese). Participants above the percentile point of FMI 
corresponding to the obesity cut-off for WC (28.7th percentile in this dataset) were also 
classified as obese (>11.1 kg/m2). The measure of adiposity presented in detail in 
relation to cardiovascular risk factors in this chapter was WC, classified into 4 WC 
categories (<94, 94-102, 103-105, ≥ 106 cm). 
 
4.4.3. Measures of muscle mass 
Muscle mass measures included an anthropometric measurement (mid-arm muscle 
circumference [MAMC]) and BIA measurements (fat-free mass index [FFMI] and 
skeletal muscle index [SMI]). In this chapter, two measures of muscle mass were 
presented in detail in relation to cardiovascular risk factors (MAMC and FFMI), both 
divided by quartiles of the distribution. To assess whether sarcopenic obese individuals 
had the most adverse cardiovascular risk profile, participants were categorised into four 
non-overlapping groups (non-sarcopenic, non-obese; sarcopenic; obese; sarcopenic 
obese) based on the combination of anthropometric measurements (WC and MAMC) or 
BIA measurements (FMI and FFMI). The obesity definitions used were mentioned 
above (Section 4.4.2). Since no universally accepted operational definition of 
sarcopenia has yet been adopted17, sarcopenia was defined as below the second quintile 
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of MAMC (≤ 25.9 cm) or FFMI (≤ 16.7 kg/m2), as including only those below the 
lowest quartile did not yield adequate numbers in the sarcopenic obesity group.  
 
4.4.4. Cardiovascular risk factors 
4.4.4.1 Socio-demographic and behavioural risk factors 
Adult occupational social class was based on the longest held occupation recorded at 
study entry, in 1978-80, using the Registrar General’s occupational classification, as 
described in Chapter 3 (section 3.3.4). Participants were classified as manual, non-
manual or armed forces. Behavioural risk factors (cigarette smoking, physical activity 
and alcohol intake) were measured at the re-examination in 1998-200 as described in 
Chapter 3 (section 3.3.3). Men were classified into four smoking groups (never; long-
term ex; recent ex; current). Current physical activity was classified in six groups based 
on exercise frequency and intensity (inactive; occasional; light; moderate; moderately 
vigorous; vigorous). Alcohol intake was classified into five groups based on the number 
and frequency of alcoholic beverages consumed per week (none; occasional; light; 
moderate; heavy). 
 
4.4.4.2 Dietary assessment 
A self-administered postal food frequency questionnaire, completed in 1998/2000, 
provided dietary intake data, as described in detail in Chapter 3, section 3.3.2. 
Participants reported usual frequency of consumption of 86 food and drink types. 
Nutrient intakes were derived using a validated computer program to calculate total 
nutrient composition of foods consumed301. In addition, participants were asked to 
indicate how often they consumed fresh fruit and vegetables – rarely/never, monthly, or 
1, 2, 3, 4, 5, 6, or 7 days per week. Daily consumption was classified as 7 days per 
week. The multivariate nutrient density model was used to adjust macronutrients for 
energy intake; carbohydrates, protein, total fat and saturated fat were expressed as 
percentages of energy (% kcal). Plasma vitamin C and E were also available from blood 
samples at the re-examination (1998-2000)301. 
 
4.4.4.3 Metabolic risk factors 
Metabolic markers (glucose, insulin, triglyceride, high density lipoprotein [HDL] 
cholesterol and blood pressure) were measured by physical examination and by the 
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collection of fasting blood samples at re-examination in 1998-2000 as described in 
Chapter 3 (section 3.3.5 and 3.3.6). The homeostasis model assessment was calculated 
to estimate insulin resistance (HOMA-IR) = fasting glucose (mmol/L) x insulin 
(U/mL)]/22.5267. Metabolic syndrome was classified according to the National 
Cholesterol Education Program definition302; ≥ 3 metabolic risk factors as follows: 1) 
Central obesity: WC >102 cm; 2) Fasting plasma glucose >6.1 mmol/L; 3) Serum 
triglyceride >1.7 mmol/L; 4) Serum HDL cholesterol <1.04 mmol/L; and 5) 
Hypertension: blood pressure >130/85 mmHg or using blood pressure medication.  
 
4.4.4.4 Inflammatory/hemostatic risk factors 
Plasma concentrations of C-reactive protein (CRP), tissue plasminogen activator (t-PA), 
D-dimer, von Willebrand Factor (vWF), fibrinogen, interleukin 6 (IL-6) and 
homocysteine were measured from blood samples collected at re-examination in 1998-
2000 as described in Chapter 3 (section 3.3.6). 
 
4.4.4.5 Morbidity 
Participants completed a questionnaire at the re-examination in 1998-2000, which 
asked: “Have you ever been told by a doctor that you have or have had any of the 
following conditions?” Participants provided ’yes/no’ responses to the following 
categories: heart attack; angina; stroke; diabetes; heart failure; cancer. Prevalent CVD 
was defined as heart attack, angina or stroke diagnosis, and prevalent CHD as heart 
attack or angina diagnosis. This questionnaire also asked participants to rate their 
present state of health as excellent, good, fair or poor and enquired whether they had 
any long-standing illness or disability. Mobility limitation was determined by whether 
participants stated they had difficulty either going up/down stairs or walking for a 
quarter of a mile on a level surface303. Lung function was assessed at the re-examination 
in 1998-2000, providing measurements of forced expiratory volume in 1 second 
(FEV1). FEV1 was height-standardised to the mean height in this study (1.72m)
289. 
Additionally, at the re-examination participants were asked to report whether their 
weight had changed in the previous 3 years (weight loss; no change; gain or 
fluctuation). A dichotomous weight loss variable was created: yes (weight loss) and no 
(no change; gain or fluctuation). 
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4.4.5. Statistical methods 
Pearson correlation coefficients were used to assess the relationships between various 
measures of body composition. The distributions of HOMA-IR, CRP, D-dimer, IL-6 
and homocysteine were highly skewed and were log transformed. Descriptive 
characteristics of participants were presented by quartiles of the distribution of MAMC 
and FFMI and by the four WC groups, and p values for trend were obtained fitting 
MAMC/FFMI/WC continuously using regression analyses, adjusting for age and BMI, 
fitted as continuous variables. Descriptive characteristics of participants were also 
presented by four sarcopenic obesity groups (as defined in section 4.4.3) and p values 
for differences between groups were obtained using chi squared tests for proportions 
and analysis of variance (ANOVA) for means. 
 
Multiple logistic regression was used to provide odds ratios, and 95% CIs, for the 
associations between low muscle mass (the lowest quartile of MAMC/FFMI compared 
to the reference group of the highest three quartiles combined) and cardiovascular risk 
factors. Continuous dietary, metabolic and inflammatory risk factors were divided into 
quartiles and odds ratios for low muscle mass were presented for the highest versus the 
lowest quartile. Models were adjusted for potential confounders, which are related to 
muscle mass, in a sequential manner including age (model 1), adding BMI and 
behavioural risk factors (model 2) and adding morbidity variables (model 3). In 
addition, to adjust for total energy intake this variable was included in the models for all 
dietary variables assessed by the FFQ280. Age, BMI, FEV1 and energy intake were fitted 
as continuous variables. Smoking, physical activity, alcohol, social class, CVD, 
diabetes, cancer and poor/fair health were fitted as categorical variables. 
 
4.5.  Results 
Among 4252 men aged 60-79 years who attended the 20 year re-examination, the mean 
age was 69 years. A small proportion of the cohort were current smokers (12.8%), 
heavy drinkers (3.0%) or physically inactive (11.5%). Just over half of the men had a 
manual occupational social class (51.0%). 
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4.5.1. Body composition characteristics of the study population 
The mean body composition measures of the cohort are presented in Table 4.1. Of the 
4252 men attending the physical examination, 4204 had MAMC data, 4114 had FFMI 
data and 4225 had WC data for analysis. Defining adiposity using BMI, over two-thirds 
of the participant were overweight (BMI ≥ 25 kg/m2, n = 2944, 69.6%) and almost one 
in five were obese (BMI ≥ 30 kg/m2, n = 735, 17.4%). The proportion of participants 
classified as obese was higher when measures of central adiposity were used. Using the 
established sex-specific WC definition (WC >102cm), 29.4% of participants were 
classified as obese and using the established sex-specific WHR definition (WHR ≥ 0.90 
cm) 80.0% were classified as obese. However, when a more stringent WHR definition 
was applied (WHR ≥ 1.00 cm), only 18.7% of participants were classified as obese. 
Using bioelectrical impedance-based measures of body composition, just over a third of 
the mean body weight of participants (80.1kg) was fat mass (FM = 35.1 %) and almost 
two-thirds was lean mass (FFM = 64.9 %). Using an alternative fat-free mass 
estimate150, skeletal mass (SM) contributed a mean of 39.0% of the total mass of 
participants. 
 
4.5.2. Correlations between body composition measures 
The Pearson correlation coefficients between various body composition measures are 
shown in Table 4.2. Strong positive correlations was found between key measures of 
adiposity, including BMI and WC (r = 0.87, p <0.01), BMI and FMI (r = 0.81, p <0.01) 
and WC and FMI (r = 0.76, p <0.01). A moderate positive correlation was found 
between BMI and WHR (r = 0.55, p <0.01). Only modest positive correlations were 
found between BMI, WC or WHR with subscapular or triceps skinfold measures (r = 
0.29 to 0.63, p <0.01). FFMI and SMI, two measures of muscle mass derived from BIA 
but using different formulae, showed a near perfect positive correlation (r = 0.99, p 
<0.01). MAMC, a measure of regional muscle mass, showed weak to moderate 
correlations with FFMI (r = 0.41, p <0.01) and SMI (r = 0.36, p <0.01). Observed 
correlations between measures of adiposity and measures of muscle mass varied, 
ranging from a weak negative association (FMI and FFMI, r = -0.07, p <0.01) to a 
moderate positive correlation (BMI and MAMC, r = 0.61, p <0.01). 
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4.5.3. Muscle mass and cardiovascular risk factors 
In this chapter, results are presented for two markers of muscle mass (MAMC and 
FFMI) in relation to cardiovascular risk factors. Results are only presented for FFMI, 
and not SMI, since these two BIA-derived measures of muscle mass were highly 
correlated (Table 4.2) and showed virtually identical results in relation to cardiovascular 
risk factors. 
 
4.5.3.1 Mid-arm muscle circumference and cardiovascular risk factors 
Cardiovascular risk factors in relation to quartiles of MAMC are presented in Table 4.3. 
MAMC showed a strong inverse association with age and a strong positive association 
with BMI. After adjustment for age and BMI, MAMC was inversely associated with 
smoking, heavy drinking, physical inactivity and manual occupational social class. 
Several dietary variables, including intakes of energy, fibre, vitamin C, iron, daily fruit 
intake, daily vegetable intake and plasma vitamin E showed significant positive linear 
trends with MAMC. In contrast, the percent of energy intake from fat showed a 
significant inverse linear trend with MAMC, but no significant association was seen 
with percent of energy from saturated fat. Central obesity showed a significant positive 
linear trend with MAMC in age-adjusted analysis. HOMA-IR and high glucose were 
inversely associated with MAMC, after adjustment for age and BMI, while 
hypertension, high triglycerides, low HDL and the metabolic syndrome showed no 
associations. MAMC showed inverse graded associations with all of the 
inflammatory/hemostatic markers (CRP, t-PA, D-dimer, vWF, fibrinogen, IL-6 and 
homocysteine) after age and BMI adjustment. MAMC showed a significant positive 
association with FEV1 and a significant inverse association with prevalent CVD, CHD, 
heart failure, poor/fair self-rated health, long-standing illness/disability, mobility 
limitation and weight loss in the past 3 years, after age and BMI adjustment (p<0.01). 
 
Table 4.4 shows the relationships between low muscle mass and cardiovascular risk 
factors, with age-adjusted odds ratios for the lowest quartile of MAMC compared to the 
reference group of the other three quartiles combined. Current smoking and heavy 
drinking were initially associated with increased odds of low muscle mass in the age-
adjusted model. However, these associations were attenuated after additional adjustment 
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for BMI, and behavioural variables. In the fully adjusted model (further adjusted for 
morbidity variables), the only socio-demographic/behavioural variables significantly 
associated with increased odds of low MAMC were physical inactivity and manual 
social class. Men in the highest quartile (compared to the lowest) of percent of energy 
from protein, vitamin C intake, plasma vitamin E, and daily fruit consumers, were at 
significantly lower odds of low MAMC, adjusting for age. However, after additional 
adjustments for BMI, behavioural and morbidity variables, these associations were 
markedly attenuated and became statistically non-significant. Men with high energy 
intake and high percentage energy from carbohydrates had lower odds of low MAMC 
even after adjustment for age, BMI, behavioural and morbidity variables. In contrast, 
men with a high percentage energy from fat showed higher odds of low MAMC. High 
HOMA-IR and blood glucose were associated with increased odds of low MAMC after 
full adjustment. No independent association was seen with other metabolic risk factors. 
HOMA-IR was strongly correlated with obesity (r = 0.45, p<0.001), which explains 
why the direction of association changed after BMI adjustment. High levels of CRP, 
vWF and fibrinogen were associated with increased odds of low MAMC after 
adjustment for BMI, behavioural and morbidity variables. However, D-dimer, t-PA, IL-
6 and homocysteine were not significantly associated with low MAMC.  
 
4.5.3.2 Fat-free mass index and cardiovascular risk factors 
Cardiovascular risk factors are presented by quartiles of FFMI in Table 4.5. Similar 
linear trends were observed between variables and FFMI quartiles, compared to MAMC 
quartiles. Table 4.6 shows the relationships between low muscle mass and 
cardiovascular risk factors, with odds ratios for the lowest quartile of FFMI compared to 
the reference group of the other three quartiles combined. As for the MAMC-based 
analyses, consistent statistically significant associations were also observed, with those 
in the lowest FFMI quartile having an increased odds of physical inactivity, a lower 
percent of energy from carbohydrates, and higher levels of HOMA-IR, CRP, vWF and 
fibrinogen after adjustment for age, BMI, behavioural and morbidity variables. 
However, in contrast to MAMC-based analyses, low plasma vitamin C, and higher 
levels of central obesity, high triglycerides, t-PA and the metabolic syndrome were also 
statistically significantly associated with low FFMI.  
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4.5.4. Adiposity and cardiovascular risk factors 
As highlighted in section 4.2, the associations between adiposity and established and 
emerging cardiovascular risk markers are well established in the elderly, with a previous 
report from the BRHS already presenting the associations between adiposity (including 
BMI, WC, WHR and FM) and metabolic abnormalities and insulin resistance267. In this 
chapter, results are presented for one measure of adiposity (WC) in relation to 
cardiovascular risk factors, which will extend previous work in this cohort267 to also 
include emerging cardiovascular risk factors. WC was chosen as a valid marker of 
visceral adiposity304, which is strongly associated with CVD and mortality in older 
subjects13;79;122;125-127. 
 
4.5.4.1 Waist circumference and cardiovascular risk factors 
Cardiovascular risk factors in relation to WC groups are presented in Table 4.7. After 
adjustment for age and BMI, WC showed a strong inverse trend with current smoking 
and a strong positive trend with heavy drinking and physical inactivity. Several dietary 
variables were related to WC, with inverse trends seen with percent of energy from 
carbohydrate, percent of energy from protein, fibre, vitamin C intake, daily fruit intake 
and plasma vitamin C, and a positive linear trend with percent of energy from fat and 
percent of energy from saturated fat. Several metabolic variables were associated with 
WC, with significant positive trends seen with increasing mean HOMA-IR levels, and 
the proportion of participants with high triglycerides, low HDL, high glucose and the 
metabolic syndrome. Strong positive linear trends were also seen between WC and all 
of the inflammatory/hemostatic markers (CRP, t-PA, D-dimer, vWF, fibrinogen, IL-6 
and homocysteine) after adjustment for age and BMI. 
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4.5.5. Combined measures of adiposity and muscle mass and cardiovascular risk 
factors 
4.5.5.1 Waist circumference, mid-arm muscle circumference and cardiovascular risk 
factors 
Both WC and MAMC measurements were available for 4178 of the 4252 participants 
attending the re-examination in 1998 to 2000. Using these anthropometric measures to 
classify participants into sarcopenic obesity groups, 36.1% of men were defined as non-
sarcopenic, non-obese, 35.1% were sarcopenic only, 24.1% were obese only and 4.7% 
had sarcopenic obesity. Cardiovascular risk factors in the four sarcopenic obesity 
groups (defined by MAMC and WC) are presented in Table 4.8. Mean age was highest 
in the sarcopenic obese group, with a significant difference between groups. All 
cardiovascular risk factors, apart from two dietary variables (vitamin E and iron), 
showed significant differences between sarcopenic obesity groups (p ≤ 0.05).  
 
The non-sarcopenic, non-obese group was generally associated with the lowest levels of 
many cardiovascular risk factors. The sarcopenic only group displayed the greatest 
proportion of current smokers and self-reported weight loss, the lowest percent of 
energy intake from protein, the lowest vitamin C intake, the lowest proportion of daily 
fruit and vegetable intake and the highest percent of energy intake from carbohydrates. 
The obese only group showed the highest proportion of heavy drinkers, the lowest mean 
fibre intake, the highest levels of HOMA-IR, the highest proportion of the metabolic 
syndrome (and the highest proportion of each individual component of the metabolic 
syndrome) and the highest levels of D-dimer and t-PA. The sarcopenic obesity group 
had the highest proportion of physically inactive individuals, the highest proportion of 
manual social class, the highest total energy intake, the highest percent of energy from 
fat and saturated fat, the lowest plasma vitamin C and plasma vitamin E levels, the 
lowest mean FEV1, and the highest mean levels of several inflammatory/hemostatic 
markers (CRP, vWF, fibrinogen, IL-6 and homocycsteine).  
 
4.5.5.1 Fat mass index, fat-free mass index and cardiovascular risk factors 
Both FMI and FFMI measurements were available for 4111 of the 4252 participants 
attending the re-examination between 1998 and 2000. Using these BIA-derived 
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measures to classify participants into sarcopenic obesity groups, 41.2% of men were 
defined as non-sarcopenic, non-obese, 29.5% were sarcopenic only, 18.8% were obese 
only and 10.6% were sarcopenic obese. The prevalence of sarcopenic obesity defined 
using BIA derived measures was more than double the prevalence compared to the 
definition using MAMC and WC (Section 4.5.5.1). Cardiovascular risk factors in 
relation to four sarcopenic obesity groups, defined by FMI and FFMI, are presented in 
Table 4.9. 
 
Broadly similar results were observed defining sarcopenic obesity groups using FMI 
and FFMI to those obtained using MAMC and WC measurements (Section 4.5.5.1). 
However, there were no significant differences between sarcopenic obesity groups in 
the proportion of heavy drinkers, mean percent of energy intake from saturated fat, 
proportion consuming fruit intake daily, mean D-dimer levels, mean homocysteine 
levels and the proportion with weight loss in the past three years. In contrast to the 
MAMC and WC definition of sarcopenic obesity groups, BIA derived measured 
showed that the obese only group had the highest proportion of physically inactive 
individuals, the highest proportion of manual social class, the highest percent of energy 
intake from fat and saturated fat, and the highest mean levels of IL-6, and the sarcopenic 
obese group had the lowest proportion consuming vegetables daily and the highest 
mean t-PA levels. 
 
4.6. Discussion  
4.6.1. Summary of main findings 
This chapter has examined the cross-sectional associations between measures of low 
muscle mass and obesity, combined measures of these body composition components 
and cardiovascular risk factors. Several established and emerging cardiovascular risk 
factors in this study of older British men were related to low muscle mass, based on 
consistent associations with both MAMC and FFMI. Individuals with lower muscle 
mass had a higher prevalence of physical inactivity, lower percent of energy intake from 
carbohydrates, higher mean levels of insulin resistance and higher levels of 
inflammatory and hemostatic markers including CRP, fibrinogen and vWF, which were 
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all independent of the effects of age, BMI, behavioural and morbidity variables. 
Classifying participants into four sarcopenic obesity groups, the sarcopenic obese group 
(defined using combinations of MAMC and WC, and also FFMI and FMI) had 
significantly higher levels of inflammatory and haemostatic markers (CRP, vWF and 
fibrinogen) than the sarcopenic only, obese only or non-sarcopenic, non-obese groups. 
 
4.6.2. Comparison with previous studies 
4.6.2.1 Body composition and socio-demographic/behavioural variables 
Physical inactivity was the behavioural risk factor most strongly associated with low 
MAMC and FFMI. Levels of physical inactivity were elevated in the sarcopenic, obese 
and sarcopenic obese groups, compared to the non-sarcopenic, non-obese group, and 
physical inactivity was highest in the sarcopenic obese group when defined using 
MAMC and WC. This is consistent with previous literature showing that physical 
inactivity is an important contributor to loss of muscle mass and strength at all 
ages131;138;305;306.  
 
Men with low muscle mass (whether defined using MAMC or FFMI) had the highest 
proportion of current smokers. However, after adjustment for age, BMI and behavioural 
variables, this association was attenuated. A recent meta-analysis of studies examining 
the associations between smoking and sarcopenia reported a modest association 
between smoking and sarcopenia in men (OR: 1.20, 95% CI: 1.06 - 1.35)307. However, 
there were inconsistencies in results of the 12 individual studies included, which may 
have reflected different approaches to measuring both smoking status and sarcopenia. In 
the present study, the proportion of men with heavy alcohol intake differed between 
sarcopenic obesity groups, when defined by MAMC and WC, with the highest 
proportion of heavy drinkers in the obese only group. However, in the present study, 
heavy alcohol intake was not significantly associated with low muscle mass, which is 
consistent with previous literature131;305. The proportion of men from a manual 
occupational social class was highest in the sarcopenic obese and obese groups 
respectively for MAMC and WC, and FFMI and FMI definitions. The odds of low 
MAMC were significantly increased in men from a manual occupational social class. 
This finding conflicts with the results of a previous study, which reported that average 
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forearm muscle cross-sectional area was higher among men of manual social class, but 
these analyses were unadjusted for physical activity as an important confounder308.  
 
4.6.2.2 Body composition and dietary risk factors 
A high percentage energy intake from carbohydrates was associated with lower odds of 
both low MAMC and FFMI, after adjustment for confounders. To my knowledge, this 
is the first suggestion that high percentage energy intake of this macronutrient may be 
associated with low muscle mass. There was an association between low energy intake 
and low MAMC, emphasising the need for an adequate calorie intake in older adults. 
This is consistent with previous literature suggesting that energy intake is important for 
the prevention of low muscle mass132. Men with a higher percentage energy from fat 
showed higher odds of low MAMC. This result is consistent with a British study of 
women aged 18-79 years, which showed inverse associations between FFM and 
percentage energy from fat, saturated fatty acids, monounsaturated fatty acids, and 
trans-unsaturated fatty acids and a positive association with the polyunsaturated-to-
saturated fatty acid ratio309. No other dietary variables were significantly associated 
with low MAMC or FFMI, contrasting with previous studies showing independent 
relationships between sarcopenia and dietary variables, in particular protein and 
antioxidant nutrients vitamin C and vitamin E132;133;309. However, looking at dietary 
intake by sarcopenic obesity groups (using both the MAMC/WC definitions and the 
FFMI/FMI definition) the sarcopenia group had the lowest percent of energy intake 
from protein and the lowest mean vitamin C intake. The relationship between overall 
diet quality and sarcopenia will be explored in Chapter 6 and Chapter 8. 
 
4.6.2.3 Body composition and metabolic variables 
Insulin resistance was the only metabolic risk factor significantly associated with both 
low MAMC and FFMI, after adjustment for age, BMI, behavioural and morbidity 
variables. This is consistent with the findings of earlier research showing that insulin 
resistance is inversely associated with low muscle mass, independent of obesity, and 
may explain why diabetics are prone to sarcopenia153;169;310. High triglycerides were 
significantly associated with increased odds of low muscle mass (defined using FFMI 
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only) which supports previous research in an elderly Korean cohort which showed an 
association between sarcopenia and dyslipidemia154.  
 
However, in conflict with the above results, when examining metabolic risk factors by 
sarcopenic obesity groups (defined using MAMC/WC and FFMI/FMI), levels of insulin 
resistance and the prevalence of the metabolic syndrome, were higher in the obese 
group, followed by the sarcopenic-obese group. This result was contrary to expectations 
based on previous studies which have found that the sarcopenic obese group have the 
highest risk of metabolic variables154;155;160-167;169. However, results found here are 
consistent with a study of older adults from the New Mexico Aging Process Study, aged 
60 years or over, which reported that the prevalence of MetS and hypertension was 
highest in the non-sarcopenic obese group, followed by the sarcopenic obese group 
(assessed using DXA measurements)170.  
 
4.6.2.4 Body composition and inflammatory/hemostatic variables 
Three inflammatory/hemostatic markers (CRP, vWF and fibrinogen) were significantly 
associated with both low MAMC and FFMI. This is consistent with the results of some 
other studies and a review suggesting sarcopenia is a low-level inflammatory state 
driven by cytokines and oxidative stress157-159;174. The association described in this 
chapter between vWF and low muscle mass was novel and consistent with a review 
suggesting that endothelial dysfunction may contribute to sarcopenia development300. 
The lack of association between D-dimer, IL-6, homocysteine and low MAMC or FFMI 
supports evidence showing no consistent association between high IL-6 and 
sarcopenia158, but is contrary to research showing associations between these three 
biomarkers and sarcopenia159;174.  
 
When examining levels of inflammatory and hemostatic markers by sarcopenia and 
obesity groups, the sarcopenic obese group (defined using MAMC/WC and FFMI/FMI) 
had the highest levels of CRP, vWF and fibrinogen compared to the sarcopenic only, 
obese only and non-obese non-sarcopenic groups. The sarcopenic obese group also had 
the highest IL-6 levels, when using the WC/MAMC definition only. Previous literature 
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has shown conflicting results regarding the relationship between inflammatory and 
haemostatic markers and sarcopenic obesity. These results are comparable to those from 
the InCHIANTI study, in participants aged 65 years and older, which showed that 
sarcopenic obesity (based on grip strength and WC measurements) was associated with 
increased levels of CRP and IL-6173 and a study of Korean adults which showed that 
sarcopenic obese women had the highest CRP levels167. However, these results conflict 
with those from baseline data from the Trial of Angiotensin Converting Enzyme 
Inhibition and Novel Cardiovascular Risk Factors study, which found no significant 
interactions between sarcopenia and obesity with CRP or IL-6174, while another study 
found that CRP levels did not differ significantly between sarcopenic obese and non-
sarcopenic, non-obese postmenopausal women172.  
 
4.6.3. Strengths and limitations 
A major strength of the results presented in this chapter is that data are from a 
moderately large population-based, geographically and socioeconomically 
representative, cohort of older British men35;264. Also, two different measures of muscle 
mass and two different sarcopenic obesity definitions have been compared in relation to 
an extensive range of established and emerging cardiovascular risk factors. Gold 
standard measurements of adiposity or muscle mass such as computerised tomography 
(CT) scanning or magnetic resonance imaging (MRI) were not available in this cohort, 
but such expensive, time-consuming measures are rarely available in non-clinical 
settings and the anthropometric and BIA measures used represent a practical alternative. 
The American Heart Association recognises mid-upper arm circumference (MUAC) as 
a muscle mass proxy102 and MAMC has been shown to correlate strongly with more 
accurate DXA measures of lean body mass147. Also WC has been shown to be the 
anthropometric variable, which best correlates with adiposity stores in men, as 
measured by MRI304. The possibility of using imprecise measurements of adiposity and 
muscle mass is likely to have underestimated, rather than overestimated, the strength of 
associations observed with cardiovascular risk factors.  
 
Since no universally accepted operational definition of sarcopenia has yet been 
adopted17, a standard statistical approach was used to define low muscle mass, including 
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participants in the first and second quintile of the distribution of MAMC or FFMI. The 
cut-off used for the lowest two fifths of MAMC (≤ 25.9cm) was comparable to another 
population-based study of slightly older men (aged ≥ 80 years), which used a cut-off for 
the lowest tertile of 21.1cm179. Similarly, the cut-point for the lowest two fifths of FFMI 
(16.7 kg/m2) was comparable to a study in men and women aged 65 years and over181, 
where the lowest quartile cut-point was 14.6 kg/m2. Some differences were observed in 
the associations between cardiovascular risk factors with MAMC and FFMI as 
measures of muscle mass and in the different sarcopenic obesity definitions. These 
differences could be explained by the greater inaccuracy of BIA in assessment of FFMI 
in older people, predominantly due to fat-free mass hydration variability311;312. 
 
The European Working Group on Sarcopenia in Older People has suggested defining 
sarcopenia using both muscle mass and function (strength and performance)17 and it has 
been suggested that the age-related loss of muscle mass does not necessary equate to the 
age-related loss of muscle strength313. However, direct measures of muscle function 
(e.g. grip strength) were not available in this cohort and only markers of muscle mass 
have been used. Therefore findings are applicable to sarcopenia and sarcopenic obesity 
as defined by muscle mass, but not muscle strength. 
 
A limitation of the results is that the BRHS comprises older male participants, 
predominantly of white European ethnic origin, so the findings may not be generalisable 
to women and non-white ethnic groups. All analyses were cross-sectional in nature so 
causality of associations between components of body composition and cardiovascular 
risk factors cannot be established and findings should therefore be interpreted with 
caution. For example, the observed associations between emerging cardiovascular risk 
factors (CRP, vWF and fibrinogen) and sarcopenia and sarcopenic obesity, could 
suggest that inflammatory and heamostatic markers could causally contribute to the 
development of sarcopenia or conversely that a sarcopenic state could lead to increased 
levels of inflammatory and heamostatic markers. Therefore further prospective research 
is needed to explore the causal mechanistic pathways leading to sarcopenia. 
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Another limitation of results presented here is that measures of body composition and 
cardiovascular risk factors were assessed at one time point only. Bias from non-
participation is also possible, as men too unwell to attend the physical examination 
would have been excluded, potentially eliminating men with extremely low muscle 
mass and underestimating observed associations. This may explain why some variables 
previously reported to be associated with low muscle mass, e.g. protein intake132;133, 
were not related in this study. However, the response rate was high and BMI did not 
differ between respondents and non-respondents266, suggesting the extent of this bias is 
limited. 
 
Self-reported variables (smoking status, alcohol intake, physical activity, occupational 
social class, weight loss and morbidity variables) may have been subject to 
misclassification. In particular, although the physical activity score used here has been 
validated by the use of heart rate and lung function283;284, the measure was self-reported 
and objective measures would have more accurately captured the exact physical activity 
level. Previous studies have shown only moderate agreement between self-reported and 
accelerometry-based estimates, with self-reports tending to overestimate physical 
activity intensity and total time314. Self-reported physical activity can be subject to 
measurement error. This can be a particular problem in older age groups due to the light 
intensities of activity and vast variability in duration of activity in these age groups, 
which makes accurate recall especially difficult315-317. However, a validation study in 
older men within the BRHS has shown self-reported physical activity questions used 
within this cohort are associated with a graded increase in objectively measured 
physical activity318. This reduces the risk of measurement error and any possible 
misclassification of physical activity is likely to have been non-differential between 
body composition groups, with a previous study showing that the correlation between 
self-reported and objective measures of physical activity is not affected by BMI319. 
Therefore any non-differential misclassification of physical activity level may have led 
to some residual confounding, but this is only likely to have attenuated relative risk 
estimates320. 
 
Self-reported assessment of dietary intake is prone to error through misreporting, which 
can affect the estimation of energy intake and micronutrient intake321;322. In this study, 
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dietary intake was assessed using a FFQ which is more prone to measurement error and 
social desirability bias than other self-reported measures such as weighted food records 
or 24-hour dietary recall198-200. In elderly populations in particular non-response to 
questions could have increased the chance of underreporting of intake198;323. However 
the FFQ used in this study has previously been validated against weighed food intakes 
in British populations273;274. In addition, to reduce the risk of bias in dietary assessment, 
established minimum and maximum cut-offs for total energy intake were applied to the 
data (<500 or > 8000 kcal279) to exclude under and over-reporters, and all statistical 
models were adjusted for total energy intake280. It is possible, however, that some bias 
remains, with evidence that underreporting may be greater with increasing BMI321;324. 
Differential misclassification of energy and micronutrient intake could therefore have 
been possible between different body composition groups, but this is only likely to have 
under estimated the size of the relative risk estimates. 
 
4.6.4. Conclusions 
Chapter 4 has shown that both established and emerging cardiovascular risk factors are 
related to both sarcopenia and sarcopenic obesity. Physical inactivity and higher levels 
of insulin resistance, CRP, vWF and fibrinogen were significantly associated with 
increased odds of lower muscle mass (MAMC and FFMI) and a higher percent of 
energy intake from carbohydrates was significantly associated with decreased odds of 
low muscle mass after adjustment for age, BMI, behavioural variables and morbidity. 
With participants classified into four sarcopenic obesity groups, it was apparent that 
sarcopenic obese individuals had the highest levels of inflammatory and haemostatic 
markers including CRP, vWF and fibrinogen. However, the cross-sectional nature of the 
analyses in this chapter means that the causality of associations between components of 
body composition and cardiovascular risk factors cannot be established. Chapter 5 will 
examine the prospective associations between components of body composition and the 
risk of CVD and mortality in older age. In addition, the contribution of established and 
emerging cardiovascular risk factors, including inflammatory and haemostatic markers, 
to associations between body composition and CVD risk, will be evaluated.  
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Table 4.1 Body composition measures of men aged 60-79 years in 1998-2000 
 
Body composition measure n Mean (SD) Range 
    
Weight (kg) 4240 80.1 (12.6) 36.7 - 148.1 
Height (cm) 4235 172.3 (6.5) 148.6 - 199.0 
Body mass index (kg/m2) 4232 26.9 (3.7) 14.5 - 47.6 
Waist circumference (cm) 4225 97.3 (10.5) 56.8 - 149.1 
Hip circumference (cm) 4234 102.5 (7.2) 50.6 - 150.8 
Waist-to-hip ratio (cm) 4222 0.9 (0.1) 0.7 - 1.4 
Subscapular skinfold (mm) 4167 19.6 (6.3) 1.7 - 47.9 
Triceps skinfold (mm) 4208 12.2 (4.5) 2.2 - 39.7 
Fat mass (kg) 4111 28.6 (9.6) 0.4 - 82.1 
Fat mass (%) 4111 35.1 (8.2) 0.5-66.6 
Fat mass index (kg/m2) 4111 9.6 (3.2) 0.1 - 28.4 
Fat-free mass (kg) 4114 51.5 (7.6) 28.4 - 116.6 
Fat-free mass (%) 4111 64.9 (8.2) 33.4 - 99.5 
Fat-free mass index (kg/m2) 4114 17.3 (2.2) 9.6 - 35.5 
Skeletal muscle (kg) 4164 31.0 (5.4) 17.1 - 79.7 
Skeletal muscle (%) 4161 39.0 (6.0) 20.2 - 99.0 
Skeletal muscle index (kg/m2) 4164 10.4 (1.6) 5.8 - 27.2 
Mid-upper arm circumference (cm) 4246 30.4 (2.8) 20.0 - 47.3 
Mid-arm muscle circumference (cm) 4204 26.5 (2.3) 18.0 - 38.6 
  
SD, standard deviation. 
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Table 4.2 Correlations between body composition measures in men aged 60-79 years in 1998-2000 
 
 
Body composition measure 
Pearson correlation coefficients* 
BMI WC HC WHR Subscapular skinfold Triceps skinfold FMI FFMI SMI 
BMI                    
WC 0.87                 
HC  0.81 0.81               
WHR 0.55 0.76 0.23             
Subscapular skinfold  0.63 0.61 0.54 0.41           
Triceps skinfold  0.54 0.51 0.50 0.29 0.59         
FMI 0.81 0.76 0.68 0.51 0.55 0.49       
FFMI  0.53 0.38 0.40 0.20 0.26 0.21 -0.07     
SMI  0.44 0.31 0.31 0.16 0.22 0.16 -0.06 0.99   
MAMC  0.61 0.52 0.51 0.30 0.33 0.05 0.42 0.41 0.36 
 
BMI, body mass index; FMI, fat mass index; FFMI, fat-free mass index; HC, hip circumference; MAMC, mid-arm muscle circumference; SMI, skeletal muscle index; WC, 
waist circumference; WHR, waist-to-hip ratio. 
*For all: p <0.01. 
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Table 4.3 Cardiovascular risk factors by quartiles of mid-arm muscle circumference in men aged 60-79 years in 1998-2000 
 
              
    MAMC Quartiles (cm) p-trend 
(age 
adjusted) 
p-trend  
(age & BMI 
adjusted)     ≤ 24.95 24.95-26.45 26.45-27.97 ≥ 27.97 
  n 1051 1051 1051 1051     
Socio-demographic/Behavioural variables             
  Age (years) 70.2 (5.7) 69.3 (5.5) 68.4 (5.3) 67.0 (5.0) <0.001* <0.001† 
  Obesity (BMI ≥ 30 kg/m2) (%) 2.9 7.7 17.1 39.4 <0.001 n/a 
  Current smokers (%) 17.9 14.1 9.8 9.4 <0.001 <0.001 
  Heavy drinkers (%) 3.8 3 2.5 2.4 0.29 0.03 
  Physically inactive (%) 15.1 9.4 10.2 10.8 0.09 <0.001 
  Manual social class (%) 53.2 49.1 50.1 50.8 0.3 <0.001 
Dietary variables              
  Energy intake (kcal) 2125.7 (524.4) 2125.6 (528.6) 2100.4 (524.3) 2103.0 (542.4) 0.41 0.02 
  Carbohydrates (% kcal) 53.1 (6.9) 52.8 (6.9) 52.5 (6.9) 52.1 (7.1) <0.001 0.06 
  Protein (% kcal) 15.4 (2.3) 15.7 (2.4) 15.8 (2.3) 15.8 (2.3) 0.001 0.10 
  Fat (% kcal) 30.5 (6.1) 30.1 (6.2) 29.9  (6.3) 30.0 (6.3) 0.99 0.04 
  Saturated fat (% kcal) 12.5 (3.6) 12.2 (3.5) 12.1 (3.7) 12.3 (3.6) 0.96 0.16 
  Fibre (g/day) 25.6 (9.0) 26.1 (8.6) 25.8 (8.5) 26.2 (8.9) 0.25 <0.001 
  Vitamin C (mg/day) 79.2 (36.3) 82.8 (36.3) 83.7 (36.2) 87.1 (39.5) <0.001 0.001 
  Vitamin E (mg/day) 8.4 (4.8) 8.4 (4.8) 8.5 (4.7) 8.5 (5.0) 0.31 0.08 
  Iron (mg/day) 14.0 (5.1) 14.4 (5.5) 14.1 (5.0) 14.2 (5.3) 0.26 <0.001 
  Daily fruit intake (%) 40.5 42.8 44.7 44.2 0.002 0.01 
  Daily vegetable intake (%) 30.9 32.9 33.2 35.1 0.002 <0.001 
  Plasma vitamin C (µmol/L) 30.1 (28.9) 30.1 (28.6) 31.0 (27.9) 29.5 (23.5) 0.39 0.26 
  Plasma vitamin E (µmol/L) 32.1 (11.4) 33.8 (12.0) 34.3 (11.8) 33.8 (12.2) 0.001 0.01 
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Table 4.3 Continued. Cardiovascular risk factors by quartiles of mid-arm muscle circumference in men aged 60-79 years in 1998-2000 
 
              
    MAMC Quartiles (cm) p-trend 
(age 
adjusted) 
p-trend  
(age & BMI 
adjusted) 
    ≤ 24.95 24.95-26.45 26.45-27.97 ≥ 27.97 
Metabolic variables             
  HOMA-IR‡ 1.9 (1.1-2.7) 2.1 (1.4-3.0) 2.3 (1.5-3.2) 2.7 (1.7-4.0) <0.001 0.002 
  Central obesity (%) 9 19.5 31.9 54.7 <0.001 n/a 
  Hypertension (%) 53.8 56.1 62.9 63.4 <0.001 0.32 
  High triglycerides (%) 33.4 42.4 46.8 56.9 <0.001 0.08 
  Low HDL (%) 15.2 18.7 21.3 27.9 <0.001 0.77 
  High glucose (%) 25 24.2 23.5 27.3 0.001 0.006 
  Metabolic Syndrome (%) 13.5 20.8 29.7 42.9 <0.001 0.57 
Inflammatory/hemostatic markers             
  CRP (mg/L) ‡ 1.8 (0.8-3.8) 1.7 (0.8-3.5) 1.7 (0.8-3.3) 1.7 (0.9-3.4) 0.09 <0.001 
  t-PA (ng/mL) 10.5 (4.6) 10.9 (4.4) 11.2 (4.5) 11.6 (4.2) <0.001 0.01 
  D-dimer (ng/mL) ‡ 94.2 (52.0-145.0) 88.4 (50.0-134.0) 83.5 (47.0-128.0) 72.8 (46.0-105.0) 0.002 <0.001 
  vWF (IU/dL) 147.3 (48.6) 141.2 (46.1) 136.6 (44.1) 134.0 (44.4) <0.001 <0.001 
  Fibrinogen (g/L) 3.4 (0.8) 3.3 (0.8) 3.3 (0.7) 3.2 (0.7) <0.001 <0.001 
  IL-6 (pg/mL) ‡ 2.6 (1.6-3.8) 2.5 (1.6-3.4) 2.6 (1.5-3.4) 2.4 (1.6-3.3) 0.53 <0.001 
  Homocysteine (µmol/L) ‡ 13.2 (10.4-16.0) 12.7 (10.3-14.9) 12.6 (10.3-14.7) 12.2 (10.0-14.2) 0.002 <0.001 
Morbidity             
  CVD (%) 24.7 22.4 22.5 21.2 0.98 <0.001 
  CHD (%) 20.7 18.5 19.3 18.2 0.91 <0.001 
  Stroke (%) 6.9 5.7 5.3 5.6 0.28 0.24 
  Diabetes (%) 5.9 6.7 6.7 7.8 0.01 0.1 
  Heart failure (%) 1.8 2.2 1.9 1.3 0.71 0.003 
  Cancer (%) 7.5 6.6 5.1 5.2 0.19 0.05 
  Poor/fair self-rated health (%) 30.7 25.5 22.4 25.2 0.007 <0.001 
  
 
123 
 
Table 4.3 Continued. Cardiovascular risk factors by quartiles of mid-arm muscle circumference in men aged 60-79 years in 1998-2000 
 
              
    MAMC Quartiles (cm) p-trend 
(age 
adjusted) 
p-trend  
(age & BMI 
adjusted) 
    ≤ 24.95 24.95-26.45 26.45-27.97 ≥ 27.97 
Disability             
  Long-standing illness/disability (%) 36.2 33.9 31.5 34 0.26 <0.001 
  Mobility limitation (%) 23.9 18.6 20.1 21.3 0.68 <0.001 
Other              
  FEV1 (L) 2.4 (0.7) 2.6 (0.7) 2.6 (0.6) 2.7 (0.6) <0.001 <0.001 
  Weight loss in past 3 years (%) 21.3 13.3 14.7 13.5 <0.001 0.001 
 
Values presented as mean (SD) unless otherwise stated.  
BMI, body mass index; CHD, coronary heart disease; CRP, C-reactive protein; CVD, cardiovascular disease; FEV1, forced expiratory volume in 1 second; HOMA-IR, 
homeostasis model assessment insulin resistance; IL-6, interleukin 6; MAMC, mid-arm muscle circumference; t-PA, tissue plasminogen activator; vWF, von Willebrand 
factor. 
*Unadjusted. 
†Adjusted for BMI only. 
‡Log-transformed values - geometric mean (interquartile range). 
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Table 4.4 Odds ratios (95% CI) for low mid-arm muscle circumference by cardiovascular risk factors in men aged 60-79 years in 1998-
2000 
 
    Low MAMC (OR, 95% CI) 
    Model 1 Model 2 Model 3 
Socio-demographic/Behavioural variables      
  Current smokers  1.87 (1.54-2.28)** 1.12 (0.87-1.44) 1.01 (0.78-1.32) 
  Heavy drinkers  1.55 (1.04-2.30)* 1.52 (0.93-2.49) 1.54 (0.92-2.56) 
  Physically inactive  1.43 (1.15-1.76)** 1.97 (1.50-2.59)** 1.69 (1.26-2.27)** 
  Manual social class 1.14 (0.99-1.31) 1.31 (1.10-1.56)** 1.31 (1.09-1.57)** 
Dietary variables      
  Energy intake† 0.99 (0.80-1.22) 0.74 (0.57-0.95)* 0.73 (0.56-0.95)* 
  Carbohydrates (% kcal) †‡ 1.17 (0.95-1.43) 0.72 (0.56-0.94)* 0.73 (0.55-0.96)* 
  Protein (% kcal) †‡ 0.78 (0.62-0.96)* 1.21 (0.93-1.59) 1.16 (0.88-1.54) 
  Fat (% kcal) †‡ 1.18 (0.95-1.46) 1.33 (1.03-1.72)* 1.31 (1.00-1.71)* 
  Saturated fat (% kcal) †‡ 1.14 (0.92-1.41) 1.23 (0.95-1.59) 1.24 (0.94-1.62) 
  Fibre†‡ 0.81 (0.65-1.00) 0.93 (0.70-1.22) 0.97 (0.73-1.30) 
  Vitamin C†‡ 0.65 (0.53-0.80)** 0.94 (0.73-1.22) 0.92 (0.70-1.21) 
  Vitamin E†‡ 0.86 (0.69-1.05) 0.95 (0.73-1.25) 0.91 (0.69-1.21) 
  Iron†‡ 0.84 (0.65-1.08) 1.03 (0.75-1.42) 1.01 (0.72-1.41) 
  Daily fruit intake‡ 0.85 (0.73-0.99)* 1.01 (0.84-1.21) 0.98 (0.81-1.18) 
  Daily vegetable intake‡  0.86 (0.74-1.01) 0.94 (0.78-1.13) 0.94 (0.78-1.14) 
  Plasma vitamin C† 0.84 (0.69-1.04) 0.77 (0.60-1.00)* 0.82 (0.63-1.07) 
  Plasma vitamin E† 0.71 (0.57-0.88)** 0.87 (0.67-1.13) 0.88 (0.67-1.15) 
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Table 4.4 Continued. Odds ratios (95% CI) for low mid-arm muscle circumference by cardiovascular risk factors in men aged 60-79 
years in 1998-2000 
    Low MAMC (OR, 95% CI) 
    Model 1 Model 2 Model 3 
Metabolic variables        
  HOMA-IR† 0.37 (0.30-0.46)** 1.64 (1.25-2.17)** 1.60 (1.19-2.17)** 
  Central obesity  0.18 (0.14-0.22)** 1.07 (0.79-1.44) 0.95 (0.70-1.30) 
  Hypertension  0.72 (0.63-0.84)** 0.96 (0.81-1.15) 0.94 (0.78-1.12) 
  High triglycerides  0.54 (0.47-0.63)‡ 0.93 (0.77-1.11) 0.86 (0.71-1.04) 
  Low HDL 0.62 (0.51-0.75)** 1.02 (0.81-1.30) 1.00 (0.78-1.28) 
  High glucose  0.96 (0.81-1.13) 1.37 (1.11-1.68)** 1.34 (1.07-1.69)* 
  Metabolic Syndrome  0.34 (0.28-0.42)‡ 0.99 (0.77-1.27) 0.89 (0.69-1.16) 
Inflammatory/hemostatic markers     
  CRP† 0.89 (0.73-1.10) 1.66 (1.28-2.15)** 1.44 (1.09-1.89)* 
  t-PA† 0.46 (0.40-0.61)** 1.11 (0.85-1.45) 1.01 (0.76-1.33) 
  D-dimer† 1.15 (0.93-1.43) 1.14 (0.88-1.48) 1.03 (0.79-1.36) 
  vWF† 1.49 (1.21-1.83)** 1.74 (1.36-2.23)** 1.67 (1.29-2.17)** 
  Fibrinogen† 1.52 (1.24-1.87)** 1.63 (1.26-2.11)** 1.48 (1.13-1.95)** 
  IL-6† 1.10 (0.90-1.36) 1.33 (1.02-1.73)* 1.23 (0.94-1.63) 
  Homocysteine† 1.23 (1.00-1.51) 1.22 (0.95-1.58) 1.20 (0.92-1.57) 
 
Low MAMC = lowest quartile of MAMC (≤ 24.95 cm). Model 1: adjusted for age; Model 2: adjusted for model 1 + BMI, smoking, physical activity, alcohol, social class; 
Model 3: adjusted for model 2 + morbidity (CVD, diabetes, cancer, FEV1, poor/fair health).  
CRP, C-reactive protein; HOMA-IR, homeostasis model assessment insulin resistance; IL-6, interleukin 6; MAMC, mid-arm muscle circumference; t-PA, tissue plasminogen 
activator; vWF, von Willebrand factor.  
* p<0.05 ** p<0.01 
†Highest vs. lowest quartile  
‡Additionally adjusted for energy intake in all models. 
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Table 4.5 Cardiovascular risk factors by quartiles of fat-free mass index in men aged 60-79 years in 1998-2000 
 
    FFMI Quartiles (kg/m2) 
p-trend  
(age 
adjusted) 
p-trend 
(age & 
BMI 
adjusted)     ≤ 15.96 15.96-17.09 17.09-18.36 ≥ 18.36 
  n 1029 1028 1029 1028     
Socio-demographic/Behavioural variables             
 
Age (years) 69.0 (5.5) 68.8 (5.5) 68.3 (5.5) 68.7 (5.5) 0.19* 0.07† 
  Obesity (BMI ≥ 30 kg/m2) (%) 2.7 9.1 16.4 42.0 <0.001 n/a 
  Current smokers (%) 16.4 12.8 11.4 10.2 <0.001 0.12 
  Heavy drinkers (%) 3.0 3.2 2.8 3.3 0.77 0.52 
  Physically inactive (%) 13.4 10.8 9.1 12.6 0.28 <0.001 
  Manual social class (%) 51.6 49.4 51.7 52.2 0.37 <0.001 
Dietary variables              
  Energy intake (kcal) 2140.0 (523.6) 2108.4 (514.4) 2107.6 (529.7) 2097.5 (552.2) 0.24 0.2 
  Carbohydrates (% kcal) 52.9 (6.9) 52.7 (7.0) 52.7 (7.0) 51.9 (6.8) <0.001 0.13 
  Protein (% kcal) 15.4 (2.4) 15.6 (2.2) 15.7 (2.3) 16.0 (2.3) <0.001 0.02 
  Fat (% kcal) 30.4 (6.2) 30.0 (6.0) 29.9 (6.4) 30.3 (6.1) 0.41 0.27 
  Saturated fat (% kcal) 12.4 (3.6) 12.2 (3.5) 12.2 (3.8) 12.3 (3.5) 0.67 0.06 
  Fibre (g/day) 25.6 (8.9) 25.8 (8.5) 26.1 (8.6) 26.3 (9.1) 0.08 <0.001 
  Vitamin C (mg/day) 80.5 (37.5) 82.1 (35.7) 83.3 (36.2) 86.3 (39.3) 0.002 0.21 
  Vitamin E (mg/day) 8.6 (5.0) 8.4 (4.7) 8.3 (4.7) 8.6 (4.9) 0.05 0.03 
  Iron (mg/day) 14.1 (5.3) 14.2 (5.1) 14.1 (5.3) 14.3 (5.1) 0.49 0.01 
  Daily fruit intake (%) 39.5 44.2 41.7 47.3 <0.001 0.001 
  Daily vegetable intake (%) 30.0 33.9 32.7 35.0 0.02 0.002 
  Plasma vitamin C (µmol/L) 28.7 (24.8) 31.2 (30.4) 31.0 (27.9) 29.4 (22.6) 0.59 0.02 
  Plasma vitamin E (µmol/L) 32.6 (11.5) 33.8 (12.2) 33.6 (12.2) 34.3 (11.8) 0.002 0.03 
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Table 4.5 Continued. Cardiovascular risk factors by quartiles of fat-free mass index in men aged 60-79 years in 1998-2000 
    FFMI Quartiles (kg/m2) 
p-trend  
(age 
adjusted) 
p-trend 
(age & 
BMI 
adjusted)     ≤ 15.96 15.96-17.09 17.09-18.36 ≥ 18.36 
Metabolic variables             
  HOMA-IR‡ 2.0 (1.2-2.9)  2.2 (1.4-3.0)  2.3 (1.4-3.2)  2.7 (1.6-4.0)  <0.001 <0.001 
  Central obesity (%) 14.6 23.1 31.5 49.6 <0.001 n/a 
  Hypertension (%) 54.4 60.5 58.4 64.3 0.001 0.02 
  High triglycerides (%) 40 44.3 46.5 50.5 <0.001 <0.001 
  Low HDL (%) 15.5 17.6 22.8 27.7 <0.001 0.47 
  High glucose (%) 23.7 25.6 23.0 29.2 0.004 0.04 
  Metabolic Syndrome (%) 17.5 23.8 28.6 39.7 <0.001 <0.001 
Inflammatory/hemostatic markers             
  CRP (mg/L) ‡ 1.8 (0.8-3.8) 1.8 (0.8-3.6) 1.7 (0.8-3.3)  1.7 (0.9-3.3)  0.77 <0.001 
  t-PA (ng/mL) 11.2 (4.7) 11.1 (4.4) 10.7 (4.3) 11.5 (4.4) 0.01 <0.001 
  D-dimer (ng/mL) ‡ 85.1 (49.0-133.0)  83.1 (49.0-123.0)  83.6 (47.0-133.5)  83.9 (50.0-127.0)  0.66 0.71 
  vWF (IU/dL) 144.6 (48.2) 140.0 (45.7) 136.6 (43.2) 138.6 (47.1) 0.23 <0.001 
  Fibrinogen (g/L) 3.4 (0.8) 3.3 (0.8) 3.2 (0.7) 3.2 (0.7) <0.001 <0.001 
  IL-6 (pg/mL) ‡ 2.4 (1.6-3.5)  2.4 (1.6-3.4)  2.4 (1.6-3.4)  2.5 (1.6-3.7)  0.05 <0.001 
  Homocysteine (µmol/L) ‡ 12.9 (10.2-15.5)  12.5 (10.1-14.7)  12.5 (10.1-14.3)  12.8 (10.4-14.8)  0.5 0.11 
Morbidity             
  CVD (%) 22.7 22.6 21.7 22.8 0.92 <0.001 
  CHD (%) 18.7 19.1 19.1 19.1 0.78 0.004 
  Stroke (%) 6.1 5.6 4.8 6.5 0.54 0.19 
  Diabetes (%) 5.3 5.1 7.4 9.8 <0.001 0.08 
  Heart failure (%) 2.6 1.3 1.2 1.9 0.48 0.005 
  Cancer (%) 7.4 5.7 5.9 5.5 0.3 0.18 
  Poor/fair self-rated health (%) 29.0 23.8 23.5 27.6 0.9 <0.001 
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Table 4.5 Continued. Cardiovascular risk factors by quartiles of fat-free mass index in men aged 60-79 years in 1998-2000 
    FFMI Quartiles (kg/m2) 
p-trend  
(age 
adjusted) 
p-trend 
(age & 
BMI 
adjusted)     ≤ 15.96 15.96-17.09 17.09-18.36 ≥ 18.36 
Disability             
  Long-standing illness/disability (%) 33.0 33.5 31.6 36.4 0.12 0.1 
  Mobility limitation (%) 21.0 19.9 19.3 23.2 0.09 <0.001 
Other 
      
 
  FEV1 (L) 2.5 (0.7) 2.5 (0.6) 2.6 (0.6) 2.6 (0.6) <0.001 <0.001 
  Weight loss in past 3 years (%) 17.0 14.8 14.7 15.3 0.22 0.58 
 
Values presented as mean (SD) unless otherwise stated.  
BMI, body mass index; CHD, coronary heart disease; CRP, C-reactive protein; CVD, cardiovascular disease; FEV1, forced expiratory volume in 1 second; FFMI, fat-free 
mass index; HOMA-IR, homeostasis model assessment insulin resistance; IL-6, interleukin 6; t-PA, tissue plasminogen activator; vWF, von Willebrand factor.  
*Unadjusted. 
†Adjusted for BMI only. 
‡Log-transformed values - geometric mean (interquartile range). 
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Table 4.6 Odds ratios (95% CI) for low fat-free mass index by cardiovascular risk factors in men aged 60-79 years in 1998-2000 
 
    
Lowest FFMI quartile      
(OR, 95% CI) 
    Model 1 Model 2 Model 3 
Socio-demographic/Behavioural variables        
  Current smokers  1.53 (1.25-1.87)** 1.06 (0.83-1.35) 0.94 (0.73-1.22) 
  Heavy drinkers  0.99 (0.65-1.50) 0.85 (0.51-1.41) 0.80 (0.47-1.36) 
  Physically inactive  1.25 (1.00-1.55)* 1.67 (1.28-2.18)** 1.43 (1.07-1.90)* 
  Manual social class 1.02 (0.89-1.18) 1.09 (0.92-1.30) 1.04 (0.87-1.24) 
Dietary variables        
  Energy intake† 1.19 (0.97-1.45) 1.05 (0.83-1.35) 1.03 (0.81-1.33) 
  Carbohydrates (% kcal) †‡ 1.19 (0.97-1.46) 0.77 (0.59-0.99)* 0.76 (0.58-0.99)* 
  Protein (% kcal) †‡ 0.66 (0.53-0.82)** 0.89 (0.69-1.14) 0.89 (0.68-1.16) 
  Fat (% kcal) †‡ 1.07 (0.86-1.32) 1.21 (0.95-1.56) 1.24 (0.96-1.60) 
  Saturated fat (% kcal) †‡ 1.06 (0.86-1.31) 1.13 (0.88-1.45) 1.17 (0.91-1.52) 
  Fibre†‡ 0.77 (0.62-0.96)* 0.84 (0.65-1.10) 0.85 (0.64-1.12) 
  Vitamin C†‡ 0.73 (0.59-0.90)** 1.00 (0.78-1.28) 0.98 (0.76-1.28) 
  Vitamin E†‡ 0.93 (0.75-1.16) 1.11 (0.85-1.44) 1.05 (0.80-1.37) 
  Iron†‡ 0.71 (0.55-0.91)** 0.77 (0.57-1.04) 0.77 (0.56-1.06) 
  Daily fruit intake‡ 0.82 (0.70-0.95)** 0.92 (0.77-1.09) 0.89 (0.75-1.07) 
  Daily vegetable intake‡  0.82 (0.70-0.96)** 0.85 (0.71-1.01) 0.83 (0.69-1.00) 
  Plasma vitamin C† 0.78 (0.63-0.96)* 0.70 (0.54-0.89)** 0.71 (0.55-0.92)* 
  Plasma vitamin E† 0.79 (0.64-0.98)* 0.89 (0.69-1.14) 0.93 (0.72-1.20) 
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Table 4.6 Continued. Odds ratios (95% CI) for low fat-free mass index by cardiovascular risk factors in men aged 60-79 years in 1998-
2000 
    
Lowest FFMI quartile                               
(OR, 95% CI) 
    Model 1 Model 2 Model 3 
Metabolic variables        
  HOMA-IR† 0.52 (0.43-0.65)** 2.14 (1.63-2.81)** 2.22 (1.65-2.98)** 
  Central obesity  0.32 (0.27-0.39)** 2.21 (1.69-2.90)** 2.01 (1.52-2.67)** 
  Hypertension  0.75 (0.65-0.87)** 1.04 (0.88-1.23) 1.00 (0.84-1.19) 
  High triglycerides  0.76 (0.65-0.88)** 1.35 (1.13-1.61)** 1.32 (1.10-1.59)** 
  Low HDL 0.63 (0.52-0.76)** 0.97 (0.77-1.22) 0.98 (0.77-1.24) 
  High glucose  0.89 (0.75-1.05) 1.20 (0.99-1.47) 1.20 (0.96-1.49) 
  Metabolic Syndrome  0.48 (0.40-0.58)** 1.38 (1.09-1.73)** 1.30 (1.02-1.66)* 
Inflammatory/hemostatic markers       
  CRP† 1.05 (0.86-1.29) 2.04 (1.58-2.64)** 1.94 (1.48-2.54)** 
  t-PA† 0.91 (0.74-1.11) 2.46 (1.90-3.18)** 2.33 (1.78-3.04)** 
  D-dimer† 0.99 (0.80-1.22) 0.97 (0.76-1.25) 0.91 (0.70-1.19) 
  vWF† 1.36 (1.10-1.66)** 1.48 (1.17-1.88)** 1.57 (1.22-2.02)** 
  Fibrinogen† 1.47 (1.20-1.80)** 1.55 (1.21-1.98)** 1.52 (1.17-1.96)** 
  IL-6† 0.93 (0.75-1.14) 1.19 (0.92-1.53) 1.13 (0.86-1.47) 
  Homocysteine† 1.15 (0.94-1.42) 1.12 (0.87-1.43) 1.09 (0.84-1.41) 
Low FFMI = lowest quartile of FFMI (≤ 15.96 kg/m2). Model 1: adjusted for age; Model 2: adjusted for model 1 + BMI, smoking, physical activity, alcohol, social class; 
Model 3: adjusted for model 2 + morbidity (CVD, diabetes, cancer, FEV1, poor/fair health).  
CRP, C-reactive protein; FFMI, fat-free mass index; HOMA-IR, homeostasis model assessment insulin resistance; IL-6, interleukin 6; t-PA, tissue plasminogen activator; 
vWF, von Willebrand factor.  
* p<0.05 ** p<0.01 
†Highest vs. lowest quartile  
‡Additionally adjusted for energy intake in all models. 
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Table 4.7 Cardiovascular risk factors by waist circumference groups in men aged 60-79 years in 1998-2000 
 
    WC (cm) 
p-trend  
(age adjusted) 
p-trend  
(age & BMI 
adjusted)     <94 94-102 103-105 ≥ 106 
  n 1593 1390 467 775     
Socio-demographic/Behavioural variables          
  Age (years) 68.8 (5.7) 68.7 (5.4) 68.5 (5.3) 68.6 (5.3) 0.07* <0.001† 
  Obesity (BMI ≥ 30 kg/m2) (%) 0.1 4.9 24.1 29.2 <0.001 n/a 
  Current smokers (%) 14.8 12.0 10.9 10.4 <0.001 <0.001 
  Heavy drinkers (%) 2.3 3.0 3.3 4.4 0.001 <0.001 
  Physically inactive (%) 8.7 8.9 12.2 20.6 <0.001 0.006 
  Manual social class (%) 48.0 49.4 52.7 59.0 <0.001 0.47 
Dietary variables              
  Energy intake (kcal) 2139.7 (515.4) 2111.7 (539.9) 2097.3 (511.3) 2076.4 (551.4) 0.004 0.06 
  Carbohydrates (% kcal) 53.6 (6.6) 52.6 (7.0) 51.6 (7.3) 51.1 (7.0) <0.001 0.006 
  Protein (% kcal) 15.5 (2.3) 15.7 (2.3) 15.8 (2.3) 16.0 (2.5) <0.001 <0.001 
  Fat (% kcal) 29.8 (6.0) 30.1 (6.3) 30.2 (6.3) 30.8 (6.5) <0.001 0.04 
  Saturated fat (% kcal) 12.1 (3.5) 12.3 (3.6) 12.3 (3.7) 12.6 (3.8) 0.001 0.005 
  Fibre (g/day) 26.7 (8.9) 25.8 (8.8) 25.3 (9.1) 25.1 (8.5) <0.001 0.001 
  Vitamin C (mg/day) 83.0 (36.8) 81.1 (35.6) 85.9 (38.5) 86.2 (40.7) 0.04 0.01 
  Vitamin E (mg/day) 8.5 (4.7) 8.5 (5.1) 8.3 (4.5) 8.5 (4.8) 0.73 0.23 
  Iron (mg/day) 14.3 (5.3) 14.2 (5.2) 13.9 (5.1) 13.9 (5.1) 0.008 0.69 
  Daily fruit intake (%) 44.0 41.5 43.2 44.3 0.67 0.03 
  Daily vegetable intake (%) 35.2 31.1 32.9 32 0.20 0.15 
  Plasma vitamin C (µmol/L) 32.2 (28.0) 29.3 (26.3) 29.8 (29.8) 27.2 (24.1) <0.001 0.002 
  Plasma vitamin E (µmol/L) 33.3 (12.0) 33.6 (11.8) 34.0 (11.8) 33.9 (12.2) 0.10 0.38 
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Table 4.7 Continued. Cardiovascular risk factors by waist circumference groups in men aged 60-79 years in 1998-2000 
 
    WC (cm) 
p-trend  
(age adjusted) 
p-trend  
(age & BMI 
adjusted) 
    <94 94-102 103-105 ≥ 106 
Metabolic variables             
  HOMA-IR‡ 1.6 (1.1-2.3) 2.3 (1.5-3.1) 2.7 (1.8-3.8) 2.0 (2.3-5.6) <0.001 <0.001 
  Hypertension (%) 53.0 58.8 65.4 68.9 <0.001 0.60 
  High triglycerides (%) 28.7 51.3 55.7 62.7 <0.001 <0.001 
  Low HDL (%) 12.1 22.8 26.4 32.3 <0.001 0.01 
  High glucose (%) 19.3 24.4 28.3 36.5 <0.001 <0.001 
  Metabolic Syndrome (%) 8.2 18.9 55.8 66.2 <0.001 <0.001 
Inflammatory/hemostatic markers             
  CRP (mg/L) ‡ 1.3 (0.6-2.6) 1.8 (0.8-3.4) 2.1 (1.1-3.9) 2.6 (1.3-4.9) <0.001 <0.001 
  t-PA (ng/mL) 9.6 (4.2) 11.4 (4.2) 12.0 (4.5) 13.1 (4.4) <0.001 <0.001 
  D-dimer (ng/mL) ‡ 81.5 (47.0-128.0) 85.0 (49.0-130.0) 83.1 (50.0-125.0) 88.5 (52.0-130.0) 0.003 0.001 
  vWF (IU/dL) 137.0 (45.5) 138.7 (45.3) 139.8 (44.7) 148.1 (49.0) <0.001 <0.001 
  Fibrinogen (g/L) 3.2 (0.7) 3.3 (0.7) 3.3 (0.7) 3.4 (0.7) <0.001 <0.001 
  IL-6 (pg/mL) ‡ 2.4 (1.4-3.2) 2.4 (1.5-3.3) 2.6 (1.7-3.6) 3.0 (2.0-4.3) <0.001 <0.001 
  Homocysteine (µmol/L) ‡ 12.4 (10.0-14.7) 12.8 (10.3-14.9) 12.7 (10.4-14.5) 13.6 (10.4-15.2) 0.008 0.001 
 
Values presented as mean (SD) unless otherwise stated.  
BMI, body mass index; CRP, C-reactive protein; HOMA-IR, homeostasis model assessment insulin resistance; IL-6, interleukin 6; t-PA, tissue plasminogen activator; vWF, 
von Willebrand factor; WC, waist circumference.  
*Unadjusted. 
†Adjusted for BMI only. 
‡Log-transformed values - geometric mean (interquartile range). 
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Table 4.8 Cardiovascular risk factors by sarcopenic obesity groups (defined by mid-arm muscle circumference and waist circumference) 
in men aged 60-79 years in 1998-2000 
    
Sarcopenic Obesity Groups                                                                                       
(MAMC lowest 2 fifths; WC >102cm)* 
p† 
    
Non-sarcopenic,  
non-obese 
Sarcopenic Obese 
Sarcopenic 
obese 
  Total (%) 1507 (36.1) 1467 (35.1) 1006 (24.1) 198 (4.7)   
Socio-demographic/Behavioural variables         
  Age (years) 67.6 (5.3) 70.0 (5.6) 68.2 (5.3) 70.3 (5.5) <0.001 
  Obesity (BMI ≥ 30 kg/m2) (%) 3.9 0.6 56.8 29.8 <0.001 
  Current smokers (%) 10.6 16.7 10.1 13.3 <0.001 
  Heavy drinkers (%) 1.9 3.3 4.0 3.1 0.02 
  Physically inactive (%) 6.2 11.5 16.4 21.0 <0.001 
  Manual social class (%) 46.6 50.6 55.7 58.1 <0.001 
Dietary variables            
  Energy intake (kcal) 2129.7 (532.9) 2124.3 (521.6) 2064.6 (522.61) 2179.8 (581.9) 0.005 
  Carbohydrates (% kcal) 53.1 (6.6) 53.2 (7.0) 51.2 (7.1) 51.4 (7.0) <0.001 
  Protein (% kcal) 15.7 (2.2) 15.5 (2.3) 15.9 (2.4) 15.7 (2.5) <0.001 
  Fat (% kcal) 29.7 (6.2) 30.2 (6.1) 30.4 (6.4) 31.1 (6.5) 0.004 
  Saturated fat (% kcal) 12.1 (3.6) 12.4 (3.6) 12.4 (3.7) 13.0 (3.8) 0.01 
  Fibre (g/day) 26.6 (8.6) 25.9 (9.1) 25.1 (8.7) 25.6 (8.8) <0.001 
  Vitamin C (mg/day) 84.6 (36.3) 79.6 (36.1) 85.6 (39.5) 87.8 (39.4) <0.001 
  Vitamin E (mg/day) 8.5 (4.8) 8.5 (5.0) 8.4 (4.7) 8.0 (4.1) 0.59 
  Iron (mg/day) 14.4 (5.2) 14.1 (5.3) 13.8 (5.0) 14.4 (5.8) 0.06 
 
Daily fruit intake (%) 45.5 40.0 43.7 44.0 0.03 
  Daily vegetable intake (%) 35.8 30.7 32.7 32.3 0.03 
  Plasma vitamin C (µmol/L) 31.2 (24.6) 30.5 (29.8) 28.3 (26.3) 26.8 (25.6) 0.03 
  Plasma vitamin E (µmol/L) 34.0 (12.0) 32.8 (11.6) 34.2 (12.0) 31.9 (10.9) 0.004 
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Table 4.8 Continued. Cardiovascular risk factors by sarcopenic obesity groups (defined by mid-arm muscle circumference and waist 
circumference) in men aged 60-79 years in 1998-2000 
    
Sarcopenic Obesity Groups                                                                                       
(MAMC lowest 2 fifths; WC >102cm)* 
p† 
    
Non-sarcopenic,  
non-obese 
Sarcopenic Obese 
Sarcopenic 
obese 
Metabolic variables           
  HOMA-IR‡ 2.0 (1.4-2.8) 1.8 (1.1-2.6) 3.3 (2.1-4.8) 3.2 (2.0-4.2) <0.001 
 
Hypertension (%) 58.2 52.9 68.2 62.9 <0.001 
  High triglycerides (%) 43.5 34.9 61.3 50.3 <0.001 
  Low HDL (%) 19.1 15 31.7 21.7 <0.001 
 
High glucose (%) 20.1 23.4 33.7 33.3 <0.001 
  Metabolic Syndrome (%) 15.3 11.1 63.7 52.6 <0.001 
Inflammatory/hemostatic markers           
  CRP (mg/L) ‡ 1.4 (0.7-2.7) 1.7 (0.7-3.4) 2.3 (1.2-4.1) 4.8 (1.4-5.5) <0.001 
  t-PA (ng/mL) 10.5 (4.2) 10.4 (4.4) 12.7 (4.5) 12.3 (4.4) <0.001 
  D-dimer (ng/mL) ‡ 76.4 (45.0-116.0) 83.6 (51.0-139.0) 103.4 (50.0-123.0) 101.0 (59.0-152.0) <0.001 
  vWF (IU/dL) 132.4 (43.4) 143.1 (46.7) 142.1 (45.8) 156.7 (53.0) <0.001 
  Fibrinogen (g/L) 3.2 (0.7) 3.3 (0.7) 3.3 (0.7) 3.4 (0.8) <0.001 
  IL-6 (pg/mL) ‡ 2.2 (1.4-3.0) 2.5(1.6-3.4) 2.8 (1.8-3.9) 3.1 (2.0-4.3) <0.001 
  Homocysteine (µmol/L) ‡ 12.3 (10.0-14.2) 13.0 (10.3-15.6) 12.7 (10.3-14.9) 13.4 (10.5-15.65) <0.001 
Other           
  FEV1 (L) 2.8 (0.6) 2.4 (0.7) 2.6 (0.7) 2.3 (0.7) <0.001 
  Weight loss in past 3 years (%) 13.7 17.7 15.0 16.1 0.03 
Values presented as mean (SD) unless otherwise stated. CRP, C-reactive protein; FEV1, forced expiratory volume in 1 second; HOMA-IR, homeostasis model assessment 
insulin resistance; IL-6, interleukin 6; MAMC, mid-arm muscle circumference; t-PA, tissue plasminogen activator; WC, waist circumference; vWF, von Willebrand factor.  
 *Non-sarcopenic, non-obese (WC ≤ 102 cm, MAMC >25.9cm); sarcopenic (WC ≤ 102 cm, MAMC ≤ 25.9 cm); obese (WC >102 cm, MAMC >25.9 cm); sarcopenic obese 
(WC >102 cm, MAMC ≤ 25.9 cm).  
†p value for difference between groups (x2 for percentages; ANOVA for means). 
‡Log-transformed values - geometric mean (interquartile range). 
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Table 4.9 Cardiovascular risk factors by sarcopenic obesity groups (defined by fat-free mass index and fat mass index) in men aged 60-
79 years in 1998-2000 
 
    
Sarcopenic Obesity Groups      
 (FFMI lowest 2 fifths; FMI highest 29.4%)* 
p† 
    
Non-sarcopenic,  
non-obese 
Sarcopenic Obese 
Sarcopenic 
obese 
  n (%) 1692 (41.2) 1211 (29.5) 773 (18.8) 435 (10.6)   
Socio-demographic/Behavioural variables         
  Age (years) 68.7 (5.6) 69.2 (5.5) 68.0 (5.3) 68.6 (5.3) 0.0001 
  Obesity (BMI ≥ 30 kg/m2) (%) 5.4 0 71.5 17.5 <0.001 
  Current smokers (%) 11.8 16.8 9.5 10.6 <0.001 
  Heavy drinkers (%) 2.8 3.2 2.8 4.3 0.43 
  Physically inactive (%) 8.1 11.1 17.1 15.9 <0.001 
  Manual social class (%) 48.2 48.3 59.8 55.9 <0.001 
Dietary variables            
  Energy intake (kcal) 2118.9 (526.6) 2143.8 (519.8) 2061.9 (565.0) 2095.2 (503.1) 0.009 
  Carbohydrates (% kcal) 52.9 (6.8) 53.2 (6.7) 51.1 (7.1) 51.9 (7.1) <0.001 
  Protein (% kcal) 15.7 (2.2) 15.4 (2.3) 16.1 (2.4) 15.5 (2.3) <0.001 
  Fat (% kcal) 29.9 (6.1) 30.1 (5.9) 30.6 (6.7) 30.5 (6.3) 0.05 
  Saturated fat (% kcal) 12.2 (3.6) 12.3 (3.5) 12.5 (3.9) 12.4 (3.5) 0.20 
  Fibre (g/day) 26.6 (8.9) 25.8 (8.6) 25.3 (8.6) 24.9 (8.7) <0.001 
  Vitamin C (mg/day) 83.6 (36.3) 80.8 (35.3) 86.2 (41.1) 81.7 (38.9) 0.01 
  Vitamin E (mg/day) 8.5 (4.8) 8.5 (4.8) 8.4 (4.8) 8.5 (4.9) 0.98 
  Iron (mg/day) 14.3 (5.3) 14.2 (5.1) 13.8 (5.1) 13.9 (5.3) 0.13 
  Daily fruit intake (%) 44.7 41.2 44.5 40.1 0.13 
  Daily vegetable intake (%) 35.3 32.28 30.72 28.8 0.02 
  Plasma vitamin C (µmol/L) 31.4 (26.0) 29.8 (27.2) 28.9 (27.7) 27.5 (25.4) 0.03 
  Plasma vitamin E (µmol/L) 34.1 (12.3) 32.8 (11.3) 33.7 (12.2) 33.2 (12.0) 0.04 
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Table 4.9 Continued. Cardiovascular risk factors by sarcopenic obesity groups (defined by fat-free mass index and fat mass index) in 
men aged 60-79 years in 1998-2000 
    
Sarcopenic Obesity Groups      
 (FFMI lowest 2 fifths; FMI highest 29.4%)* 
p† 
    
Non-sarcopenic,  
non-obese 
Sarcopenic Obese 
Sarcopenic 
obese 
Metabolic variables           
  HOMA-IR‡ 2.0 (1.3-2.8 ) 1.8 (1.2-2.5) 3.6 (2.2-5.2) 3.0 (1.9-4.0) <0.001 
  Central obesity (%) 16.6 3.3 84 57.1 <0.001 
  Hypertension (%) 58.1 52.5 68.5 67.5 <0.001 
  High triglycerides (%) 41 35.4 64.7 56.3 <0.001 
  Low HDL (%) 20.5 13.3 32.7 23.5 <0.001 
  High glucose (%) 22.8 21.7 34.1 30.2 <0.001 
  Metabolic Syndrome (%) 20.7 10.8 61.1 42.6 <0.001 
Inflammatory/hemostatic markers           
  CRP (mg/L) ‡ 1.5 (0.7-2.9) 1.6 (0.7-3.1) 2.4 (1.2-4.6) 2.6 (1.4-5.0) <0.001 
 
t-PA (ng/mL) 10.3 (4.1) 10.5 (4.5) 12.8 (4.2) 12.9 (4.7) <0.001 
  D-dimer (ng/mL) ‡ 84.4 (48.0-130.5) 82.4 (49.0-131.0) 83.5 (49.0-125.0) 96.5 (51.0-120.5) 0.92 
  vWF (IU/dL) 135.5 (44.9) 141.7 (46.4) 142.9 (45.8) 147.1 (49.5) <0.001 
  Fibrinogen (g/L) 3.2 (0.7) 3.3 (0.8) 3.3 (0.7) 3.4 (0.8) <0.001 
  IL-6 (pg/mL) ‡ 2.3 (1.5-3.3) 2.3 (1.5-3.3) 2.8 (1.8-4.0) 2.7 (1.8-3.8) <0.001 
  Homocysteine (µmol/L) ‡ 12.6 (10.3-14.6) 12.6 (10.1-15.0) 12.5 (10.2-14.7) 13.0 (10.3-15.6) 0.39 
Other           
  FEV1 (L) 2.7 (0.7) 2.5 (0.7) 2.5 (0.7) 2.5 (0.7) <0.001 
  Weight loss in past 3 years (%) 15.3 16.5 13.7 16.1 0.40 
Values presented as mean (SD) unless otherwise stated. CRP, C-reactive protein; FEV1, forced expiratory volume in 1 second; FMI, fat mass index; FFMI, fat-free mass 
index; HOMA-IR, homeostasis model assessment insulin resistance; IL-6, interleukin 6; t-PA, tissue plasminogen activator; vWF, von Willebrand factor. 
*Non-sarcopenic, non-obese (FMI ≤ 11.1cm, FFMI >16.7cm); sarcopenic (FMI ≤ 11.1cm, FFMI ≤ 16.7cm); obese (FMI >11.1cm, FFMI >16.7cm); sarcopenic obese (FMI 
>11.1cm, FFMI ≤ 16.7cm).  
†p value for difference between groups (x2 for percentages; ANOVA for means). 
‡Log-transformed values - geometric mean (interquartile range). 
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CHAPTER 5 Prospective associations between body composition and risk of 
cardiovascular disease and mortality in older British men  
5.1. Summary  
Important changes to body composition occur with age – typically visceral fat increases and 
muscle mass decreases (sarcopenia). Sarcopenic obesity refers to the age-associated loss of 
muscle mass coupled with high adiposity levels. Both obesity and low muscle mass 
(sarcopenia) have been linked to increased all-cause mortality and morbidity. However, 
whether sarcopenia is associated with cardiovascular disease (CVD) is not well established 
and the combined effects of sarcopenia and obesity on the risk of CVD and mortality 
remain unclear. In this chapter, the prospective associations between various measures of 
sarcopenia and obesity with the risk of CVD and mortality were examined. 4182 men, aged 
60-79 years, from the British Regional Heart Study (BRHS) were followed up from 
physical examination in 1998-2000 until 2010 for cardiovascular mortality and morbidity. 
Participants were classified as either non-sarcopenic non-obese, sarcopenic only, obese 
only, or sarcopenic obese, using baseline anthropometric or bioelectrical impedance 
analysis (BIA) measurements to define them. Cox proportional hazards regression was used 
to assess associations with coronary heart disease (CHD) events, CVD events, CVD 
mortality and all-cause mortality. 1340 deaths, 528 cardiovascular deaths, 865 CVD events 
and 466 CHD events occurred during a mean follow-up of 11.3 years. Defining sarcopenic 
obesity groups using waist circumference (WC), as a measure of obesity, and mid-arm 
muscle circumference (MAMC), as a measure of low muscle mass, the sarcopenic group 
and the obese group were each significantly associated with increased cardiovascular 
mortality and all-cause mortality, after adjustment for behavioural variables. Men with both 
sarcopenia and obesity showed the highest risk of all-cause mortality (hazard ratio [HR]: 
1.72, 95% CI: 1.35-2.18) and also an increased risk of cardiovascular mortality, although 
non-significant (HR: 1.38, 95% CI: 0.91-2.08). Broadly similar associations were observed 
when defining sarcopenic obesity groups using waist-to-hip ratio (WHR) and MAMC 
measurements, and using body mass index (BMI) and MAMC showed slightly weaker 
associations. However, no significant associations with outcomes were observed when 
using BIA measures for the classification of sarcopenia. Moreover, no association was seen 
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between sarcopenia or obesity with incident CHD events or CVD events. It is therefore 
important to consider both muscle mass and adiposity as determinants of CVD mortality 
and all-cause mortality in older adults. A combination of anthropometric measures of 
central adiposity (WC or WHR) and muscle mass (MAMC) appear to be the strongest 
predictors of cardiovascular mortality and all-cause mortality in older men.  
 
5.2. Introduction 
Body mass index (BMI) is commonly used to assess obesity, but the relationship between 
BMI and all-cause mortality is controversial in the elderly. A systematic review and meta-
analysis of men and women aged ≥ 65 years found that BMI in the overweight range is not 
associated with a significantly increased risk of all-cause mortality, while BMI in the 
moderately obese range is only associated with a modest increase in mortality risk14. 
Important changes to body composition occur with age; typically fat (particularly visceral 
fat) increases and muscle mass decreases, meaning that overall body weight and BMI may 
remain relatively unchanged3. Since BMI combines both fat and muscle mass, the validity 
of the use of BMI in measuring the impact of obesity in the elderly may therefore be 
limited. However, in recent years there has been a focus on visceral/abdominal obesity as a 
potentially better measure of adiposity than BMI, and meta-analyses have supported this 
possibility; analysis of 29 cohorts of older men and women aged 65 to 74 years, showed 
positive associations between WC and all-cause and cardiovascular mortality risks, which 
was consistent across BMI categories127. 
 
In contrast, muscle mass has opposing effects on mortality to those of obesity. Prospective 
studies have shown consistent associations between low muscle mass (sarcopenia), as 
measured by dual energy X-ray absorptiometry (DXA), BIA, and anthropometric measures, 
and an increased risk of mortality178;179;181;183;191. However, whether sarcopenia is 
associated with CVD risk is not clearly established. Since adiposity is positively associated 
with risk of CVD and mortality and muscle mass is inversely associated with mortality, 
there is a need to combine both these component measures of body composition in the 
elderly to fully understand the associations of body composition with both CVD risk and 
Chapter 5 Body composition, CVD and mortality in older British men 
139 
 
all-cause mortality. Recently the concept of sarcopenic obesity has been developed, which 
refers to the age-associated loss of muscle mass coupled with high levels of adiposity18;22. 
However, to date no universally accepted operational definition or classification of 
sarcopenic obesity exists17 so that prevalence estimates, obtained using differing 
measurement methods in different study populations, have ranged widely, between about 
1% and 15% in men138.  
 
The combined effects of sarcopenia and obesity on CVD and all-cause mortality have been 
sparsely studied. The majority of studies examining the associations between sarcopenic 
obesity and health outcomes have focused on functional capacity or disability or have been 
cross-sectional rather than longitudinal152; there is a paucity of prospective studies 
examining the concept of sarcopenic obesity on CVD outcomes and mortality. The small 
number of studies so far reported show that sarcopenic obesity has been linked 
prospectively to an increased risk of all-cause mortality in study populations with specific 
prevalent diseases190;325. Also, a large longitudinal study, the Cardiovascular Health Study, 
found that sarcopenic obesity, with the definition of sarcopenia based on muscle strength, 
was associated with a 23% increased risk of CVD. However, risks were not significantly 
increased in either the sarcopenic or obese groups alone177. A previous report from this 
cohort examined anthropometric indexes of body composition and found that high WC and 
low muscle mass, as measured by MAMC, were both associated with all-cause mortality191. 
However the influence of low muscle mass on CVD risk was not explored and the concept 
of sarcopenic obesity was not examined. 
 
The aim of this chapter is therefore to examine the prospective associations between 
individual and combined measures of obesity and low muscle mass (sarcopenia) with the 
risk of CHD events, CVD events, CVD mortality and all-cause mortality in older men (60-
79 years). The association of obesity with CVD and mortality has been widely studied in 
the elderly. However, little is known about the extent to which sarcopenia and the 
combination of sarcopenia and obesity are associated with risks of CVD and all-cause 
mortality. This chapter will therefore specifically focus on measures of muscle mass and 
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composite measures of obesity and low muscle mass in order to address these gaps in 
research. 
 
5.3. Objectives 
The specific objectives of this chapter are: 
i) To explore the relationships between a range of adiposity measures and the risk of 
CHD events, CVD events, CVD mortality and all-cause mortality in older age (60-
79 years). 
ii) To explore the relationships between a range of muscle mass measures and the risk 
of CHD events, CVD events, CVD mortality and all-cause mortality in older age. 
iii) To examine the combined effects of obesity and low muscle mass (sarcopenia) on 
the risk of CHD events, CVD events, CVD mortality and all-cause mortality, and to 
investigate the contribution of established and emerging CVD risk factors to these 
relationships in older age. 
 
5.4. Methods 
5.4.1. Subjects and methods of data collection 
Data for this chapter are based on the 20 year re-examination of BRHS participants in 
1998-2000, then aged 60-79 years. 4252 men (77% of survivors) completed a mailed 
questionnaire answering questions on their lifestyle and medical history, attended a 
physical examination and provided a fasting blood sample264. Participants were followed 
prospectively for cardiovascular mortality and morbidity from re-examination (1998-2000) 
through to June 2010 and follow-up was achieved for 98% of the cohort participants35. 
Information on deaths was collected through the National Health Service Central Register 
(death certificates coded using International Classification of Diseases, ninth revision [ICD-
9]). Evidence regarding non-fatal events was obtained by on-going reports from general 
practitioners and by biennial reviews of the patients’ medical records264. The four outcome 
measures examined were: CHD events (diagnosis of non-fatal myocardial infarction [MI] 
or fatal CHD [ICD-9 codes 410-414]); CVD events (diagnosis of non-fatal MI, non-fatal 
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stroke or fatal CVD [ICD-9 codes 390-459]); CVD mortality (ICD-9 codes 390-459) and 
all-cause mortality. Two additional outcomes were also considered in further exploratory 
analysis: non-CVD mortality (all deaths excluding ICD-9 codes 390-459) and cancer 
mortality (ICD-9 codes 140-209). Participants were censored at date of death or at the end 
of the study period (June 2010) if still alive. 
 
Of the 4252 men attending the physical examination, 70 men with prevalent heart failure 
were excluded from the analyses because of their exceptionally high mortality rates, due to 
the strong association between heart failure and weight loss, and because of the established 
inverse relationship between BMI and mortality in this group326. This left 4182 participants 
for analyses. 
 
5.4.2. Measures of adiposity and muscle mass 
Anthropometric measurements at the 20 year re-examination included height, weight, waist 
circumference, hip circumference, mid-upper arm circumference, triceps skinfold thickness, 
subscapular skinfold thickness, and also bioelectrical impedance analysis (BIA) as 
described in detail in Chapter 3 (Section 3.3.1). Adiposity measures included whole body 
adiposity (BMI and fat mass index [FMI], assessed using BIA), central adiposity (WC, 
WHR and subscapular skinfold thickness) and peripheral adiposity (triceps skinfold 
thickness). Muscle mass measures included an anthropometric measurement (MAMC) and 
BIA measurements (fat-free mass index [FFMI] and skeletal muscle mass index [SMI]). 
Participants were classified into 5 BMI categories (<18.5, 18.5-24.9, 25-27.4, 27.5-29, ≥ 30 
kg/m2) and 4 WC categories (<94, 94-102, 103-105, ≥ 106 cm). For all other measures of 
adiposity (FMI, WHR, triceps skinfold thickness, subscapular skinfold thickness) and 
muscle mass (MAMC, FFMI, SMI) men were divided by quintiles of the distribution. 
Obesity was defined using established cut-points for BMI (≥ 30 kg/m2) and cut-points 
specific for men for WC (>102 cm) and WHR (≥ 1.00 cm)105. Recent literature suggests 
using ≥ 0.90 cm as the WHR cut-point for men270. However, since this would have 
classified 79.8% of participants as obese, a more stringent cut-point of ≥ 1.00 cm was used 
for this cohort (classifying 18.6% of men as obese). Participants above the percentile point 
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of FMI corresponding to the obesity cut-off for WC (28.7th percentile in this dataset) were 
also classified as obese (>11.1 kg/m2). Since no universally accepted operational definition 
of sarcopenia has yet been adopted17, low muscle mass (sarcopenia) was defined as below 
the second quintile of MAMC (≤ 25.9 cm), FFMI (≤ 16.7 kg/m2) or SMI (≤ 9.2 kg/m2); an 
alternative definition, including only those in the lowest quartile of muscle mass, did not 
yield adequate numbers in the sarcopenic obesity group and was therefore rejected. 
 
To assess the combined effects of sarcopenia and obesity on the risk of the relevant 
outcomes, participants were categorised into four non-overlapping groups (non-sarcopenic 
non-obese, sarcopenic only, obese only and sarcopenic obese), according to different 
combinations of obesity and sarcopenia classifications. 
 
5.4.3. Cardiovascular risk factors 
Established and emerging cardiovascular risk factors were measured at the re-examination 
in 1998-2000, as described in detail in Chapter 3, section 3.3. Cigarette smoking, physical 
activity and alcohol intake were assessed by a self-administered questionnaire. Participants 
were classified into four cigarette smoking groups (never smoked; long-term ex-smokers, 
>15 years; recent ex-smokers, ≤ 15 years; current smokers)90. Current physical activity was 
classified into six groups based on intensity and frequency of exercise (inactive; occasional; 
light; moderate; moderately vigorous and vigorous)283. Alcohol intake was classified into 
five groups based on the number and frequency of alcoholic drinks consumed per week 
(none; occasional; light; moderate; heavy)282. Social class was measured using the baseline 
questionnaire in 1978-80, as described in Chapter 3, section 3.3.4. Social class was based 
on the longest held occupation coded using the Registrar General’s occupational 
classification285 and participants were classified as manual, non-manual or armed forces. 
 
Systolic blood pressure (SBP) and forced expiratory volume in one second (FEV1) were 
assessed by physical examination at the twenty year re-examination in 1998-2000 (see 
section 3.3.5). FEV1 was height-standardised to the mean height of this cohort (1.72m)
289. 
Plasma concentrations of high density lipoprotein [HDL], C-reactive protein (CRP), D-
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dimer and von Willebrand factor (vWF) were measured from fasting blood samples 
collected at re-examination in 1998-2000 as described in Chapter 3 (section 3.3.6). In 
addition, at the 20th year examination, participants were classified as having prevalent MI 
and prevalent stroke, if they had a previous diagnosis, according to self-report. 
Additionally, at the re-examination participants were asked to report whether their weight 
had changed in the previous 3 years (weight loss; no change; weight gain or weight 
fluctuation). A dichotomous weight loss variable was created: yes (weight loss) and no (no 
change; gain or fluctuation). 
 
5.4.4. Statistical methods 
Cox proportional hazards regression models were used to calculate age-adjusted hazard 
ratios (HRs) with 95% CIs for the risk of CHD events, CVD events, CVD mortality and all-
cause mortality according to different measures of adiposity and muscle mass. For 
adiposity measures, the reference categories used were normal BMI (18.5-24.9 kg/m2), 
normal WC (<94cm) and the lowest fifths of the distribution of FMI, WHR, triceps 
skinfold thickness and subscapular skinfold thickness. For muscle mass measures, the 
reference categories used were the lowest fifths of the distribution of MAMC, FFMI and 
SMI. A linear trend was tested for by fitting adiposity or muscle mass variables 
continuously. In addition, a non-linear trend was tested for by adding a quadratic term to 
the model (the square of the continuous adiposity or muscle mass variable).  
 
Survival analysis was carried out and Kaplan Meier curves were plotted to examine the 
survival probability of the cohort for all-cause mortality, CVD mortality, CVD events and 
CHD events, by sarcopenic obesity groups. Cox proportional hazards regression models 
were also used to calculate adjusted HRs with 95% CIs for the risk of outcomes by 
sarcopenic obesity groups (defined used various combinations of adiposity and muscle 
mass). Sarcopenic, obese and sarcopenic obese groups were compared to the non-
sarcopenic non-obese group as the reference category. Models were adjusted for potential 
confounders in a sequential manner based on the risk factors identified as being associated 
with adiposity or muscle mass in this cohort (see Chapter 4) and in previous literature (see 
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Chapter 2). Specific confounding variables adjusted for were age (model 1), adding 
smoking status, alcohol intake, social class and physical activity (model 2), adding 
prevalent MI, prevalent stroke, HDL, SBP and FEV1 (model 3), adding CRP, D-dimer, 
vWF (model 4), and finally weight loss (model 5). Smoking status, alcohol intake, social 
class, physical activity, prevalent MI, prevalent stroke and weight loss were fitted as 
categorical variables and age, HDL, SBP, FEV1, CRP, D-dimer and vWF were fitted as 
continuous variables. The distributions of CRP and D-dimer were highly skewed so log 
transformation was used. In addition, the possibility of a sarcopenia x obesity interaction 
was formally examined, using a Cox proportional hazards model with an interaction term 
between obesity and sarcopenia (each fitted as binary variables using the cut-points 
described earlier), adjusting for confounders. Further sensitivity analysis examined the 
interaction between sarcopenia and obesity, fitting muscle mass as a continuous variable. 
All Cox models were tested for the proportional-hazards assumption, on the basis of 
Schoenfeld residuals, which was not found to be violated. 
 
For the Cox regression analysis of sarcopenic obesity groups and outcomes, sensitivity 
analyses were carried out excluding men with prevalent MI or stroke (n = 653). However, 
this made no difference to the direction or magnitude of observed associations. Prevalent 
cases of MI or stroke were therefore included in the analysis and prevalent MI and 
prevalent stroke was added as covariates to the models (Model 3).  
 
5.5. Results 
Analyses were based on 4182 men, aged 60-79 years, who attended the 20 year re-
examination. The body composition characteristics of the study population and 
relationships between cardiovascular risk factors and various measures of adiposity and 
muscle mass were presented in Chapter 4. Participants were followed up for a mean period 
of 11.3 years (range: 10.3-12.3 years). During this follow-up period, 1340 men died from 
all causes; 528 (39.4%) of these deaths were attributed to CVD. Also, 466 men had an 
incident non-fatal or fatal CHD event, and 865 men had an incident non-fatal or fatal CVD 
event. The rate of all-cause mortality was 33.4 per 1000 person years, the rate of CVD 
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mortality was 13.2 per 1000 person years, the rate of CVD events was 22.6 per 1000 person 
years and the rate of CHD events was 11.9 per 1000 person years.  
 
5.5.1. Adiposity and risk of all-cause mortality, CVD mortality, CVD events and CHD 
events 
The crude incidence and mortality rates for all-cause mortality, CVD mortality, CVD 
events and CHD events by the different measures of adiposity are presented in Figures 5.1 
to 5.6 and the age-adjusted HRs for the risk of outcomes by adiposity measures can be 
found in Table 5.1. Measures of whole body adiposity (BMI and FMI) and central adiposity 
(WC) showed statistically significant quadratic relationships with all-cause mortality, but 
only BMI and WC showed a significant quadratic relationship with cardiovascular 
mortality. These quadratic relationships may be explained by the high correlation observed 
between these adiposity measures and measures of muscle mass (see section 4.5.2). Despite 
a high correlation between BMI and WC, WC showed a stronger positive relationship with 
all-cause mortality, CVD mortality and CVD events. WHR (an alternative measure of 
central adiposity) showed a significant positive linear trend with all-cause mortality, CVD 
mortality and CVD events. Subscapular skinfold thickness showed a slight inverse 
relationship with all-cause mortality, but no trend with CVD mortality or CVD events. 
Triceps skinfold thickness did not show any significant trends with all-cause mortality, 
CVD mortality or CVD events. No significant relationships were seen between any of the 
adiposity variables and CHD events. Overall, the impact of obesity was best seen for 
central adiposity measures (WC and WHR) as these were most strongly associated with 
CVD events, CVD mortality and all-cause mortality. Skinfold thickness measurements 
were not strongly associated with CVD and all-cause mortality and hence were excluded 
from further analysis of combined adiposity and muscle mass measures.  
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5.5.2. Muscle mass and risk of all-cause mortality, CVD mortality, CVD events and 
CHD events 
The crude incidence rates of all-cause mortality, CVD mortality, CVD events, and CHD 
events by measures of muscle mass are presented in Figures 5.7 to 5.9; age-adjusted HRs 
for the risk of outcomes by muscle mass measures can be found in Table 5.2. The risks of 
these outcomes tended to decrease with increasing muscle mass, but with a slight upturn in 
risk in the highest muscle mass quintile. A significant quadratic trend was observed 
between MAMC and three of the outcomes, with the lowest risks of all-cause mortality 
(age-adjusted HR: 0.62, 95% CI: 0.52-0.73), CVD mortality (age-adjusted HR: 0.79, 95% 
CI: 0.60-1.03) and CHD events (age-adjusted HR: 0.82, 95% CI: 0.62-1.10) in the fourth 
quintile of MAMC (27.0-28.3 cm). However, these quadratic trends could be explained by 
the highest muscle mass group having the highest mean BMI; when obese participants were 
excluded (BMI >30 kg/m2), there were significant inverse linear trends between MAMC 
and all-cause mortality (HR: 0.89, 95% CI:0.86-0.91), CVD mortality (HR: 0.91, 95% CI: 
0.87-0.95) and CHD events (HR: 0.95, 95% CI: 0.90-0.99), with no evidence of appreciable 
quadratic trends. No significant quadratic or linear trend was found between MAMC and 
CVD events, either before or after exclusion of obese individuals. Both FFMI and SMI 
showed similar initial significant quadratic relationships with all-cause mortality and CVD 
mortality. SMI showed a significant linear trend with CVD events. No significant trend was 
found between either FFMI or SMI with CHD events. In overall age-adjusted analysis, 
MAMC was the strongest predictor of both CVD and all-cause mortality. 
 
5.5.3. Combined measures of adiposity and muscle mass and risk of all-cause 
mortality, CVD mortality, CVD events and CHD events 
As outlined in Chapter 2 (section 2.4), since adiposity is positively associated and muscle 
mass is inversely associated with risk of CVD and mortality, there is a need to combine 
both measures to fully understand risk. Different classifications of sarcopenic obesity were 
explored, starting with obesity and muscle mass variables which emerged as strongly 
associated with CVD and mortality: WC and MAMC (n = 4111), WHR and MAMC (n = 
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4108), BMI and MAMC (n = 4118), WC and SMI (n = 4078) and FFMI and FMI (n = 
4045).  
 
5.5.3.1 Waist circumference and mid-arm muscle circumference 
Defining sarcopenic obesity using WC as a measure of central obesity and MAMC as a 
measure of low muscle mass (sarcopenia), 1490 (36.2%) men were classified as non-
sarcopenic non-obese, 1443 (35.1%) were classified as sarcopenic only, 983 (23.9%) were 
classified as obese only and 195 (4.7%) were classified as sarcopenic obese. Kaplan Meier 
survival curves for all-cause mortality, CVD mortality, CVD events and CHD events 
calculated for each sarcopenic obesity group showed that the survival probabilities for all 
outcomes were highest in the non-sarcopenic non-obese group and lowest in the sarcopenic 
obesity group (Figures 5.10 to 5.13).  
 
Table 5.3 shows adjusted HRs for outcomes by sarcopenic obesity groups. Sarcopenic and 
obese men both had a significantly increased risk of all-cause mortality after adjustment for 
smoking, alcohol, social class and physical activity (model 2) with the highest risk seen in 
sarcopenic obese men, compared to non-sarcopenic non-obese (sarcopenic, HR: 1.41, 95% 
CI: 1.22-1.63; obese, HR: 1.21, 95% CI: 1.03-1.42; sarcopenic obese, HR: 1.72, 95% CI: 
1.35-2.18). The increased mortality associated with sarcopenia and sarcopenic obesity (but 
not obesity) remained after adjustment for prevalent MI, prevalent stroke, HDL, SBP, 
FEV1, CRP, D-dimer, vWF and weight loss (model 5) although the HRs were slightly 
attenuated; 1.34 (1.15-1.57) for sarcopenia and 1.44 (1.10-1.90) for sarcopenic obesity.  
 
Further exploratory analysis, examining non-CVD mortality, showed that risks were 
significantly increased in sarcopenic men (HR: 1.39, 95% CI: 1.14-1.70) and sarcopenic 
obese men (HR: 1.73, 95% CI: 1.23-2.42) compared to the non-sarcopenic non-obese 
group, in the maximally adjusted model. However, a significantly increased risk in non-
CVD mortality was not apparent in the obese group. When examining cancer mortality, the 
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risk was significantly higher in the sarcopenic obese group compared to the non-sarcopenic 
non-obese group (HR: 1.64, 95% CI: 1.05-2.57), but was not significantly higher in the 
sarcopenic group or the obese group. 
 
The risk of CVD mortality was significantly increased in sarcopenic men (HR: 1.35, 95% 
CI: 1.07-1.70) and obese men (HR: 1.39, 95% CI: 1.07-1.80) compared to the non-
sarcopenic non-obese group after adjusting for behavioural variables. This risk was also 
elevated in sarcopenic obese men (HR: 1.38, 95% CI: 0.91-2.08), but the association was 
non-significant, possibly due to small numbers in this group. Additional adjustment for 
morbidity and CVD risk factors attenuated the HR for the obese group but the risk of CVD 
mortality remained significantly higher in the sarcopenic group. However, further 
adjustment for CRP, D-dimer and vWF in the sarcopenic group attenuated the associations 
which became non-significant. The risk of CVD events and CHD events was not 
significantly increased in any of the body composition groups after adjusting for smoking 
status, alcohol intake, physical activity and social class.  
 
In addition, the possibility of a sarcopenia x obesity interaction (both fitted as binary 
variables) was formally examined in relation to the risk of all-cause mortality, CVD 
mortality, CVD events and CHD events (see Table 5.3). However, there was no evidence of 
interaction between sarcopenia and obesity for any of the outcomes. In further sensitivity 
analysis, fitting MAMC as a continuous variable and waist circumference as a binary 
variable, results were essentially unchanged and there was still no significant interaction 
between sarcopenia and obesity in relation to the outcomes (results not presented). 
 
5.5.3.2 Alternative sarcopenic obesity definitions  
Using MAMC and WHR to define sarcopenic obesity groups (instead of WC as a measure 
of central adiposity) resulted in broadly similar associations, with the highest risk of all-
cause mortality in the sarcopenic obese group (HR: 1.61, 95% CI: 1.27-2.03), after 
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adjustment for behavioural variables (Table 5.4). However, WHR appeared to be a slightly 
stronger predictor of CVD mortality than WC, with a significant increase in risk in the 
sarcopenic obese group (HR: 1.48, 95% CI: 1.02-2.16). Similar, although weaker, 
associations were observed when defining sarcopenic obesity groups using BMI (reflecting 
whole body adiposity) and MAMC measurements (Table 5.5). Also, the observed 
association between sarcopenic obesity and all-cause mortality became non-significant after 
adjustment for morbidity and cardiovascular risk factors. This may be explained by the 
small number of participants classified as sarcopenic obese, based on BMI and MAMC 
measurements, (n=68, 1.7%) compared to the larger proportion identified when using the 
WC-MAMC classification (n=195, 4.7%).  
 
In additional exploratory analysis, in order to maximise the number of participants 
identified as sarcopenic obese, classifications were also explored defining obesity using any 
one of the three criteria for BMI, WC and WHR, together with MAMC. By increasing the 
numbers in the sarcopenic obesity group (n = 294, 7.1%), associations with all-cause 
mortality were strengthened in men with sarcopenia only (HR: 1.45, 95% CI: 1.24-1.69), 
obesity only (HR: 1.26, 95% CI: 1.07-1.49) and sarcopenic obese (HR: 1.74, 95% CI: 1.41-
2.16) groups, after adjustment for behavioural variables. Similarly, associations with CVD 
mortality were also stronger in the sarcopenic (HR: 1.36, 95% CI: 1.06-1.75), obese (HR: 
1.51, 95% CI: 1.16-1.96) and sarcopenic obese (HR: 1.80, 95% CI: 1.27-2.53) groups. 
However, after additional adjustment for morbidity, cardiovascular risk factors and 
inflammation, hazard ratios were attenuated to similar levels to those observed when using 
a single measure of obesity in the definition. 
 
Other composite measures of obesity and muscle mass, using BIA measurements, showed 
no significant associations with outcomes. The risks of CHD events, CVD events, CVD 
mortality and all-cause mortality were not significantly elevated when using WC and SMI 
measurements (Table 5.6) or when using FFMI and FMI measurements (Table 5.7), after 
adjustment for behavioural risk factors. Overall, central adiposity (WC or WHR) and 
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MAMC seem to be the best composite measures to predict cardiovascular mortality and all-
cause mortality in the older adults.  
 
5.6. Discussion  
5.6.1. Summary of main findings 
This chapter has examined the relationship between sarcopenia, obesity and sarcopenic 
obesity and the risk of CHD events, CVD events, CVD mortality and all-cause mortality in 
a prospective cohort of older men, aged 60-79 years. Few studies have looked at composite 
measures of sarcopenia and obesity in relation to CVD and mortality and these findings add 
to the limited literature in this area. Sarcopenia (defined as below the second quintile of 
MAMC; ≤ 25.9cm) and abdominal obesity (defined as WC >102cm) were associated with 
increased all-cause mortality risks compared to non-sarcopenic non-obese, with sarcopenic 
obese men showing the highest all-cause mortality risk. For sarcopenia and sarcopenic 
obesity, this association could not be explained by established CV risk factors or 
inflammation. Sarcopenia and obesity were not associated with CHD events or CVD events 
after adjustment for behavioural characteristics but both were associated with increased 
CVD mortality and this was to a large extent explained by their influence on CV risk 
factors (blood pressure, blood lipids and inflammation). Sarcopenic obese men also had an 
increased risk of cardiovascular mortality, although this was not statistically significant. 
Broadly similar associations were observed when defining sarcopenic obesity groups using 
WHR and MAMC. Weaker associations were found using BMI and MAMC, but no 
associations were observed when using BIA measurements to define sarcopenia. Overall, a 
combination of anthropometric measures of central adiposity (WC or WHR) and muscle 
mass (MAMC) appeared to be most strongly associated with cardiovascular mortality and 
all-cause mortality in older men.  
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5.6.2. Comparison with previous studies 
5.6.2.1 Individual measures of adiposity and muscle mass and risk of outcomes 
Many measures of adiposity have previously been explored to assess the impact of obesity 
on the risk of CVD and mortality in healthy adults. Most studies on BMI and CVD and 
mortality tend to show either U-shaped, flat or even inverse relationships because of 
opposing effects of muscle mass and adiposity76;78;128. This is in keeping with findings from 
this analysis, which showed a significant quadratic trend between BMI and FMI (an 
alternative measure of whole body adiposity) with CVD and all-cause mortality. The 
general consensus in the literature is that central adiposity is best in predicting CVD and 
mortality79;126;128;327 which again fits with analysis reported here, showing significant trends 
between higher WC and WHR and an increased risk of CVD mortality and all-cause 
mortality. Analysis of other UK cohorts have previously found an association between 
individual skinfold thickness measurements and CHD but not with all-cause mortality328. In 
comparison, the only significant association observed here was a slight inverse relationship 
between subscapular skinfold thickness and all-cause mortality. Overall, of the adiposity 
measures explored, central adiposity (WC or WHR) were the best indicators of mortality, 
consistent with the results of a recent meta-analysis of elderly cohorts showing a strong 
positive association between WC and mortality risk127.  
 
A range of markers of muscle mass were explored, including anthropometric (MAMC) and 
BIA measures (FFMI and SMI). All measures showed significant trends with CVD 
mortality and all-cause mortality, adjusting for age only. In addition, SMI showed a 
significant trend with CVD events and MAMC showed a significant trend with CHD 
events. Similarly, previous prospective studies have reported an inverse J-shaped or U-
shaped associations between all-cause mortality and a range of muscle mass measurements, 
including appendicular skeletal muscle mass (measured by DXA), lean mass (measured by 
BIA) and arm circumference measurements178;179;181;183;191. Few previous studies have 
investigated the prospective associations between sarcopenia and CVD risk, but cross-
sectional studies have shown associations between sarcopenia and CVD risk 
factors161;168;175;329. Overall, MAMC was the measure which best described muscle mass in 
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this cohort, suggesting that a simple anthropometric measure of measure mass is better than 
alternative BIA measures in predicting risk of CVD and mortality in older adults. The 
exclusion of participants with a BMI above 30 kg/m2 resulted in significant inverse linear 
trends between muscle mass and outcomes, stressing the fact that composite measures of 
muscle mass and adiposity provide a clearer picture. 
 
5.6.2.2 Combined measures of adiposity and muscle mass and risk of all-cause mortality 
A composite measure of central adiposity (WC or WHR) and MAMC best described body 
composition in terms of all-cause mortality risk. Using WC and MAMC to define 
sarcopenic obesity groups, sarcopenia was associated with increased all-cause mortality, 
which was independent of behavioural and cardiovascular risk markers. This is consistent 
with previous prospective studies in older adults which have shown associations between 
various measures of low muscle mass and an increased mortality risk178;179;181;183;330. 
Although inflammation is strongly related to sarcopenia and all-cause mortality these 
previous studies did not assess the contributing role of CRP82;157; this study showed that the 
sarcopenia-mortality association could only partially be explained by inflammation. 
Obesity was associated with increased all-cause mortality, independent of behavioural 
variables, but the association disappeared after adjustment for established cardiovascular 
risk factors. Despite obesity being a strong risk factor for mortality in middle age76, some 
previous studies have shown that overweight/obesity is not as adverse in elderly 
populations13;14;331;332. Sarcopenic obese older men were at the highest risk of all-cause 
mortality compared to the non-sarcopenic non-obese group, after adjustment for 
behavioural variables, but there was no evidence of an interaction between sarcopenia and 
obesity. This lack of interaction suggests that the relationship between sarcopenia and all-
cause mortality was consistent across obese and non-obese body composition groups. The 
observed association between sarcopenic obesity and mortality diminished slightly after 
adjustment for potential mediators (blood pressure, blood lipids and inflammation) but a 
significant increase in risk remained. This suggests that cardiovascular and inflammatory 
risk markers only partially explain the relationship between sarcopenic obesity and 
mortality.  
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These findings confirm initial work carried out in this cohort suggesting that the combined 
use of WC and MAMC provides anthropometric body composition measures which are 
associated with the risk of mortality in older men191. This current analysis had almost 
double the length of follow-up of previous analyses (follow-up period extended from 6 to 
11 years) and included additional outcomes (CHD events, CVD events and CVD 
mortality). Previous prospective studies of the association between sarcopenic obesity and 
mortality are limited. However, these findings support previous research which has shown 
an association between sarcopenic obesity and a greater mortality risk in cohorts with end-
stage renal disease and cancer190;325 and demonstrates that this association holds true in a 
population-based cohort. This study showed a similar direction of association between 
sarcopenic obesity and all-cause mortality as a previous study with 30 years of follow-up in 
which overweight men in the lowest grip strength tertile had about a 40% higher mortality 
risk compared to normal weight men in the highest tertile194.  
 
As expected, very similar results were observed when defining sarcopenic obesity using 
MAMC and WHR (an alternative measure of central adiposity standardised for hip 
circumference). The use of this alternative central adiposity measure added little in terms of 
risk prediction for all-cause mortality beyond that of WC. Since WC would be quicker and 
easier to measure than WHR in a clinical setting, the use of WHR instead of WC offers no 
real additional advantages. Sarcopenic obesity (defined by BMI and MAMC) resulted in a 
similar, but weaker, pattern of association to those seen for WC and MAMC. BMI reflects 
both fat and muscle mass; therefore taking muscle mass into account strengthened the 
impact of obesity, as measured by BMI, on all-cause mortality risk. However, the 
significant association initially observed between sarcopenic obesity and all-cause mortality 
disappeared after adjustment for CVD risk factors. This observation was consistent with the 
findings of a recent meta-analysis in the elderly, which highlighted the limitations of BMI 
as a measure of adiposity in older people and suggested that WC may be a stronger risk 
factor for mortality128.  
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5.6.2.3 Combined measures of adiposity and muscle mass and risk of cardiovascular 
outcomes 
Using WC and MAMC to define sarcopenic and obesity groups, sarcopenia was not 
associated with CHD events or CVD events after adjustment for behavioural variables. 
However, sarcopenia was associated with CVD mortality even after adjustment for blood 
pressure and blood lipids, but this association was no longer significant after adjustment for 
CRP, D-dimer and vWF. This attenuated association between sarcopenia and CVD 
mortality after adjusting for CRP, D-dimer and vWF in multivariable models suggests a 
plausible mechanism by which chronic inflammation and hemostatic dysfunction may in 
part mediate the relationship between low muscle mass and cardiovascular mortality. This 
would be consistent with the finding that CRP is more strongly associated with the risk of 
fatal vascular events than non-fatal vascular events333. Obesity was not associated with 
CHD events or CVD events but was associated with an increased risk of CVD mortality, 
which was largely due to its associations with established cardiovascular risk factors. The 
observed association between obesity and an increased risk of CVD mortality is consistent 
with a previous meta-analysis in the elderly127. Cross-sectionally, sarcopenic obese men 
have an especially adverse cardiovascular risk profile, as observed in both previous 
literature (Section 2.4.7) and in this study population (Section 4.5.5). Prospective analyses 
in this chapter have shown that sarcopenic obese men also have an elevated risk of CVD 
mortality, after adjustment for behavioural variables. This association was significant using 
WHR and MAMC measurements but not when using WC and MAMC measurements, 
perhaps due to the small numbers in the sarcopenic obesity group. WHR therefore seemed 
to be a slightly stronger predictor of CVD mortality than WC, consistent with findings from 
a meta-regression analysis of prospective studies126. 
 
Chapter 2 established that previous research investigating prospective associations between 
sarcopenia or sarcopenic obesity and CVD outcomes is extremely limited (see Table 2.2), 
with the few studies available mostly cross-sectionally examining CV risk factors (see 
Table 2.1). The findings from this chapter are broadly consistent with one published 
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prospective study of community-dwelling older men and women (≥ 65 years) which 
showed that the risk of CHD events and CVD events was not significantly elevated within 
the sarcopenic, obese or sarcopenic obese groups (as determined by WC and BIA-measured 
muscle mass) compared to the non-sarcopenic non-obese group, after adjustment for 
behavioural variables and cognitive function177. However, this previous study did not 
specifically look at CVD mortality, which did show an association with both sarcopenia 
and obesity in this study, after adjustment for behavioural variables. The authors of this 
aforementioned study did however imply that muscle strength rather than muscle mass may 
be more important, since sarcopenic obesity (defined using grip strength) was predictive of 
increased risk of CVD events177. 
 
Using BIA measurements to define sarcopenic obesity (FMI and FFMI or WC and SMI) no 
significant associations were observed with any of the outcomes. This is consistent with 
previous research in this cohort, suggesting that a composite measure of MAMC and WC is 
more effective in predicting all-cause mortality than measures of FFMI and FMI. These 
results are also consistent with those of a prospective study of older adults from NHANES 
III, which found that the risk of mortality in sarcopenic obese men (based on BIA 
measurements) was not significantly increased192. This lack of observed associations 
between sarcopenic obesity, defined using BIA measures, and outcomes may be explained 
by the imprecision of BIA in assessment of muscle mass in older people, principally due to 
the variability that exists in fat-free mass hydration311;312, as referred to in section 4.6.3. 
 
5.6.3. Strengths and limitations 
A major strength of the results presented in this chapter is that data are from a moderately 
large population-based, geographically and socioeconomically representative, cohort of 
older British men with very high follow-up rates35;264. However, since the study comprised 
older male participants, predominantly of white European ethnic origin, the findings may 
not be generalisable to women and non-white ethnic groups. Moreover, results may not be 
applicable to men with prevalent heart failure since such participants were excluded from 
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analyses. Although all mortality and morbidity outcomes were based on objective 
measurements, self-reported variables (e.g. smoking status, alcohol intake, and physical 
activity) may have been subject to misclassification which could lead to residual 
confounding. In particular, self-reported measures of physical activity can be a particular 
problem in older age groups due to the light intensities of activity and vast variability in 
duration of activity in these age groups which make accurate recall especially difficult315-317 
(as discussed in Chapter 4, Section 4.6.3). However, a validation study in older men within 
the BRHS has shown self-reported physical activity questions used within this cohort are 
associated with a graded increase in objectively measured physical activity318. This reduces 
the risk of measurement error, and any possible misclassification of physical activity is 
likely to have been non-differential between body composition groups and is only likely to 
have attenuated relative risk estimates between body composition groups and outcomes320.  
 
An additional strength of this study is the wide range of body composition measures used to 
assess adiposity and muscle mass. Although this study did not have direct measurements of 
adiposity or muscle mass such as computerised tomography (CT), magnetic resonance 
imaging (MRI) or dual-energy X-ray absorptiometry (DXA), these expensive, time-
consuming measures are rarely available in non-clinical settings and the anthropometric 
and BIA measures used represent a practical alternative (as discussed in section 4.6.3). The 
American Heart Association recognises MAMC as a proxy marker for muscle mass102 
which is strongly correlated with more accurate dual-energy X-ray absorptiometry 
measures of lean mass147. In addition, the European Working Group on Sarcopenia has 
approved BIA measures as a portable alternative to dual-energy X-ray absorptiometry17. 
Also, WC has been shown to be the anthropometric variable which best correlates with 
adiposity stores in men, as measured by MRI304. Any imprecision in the assessment of 
adiposity and muscle mass may have weakened (rather than strengthened) the estimates of 
the strength of associations observed in this chapter between sarcopenic obesity groups and 
disease outcomes and mortality.  
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Since no universally accepted operational definition of sarcopenia has yet been adopted17, a 
statistical approach was used to define low muscle mass as participants below the second 
quintile of the distribution of MAMC, FFMI or SMI. However, as discussed in Chapter 4 
(section 4.6.3), the cut-offs used in this study for MAMC and FFMI were comparable to 
those used in previous studies179;181. In addition, the cut-point used for the lowest two fifths 
of SMI (9.9 kg/m2) was very similar to the definition of low muscle mass used previously 
in NHANES III in men aged 70 years and over (lower two fifths of SMI: <9.12 kg/m2)334.   
 
As outlined in Chapter 2 (Section 2.4.6) the European Working Group on Sarcopenia in 
Older People proposed a definition of sarcopenia which included the presence of both low 
muscle mass and low muscle function17. However, measures of muscle function were not 
available in this study population and only markers of muscle mass were used. Findings 
from this chapter are therefore applicable to sarcopenia and sarcopenic obesity as defined 
by muscle mass, but not muscle strength. Another consideration is that the body 
composition measures used within this chapter were assessed at one time point only, so 
information was unavailable on whether participant’s sarcopenia and obesity status changed 
over time.  
 
5.6.4. Conclusions 
The results of this chapter show that both muscle mass and adiposity are associated with 
risks of CVD mortality and all-cause mortality in older adults. A combination of 
anthropometric measures of central adiposity (WC or WHR) and muscle mass (MAMC) 
appear to be the strongest predictors of cardiovascular mortality and all-cause mortality in 
older men. Using these combined measures, sarcopenia and abdominal obesity are both 
associated with increased all-cause mortality with the highest risk in sarcopenic obese men. 
Sarcopenia and sarcopenic obesity, but not obesity on its own, were associated with 
increased all-cause mortality independent of CVD risk factors, inflammation and weight 
loss. No association was seen between sarcopenia and obesity with CHD events or CVD 
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events, but sarcopenia and obesity were both associated with increased CVD mortality 
largely due to their associations with blood pressure, blood lipids and inflammation.  
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Table 5.1 Hazard ratios (95% CI) for risk of all-cause mortality, CVD mortality, CVD 
events and CHD events by measures of adiposity and in men aged 60-79 years in 1998-
2000 
 
  
n 
All-cause 
mortality CVD mortality CVD events CHD events 
   Age-adjusted HR (95% CI) 
BMI (kg/m2)           
<18.5 25 2.93 (1.80-4.75)* 2.70 (1.20-6.10) 1.99 (0.94-4.21) 2.72 (1.11-6.64) 
18.5-24.9 1,249 1.00 1.00 1.00 1.00 
25-27.4 1,248 0.81 (0.70-0.93)* 0.87 (0.69-1.09) 0.99 (0.83-1.18) 1.12 (0.88-1.42) 
27.5-29.9 928 0.89 (0.76-1.03) 0.96 (0.76-1.23) 1.10 (0.91-1.32) 1.08 (0.84-1.40) 
≥ 30 713 1.11 (0.95-1.30) 1.39 (1.09-1.78)* 1.23 (1.01-1.51)* 1.23 (0.93-1.62) 
p for linear trend   0.88 0.02 0.02 0.44 
p for quadratic trend   <0.001 0.01 0.44 0.34 
FMI (kg/m2)           
Q1 (≤ 7.19) 809 1.00 1.00 1.00 1.00 
Q2 (7.19-8.70) 809 0.93 (0.78-1.10) 0.94 (0.71-1.24)) 0.93 (0.75-1.16) 0.94 (0.71-1.23) 
Q3 (8.70-10.24) 809 0.88 (0.74-1.05) 0.82 (0.61-1.09) 0.98 (0.79-1.22) 0.86 (0.64-1.16) 
Q4 (10.24-12.04) 809 0.92 (0.77-1.09) 0.96 (0.73-1.27) 0.99 (0.79-1.22) 0.96 (0.72-1.28) 
Q5 (≥ 12.04) 809 1.15 (0.97-1.36) 1.34 (1.03-1.74)* 1.20 (0.97-1.48) 1.15 (0.87-1.53) 
p for linear trend   0.27 0.05 0.13 0.48 
p for quadratic trend   0.007 0.07 0.18 0.30 
WC (cm)           
 <94 1,573 1.00 1.00 1.00 1.00 
94-102 1,369 0.95 (0.83-1.08) 0.96 (0.77-1.18) 1.04 (0.89-1.23) 1.00 (0.80-1.24) 
103-105 457 1.06 (0.89-1.28) 0.97 (0.71-1.32) 1.02 (0.81-1.29) 1.16 (0.86-1.58) 
≥ 106 758 1.24 (1.07-1.44)* 1.46 (1.16-1.83)* 1.32 (1.10-1.59)* 1.20 (0.93-1.54) 
p for linear trend   0.04 0.006 0.009 0.32 
p for quadratic trend   <0.001 0.01 0.46 0.73 
WHR (cm)           
Q1 (≤ 0.90) 831 1.00 1.00 1.00 1.00 
Q2 (0.90-0.93) 831 1.00 (0.84-1.19) 0.99 (0.75-1.30) 0.94 (0.75-1.17) 1.06 (0.79-1.44) 
Q3 (0.93-0.96) 831 1.00 (0.84-1.20) 0.87 (0.65-1.16) 0.98 (0.79-1.22) 1.04 (0.76-1.41) 
Q4 (0.96-1.00) 831 1.11 (0.93-1.31) 1.06 (0.81-1.40) 1.12 (0.91-1.39) 1.33 (0.99-1.78) 
Q5 (≥ 1.00) 830 1.26 (1.07-1.49)* 1.30 (1.01-1.69)* 1.27 (1.03-1.560* 1.36 (1.02-1.82)* 
p for linear trend   0.002 0.04 0.01 0.05 
p for quadratic trend   0.14 0.59 0.66 0.73 
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Table 5.1 Continued. Hazard ratios (95% CI) for risk of all-cause mortality, CVD 
mortality, CVD events and CHD events by measures of adiposity and in men aged 60-
79 years in 1998-2000 
 
  
n 
All-cause 
mortality CVD mortality CVD events CHD events 
   Age-adjusted HR (95% CI) 
Subscapular skinfold 
(mm)           
Q1 (≤ 14.40) 822 1.00 1.00 1.00 1.00 
Q2 (14.40-17.27) 820 0.76 (0.64-0.89)* 1.06 (0.82-1.39) 0.98 (0.79-1.20) 1.15 (0.87-1.52) 
Q3 (17.27-20.50) 820 0.80 (0.68-0.94)* 0.93 (0.71-1.23) 0.92 (0.74-1.14) 0.94 (0.70-1.27) 
Q4 (20.50-24.65) 820 0.74 (0.63-0.88)* 0.95 (0.72-1.25) 0.94 (0.76-1.16) 0.93 (0.69-1.25) 
Q5 (≥ 24.65) 819 0.81 (0.68-0.95)* 1.01 (0.76-1.33) 0.99 (0.80-1.22) 0.99 (0.73-1.33) 
p for linear trend   0.03 0.98 0.99 0.64 
p for quadratic trend   <0.001 0.09 0.23 0.08 
Triceps Skinfold (mm)           
Q1 (≤ 8.76) 828 1.00 1.00 1.00 1.00 
Q2 (8.76-10.49) 828 0.88 (0.74-1.04) 0.83 (0.62-1.11) 0.92 (0.74-1.15) 0.95 (0.72-1.27) 
Q3 (10.49-12.39) 828 0.83 (0.70-0.98)* 1.02 (0.78-1.33) 1.08 (0.88-1.34) 0.88 (0.66-1.18) 
Q4 (12.39-15.15) 828 0.95 (0.80-1.12) 1.09 (0.83-1.43) 1.07 (0.86-1.32) 1.00 (0.66-1.18) 
Q5 (≥ 15.15) 827 1.09 (0.93-1.29) 1.26 (0.97-1.64) 1.16 (0.94-1.43) 1.04 (0.78-1.38) 
p for linear trend   0.42 0.11 0.18 0.75 
p for quadratic trend   0.38 0.14 0.26 0.99 
 
BMI, body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; FMI, fat mass index; 
WC, waist circumference; WHR, wait-to-hip ratio. P-value for quadratic trend adjusted for linear trend. 
* p<0.05 
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Table 5.2 Hazard ratios (95% CI) for risk of all-cause mortality, CVD mortality, CVD 
events and CHD events by measures of muscle mass and in men aged 60-79 years in 
1998-2000 
 
  
n 
All-cause mortality CVD mortality CVD events CHD events 
  Age-adjusted HR (95% CI) 
MAMC (cm)           
Q1 (≤ 24.54) 827 1.00 1.00 1.00 1.00 
Q2 (24.54-25.90) 827 0.79 (0.68-0.92)* 0.99 (0.78-1.26) 1.05 (0.86-1.28) 0.85 (0.65-1.12) 
Q3 (25.90-27.00) 827 0.65 (0.55-0.77)* 0.81 (0.62-1.06) 0.90 (0.73-1.11) 0.83 (0.63-1.10) 
Q4 (27.00-28.33) 827 0.62 (0.52-0.73)* 0.79 (0.60-1.03) 0.94 (0.76-1.16) 0.82 (0.62-1.10) 
Q5 (≥ 28.33) 827 0.67 (0.57-0.80)* 0.85 (0.64-1.13) 1.03 (0.82-1.27) 0.90 (0.68-1.21) 
p for linear trend   <0.001 0.12 0.93 0.48 
p for quadratic trend   <0.001 0.03 0.13 0.004 
FFMI (kg/m2)           
Q1 (≤ 15.71) 810 1.00 1.00 1.00 1.00 
Q2 (15.71-16.66) 810 0.88 (0.74-1.04) 0.89 (0.68-1.17) 1.09 (0.88-1.34) 1.19 (0.90-1.58) 
Q3 (16.66-17.55) 809 0.77 (0.65-0.92)* 0.72 (0.54-0.96)* 0.85 (0.68-1.07) 0.86 (0.64-1.72) 
Q4 (17.55-18.70) 810 0.86 (0.73-1.02) 0.79 (0.60-1.05) 0.89 (0.71-1.11) 0.93 (0.69-1.25) 
Q5 (≥ 18.70) 809 0.91 (0.77-1.07) 1.07 (0.82-1.38) 1.21 (0.98-1.48) 1.03 (0.77-1.37 
p for linear trend   0.38 0.16 0.06 0.75 
p for quadratic trend   <0.001 0.002 0.23 0.19 
SMI (kg/m2)           
Q1 (≤ 9.35) 820 1.00 1.00 1.00 1.00 
Q2 (9.35-9.92) 820 0.80 (0.68-0.94)* 0.73 (0.56-0.96) 1.04 (0.84-1.28) 1.16 (0.88-1.53) 
Q3 (9.92-10.48) 819 0.81 (0.68-0.95)* 0.80 (0.61-1.04) 0.91 (0.73-1.13) 0.93 (0.69-1.25) 
Q4 (10.48-11.18) 820 0.80 (0.67-0.94)* 0.76 (0.58-1.00) 0.95 (0.76-1.17) 0.95 (0.71-1.27) 
Q5 (≥ 11.18) 819 0.93 (0.78-1.09) 1.11 (0.87-1.43) 1.24 (1.01-1.52)* 1.09 (0.81-1.45) 
p for linear trend   0.74 0.03 0.01 0.75 
p for quadratic trend   0.001 0.05 0.46 0.63 
 
CHD, coronary heart disease; CVD, cardiovascular disease; FFMI, fat-free mass index; MAMC, mid-arm 
muscle circumference; SMI, skeletal muscle index. P-value for quadratic trend adjusted for linear trend. 
* p<0.05 
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Table 5.3 Hazard ratios (95% CI) for risk of all-cause mortality, CVD mortality, CVD events and CHD events by sarcopenic 
obesity groups (as defined by mid-arm muscle circumference and waist circumference) in men aged 60-79 years in 1998-2000 
 
    Sarcopenic Obesity Groups 
p value          
(sarcopenia*obesity 
interaction) 
    (MAMC lowest 2 quintiles; WC >102cm) 
    
Non-sarcopenic 
non-obese Sarcopenic  Obese Sarcopenic obese 
Total (%)   1 490 (36.2) 1 443 (35.1) 983 (23.9) 195 (4.7)   
              
CHD events Model 1  1.00 1.22 (0.97-1.53) 1.33 (1.04-1.70)* 1.37 (0.90-2.08) 0.50 
Model 2  1.00 1.09 (0.86-1.38) 1.19 (0.92-1.55) 1.11 (0.71-1.75) 0.55 
            
CVD events Model 1 1.00 1.19* (1.01-1.41) 1.30* (1.08-1.56) 1.39* (1.02-1.89) 0.55 
  Model 2 1.00 1.11 (0.93-1.32) 1.18 (0.98-1.43) 1.08 (0.77-1.52) 0.31 
              
CVD mortality Model 1  1.00 1.48 (1.19-1.85)* 1.60 (1.25-2.03)* 1.79 (1.19-1.85)* 0.21 
Model 2  1.00 1.35 (1.07-1.70)* 1.39 (1.07-1.80)* 1.38 (0.91-2.08) 0.20 
Model 3  1.00 1.33 (1.04-1.70)* 1.18 (0.89-1.55) 1.29 (0.83-2.00) 0.44 
Model 4 1.00 1.26 (0.98-1.61) 1.12 (0.84-1.48) 1.14 (0.73-1.79) 0.42 
            
All-cause mortality Model 1  1.00 1.54 (1.34-1.76)* 1.41 (1.21-1.64)* 2.09 (1.67-2.62)* 0.78 
Model 2  1.00 1.41 (1.22-1.63)* 1.21 (1.03-1.42)* 1.72 (1.35-2.18)* 0.95 
Model 3 1.00 1.37 (1.18-1.59)* 1.11 (0.93-1.32) 1.61 (1.25-2.08)* 0.70 
Model 4 1.00 1.34 (1.15-1.56)* 1.07 (0.90-1.28) 1.49 (1.15-1.93)* 0.81 
Model 5 1.00 1.34 (1.15-1.57)* 1.07 (0.89-1.28) 1.44 (1.10-1.90)* 0.96 
   
CHD, coronary heart disease; CVD, cardiovascular disease; MAMC, mid-arm muscle circumference; WC, waist circumference.  
Model 1: adjusted for age; Model 2: adjusted for model 1 + smoking, alcohol, social class, physical activity; Model 3: adjusted for model 2 + prevalent MI, 
prevalent stroke, HDL, SBP, FEV1; Model 4: adjusted for model 3 + CRP, D-dimer, vWF; Model 5: adjusted for model 4 + weight loss. 
* p<0.05  
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Table 5.4 Hazard ratios (95% CI) for risk of all-cause mortality, CVD mortality, CVD events and CHD events by sarcopenic 
obesity groups (as defined by mid-arm muscle circumference and waist-to-hip ratio) in men aged 60-79 years in 1998-2000 
 
    Sarcopenic Obesity Groups 
p value          
(sarcopenia*obesity 
interaction) 
    (MAMC lowest 2 quintiles; WHR >1.00 cm) 
    
Non-sarcopenic 
non-obese Sarcopenic  Obese Sarcopenic obese 
Total (%) 
 
1921 (46.8) 1440 (35.1) 550 (13.4) 197 (4.8)   
  
     
  
CHD events Model 1 1.00 1.16 (0.94-1.43) 1.38 (1.05-1.81)* 1.35 (0.90-2.02) 0.49 
Model 2 1.00 1.05 (0.84-1.31) 1.21 (0.91-1.61) 1.09 (0.70-1.70) 0.55 
  
     
  
CVD events Model 1 1.00 1.11 (0.95-1.30) 1.28 (1.05-1.58)* 1.49 (1.13-1.98)* 0.80 
  Model 2 1.00 1.05 (0.90-1.24) 1.19 (0.96-1.48) 1.25 (0.92-1.71) 0.99 
  
     
  
CVD mortality Model 1 1.00 1.33 (1.09-1.62)* 1.53 (1.18-1.99)* 1.74 (1.23-2.47)* 0.49 
Model 2 1.00 1.23 (0.99-1.52) 1.32 (0.99-1.74) 1.48 (1.02-2.16)* 0.72 
Model 3 1.00 1.26 (1.00-1.58) 1.18 (0.88-1.59) 1.49 (1.01-2.21)* 0.99 
Model 4 1.00 1.19 (0.95-1.50) 1.12 (0.83-1.51) 1.41 (0.95-2.09) 0.83 
  
     
  
All-cause mortality Model 1 1.00 1.46 (1.29- 1.65)* 1.42 (1.29-1.65)* 1.87 (1.50-2.34)* 0.48 
Model 2 1.00 1.36 (1.19-1.55)* 1.19 (0.99-1.42) 1.61 (1.27-2.03)* 0.98 
Model 3 1.00 1.35 (1.17-1.55)* 1.12 (0.92-1.35) 1.57 (1.23-2.00)* 0.81 
Model 4 1.00 1.32 (1.15-1.52)* 1.08 (0.89-1.31) 1.47 (1.15-1.89)* 0.83 
Model 5 1.00 1.31 (1.14-1.52)* 1.08 (0.89-1.32) 1.54 (1.19-1.99)* 0.62 
 
CHD, coronary heart disease; CVD, cardiovascular disease; MAMC, mid-arm muscle circumference; WHR, waist-to-hip ratio.  
Model 1: adjusted for age; Model 2: adjusted for model 1 + smoking, alcohol, social class, physical activity; Model 3: adjusted for model 2 + prevalent MI, 
prevalent stroke, HDL, SBP, FEV1; Model 4: adjusted for model 3 + CRP, D-dimer, vWF; Model 5: adjusted for model 4 + weight loss. 
* p<0.05
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Table 5.5 Hazard ratios (95% CI) for risk of all-cause mortality, CVD mortality, CVD events and CHD events by sarcopenic 
obesity groups (as defined by mid-arm muscle circumference and body mass index) in men aged 60-79 years in 1998-2000 
 
    Sarcopenic Obesity Groups 
p value          
(sarcopenia*obesity 
interaction) 
    (MAMC lowest 2 quintiles; BMI ≥ 30 
    
Non-sarcopenic 
non-obese Sarcopenic  Obese Sarcopenic obese 
Total (%)   1858 (45.1) 1579 (38.3) 613 (14.9) 68 (1.7)   
              
CHD events Model 1  1.00 1.15 (0.93-1.41) 1.25 (0.96-1.55) 1.06 (0.50-2.26) 0.44 
  Model 2  1.00 1.04 (0.84-1.29) 1.13 (0.85-1.50) 0.79 (0.35-1.80) 0.34 
              
CVD events Model 1 1.00 1.13 (0.97-1.32) 1.26 (1.04-1.54)* 1.58 (1.00-2.52) 0.69 
  Model 2 1.00 1.06 (0.90-1.24) 1.14 (0.93-1.41) 1.22 (0.74-1.99) 0.98 
              
CVD mortality Model 1  1.00 1.41 (1.16-1.72)* 1.73 (1.35-2.24)* 2.06 (1.17-3.63)* 0.57 
  Model 2  1.00 1.31 (1.06-1.62)* 1.52 (1.16-2.00)* 1.62 (0.89-2.94) 0.52 
  Model 3  1.00 1.29 (1.03-1.61)* 1.23 (0.92-1.65) 1.49 (0.77-2.85) 0.85 
  Model 4 1.00 1.23 (0.98-1.54) 1.17 (0.87-1.57) 1.28 (0.66-2.47) 0.75 
              
All-cause mortality Model 1  1.00 1.52 (1.35-1.72)* 1.46 (1.24-1.73)* 1.92 (1.33-2.78)* 0.46 
  Model 2  1.00 1.42 (1.25-1.62)* 1.26 (1.06-1.50)* 1.59 (1.09-2.33)* 0.57 
  Model 3 1.00 1.39 (1.21-1.60)* 1.17 (0.97-1.41) 1.40 (0.92-2.15) 0.53 
  Model 4 1.00 1.37 (1.19-1.57)* 1.14 (0.94-1.37) 1.26 (0.82-1.94) 0.36 
  Model 5 1.00 1.37 (1.19-1.58)* 1.14 (0.94-1.39) 1.18 (0.75-1.87) 0.24 
 
BMI, body mass index; CHD, coronary heart disease; CVD, cardiovascular disease; MAMC, mid-arm muscle circumference.  
Model 1: adjusted for age; Model 2: adjusted for model 1 + smoking, alcohol, social class, physical activity; Model 3: adjusted for model 2 + prevalent MI, 
prevalent stroke, HDL, SBP, FEV1; Model 4: adjusted for model 3 + CRP, D-dimer, vWF; Model 5: adjusted for model 4 + weight loss. 
* p<0.05  
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Table 5.6 Hazard ratios (95% CI) for risk of all-cause mortality, CVD mortality, CVD events and CHD events by sarcopenic 
obesity groups (as defined by skeletal muscle index and waist circumference) in men aged 60-79 years in 1998-2000 
 
    Sarcopenic Obesity Groups 
p value          
(sarcopenia*obesity 
interaction) 
    (SMI lowest 2 quintiles; WC >102cm) 
    
Non-sarcopenic 
non-obese Sarcopenic  Obese Sarcopenic obese 
Total (%)   1540 (37.8) 1338 (32.8) 902 (22.1) 297 (7.3)   
              
CHD events Model 1  1.00 1.14 (0.91-1.43) 1.21 (0.94-1.56) 1.38 (0.98-1.94) 0.98 
  Model 2  1.00 1.12 (0.88-1.41) 1.14 (0.87-1.48) 1.20 (0.83-1.73) 0.80 
              
CVD events Model 1 1.00 1.08 (0.92-1.27) 1.26 (1.05-1.51)* 1.17 (0.90-1.52) 0.34 
  Model 2 1.00 1.06 (0.89-1.26) 1.17 (0.96-1.41) 0.96 (0.72-1.29) 0.15 
              
CVD mortality Model 1  1.00 1.08 (0.87-1.34) 1.34 (1.06-1.69)* 1.35 (0.97-1.86) 0.72 
  Model 2  1.00 1.03 (0.82-1.29) 1.18 (0.92-1.52) 1.04 (0.72-1.49) 0.46 
              
All-cause mortality Model 1  1.00 1.18 (1.03-1.35)* 1.31 (1.13-1.52)* 1.33 (1.08-1.64)* 0.25 
  Model 2  1.00 1.08 (0.94-1.24) 1.12 (0.96-1.32) 1.07 (0.86-1.33) 0.34 
 
 
CHD, coronary heart disease; CVD, cardiovascular disease; SMI, skeletal muscle index; WC, waist circumference.  
Model 1: adjusted for age; Model 2: adjusted for model 1 + smoking, alcohol, social class, physical activity; Model 3: adjusted for model 2 + prevalent MI, 
prevalent stroke, HDL, SBP, FEV1; Model 4: adjusted for model 3 + CRP, D-dimer, vWF; Model 5: adjusted for model 4 + weight loss. 
* p<0.05 
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Table 5.7 Hazard ratios (95% CI) for risk of all-cause mortality, CVD mortality, CVD events and CHD events by sarcopenic 
obesity groups (as defined by fat-free mass index and fat mass index) in men aged 60-79 years in 1998-2000 
 
    Sarcopenic Obesity Groups 
p value          
(sarcopenia*obesity 
interaction) 
    (FFMI lowest 2 quintiles; FMI highest 28.7%) 
    
Non-sarcopenic 
non-obese Sarcopenic  Obese Sarcopenic obese 
Total (%)   1670 (41.3) 1190 (29.4) 756 (18.7) 429 (10.6)   
              
CHD events Model 1  1.00 1.17 (0.94-1.46) 1.13 (0.87-1.48) 1.35 (1.00-1.83)* 0.92 
  Model 2  1.00 1.15 (0.91-1.45) 1.04 (0.79-1.38) 1.13 (0.82-1.56) 0.79 
              
CVD events Model 1 1.00 1.05 (0.89-1.24) 1.10 (0.90-1.33) 1.21 (0.97-1.51) 0.77 
  Model 2 1.00 1.03 (0.87-1.22) 1.01 (0.82-1.24) 1.01 (0.79-1.29) 0.85 
              
CVD mortality Model 1  1.00 1.18 (0.95-1.46) 1.43 (1.12-1.82)* 1.37 (1.02-1.82)* 0.29 
  Model 2  1.00 1.11 (0.89-1.39) 1.25 (0.96-1.62) 1.11 (0.81-1.53) 0.30 
 
            
All-cause mortality Model 1  1.00 1.19 (1.05-1.36)* 1.26 (1.08-1.47)* 1.18 (0.98-1.42) 0.05 
  Model 2  1.00 1.08 (0.94-1.24) 1.09 (0.92-1.27) 0.98 (0.80-1.20) 0.19 
 
CHD, coronary heart disease; CVD, cardiovascular disease; FFMI, fat-free mass index; FMI fat mass index.  
Model 1: adjusted for age; Model 2: adjusted for model 1 + smoking, alcohol, social class, physical activity. Cut-off for obesity (FMI >28.7th percentile) 
corresponds to the WC >102cm cut-off. 
*p<0.05 
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Figure 5.1 Rate of CHD events, CVD events, CVD mortality and all-cause 
mortality by body mass index in men aged 60-79 years in 1998-2000  
 
 
 
 
Figure 5.2 Rate of CHD events, CVD events, CVD mortality and all-cause 
mortality by fat mass index in men aged 60-79 years in 1998-2000   
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Figure 5.3 Rate of CHD events, CVD events, CVD mortality and all-cause 
mortality by waist circumference in men aged 60-79 years in 1998-2000 
 
 
 
Figure 5.4 Rate of CHD events, CVD events, CVD mortality and all-cause 
mortality by waist-to-hip ratio in men aged 60-79 years in 1998-2000  
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Figure 5.5 Rate of CHD events, CVD events, CVD mortality and all-cause mortality 
by subscapular skinfold thickness in men aged 60-79 years in 1998-2000 
 
 
 
Figure 5.6 Rate of CHD events, CVD events, CVD mortality and all-cause mortality 
by triceps skinfold thickness in men aged 60-79 years in 1998-2000 
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Figure 5.7 Rate of CHD events, CVD events, CVD mortality and all-cause mortality 
by mid-arm muscle circumference in men aged 60-79 years in 1998-2000 
 
 
Figure 5.8 Rate of CHD events, CVD events, CVD mortality and all-cause mortality 
by fat-free mass index in men aged 60-79 years in 1998-2000 
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Figure 5.9 Rate of CHD events, CVD events, CVD mortality and all-cause mortality 
by skeletal muscle index in men aged 60-79 years in 1998-2000 
 
Figure 5.10 Kaplan-Meier survival curves comparing all-cause mortality by 
sarcopenic obesity groups (defined by mid-arm muscle circumference and waist 
circumference) in men aged 60-79 years in 1998-2000 
 
Sarcopenic obesity defined as: MAMC = below the second quintile; WC >102cm.  
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Figure 5.11 Kaplan-Meier survival curves comparing CVD mortality by sarcopenic 
obesity groups (defined by mid-arm muscle circumference and waist circumference) 
in men aged 60-79 years in 1998-2000 
 
Sarcopenic obesity defined as: MAMC = below the second quintile; WC >102cm. 
Figure 5.12 Kaplan-Meier survival curves comparing CVD events by sarcopenic obesity 
groups (defined by mid-arm muscle circumference and waist circumference) in men 
aged 60-79 years in 1998-2000 
 
Sarcopenic obesity defined as: MAMC = below the second quintile; WC >102cm. 
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Figure 5.13 Kaplan-Meier survival curves comparing CHD events by sarcopenic obesity 
groups (defined by mid-arm muscle circumference and waist circumference) in men 
aged 60-79 years in 1998-2000 
 
Sarcopenic obesity defined as: MAMC = below the second quintile; WC >102cm. 
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CHAPTER 6 Associations between diet quality scores, cardiovascular risk factors 
and risk of cardiovascular disease and mortality in older British men  
6.1. Summary 
Diet is a well-established risk factor for cardiovascular disease (CVD) and in recent 
times the focus of dietary research has been on overall diet quality rather than on 
individual foods or nutrients. However, few studies have investigated the relationship 
between a priori defined dietary patterns (using pre-defined diet indexes or scores) and 
the risks of CVD and mortality in older adults. This chapter examines the prospective 
associations between a priori diet quality scores and the risk of CVD and all-cause 
mortality in older British men. At the 20 year re-examination in 1998-2000, 4252 men 
from the British Regional Heart Study (BRHS) attended a physical examination, 
provided a fasting blood sample and completed both a general lifestyle questionnaire 
and a food frequency questionnaire (FFQ), and were followed up until 2010 for 
cardiovascular events and mortality. Baseline FFQ data were used to generate two 
dietary scores – the Healthy Diet Indicator (HDI), based on World Health Organization 
(WHO) dietary guidelines, and the Elderly Dietary Index (EDI), based on a 
Mediterranean-style dietary intake, with higher scores of both indicating healthier diets. 
A total of 3328 men, aged 60-79 years, free from CVD at baseline, were included in the 
analysis. Cox proportional hazards regression analyses were used to assess prospective 
associations between quartiles of adherence to the HDI or the EDI and the risk of all-
cause mortality, CVD mortality, CVD events and coronary heart disease (CHD) events. 
During the follow-up period, there were 933 deaths, 327 CVD deaths, 582 incident 
CVD events and 307 incident CHD events. Men in the highest compared to the lowest 
quartile of EDI adherence had significantly lower risks of all-cause mortality (hazard 
ratio [HR]: 0.75, 95% CI: 0.60-0.94, p-trend: 0.03), CVD mortality (HR: 0.63, 95% CI: 
0.42-0.94, p-trend: 0.03) and CHD events (HR: 0.66, 95% CI: 0.45-0.97, p-trend: 0.05), 
and a lower risk, but non-significant, for CVD events (HR: 0.79, 95% CI: 0.60-1.05, p-
trend: 0.16) after adjustment for socio-demographic, behavioural and cardiovascular 
risk factors. However, HDI was not significantly associated with any of the outcomes. 
Thus the EDI rather than the HDI was associated with CVD and mortality risk in older 
men. Encouraging older adults to adhere to a dietary pattern close to that defined in the 
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EDI criteria may reduce the risk of all-cause mortality, especially from CVD, and hence 
have public health benefits. 
 
6.2. Introduction 
Diet quality is a major modifiable risk factor well established in the prevention of CVD 
and mortality and diet may be particularly important in the elderly, who are a group at 
high risk of CVD 8;23;202, as discussed in Chapter 2, section 2.5. Historically, research 
into the relationships between diet and CVD or mortality has focused on single nutrients 
or foods, but more recently the focus has shifted towards markers of overall diet quality 
and dietary patterns, in order to reflect the multidimensional nature of diets consumed in 
the population28;29. Chapter 2 introduced the two main approaches to assess dietary 
patterns: (1) a priori approaches, which are hypothesis oriented or theoretically defined, 
since they use available scientific evidence to generate predefined dietary scores or 
indices based on dietary recommendations or guidelines; and (2) a posteriori 
approaches, which are data-driven or exploratory, since dietary patterns are derived 
from the available data based on methods such as principal component analysis, or 
cluster analysis29;30. However, few studies have examined the relationship between both 
a priori or a posteriori defined dietary patterns and the risk of CVD and mortality in 
older adults in particular. This chapter will focus on a priori diet quality scores in 
relation to CVD and mortality, and the associations with a posteriori dietary patterns 
will be addressed later in the thesis (see Chapter 8). 
 
To date, many different a priori dietary scores have been developed to assess diet 
quality, based on adherence to dietary patterns or dietary recommendations195;204. 
Although several studies have examined the associations between a priori diet quality 
scores and CVD risk in middle age, few studies have investigated the relationship 
specifically in older adults31-33;335. The Healthy Diet Indicator (HDI) is based on 
adherence to WHO nutrient intake dietary guidelines, and which has been shown to be 
inversely associated with all-cause mortality risk in older European men234. One of the 
most commonly used predefined dietary patterns is the Mediterranean Diet Score 
(MDS), which is characterised by a high consumption of fruit, vegetables, legumes, 
cereal and fish, and a low-to-moderate consumption of meat, dairy products and 
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alcohol, mostly as wine226. MDS adherence has been consistently associated with a 
lower risk of CVD and mortality in European cohorts31;32;226;336. However, the MDS is 
based on a dichotomous scoring system, defining each food intake as high/low using the 
median intake of foods as a cut-point. Such an approach may be too crude to apply to a 
UK population, which has previously shown to have low adherence to a Mediterranean 
style diet223. The Elderly Dietary Index (EDI) was developed as a slightly modified 
version of the MDS based on the consumption frequency of specific foods, but it was 
developed specifically to address adherence to nutritional recommendations for older 
adults in the Mediterranean Islands Study233. Unlike the MDS, the EDI uses a four-point 
scoring system for each food component and it therefore takes account of the U-shaped 
relationship between certain foods and the risk of health outcomes e.g. meat. Therefore, 
the EDI may be better suited to an older UK population in which intake of 
Mediterranean style dietary components is low.  
 
The majority of studies examining the associations between a priori diet quality scores 
and health outcomes in the older adults have focused on all-cause mortality and a recent 
review suggested that scores which reflect adherence to dietary recommendations based 
on single nutrients, such as the HDI, were not as strongly associated with mortality as 
alternative scores based on whole foods or patterns, such as the MDS 234;335;336. Fewer 
studies in older age have provided evidence on associations between a priori diet 
quality scores with the risk of cardiovascular outcomes33. The EDI is associated with 
CVD risk factors in the Mediterranean population in which it was developed but it has 
not been applied to other populations or compared to more widely used dietary indices 
such as the HDI, which uses a fundamentally different approach to the assessment of 
diet quality. The HDI is based on adherence to international dietary recommendations 
(nutrient intake guidelines developed by the WHO)234 so it has been more widely used 
(not only in Mediterranean populations) and would therefore make a useful complement 
to the EDI.  
 
The aim of this chapter is therefore to examine existing dietary patterns that have been 
shown to have a protective effect on CVD and mortality and to investigate which 
marker of diet quality would be most applicable to an older UK population. Two a 
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priori dietary scores (the HDI and the EDI), were applied to older British men aged 60-
79 years and cross-sectional associations between these dietary patterns and 
cardiovascular risk factors, and prospective associations with the risk of incident CHD 
events, incident CVD events, CVD mortality and all-cause mortality were examined. 
 
6.3. Objectives 
To examine the associations of a priori defined dietary scores and cardiovascular risk 
factors, and the risk of CVD and mortality in older age (60-79 years). The specific aims 
of this chapter are: 
i) To describe the dietary intake of a cohort of older men. 
ii) To apply a priori dietary scores to the BRHS cohort.  
iii) To examine the relationship of a priori dietary scores and cardiovascular risk 
factors.  
iv) To examine the association between a priori dietary scores and risk of CHD 
events, CVD events, CVD mortality and all-cause mortality. 
v) To examine the association between individual components of a priori dietary 
scores and risk of CHD events, CVD events, CVD mortality and all-cause 
mortality. 
 
6.4. Methods 
6.4.1. Subjects and methods of data collection 
Data analysed in this chapter are based on the 20 year re-examination of BRHS 
participants in 1998-2000, aged 60-79 years. In all, 4252 men (77% of survivors) 
attended a physical examination, provided a fasting blood sample, and completed both a 
general questionnaire, answering questions on their lifestyle and medical history, and a 
food frequency questionnaire (FFQ)264. Participants were then followed up 
prospectively from re-examination (1998-2000) through to June 2010 for cardiovascular 
mortality and morbidity; follow-up was successfully achieved for 98% of the cohort35. 
Information on deaths was collected through the National Health Service Central 
Register (death certificates were coded using International Classification of Diseases, 
ninth revision [ICD-9]). On-going reports from general practitioners and biennial 
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reviews of the patients’ medical records provided evidence regarding non-fatal 
cardiovascular events264. The four main outcomes examined in this chapter were: CHD 
events (diagnosis of non-fatal myocardial infarction [MI] or fatal CHD [ICD-9 codes 
410-414]); CVD events (diagnosis of non-fatal MI, non-fatal stroke or fatal CVD [ICD-
9 codes 390-459]); CVD mortality (ICD-9 codes 390-459) and all-cause mortality. Two 
additional outcomes were also considered in further exploratory analysis: stroke events 
(defined as non-fatal or fatal stroke; ICD-9 codes 430-438) and non-CVD mortality (all 
deaths excluding ICD-9 codes 390-459). Participants were censored at date of death or 
at the end of the study period (June 2010) if still alive. Of the 4252 men attending the 
physical examination, 723 participants free from prevalent MI, stroke and heart failure 
at baseline were excluded, leaving 3529 participants for analysis. Men with prevalent 
CVD were excluded, since dietary changes may have occurred in these individuals 
following diagnosis and also no measure of the severity of CVD was available for these 
participants. 
 
6.4.2. Dietary assessment 
Dietary intake was measured at aged 60-79 years in 1998-2000 via a self-completed 
postal FFQ, with participants reporting their usual frequency of consumption of 86 food 
and drink items, as described in detail in Chapter 3, section 3.3.2 (see Appendix VI for a 
copy of the FFQ used). Total macronutrient and micronutrient intakes were derived 
using a validated computer program to calculate the total nutrient composition of foods 
consumed301. The multivariate nutrient density model was used to adjust macronutrients 
for energy intake280; carbohydrates, fats and protein were expressed as percentages of 
energy (% kcal). Participants were asked how often they consumed fresh fruit and 
vegetables (rarely/never, monthly, or 1, 2, 3, 4, 5, 6, or 7 days per week), with daily 
consumption classified as 7 days per week. Plasma vitamin C and E levels were also 
available from blood samples collected at the re-examination (1998-2000)301. 
 
6.4.3. Defining dietary patterns a priori  
Diet quality was assessed using two predefined a priori dietary scores – the Healthy 
Diet Indicator (HDI) and the Elderly Dietary Index (EDI). In additional analyses, the 
Mediterranean Diet Score (MDS) was also used for comparative purposes. 
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6.4.3.1 The Healthy Diet Indicator  
The HDI was constructed using the WHO dietary guidelines for the intake of nutrients 
and food components, as originally used by Huijbregts et al8;234 (see table 2.3 for details 
of original components and scoring). The slightly modified HDI used here consisted of 
eight components (saturated fatty acids [SFA]; polyunsaturated fatty acids [PUFA]; 
protein; carbohydrates; sugar; fibre; cholesterol; fruit and vegetables), each scoring one 
if the dietary guideline was met or zero otherwise, resulting in a total score ranging from 
0 to 8 (see Table 6.1 for full details). Dietary data for pulses, nuts and seeds were not 
available so this component could not be included in the HDI. The cut-off points for 
PUFA and ﬁbre intake were modified for use in a British population as performed 
previously232;337. The weight of fruit and vegetables consumed was not available, so this 
component was modified from the recommendation of ≥ 400g/day to the daily 
consumption of both fruit and vegetables (defined as a consumption frequency of 7 days 
per week for both fruits and vegetables). A higher HDI score indicated greater 
compliance with WHO dietary recommendations and hence a healthier diet. 
 
6.4.3.2 The Elderly Dietary Index 
 The EDI was developed by Kourlaba et al, specifically to address adherence to 
nutritional recommendations for older adults, based on the consumption frequency of 
specific foods in the Modified MyPyramid for Older Adults233. The EDI consisted of 
nine components (meat; fish and seafood; legumes; fruit; vegetables; cereals; bread; 
olive oil; dairy), each assigned a four-point scoring system based on the frequency of 
consumption, resulting in a total score range from 9 to 36 (see Table 6.2 for full details). 
Score 4 was assigned for the highest consumption of fruits, vegetables, cereals and olive 
oil. However, for meat, fish/seafood, and legumes, score 4 was achieved for moderate 
consumption (1-2 days/week). For bread intake, score 4 was assigned when someone 
consumed only whole grain bread and for dairy, score 4 was assigned for low fat milk 
and cheese intake only. The frequency of olive oil consumption was not available so the 
scoring of this component was modified from the original score used (1 = <1 day/week; 
2 = 1-2 days/week; 3 = 3-6 days/week; 4 = daily) to the quantity of weekly consumption 
(1 = never/rarely consumed; 2-4 = tertiles 1-3 of intake for those who did consume olive 
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oil). The EDI was limited to food items to make it more comparable to the HDI and 
therefore the alcohol component was not included. However, alcohol (frequency of 
wine consumption collected as glasses/week in the FFQ) was included as an additional 
component of the EDI for sensitivity analysis only. A higher EDI score indicated 
greater adherence to the dietary pattern and hence a healthier diet. 
 
6.4.3.3 The Mediterranean Diet Score 
For comparative purposes with the HDI and the EDI, the modified Mediterranean Diet 
Score (MDS), as initially developed by Trichopoulou et al226;336, was also applied to this 
cohort. The MDS consisted of eight components with a total score range from 0 to 8 
(see Table 6.3 for details). Participants whose consumption of each of six beneficial 
dietary components (vegetables; legumes; fruits; cereals; fish and the ratio of the intakes 
of the sum of monounsaturated and polyunsaturated to saturated fatty acids) was below 
the median scored zero for each item, or a value of one otherwise. Participants whose 
consumption of detrimental components (meat; dairy) was below the median 
consumption scored one or a value of zero otherwise. 
 
6.4.4. Cardiovascular risk factors 
Established and emerging cardiovascular risk factors were measured at the 20 year re-
examination in 1998-2000. Self-reported measures of smoking, physical activity and 
alcohol intake were collected via questionnaire as described in Chapter 3, section 3.3.3 
Participants were classified into four cigarette smoking groups (never smoked; long-
term ex-smokers, >15 years; recent ex-smokers, ≤ 15 years; current smokers)90. Current 
physical activity was classified into six groups based on frequency and intensity of 
exercise (inactive; occasional; light; moderate; moderately vigorous and vigorous)283. 
Alcohol intake was classified into five groups based on the number and frequency of 
alcoholic drinks consumed per week (none; occasional; light; moderate; heavy)282. 
Adult occupational social class was based on the longest held occupation recorded at 
study entry, in 1978-80, using the Registrar General’s occupational classification285, as 
described in Chapter 3 (section 3.3.4). Participants were classified as manual, non-
manual or armed forces. Region of residence was categorised according to whether the 
town of each participant at the examination in 1998-2000 was in southern England 
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region or the rest of Britain. At the physical examination in 1998-2000, systolic blood 
pressure (SBP) was measured and the collection of a fasting blood sample allowed the 
measurement of plasma concentrations of metabolic risk factors (glucose, triglyceride 
and high density lipoprotein [HDL]) and inflammatory/hemostatic markers (C-reactive 
protein [CRP], tissue plasminogen activator [t-PA], D-dimer, von Willebrand Factor 
[vWF], fibrinogen, interleukin 6 (IL-6) and homocysteine) as described in Chapter 3 
(section 3.3.5 and 3.3.6). In addition, at the 20 year examination, participants were 
classified as having prevalent diabetes if they had a self-reported previous diagnosis. 
Assessment of body composition also occurred at the 20 year re-examination and 
measures used within this chapter include body mass index (BMI), waist circumference 
(WC) and mid-arm muscle circumference (MAMC), as described in Chapter 3 (section 
3.3.1). Participants were classified into four BMI categories using WHO cut-points 
(underweight, <18.5 kg/m2; normal weight, 18.5-24.99 kg/m2; overweight, 25-29.99 
kg/m2; obese, ≥ 30 kg/m2)105. 
 
6.4.5. Statistical methods 
Of the 3529 men free from prevalent CVD, 3328 had adequate data to generate either 
the HDI or the EDI score (n = 3133 and n = 3269 respectively). Sensitivity analyses 
were carried out, restricting the sample to those where both HDI and EDI measures 
were available (n = 3074). However, the results were largely unchanged, so the number 
of individuals with data on HDI or EDI respectively were kept in the analysis for each 
index in order to maximise the sample size and hence the power. Participants were 
categorised into quartiles of the HDI and the EDI, using cut off points that produced the 
nearest categorisation into equal sized groups that these integer data would allow. 
Baseline cardiovascular risk factors of participants were presented by quartiles of HDI 
and EDI scores with continuous variables reported as means and standard deviations, 
and categorical variables as percentages. The distributions of CRP, D-dimer, IL-6 and 
homocysteine were highly skewed, so log transformation and the interquartile range 
was presented.  
 
Cox proportional hazards models were used to estimate HRs and 95% CIs for the 
associations between individual components of the HDI/EDI scores with the risk of 
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each outcome. To assess the effect of each indivivual HDI/EDI component 
independently of the other compoenents, modified versions of the HDI/EDI score, not 
containing the individual component of interest, was generated. For example, when 
examining the association between meat intake (an individual component of the EDI) 
and outcomes, a modified version of the EDI score was created which did not contain 
meat as a component part. Models were then adjusting for age (model 1) and energy 
intake, smoking status, alcohol intake, physical activity, social class, BMI and the 
modified version of the HDI/EDI score, not containing the individual component of 
interest (model 2).  
 
Cox proportional hazards models were also used to assess associations between 
quartiles of the total HDI/EDI scores with the risk of each outcome. Tests for trend of 
outcome risk across quartiles of HDI/EDI were performed. Similarly, comparative 
analyses were carried out to assess associations between quartiles of the total MDS 
score with the risk of outcomes. All Cox models were tested for the proportional-
hazards assumption, on the basis of Schoenfeld residuals, which was not found to be 
violated. Models were adjusted by adding potential confounders, related to both diet 
quality and cardiovascular risk, in a sequential manner, including age (model 1), energy 
intake, smoking status, alcohol intake, physical activity, social class and BMI (model 2), 
HDL, SBP and diabetes (model 3) and finally CRP and vWF (model 4). Age, energy 
intake, HDL, SBP, CRP and vWF were fitted as continuous variables. Smoking status, 
alcohol intake, physical activity, social class, BMI and diabetes were fitted as 
categorical variables.  
 
6.5. Results 
6.5.1. Dietary characteristics of the study population  
The proportion of men adhering to dietary guidelines according to the HDI is presented 
in Table 6.1, the proportion of men achieving the highest score for each of the EDI 
components is presented in Table 6.2 and the mean dietary intake of the cohort is 
presented in Table 6.4. The mean total energy intake was 2140 kcal/day, with 52.4% of 
energy coming from carbohydrates, 15.6% from protein and 30.3% from fat (of which 
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12.4% was from saturated fat and 4.5% from polyunsaturated fat). The HDI and EDI 
scores were both normally distributed. The mean HDI score was 2.9, ranging from 0 to 
7, and the mean EDI score was 24.2, ranging from 12 to 35. HDI and EDI scores were 
significantly, but modestly correlated (r: 0.25, 95% CI: 0.22-0.29, p <0.001). Most men 
met the HDI dietary guideline for carbohydrate intake (64.6% had between 50 and 70% 
energy from carbohydrates). However, only 41.4% of men had sufficient protein intake 
to meet the recommended protein intake (10-15% of total energy). Intake of saturated 
and polyunsaturated fat was higher than recommended for most men; only 25.2% met 
the dietary guideline of less than 10% energy intake from saturated fat and only 14.6% 
met the dietary guideline of between 6 and 10% energy intake for polyunsaturated fat. 
The mean cholesterol intake was 278 mg/d, with 64.4% of the cohort meeting the 
dietary recommendation of less than 300 mg/d. The dietary recommendation for fibre 
was met by 61.3% of the men, with a mean daily intake of 26g. Over a third of 
participants consumed fruit (42.3%) or vegetables (33.4%) daily but less than one in 
five consumed both fruit and vegetables daily (18.1%). In terms of the individual EDI 
components, more than half of all men achieved the highest score for intake of 
fish/seafood (56.0% had a consumption of 1-2 days/week), legumes (50.6% had a 
consumption of 1-2 days/week) and cereals (65.8% had daily consumption). 
Components of the EDI in which very few men achieved the highest score included 
meat (only 4.9% consumed meat on 1-2 days/week) and olive oil (only 9.2% were in the 
highest tertile of intake).  
 
6.5.2. A priori diet quality scores, cardiovascular risk factors and dietary factors 
6.5.2.1 Healthy Diet Indicator, cardiovascular risk factors and dietary factors 
Cardiovascular risk factors and dietary factors are presented by quartiles of HDI in 
Table 6.5. Men with a higher adherence to the HDI were significantly less likely to be 
current smokers, heavy drinkers and of manual social class, and significantly more 
likely to live in the southern England region. HDI scores showed a significant inverse 
trend with the proportion of obese men and with mean WC, but no significant trend was 
observed with MAMC. As expected, several dietary variables showed significant trends 
with HDI. Men with the highest adherence to HDI dietary recommendations had lower 
levels of total energy intake and a lower percentage energy from total fat, saturated fat 
and protein, and a higher percentage energy from carbohydrates, higher intake of fibre, 
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vitamin C, vitamin E, higher plasma vitamin E and a higher proportion of these men 
consumed fruit and vegetables daily. Men with higher HDI scores showed significantly 
lower HDL and glucose levels, but SBP, triglycerides and prevalent diabetes were not 
associated. HDI scores also showed significant inverse trends with a number of 
inflammatory and haemostatic markers, including CRP, t-PA, IL-6 and homocysteine, 
but no relationship was seen with D-dimer, vWF or fibrinogen. 
 
6.5.2.2 Elderly Dietary Index, cardiovascular risk factors and dietary factors 
Cardiovascular risk factors and dietary factors are presented by quartiles of EDI in 
Table 6.6. Very similar relationships were observed as with the HDI, with participants 
in the highest EDI quartile having the least adverse cardiovascular risk profile. 
However, in contrast to HDI, EDI showed a significant positive, rather than an inverse, 
trend with percentage energy from protein. Compared to the HDI, the EDI also showed 
significant inverse trends with age and triglycerides, and significant positive trends with 
MAMC, iron intake, plasma vitamin C, the prevalence of diabetes, and levels of 
glucose, D-dimer, VWF and fibrinogen. 
 
6.5.3. A priori diet quality scores and risk of CVD/mortality  
During a mean follow-up period of 11.3 years, there were 933 deaths from all causes, 
327 CVD deaths, 582 CVD events and 307 CHD events. 
 
Associations between a priori diet quality scores (HDI and EDI scores) and risk of 
cardiovascular outcomes and all-cause mortality were all adjusted for total energy 
intake280. However, since total energy intake showed strong inverse associations with 
both the HDI and the EDI dietary scores (Table 6.5 and Table 6.6), the associations 
between total energy intake and the risks of outcomes were investigated, to ensure 
adjusting for energy intake would not represent an over-adjustment338. However, total 
energy intake was not significantly associated with all-cause mortality, CVD mortality 
or CHD events in age-adjusted analysis (p-trend all less than 0.05). Energy intake 
showed a slight positive association with CVD events (p-trend: 0.03), but this became 
non-significant after adjustment for cardiovascular risk factors including, smoking 
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status, alcohol intake, physical activity, social class, BMI, HDL, SBP and prevalent 
diabetes. 
 
6.5.3.1 Healthy Diet Indicator and risk of CVD/mortality  
Hazard ratios for CHD events, CVD events, CVD mortality and all-cause mortality by 
quartiles of total HDI score are presented in Table 6.7. Quartiles of HDI were not 
significantly associated with all-cause mortality, CVD mortality, CVD events or CHD 
events after adjustment for age (model 1). This lack of association was unchanged after 
further adjustment for energy intake, socio-demographic, behavioural and 
cardiovascular risk factors. 
 
6.5.3.2 Healthy Diet Indicator components and risk of CVD/mortality  
The associations between individual HDI components and the risk of CHD events, CVD 
events, CVD mortality and all-cause mortality were also examined (Table 6.8). Few 
individual components were significantly related to outcomes. Meeting the dietary 
guideline for protein intake was associated with an increase in risk of all-cause mortality 
and CHD events in the age-adjusted model. However, these associations became non-
significant after further adjustment for socio-demographic and behavioural risk factors, 
and a modified version of the HDI score not containing the individual component of 
interest. Dietary cholesterol was the only component associated with outcomes after 
adjustment, with participants meeting the dietary recommendation for cholesterol intake 
having a 33% lower risk of CVD mortality (HR: 0.67, 95% CI; 0.50-0.90.)  
 
6.5.3.3 Elderly Dietary Index and risk of CVD/mortality  
Hazard ratios for the risks of CHD events, CVD events, CVD mortality and all-cause 
mortality are presented by quartiles of total EDI in Table 6.9. The risk of all-cause 
mortality showed a significant inverse trend with EDI quartiles, which remained but 
was attenuated slightly after adjustment for energy intake, smoking status, alcohol 
intake, physical activity, social class, BMI, HDL, SBP, diabetes, CRP and vWF (model 
4); the risk of all-cause mortality was significantly lower in participants in the highest 
compared to the lowest EDI quartile (HR: 0.75, 95% CI: 0.60-0.94, p-trend; 0.03). 
Chapter 6 Dietary scores, CVD and mortality in older British men 
 
 186 
Similarly, the risks of CVD mortality and CHD events were also inversely associated 
with EDI quartiles and although the association was attenuated slightly by adjustment 
for socio-demographic, behavioural and cardiovascular risk factors, participants in the 
highest quartile of EDI still had a significantly lower risk of CVD mortality (HR: 0.63, 
95% CI: 0.42-0.94, p-trend: 0.03) and CHD events (HR: 0.66, 95% CI: 0.45-0.97, p-
trend: 0.05). To explore whether the inverse associations observed between EDI 
quartiles and risk of all-cause mortality, CVD mortality and CHD events were 
potentially mediated by the effects of muscle mass, analyses were further adjusted for 
MAMC. However, results were virtually unchanged after this additional adjustment. 
 
Although the risk of CVD events was lower in participants in the highest EDI quartile, 
this difference was not however significant after adjustment for confounders (HR: 0.79, 
95% CI: 0.60-1.05, p-trend: 0.16) [model 4]. Further exploration of the data showed that 
there was no appreciable association between quartiles of EDI and stroke events (stroke 
events, n = 221; age-adjusted p-trend: 0.41). Additional analysis of cause-specific 
mortality showed that the risk of non-CVD mortality was not significantly associated 
with EDI quartiles after adjusting for confounders (p-trend: 0.24). 
 
A sensitivity analysis was also carried out, including alcohol as an additional 
component of the EDI, and this yielded broadly similar results to those presented above. 
Risks of outcomes tended to show an inverse trend with EDI quartiles, with men in the 
highest compared to the lowest EDI quartile having lower risks of all-cause mortality 
(HR: 0.71, 95% CI: 0.55-0.91, p-trend : 0.02) and CVD mortality (HR: 0.58, 95% CI: 
0.37-0.91, p-trend: 0.03), after adjustment for socio-demographic, behavioural and 
cardiovascular risk factors. However, this trend was weaker and was of borderline 
significance for CVD events (HR: 0.70, 95% CI: 0.51-0.96, p-trend: 0.06) and CHD 
events (HR: 0.66, 95% CI: 0.43-1.02, p-trend: 0.08). 
 
6.5.3.4 Elderly Dietary Index and risk of CVD/mortality, in men with prevalent CVD 
The results presented above on the associations between EDI quartiles and outcomes are 
based on participants free from prevalent MI, stroke and heart failure at baseline. In 
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sensitivity analysis, analyses were also carried out in participants with and without 
prevalent CVD at baseline (n = 4252) and in those with prevalent CVD at baseline only 
(n = 723). However, no significant associations were observed between EDI quartiles 
and all-cause mortality, CVD mortality, CVD events or CHD events in either of these 
groups. This justifies excluding individuals with prevalent CVD from the current 
analysis, as including them would have contaminated results. 
 
6.5.3.5 Elderly Dietary Index components and risk of CVD/mortality 
The associations between individual EDI components and the risk of CHD events, CVD 
events, CVD mortality and all-cause mortality were also examined (Table 6.10). As 
with the individual HDI components, few EDI components were significantly related to 
outcomes. Participants in the highest EDI quartile for fish/seafood intake had a lower 
risk of CVD mortality and CHD events, and those in the highest EDI quartile for fruit 
and vegetables had a lower risk of all-cause mortality in the age-adjusted models (model 
1). However, these associations became non-significant after further adjustment for 
socio-demographic and behavioural risk factors, and a modified version of the EDI 
score not containing the individual component of interest (model 2). Olive oil intake 
was the only individual component associated with outcomes after adjustment (model 
2); participants in the highest quartile of intake had a lower risk of all-cause mortality 
(HR: 0.68, 95% CI: 0.51-0.91), CVD mortality (HR: 0.43, 95% CI: 0.24-0.80), CVD 
events (HR: 0.58, 95% CI: 0.40-0.86) and CHD events (HR: 0.55, 95% CI: 0.32-0.95).  
 
6.5.3.6 Mediterranean Diet Score and risk of CVD/mortality  
Comparative analyses using the MDS yielded weaker associations compared to the EDI 
(results not presented). A strong significant inverse trend was observed between MDS 
quartiles and the risk of all-cause mortality in age adjusted analysis (highest vs. lowest 
quartile; HR: 0.68, 95% CI: 0.57-0.82, p-trend <0.001). However, this trend showed 
only borderline significance after adjustment for energy intake, smoking status, alcohol 
intake, physical activity, social class, BMI, HDL, SBP, diabetes, CRP and vWF (highest 
vs. lowest quartile; HR: 0.87, 95% CI: 0.70-1.07, p-trend: 0.05). However no significant 
trend was observed between MDS quartiles and the risk of CVD mortality (p-trend: 
0.40), CVD events (p-trend: 0.97) or CHD events (p-trend: 0.57) in adjusted analysis. 
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6.6. Discussion 
6.6.1. Summary of main findings 
This chapter applied two a priori diet quality scores to an older British population, the 
HDI (based on WHO dietary recommendations) and the EDI (based on the consumption 
frequency of specific foods/food groups) and examined their associations with 
cardiovascular risk factors, and the risk of cardiovascular events and mortality. Higher 
adherence to either the HDI or the EDI dietary scores was associated with the least 
adverse cardiovascular risk profile. Men with higher adherence to the EDI had a 
significantly lower risk of all-cause mortality, CVD mortality and CHD events, which 
was independent of socio-demographic, behavioural and cardiovascular risk factors. 
However, the HDI score was not significantly associated with any of the outcome 
measures, suggesting that the EDI is more strongly associated with CHD events, CVD 
mortality and all-cause mortality in an older population. The results from this chapter 
add to the limited literature on the relationships between a priori diet quality scores and 
cardiovascular mortality and morbidity in older adults.  
 
6.6.2. Comparison with previous studies 
 6.6.2.1 Diet of the cohort 
The key features of dietary intake of BRHS participants observed in this chapter, 
obtained from a FFQ in 1998-2000, were broadly comparable with those from the 
National Diet and Nutrition Survey (NDNS), a nationally representative sample of 
adults aged 19 to 64 years in Great Britain, carried out between 2000 and 2001339. Men 
aged 50 to 64 years olds in the NDNS, the oldest age group, had a slightly higher mean 
total energy intake (2271 kcal compared to 2139 kcal in the BRHS), a lower mean 
percentage of energy from carbohydrates (47.4 % compared to 52.4%), a higher mean 
percentage of energy from protein (17.0 % compared to 15.6%) and a higher mean 
percentage energy from total fat (35.6 % compared to 30.3%). In terms of meeting the 
WHO dietary guidelines included in the HDI8;234, only three components (total 
carbohydrates, dietary fibre and cholesterol) were met by the majority (>50%) of the 
men. The mean percent of energy from carbohydrate was within the 50-70% WHO 
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recommendation, however, the mean percent of energy from protein and saturated fat 
were above the WHO recommendations of 10-15% and 0-10% respectively.  
 
6.6.2.2 Healthy Diet Indicator, CVD and mortality risk  
Cross-sectional analyses showed that diet quality, assessed by the HDI, was inversely 
associated with adverse cardiovascular risk factors, which was consistent with previous 
studies340;341. Men with a higher adherence to the HDI were less likely to be current 
smokers, heavy drinkers, from manual social class, had a lower proportion of obesity, 
lower WC, lower level of HDL, glucose and several plasma/inflammatory markers. 
These findings are consistent with a review in older adults which showed that diets 
characterised by more favorable dietary scores or indices (including one study using the 
HDI342), are generally inversely related to BMI and WC343. HDI, was not however 
associated with MAMC, despite evidence that low muscle mass is related to several 
dietary components including low intake of protein, total energy, vitamin D, 
antioxidants and omega-3 polyunsaturated fatty acids132;133. 
 
However, despite cross-sectional association between the HDI and cardiovascular risk 
factors, the HDI was not significantly associated in prospective analyses with the risk of 
all-cause mortality, CVD mortality, CVD events or CHD events in the present study. 
The HDI was initially developed by Huijbregts et al who, in contrast to findings in this 
chapter, found a significant inverse association between HDI and all-cause mortality 
risk and an even stronger association with CVD mortality risk, over 20 years of follow-
up in elderly men from Finland, Italy and the Netherlands234. Results in this chapter also 
contrast with those from a review in older adults, aged 60 years or older, which assessed 
the association between adherence to the HDI and risk of mortality in 11 prospective 
cohort studies236. The meta-analysis showed that closer adherence to the WHO 
guidelines of the HDI was associated with greater longevity in elderly men and women 
in Europe and the United States. However, findings in this chapter are consistent with 
those of two studies not included in this meta-analysis. An elderly British cohort of men 
and women, aged 65 years and older, showed no significant association between a 
slightly modified version of the HDI and all-cause mortality during a follow-up period 
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of 14 years232. Similarly, an elderly male Swedish cohort, with a mean age of 71 years, 
also found no consistent associations between HDI and all-cause or CVD mortality over 
10 years of follow-up237. These differences in findings could perhaps be explained by 
different populations being studied or due to the sample size differences between 
studies. 
 
6.6.2.3 Elderly Dietary Index, CVD and mortality risk 
As with the HDI, cross-sectional analyses showed that diet quality, assessed by the EDI, 
was inversely associated with adverse cardiovascular risk factors. These results are 
consistent with the original study by Kourlaba et al, who developed the EDI, and 
showed cross-sectional associations between higher adherence to the EDI and a lower 
risk of CVD risk factors including obesity and hypertension in the Mediterranean 
Islands Study233. A significant positive association was also observed in this cohort 
between the EDI and the MAMC. Interestingly, in this cohort, measures of muscle mass 
showed weak associations with individual nutrients (see Chapter 4) but stronger 
associations were observed here between muscle mass and diet quality. 
 
One important finding in this chapter was the observation that only one individual 
component of the EDI (olive oil intake) was inversely associated with CVD outcomes 
and mortality. This is consistent with the results of a meta-analysis showing that higher 
intake of olive oil is associated with a lower risk of all-cause mortality, CVD mortality 
and CVD events in pooled analysis of 32 cohort studies344. There was a significant trend 
between increasing EDI score and decreasing risk of CHD events, CVD mortality and 
all-cause mortality, and broadly similar results were found in sensitivity analysis when 
including alcohol as an additional component of the EDI. The fact that the majority of 
individual components of the EDI were not associated with outcomes (except olive oil), 
but the total score was significantly associated with CHD events, CVD mortality and 
all-cause mortality supports the notion that research on individual food items is not 
useful and justifies the use of diet scores in nutritional research, as suggested 
previously28;29;195.  
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To my knowledge, this is the first study to apply the EDI to another population, and to 
examine the incidence of cardiovascular events and mortality by EDI score. The results 
observed in this cohort are consistent with those of Kourlaba et al233, while also 
extending them in suggesting that the EDI is valid for use in an older British population 
and that higher adherence to the EDI showed significant lower risks of all-cause 
mortality, CVD mortality and CHD events. These results are consistent with a 
substantial body of literature showing strong associations between a Mediterranean 
style diet and lower risk of CVD and all-cause mortality, in both middle aged and older 
populations31-33;336;345. The associations observed here between the EDI and CHD 
events, CVD mortality and all-cause mortality were attenuated slightly, although they 
remained statistically significant, after adjustment for BMI, HDL, SBP and diabetes, 
The relationship could therefore to some extent be associated with higher BMI in those 
with lower EDI scores which in turn may lead to physiological risk factors for CVD e.g. 
higher lipid levels and blood pressure. Further adjustment for CRP and vWF attenuated 
the association slightly further suggesting that the association between diet quality and 
CVD could to a small extent also be explained by chronic inflammation and endothelial 
dysfunction, with a diet low in antioxidants possibly leading to higher inflammation, as 
has been suggested previously346-348. Muscle mass however, did not appear to be a 
mediator of this relationship, as results were essentially unchanged after adjustment for 
MAMC. 
  
Despite the observed association with CVD mortality and CHD events, EDI was not 
associated with CVD events. This could be explained by the fact that the EDI was not 
associated with stroke events, and fatal CVD was dominated by fatal CHD (n = 189) 
with far fewer stroke deaths (n = 64) in this cohort. Results observed in this chapter are 
in keeping with literature suggesting adherence to a Mediterranean style diet is more 
strongly associated with fatal CVD than total CVD349.  
 
In comparison with the EDI, the MDS showed a weaker association with all-cause 
mortality and no significant associations with CVD mortality, CVD events or CHD 
mortality. EDI components are very similar to those of the MDS but the EDI was 
developed specifically to address adherence to nutritional recommendations for older 
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adults. The MDS uses dichotomous median cut-off values, and hence does not take into 
account the full range of consumed foods, which may not be appropriate for a 
population with low adherence to dietary guidelines204;223. In comparison, the EDI uses 
a four-point scoring range which captures a wider range of food intakes and also takes 
into account U-shaped relationships that exist between some foods, such as meat, and 
disease risk204;233;336. Results in this chapter suggest that the EDI may be more suited to 
an older UK population than the MDS, as it seemed to be a less crude Mediterranean 
diet quality measure for use in a population with low Mediterranean style dietary 
adherence223. The median scoring system used for the MDS makes generalisability to 
other populations difficult, in contrast with the EDI. 
 
6.6.2.4 Elderly Dietary Index versus the Healthy Diet Indicator 
Results from this chapter suggest that diet quality scores based on specific food or food 
groups, such as the EDI, may be a better predictor of CHD events, CVD mortality and 
all-cause mortality compared to scores based on recommended nutrient intakes, such as 
the HDI, in an older population. This is consistent with the findings of a recent review 
which found that a priori defined scores based on nutrient dietary recommendations, 
such as the HDI, were not as strongly associated with mortality as scores based on 
whole foods or dietary patterns, such as the EDI or MDS335. This may be explained by 
the fact that the intake of specific food/food groups are simpler to measure and less 
prone to measurement error compared to the process of generating total dietary 
macronutrient and micronutrient intakes for the HDI, which assumes standard portion 
sizes of foods consumed and relies on having a food composition database that is 
complete and up to date104. Furthermore, a critical review of predefined diet quality 
scores previously questioned the use of diet quality indexes based on dietary guidelines, 
such as the HDI, and suggested that diet score ranges are preferable to simple cut-offs, 
since they are more subtle; the EDI may be more nuanced than the HDI as it uses a four-
point scoring system as opposed to a dichotomous scoring system, and can also take 
into account U-shaped associations between foods and health outcomes204. The EDI 
therefore seems to have practical advantages over the HDI, as it is a more easily 
applicable tool for assessing diet quality among the elderly233 and more strongly 
predictive of the risk of CHD events, CVD mortality and all-cause mortality.  
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6.6.3. Strengths and limitations 
The major strengths of the results presented in this chapter are that data are from a 
moderately large and representative prospective population-based study, with negligible 
loss to follow-up and objective ascertainment of CVD and mortality outcomes35;264. 
However, since the study comprised predominately of white European older male 
participants, the generalisability of the findings to non-white ethnic groups and women 
is uncertain. Moreover, results may not be applicable to men with prevalent MI, stroke 
or heart failure since such participants were excluded from analyses. 
 
Assessment of dietary intake by self-reported measures can be prone to measurement 
error through misreporting, which can affect the estimation of energy intake and 
micronutrient intake321;322. The FFQ method in particular, as used in this study, is more 
prone to measurement error than other dietary measures such as 24-hour dietary recall, 
dietary diaries or weighed food records that have been collected on several separate 
occasions198;200. Also, in older populations non-response to FFQ questions may have 
increased the chance of underreporting190;312. Misreporting of energy intake may 
therefore affect dietary pattern analysis, especially since underreporting can be more 
prevalent for some specific food groups350;351. However, the FFQ used in this study has 
previously been validated against weighed food intakes in British populations273;274. In 
addition, to reduce the risk of bias in dietary assessment, established minimum and 
maximum cut-offs for total energy intake were applied to the data (<500 or > 8000 
kcal279) to exclude under and over-reporters. All statistical models were also adjusted 
for total energy intake to reduce the risk of bias280, and since total energy intake was not 
associated with the risk of mortality or cardiovascular outcomes this was not considered 
an over-adjustment338. It is possible that some residual confounding remains in the 
assessment of dietary patterns, but underreporting of food intake is only likely to have 
biased the relative risk estimates towards the null.  
 
Another consideration is that the FFQ measured dietary intake at one time point only, so 
no information was available on whether participants maintained dietary practices 
throughout the study period or if diet quality changed over time. A priori methods of 
defining dietary patterns also have some limitations. They may be culturally or 
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regionally specific so may not be universally applicable30;204. Results from this chapter 
show that the HDI did not seem to be associated with the risk of CVD or mortality in an 
older UK population, but the EDI did show associations. Another limitation of a priori 
diet quality scores is that adding together equally weighed dietary components implies 
that each component is equally important to the risk of an outcome, which may not be 
the case30. For example, when individual components of the EDI were analysed, olive 
oil was the only specific component significantly associated with the risk of all-cause 
mortality, CVD mortality, CVD events and CHD events.  
 
A number of the cardiovascular risk factors examined in this chapter are self-reported in 
nature, including smoking status, alcohol intake, and physical activity. Therefore, 
misclassification is possible which could have led to over or under-estimates of hazard 
ratios. In particular, self-reported measures of physical activity can be a particular 
problem in older age groups due to the light intensities of activity and vast variability in 
duration of activity in these age groups which make accurate recall especially 
difficult315-317 (as discussed in Chapter 4, Section 4.6.3). However, a validation study in 
older men within the BRHS has shown self-reported physical activity questions used 
within this cohort are associated with a graded increase in objectively measured 
physical activity318. This reduces the risk of measurement error, and any possible 
misclassification of physical activity is likely to have been non-differential between 
participants with low and high dietary scores and is only likely to have attenuated 
relative risk estimates between a priori dietary scores and outcomes320.  
 
It is also possible a healthy-adherer/healthy-user effect may also have existed in 
participants with higher dietary scores, meaning these participants may have been on 
average more health-conscious and more likely to have exhibited a series of healthier 
behaviours, including regular visits to their general practitioner, having more preventive 
tests, higher adherence to medicine etc352;353. Such potential confounding variables were 
unmeasured in this study and hence may have caused a slight over-estimation of the 
magnitude of effect of diet quality scores on CVD and mortality risk. 
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6.6.4. Conclusions 
High adherence to a priori diet quality scores, such as the HDI and the EDI, are 
associated with the least adverse cardiovascular risk factors in older British men. In this 
cohort, higher adherence to the EDI dietary score was associated with a lower risk of 
all-cause mortality, CVD mortality and CHD events which were independent of socio-
demographic, behavioural and cardiovascular risk factors, including inflammation. 
Among older men, the EDI is a better measure of a healthy diet than the HDI and may 
be a more useful tool for diet quality assessment as it was more strongly associated with 
CHD events, CVD mortality and all-cause mortality risk compared to the HDI, which 
was not significantly associated with these outcomes. Encouraging older adults to 
adhere to the dietary patterns inherent in the EDI criteria may lower the risk of all-cause 
mortality, CVD mortality and CHD events and hence have public health benefits. The 
influence of social circumstances across the life course on EDI will be explored in 
Chapter 7. 
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Table 6.1 Healthy Diet Indicator scoring criteria and baseline scores of men aged 
60-79 years in 1998-2000  
 
Component Criteria for score 
(0) 
Criteria for score 
(1) 
Proportion scoring 1* 
(%) 
Saturated fatty acids (% energy) >10 0-10 25.2 
Polyunsaturated fatty acids (% energy) <6 and >10 6-10 14.6 
Protein (% energy) <10 and >15 10-15 41.4 
Total carbohydrates (% energy) <50 and >70 50-70 64.6 
Sugar (% energy) >10 0-10 1.2 
Dietary Fibre (g/day) <18 and >32 18-32 61.3 
Cholesterol (mg/d) >300 0-300 64.4 
Fruits and Vegetables†  
Less frequent than 
daily consumption of 
both 
Daily consumption 
of both 
18.1 
 
*Proportion adhering to dietary guideline. 
 †The weight of fruit and vegetables consumed was not available so this component was modified from 
the original scoring used (1 = ≥ 400g/day; 0 = <400g/day) to the consumption of both fruit and vegetables 
daily.
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Table 6.2 Elderly Dietary Index scoring criteria and baseline scores of men aged 
60-79 years in 1998-2000  
 
Component Criteria for score 
(1) 
Criteria for score 
(2) 
Criteria for score 
(3) 
Criteria for score 
(4) 
Proportion 
scoring 4  
(%) 
Meat ≥ 3 days/week Never/rarely <1 day/week 1-2 days/week 4.9 
Fish/Seafood Never/rarely <1 day/week ≥ 3 days/week 1-2 days/week 56.0 
Legumes Never/rarely <1 day/week ≥ 3 days/week 1-2 days/week 50.6 
Fruit <1 day/week 1-2 days/week 3-6 days/week Daily 39.7 
Vegetables <1 day/week 1-2 days/week 3-6 days/week Daily 28.5 
Cereals <1 day/week 1-2 days/week 3-6 days/week Daily 65.8 
Bread None White 
White and whole 
grain 
Whole grain 28.6 
Olive oil* Never/Rarely Tertile 1 of intake Tertile 2 of intake Tertile 3 of intake 9.2 
Dairy 
Full-fat milk and 
full-fat cheese 
Semi-skimmed 
milk and full-fat 
cheese/full-fat 
milk and low-fat 
cheese 
Skimmed milk and 
full-fat cheese 
Skimmed/Semi-
skimmed milk and 
low-fat cheese 
13.0 
Alcohol† 
>4 glasses 
wine/day 
3-4 glasses 
wine/day 
No consumption 
>0-2 glasses 
wine/day 41.7 
 
*The frequency of olive oil consumption was not available so this component was modified from the 
original score used (1 = <1 day/week; 2 = 1-2 days/week; 3 = 3-6 days/week; 4 = daily) to the quantity of 
weekly consumption. 
† Alcohol included as an additional component of the EDI in sensitivity analysis only. 1 glass = 175 ml.
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Table 6.3 Mediterranean Diet Score scoring criteria 
 
Component Score = 0 Score = 1 
Vegetables <median intake ≥ median intake 
Legumes <median intake ≥ median intake 
Fruit <median intake ≥ median intake 
Cereal <median intake ≥ median intake 
Fish/Seafood <median intake ≥ median intake 
Monounsaturated & polyunsaturated/saturated fat ratio <median intake ≥ median intake 
Meat* ≥median intake < median intake 
Dairy ≥median intake < median intake 
 
*Does not contain poultry or fish. 
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Table 6.4 Dietary intake of men aged 60-79 years in 1998-2000  
 
Dietary variables n Mean (SD)* Range 
Energy intake (kcal/d) 3292 2139.2 (531.6) 683.5-5379.1 
Carbohydrates (% kcal) 3292 52.4 (6.9) 21.1-75.8 
Protein (% kcal) 3292 15.6 (2.3) 7.9-25.9 
Fat (% kcal) 3292 30.3 (6.2) 9.5-60.2 
Saturated fat (% kcal) 3262 12.4 (3.6) 2.4-34.0 
Polyunsaturated fat (% kcal) 3262 4.5 (1.5) 1.2-17.9 
Cholesterol (mg/day) 3164 278.1 (113.7) 31.6-972.0 
Fibre (g/day) 3328 26.2 (8.7) 0.6-77.0 
Vitamin C (mg/day) 3328 83.3 (37.1) 4.3-297.3 
Vitamin E (mg/day) 3150 8.5 (4.8 0.9-58.3 
Iron (mg/day) 3172 14.2 (5.2) 1.6-44.7 
Daily fruit intake (%) 3323 42.3  - 
Daily vegetable intake (%) 3325 33.4  - 
Plasma vitamin C (µmol/L) 3115 30.7 (26.9) 0-447.9 
Plasma vitamin E (µmol/L)  2976 33.8 (12.1) 0.6-118.7 
Healthy Diet Indicator score 3133 2.9 (1.3) 0-7 
Elderly Dietary Index score 3269 24.2 (3.2) 12-35 
 
*Values presented as mean (SD) unless otherwise stated.
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Table 6.5 Cardiovascular risk factors and dietary factors by quartiles of Healthy Diet Indicator in men aged 60-79 years in 1998-2000 
 
    HDI Quartiles 
P (trend)     Q1 Q2 Q3 Q4 
    (0-2 points) (3 points)  (4 points) (5-7 points) 
  n 1164 928 728 313   
 
Median HDI score 2 3 4 5   
Socio-demographic/Behavioural variables           
  Age (years) 68.3 (5.5) 68.2 (5.5) 68.4 (5.3) 67.5 (5.0) 0.16 
  Current smokers (%) 16.2 12.1 8.7 7.1 <0.001 
  Heavy drinkers (%) 3.9 2.2 2.1 2.3 0.02 
  Physically inactive (%) 10.4 8.7 9.5 7.7 0.20 
  Manual social class (%) 50.5 49.7 44.6 48.6 0.04 
  Living in southern England region (%) 31.9 33.8 38.1 36.1 0.01 
Body composition           
  Obesity (BMI ≥ 30 kg/m2) (%) 18.4 15.4 13.6 13.8 0.004 
  WC (cm)  97.9 (10.5) 96.6 (10.7) 96.1 (9.6) 95.7 (9.9) <0.001 
  MAMC (cm) 26.6 (2.4) 26.6 (2.3) 26.4 (2.2) 26.5 (2.2) 0.18 
Dietary variables            
  Energy intake (kcal) 2242.3 (601.4) 2136.4 (529.6) 2047.0 (431.9) 1998.5 (395.4) <0.001 
  Carbohydrates (% kcal) 47.9 (6.2) 53.6 (5.9) 56.0 (5.6) 57.0 (5.0) <0.001 
  Protein (% kcal) 15.9 (2.2) 15.6 (2.3) 15.5 (2.3) 14.7 (2.0) <0.001 
  Fat (% kcal) 33.8 (5.6) 29.6 (5.4) 27.3 (5.3) 26.2 (5.1) <0.001 
  Saturated fat (% kcal) 14.5 (3.6) 12.1 (3.0) 10.6 (2.7) 9.5 (2.2) <0.001 
  Fibre (g/day) 25.0 (9.8) 26.9 (8.9) 27.3 (7.3) 26.7 (4.9) <0.001 
  Vitamin C (mg/day) 78.5 (35.2) 83.9 (38.4) 87.7 (36.0) 93.2 (37.8) <0.001 
  Vitamin E (mg/day) 8.0 (4.8) 8.1 (4.4) 8.8 (4.8) 10.5 (5.6) <0.001 
  Iron (mg/day) 14.3 (5.6) 14.3 (5.1) 14.5 (5.2) 13.2 (3.4) 0.07 
  Daily fruit intake (%) 30.7 42.2 53.4 63.5 <0.001 
  Daily vegetable intake (%) 26.2 31.7 39.9 54.3 <0.001 
  Plasma vitamin C (µmol/L) 29.8 (24.4) 30.5 (26.9) 32.8 (32.9) 31.1 (19.8) 0.08 
  Plasma vitamin E (µmol/L)  33.1 (11.6) 33.6 (12.1) 34.2 (12.3) 35.8 (12.3) 0.001 
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Table 6.5 Continued. Cardiovascular risk factors and dietary factors by quartiles of Healthy Diet Indicator in men aged 60-79 years in 
1998-2000 
 
    HDI Quartiles 
P (trend)     Q1 Q2 Q3 Q4 
    (0-2 points) (3 points)  (4 points) (5-7 points) 
Metabolic variables           
  SBP (mmHg) 150.3 (23.6) 149.8 (24.5) 149.4 (23.7) 150.0 (23.3) 0.56 
  Triglycerides (mmol/L) 1.8 (1.1) 1.9 (1.1) 1.8 (1.0) 1.7 (0.9) 0.70 
  HDL (mmol/L) 1.4 (0.3) 1.3 (0.3) 1.3 (0.3) 1.3 (0.3) 0.006 
  Glucose (mmol/L) 6.1 (2.0) 5.9 (1.5) 6.0 (1.9) 5.8 (1.0) 0.02 
  Diabetes (%) 6.5 6.5 5.9 5.0 0.33 
Inflammatory/hemostatic markers           
  CRP (mg/L)* 1.7 (0.9-3.4) 1.6 (0.7-3.2) 1.6 (0.7-3.2) 1.4 (0.6-2.8) 0.01 
  t-PA (ng/mL) 11.0 (4.2) 10.8 (4.5) 10.2 (3.8) 10.7 (4.4) 0.001 
  D-dimer (ng/mL)* 78.1 (46.0-117.0) 77.1 (47.0-114.0) 80.1 (50.0-119.0) 77.9 (45.0-112.0) 0.71 
  vWF (IU/dL) 136.9 (45.2) 135.2 (44.9) 137.5 (45.3) 134.8 (43.8) 0.76 
  Fibrinogen (g/L) 3.2 (0.7) 3.2 (0.7) 3.3 (0.7) 3.2 (0.7) 0.81 
  IL-6 (pg/mL)* 2.4 (1.5-3.3) 2.3 (1.5-3.4) 2.2 (1.5-3.1) 2.2 (1.5-3.0) 0.001 
  Homocysteine (µmol/L)* 12.7 (10.3-14.8) 12.3 (10.0-14.3) 12.3 (10.0-14.4) 12.2 (10.1-13.9) 0.004 
 
Values presented as mean (SD) unless otherwise stated.  
BMI, body mass index; CRP, C-reactive protein; HDI, Healthy Diet Indicator; HDL, high density lipoprotein; IL-6, interleukin 6; MAMC, mid-arm muscle circumference; 
SBP, systolic blood pressure; t-PA, tissue plasminogen activator; vWF, von Willebrand factor; WC, waist circumference. 
*Log transformed - geometric mean and interquartile range presented.
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Table 6.6 Cardiovascular risk factors and dietary factors by quartiles of Elderly Dietary Index in men aged 60-79 years in 1998-2000 
 
 
  EDI Quartiles 
P (trend)     Q1 Q2 Q3 Q4 
    (12-22 points) (23-24 points) (25-26 points) (27-35 points) 
  n 897 840 744 788   
 
Median EDI score 21 24 26 28   
Socio-demographic/Behavioural variables           
  Age (years) 68.5 (5.4) 68.3 (5.5) 68.3 (5.6) 67.9 (5.2) 0.02 
  Current smokers (%) 25.7 11.6 7.3 4.5 <0.001 
  Heavy drinkers (%) 4.1 3.0 2.9 1.4 0.002 
  Physically inactive (%) 13.4 8.6 8.4 7.5 <0.001 
  Manual social class (%) 64.7 53.3 40.5 35.9 <0.001 
  Living in southern England region (%) 30.9 33.1 37.4 37.1 0.002 
Body composition           
  Obesity (BMI ≥ 30 kg/m2) (%) 17.4 17.6 16.5 12.7 0.009 
  WC (cm)  97.3 (10.9) 97.2 (10.7) 97.0 (9.7) 95.9 (9.7) 0.006 
  MAMC (cm) 26.3 (2.5) 26.6 (2.3) 26.7 (2.2) 26.7 (2.1) <0.001 
Dietary variables            
  Energy intake (kcal) 2162.1 (574.8) 2192.4 (539.5) 2160.7 (542.0) 2054.9 (442.3) <0.001 
  Carbohydrates (% kcal) 50.3 (7.3) 52.1 (6.7) 52.8 (6.4) 54.5 (6.5) <0.001 
  Protein (% kcal) 14.8 (2.3) 15.5 (2.2) 15.9 (2.3) 16.2 (2.1) <0.001 
  Fat (% kcal) 32.9 (6.2) 31.0 (5.6) 29.6 (5.7) 27.5 (5.9) <0.001 
  Saturated fat (% kcal) 14.0 (3.7) 12.8 (3.3) 11.9 (3.3) 10.7 (3.3) <0.001 
  Fibre (g/day) 20.4 (6.8) 25.9 (8.0) 28.3 (7.8) 31.2 (8.1) <0.001 
  Vitamin C (mg/day) 63.3 (30.4) 81.4 (35.0) 92.1 (34.1) 100.5 (37.1) <0.001 
  Vitamin E (mg/day) 7.8 (5.3) 8.5 (5.0) 8.8 (4.5) 8.9 (4.4) <0.001 
  Iron (mg/day) 11.8 (3.7) 14.1 (5.1) 15.4 (5.4) 15.9 (5.4) <0.001 
  Daily fruit intake (%) 12.8 34.5 54 73.6 <0.001 
  Daily vegetable intake (%) 13.4 25.4 40.8 57.8 <0.001 
  Plasma vitamin C (µmol/L) 26.6 (30.9) 30.4 (29.2) 32.1 (21.1) 34.8 (24.3) <0.001 
  Plasma vitamin E (µmol/L)  33.0 (12.6) 33.2 (11.5) 33.9 (11.6) 35.4 (12.4) <0.001 
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Table 6.6 Continued. Cardiovascular risk factors and dietary factors by quartiles of Elderly Dietary Index in men aged 60-79 years in 
1998-2000 
 
 
  EDI Quartiles 
P (trend)     Q1 Q2 Q3 Q4 
    (12-22 points) (23-24 points) (25-26 points) (27-35 points) 
Metabolic variables           
  SBP (mmHg) 149.9 (24.3) 150.4 (23.9) 150.5 (23.4) 149.3 (23.8) 0.64 
  Triglycerides (mmol/L) 1.9 (1.2) 1.9 (1.1) 1.8 (0.9) 1.8 (1.0) 0.03 
  HDL (mmol/L) 1.3 (0.4) 1.3 (0.3) 1.4 (0.3) 1.3 (0.3) 0.34 
  Glucose (mmol/L) 5.9 (1.5) 5.9 (1.7) 6.0 (1.8) 6.1 (1.9) 0.03 
  Diabetes (%) 3.9 4.8 7.7 8.6 <0.001 
Inflammatory/hemostatic markers           
  CRP (mg/L)* 2.0 (0.9-4.2) 1.7 (0.8-3.4) 1.5 (0.7-3.0) 1.3 (0.6-2.4) <0.001 
  t-PA (ng/mL) 11.5 (4.6) 10.7 (4.2) 10.7 (4.2) 10.2 (3.9) <0.001 
  D-dimer (ng/mL)* 84.4 (50.0-128.0) 77.0 (46.0-111.0) 78.6 (46.0-118.5) 74.3 (45.0-107.5) 0.003 
  vWF (IU/dL) 140.0 (45.6) 138.1 (44.3) 135.2 (45.2 131.8 (45.1) <0.001 
  Fibrinogen (g/L) 3.3 (0.7) 3.2 (0.7) 3.2 (0.8) 3.1 (0.7) <0.001 
  IL-6 (pg/mL)* 2.7 (1.7-3.7) 2.4 (1.5-3.4) 2.2 (1.4-3.2) 2.0 (1.4-2.8) <0.001 
  Homocysteine (µmol/L)* 13.7 (10.8-16.2) 12.6 (10.2-14.7) 12.0 (9.8-13.9) 11.4 (9.7-13.1) <0.001 
 
Values presented as mean (SD) unless otherwise stated.  
BMI, body mass index; CRP, C-reactive protein; EDI, Elderly Dietary Index; HDL, high density lipoprotein; IL-6, interleukin 6; MAMC, mid-arm muscle circumference; 
SBP, systolic blood pressure; t-PA, tissue plasminogen activator; vWF, von Willebrand factor; WC, waist circumference. 
*Log transformed - geometric mean and interquartile range presented.
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Table 6.7 Hazard ratios (95% CI) for CHD events, CVD events, CVD mortality and all-cause mortality by quartiles of total Healthy 
Diet Indicator score in men aged 60-79 years in 1998-2000 
 
  
HDI 
Quartiles 
Cases Rate  
(per 1,000 
person years) 
Model 1 Model 2 Model 3 Model 4 
  (n)         
All-cause mortality Q1 327 28.47 1.00 1.00 1.00 1.00 
  Q2 249 26.97 0.94 (0.80-1.11) 1.00 (0.84-1.19) 1.06 (0.89-1.28) 1.06 (0.89-1.28) 
  Q3 209 29.17 1.03 (0.86-1.22) 1.11 (0.92-1.33) 1.18 (0.97-1.44) 1.17 (0.96-1.42) 
  Q4 72 22.73 0.91 (0.70-1.17) 0.94 (0.71-1.23) 1.01 (0.75-1.34) 0.96 (0.72-1.29) 
  p-trend     0.77 0.72 0.31 0.46 
CVD mortality Q1 118 10.27 1.00 1.00 1.00 1.00 
  Q2 83 8.99 0.87 (0.66-1.16) 0.91 (0.68-1.23) 1.02 (0.75-1.39) 1.03 (0.75-1.41) 
  Q3 69 9.63 0.95 (0.70-1.27) 1.03 (0.75-1.41) 1.11 (0.79-1.55) 1.12 (0.80-1.58) 
  Q4 23 7.26 0.85 (0.54-1.33) 0.84 (0.51-1.38) 0.94 (0.56-1.59) 0.84 (0.49-1.43) 
  p-trend     0.49 0.74 0.83 0.98 
CVD events Q1 197 17.82 1.00 1.00 1.00 1.00 
  Q2 155 17.48 0.98 (0.79-1.20) 1.00 (0.80-1.25) 1.07 (0.85-1.34) 1.07 (0.85-1.35) 
  Q3 142 20.98 1.18 (0.95-1.47) 1.27 (1.01-1.60)* 1.28 (1.01-1.64)* 1.27 (0.99-1.62) 
  Q4 44 14.49 0.90 (0.65-1.25) 0.88 (0.62-1.27) 0.92 (0.64-1.34) 0.89 (0.61-1.31) 
  p-trend     0.62 0.43 0.35 0.45 
CHD events Q1 101 8.96 1.00 1.00 1.00 1.00 
  Q2 75 8.27 0.92 (0.68-1.24) 0.92 (0.67-1.25) 0.97 (0.70-1.35) 0.99 (0.71-1.37) 
  Q3 78 11.18 1.25 (0.93-1.67) 1.31 (0.96-1.79) 1.33 (0.95-1.85) 1.35 (0.97-1.89) 
  Q4 32 10.32 1.26 (0.85-1.88) 1.21 (0.78-1.87) 1.31 (0.83-2.07) 1.28 (0.81-2.04) 
  p-trend     0.10 0.10 0.08 0.08 
CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HDI, Healthy Diet Indicator.  
Model 1: Age adjusted. Model 2: Adjusted for model 1 + energy intake, smoking, alcohol, physical activity, social class and BMI. Model 3. Adjusted for model 2 + HDL, 
SBP and diabetes. Model 4. Adjusted for model 3 + CRP and vWF. 
*P <0.05 
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Table 6.8 Hazard ratios (95% CI) for CHD events, CVD events, CVD mortality and all-cause mortality by Healthy Diet Indicator 
components in men aged 60-79 years in 1998-2000 
 
HDI components 
All-cause mortality CVD mortality CVD events CHD events 
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 
Did not meet guideline (score=0) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Met guideline (score=1)                 
      SFA 1.05 (0.90-1.23) 1.14 (0.96-1.36) 1.10 (0.83-1.44) 1.28 (0.94-1.72) 1.06 (0.87-1.30) 1.15 (0.92-1.43) 1.09 (0.84-1.43) 1.14 (0.85-1.53) 
      PUFA 1.14 (0.95-1.37) 1.15 (0.95-1.39) 1.29 (0.95-1.73) 1.30 (0.95-1.78) 1.13 (0.90-1.43) 1.09 (0.86-1.39) 1.28 (0.95-1.74) 1.27 (0.93-1.75) 
      Protein 1.19 (1.04-1.36)* 1.11 (0.95-1.29) 1.18 (0.93-1.48) 1.06 (0.82-1.37) 1.17 (0.99-1.39) 1.07 (0.89-1.30) 1.28 (1.01-1.61)* 1.15 (0.89-1.48) 
      Carbohydrates  0.94 (0.82-1.08) 0.93 (0.79-1.09) 0.98 (0.77-1.25) 0.90 (0.69-1.19) 1.12 (0.93-1.34) 1.01 (0.83-1.24) 1.23 (0.96-1.58) 1.05 (0.79-1.38) 
      Sugar  1.25 (0.69-2.27) 1.10 (0.58-2.06) 0.73 (0.18-2.92) 0.79 (0.20-3.22) 0.51 (0.16-1.59) 0.56 (0.18-1.77) 0.64 (0.16-2.58) 0.73 (0.18-2.95) 
      Fibre 1.00 (0.87-1.14) 1.04 (0.90-1.20) 0.92 (0.73-1.16) 1.02 (0.80-1.31) 0.95 (0.80-1.13) 1.06 (0.88-1.27) 1.20 (0.94-1.53) 1.32 (1.02-1.70) 
      Cholesterol 0.91 (0.79-1.04) 0.88 (0.74-1.04) 0.73 (0.58-0.92)* 0.67 (0.50-0.90)* 0.90 (0.76-1.08) 0.90 (0.72-1.12) 0.87 (0.68-1.10) 0.78 (0.58-1.05) 
      Fruits & Vegetables  0.80 (0.67-0.97)* 0.92 (0.75-1.11) 0.83 (0.61-1.14) 0.92 (0.66-1.28) 0.91 (0.73-1.13) 1.01 (0.80-1.28) 0.90 (0.66-1.22) 1.01 (0.74-1.39) 
 
CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HDI, Healthy Diet Indicator; PUFA, polyunsaturated fatty acids; SFA, saturated fatty 
acids.  
Model 1: Age adjusted. Model 2: Adjusted for model 1 + energy intake, smoking, alcohol, physical activity, social class, BMI and a modified version of the HDI score, not 
containing the individual component of interest. HDI components - score 1 vs. score 0.  
*P <0.05 
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Table 6.9 Hazard ratios (95% CI) for CHD events, CVD events, CVD mortality and all-cause mortality by quartiles of total Elderly 
Dietary Index score in men aged 60-79 years in 1998-2000 
 
  
EDI 
Quartiles 
Cases Rate  
(per 1,000 
person years) 
Model 1 Model 2 Model 3 Model 4 
  (n)         
All-cause mortality Q1 314 37.28 1.00 1.00 1.00 1.00 
  Q2 233 28.06 0.75 (0.63-0.89)* 0.88 (0.73-1.06) 0.85 (0.70-1.03) 0.85 (0.70-1.03) 
  Q3 200 26.86 0.72 (0.60-0.86)* 0.89 (0.74-1.09) 0.88 (0.72-1.08) 0.89 (0.72-1.10) 
  Q4 160 19.69 0.55 (0.46-0.67)* 0.74 (0.60-0.91)* 0.73 (0.59-0.92)* 0.75 (0.60-0.94)* 
  p-trend     <0.001 0.01 0.01 0.03 
CVD mortality Q1 115 13.65 1.00 1.00 1.00 1.00 
  Q2 85 10.24 0.75 (0.57-1.00)* 0.87 (0.64-1.18) 0.80 (0.58-1.12) 0.79 (0.57-1.10) 
  Q3 69 9.27 0.68 (0.50-0.91)* 0.79 (0.57-1.10) 0.78 (0.55-1.11) 0.79 (0.55-1.13) 
  Q4 48 5.91 0.47 (0.33-0.66)* 0.60 (0.41-0.88)* 0.60 (0.41-0.90)* 0.63 (0.42-0.94)* 
  p-trend     <0.001 0.008 0.02 0.03 
CVD events Q1 181 22.42 1.00 1.00 1.00 1.00 
  Q2 145 18.17 0.81 (0.65-1.01) 0.88 (0.70-1.12) 0.85 (0.66-1.08) 0.84 (0.66-1.08) 
  Q3 126 17.7 0.80 (0.64-1.00) 0.91 (0.71-1.16) 0.89 (0.69-1.16) 0.91 (0.70-1.18) 
  Q4 118 15.22 0.71 (0.56-0.90)* 0.82 (0.63-1.07) 0.79 (0.60-1.04) 0.79 (0.60-1.05) 
  p-trend     0.01 0.17 0.14 0.16 
CHD events Q1 104 12.67 1.00 1.00 1.00 1.00 
  Q2 77 9.47 0.75 (0.56-1.01) 0.81 (0.59-1.11) 0.75 (0.54-1.05) 0.75 (0.54-1.06) 
  Q3 66 9.03 0.72 (0.53-0.98)* 0.80 (0.57-1.12) 0.79 (0.55-1.12) 0.80 (0.56-1.14) 
  Q4 54 6.74 0.56 (0.40-0.78)* 0.64 (0.44-0.92)* 0.64 (0.44-0.94)* 0.66 (0.45-0.97)* 
  p-trend     0.001 0.02 0.03 0.05 
 
CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; EDI, Elderly Dietary Index. 
Model 1: Age adjusted. Model 2: Adjusted for model 1 + energy intake, smoking, alcohol, physical activity, social class and BMI. Model 3. Adjusted for model 2 + HDL, 
SBP and diabetes. Model 4. Adjusted for model 3 + CRP and vWF. 
*P <0.05. 
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Table 6.10 Hazard ratios (95% CI) for CHD events, CVD events, CVD mortality and all-cause mortality by Elderly Dietary 
Index components in men aged 60-79 years in 1998-2000 
 
EDI components 
All-cause mortality CVD mortality CVD events CHD events 
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 
Lowest compliance 
with guideline 
(score=1) 
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Highest compliance with guideline (score=4)             
      Meat 0.90 (0.65-1.23) 1.11 (0.79-1.55) 0.64 (0.34-1.21) 0.92 (0.49-1.75) 0.63 (0.40-1.01) 0.75 (0.46-1.22) 0.59 (0.30-1.14) 0.73 (0.38-1.44) 
      Fish/Seafood 0.76 (0.53-1.09) 0.91 (0.62-1.34) 0.53 (0.31-0.91)* 0.66 (0.36-1.21) 0.75 (0.48-1.16) 0.85 (0.52-1.37) 0.54 (0.32-0.94)* 0.67 (0.37-1.21) 
      Legumes 0.85 (0.69-1.03) 0.91 (0.74-1.13) 0.81 (0.58-1.13) 0.83 (0.58-1.19) 0.92 (0.71-1.21) 0.94 (0.71-1.24) 0.83 (0.59-1.18) 0.89 (0.61-1.30) 
      Fruit 0.61 (0.48-0.76)* 0.86 (0.66-1.11) 0.67 (0.45-1.02) 0.95 (0.59-1.53) 0.75 (0.55-1.01) 0.90 (0.64-1.28) 0.68 (0.45-1.03) 0.86 (0.54-1.35) 
      Vegetables 0.67 (0.47-0.96)* 1.05 (0.70-1.58) 0.63 (0.36-1.12) 0.88 (0.47-1.65) 0.84 (0.52-1.35) 1.17 (0.69-2.01) 0.89 (0.46-1.72) 1.29 (0.65-2.56) 
      Cereals 0.86 (0.67-1.10) 1.15 (0.87-1.52) 1.10 (0.70-1.72) 1.37 (0.83-2.25) 1.08 (0.77-1.51) 1.13 (0.79-1.62) 0.99 (0.64-1.53) 1.19 (0.73-1.93) 
      Bread 0.67 (0.27-1.62) 0.77 (0.32-1.90) 0.55 (0.14-2.24) 0.57 (0.14-2.40) 0.57 (0.21-1.54) 0.60 (0.22-1.65) 0.62 (0.15-2.52) 0.76 (0.18-3.15) 
      Olive oil 0.59 (0.45-0.77)* 0.68 (0.51-0.91)* 0.42 (0.24-0.72)* 0.43 (0.24-0.80)* 0.54 (0.37-0.77)* 0.58 (0.40-0.86)* 0.47 (0.28-0.79)* 0.55 (0.32-0.95)* 
      Dairy 1.07 (0.86-1.32) 1.14 (0.90-1.44) 1.00 (0.70-1.45) 1.09 (0.73-1.62) 1.04 (0.78-1.37) 1.12 (0.83-1.52) 0.95 (0.65-1.39) 0.90 (0.59-1.36) 
 
CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; EDI, Elderly Dietary Index. 
Model 1: Age adjusted. Model 2: Adjusted for model 1 + energy intake, smoking, alcohol, physical activity, social class, BMI and a modified version of the EDI 
score, not containing the individual component of interest. EDI components - score 4 vs. score 1.  
*P <0.05 
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CHAPTER 7 Dietary quality scores in older British men: the influence of 
childhood and adult socioeconomic circumstances 
7.1. Summary 
High diet quality is associated with a reduced risk of cardiovascular disease (CVD) and 
mortality in older age and strong socioeconomic gradients in diet quality exist. 
However, the influence of material conditions particularly in childhood, and the use of a 
range of distinct socioeconomic measures on diet quality have been little studied in 
older adults. In this chapter, the roles of childhood and adult socioeconomic factors, 
social interaction and family circumstances, as determinants of diet quality are 
examined in participants from the British Regional Heart Study (BRHS). At the 20 year 
re-examination in 1998-2000, 4252 men, aged 60-79 years, attended a physical 
examination, provided a fasting blood sample and completed both a general lifestyle 
questionnaire and a food frequency questionnaire (FFQ). The FFQ provided data on 
daily fruit and vegetable intake and the Elderly Dietary Index (EDI), with higher scores 
indicating higher diet quality. Socioeconomic measures in childhood and adulthood 
included own occupation, father’s occupation, education and household amenities, 
which were combined to create composite socioeconomic scores. Measures of social 
interaction included social contact, and measures of family circumstances included 
living arrangements and marital status. Both childhood and adult socioeconomic 
measures were independently associated with diet quality. Men of manual childhood 
social class were less likely to consume fruit and vegetables daily (odds ratio [OR]: 
0.80, 95% CI: 0.66-0.97) compared to non-manual childhood social class, as were men 
of manual adult social class (OR: 0.65, 95% CI: 0.54-0.79) compared to non-manual 
adult social class. Similarly, men of manual childhood social class were less likely to be 
in the top quartile of the EDI (OR: 0.73, 95% CI: 0.61-0.88), as were men of manual 
adult social class (OR: 0.66, 95% CI: 0.55-0.79). Diet quality showed an inverse trend 
with a composite score combining different adverse adult socioeconomic indictors 
(manual social class; education ≤ 14 years; no car; not a house owner; state pension 
only; no central heating). An inverse trend was also shown between diet quality and a 
composite score combining adverse childhood socioeconomic indictors (manual 
childhood social class; no bathroom; no hot water supply; no family car ownership), but 
this association was attenuated after adjustment for adult social class. A combined 
childhood and adulthood adverse socioeconomic score was associated with lower diet 
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quality in later adult life. Diet quality was higher in men not living alone and in married 
men, but was not associated with social contact. Therefore, diet quality in older men is 
influenced by both childhood and adulthood socioeconomic factors, in addition to 
marital status and habitation. 
  
7.2. Introduction 
Diet is an important modifiable risk factor for cardiovascular disease and 
mortality8;23;202 and, as observed in Chapter 6, associations between a priori dietary 
scores and the risk of cardiovascular disease and mortality are present in older men. 
Chapter 6 demonstrated that older British men with higher scores of the Elderly Dietary 
Index (EDI), a Mediterranean style dietary score developed specifically to address 
adherence to nutritional recommendations for older adults233;354 was strongly associated 
with a lower risk of CHD events, CVD mortality and all-cause mortality. In addition, 
older British men with higher EDI scores had the least adverse cardiovascular risk 
profiles, including having the lowest proportion of men from manual social class. 
Strong socioeconomic gradients in the overall quality of diet are well established and 
previous studies have consistently shown that individuals from higher adult 
socioeconomic position are more likely to have a Mediterranean style dietary pattern, 
characterised by high consumption of fresh fruit and vegetables, whole grains, lean 
meats, fish and low-fat dairy products222;355-357. A meta-analysis of data from seven 
European countries, including 18-85 year olds, has also shown strong associations 
between higher socioeconomic position, defined by occupation or education, and a 
greater daily consumption of fruit and vegetables358. It has also been suggested that 
childhood socioeconomic factors may have an additional impact on adult dietary 
quality, independent of adult socioeconomic factors359;360. Moreover, as well as 
socioeconomic factors, social circumstances such as frequency of contact, living 
arrangement and marital status, which have been shown to be associated with an 
increased risk of CVD and mortality361, are also increasingly being identified as 
important determinants of diet particularly in older populations362;363. Socioeconomic 
gradients in the quality of diet appear to persist in older populations364-368. However, the 
influence of differing material socioeconomic conditions, especially in childhood, and 
the use of a range of distinct socioeconomic measures on quality of diet have been little 
studied in older adults. 
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This chapter will therefore focus on socioeconomic circumstances across the life course 
as determinants of diet quality in older men. Specifically, the Chapter aims to assess the 
relationship between a range of childhood and adult socioeconomic measures (including 
occupation/father’s occupation, education and household amenities), family 
circumstances (living arrangements and marital status) and social interactions with diet 
quality in older British men. The EDI will be used as an a priori marker of a 
Mediterranean style diet and hence of diet quality233, as Chapter 6 showed it was 
strongly associated with a lower risk of CHD events, CVD mortality and all-cause 
mortality in this cohort. In addition, frequency of fruit and vegetable consumption will 
also be used as a marker of diet quality, as this has been consistently shown to be 
strongly related to a lower risk of CVD mortality369 and fruit and vegetable intake is 
simpler to measure than the EDI and hence less prone to measurement error. 
 
7.3. Objectives 
To examine the influences of social circumstances on an a priori defined dietary score 
and fruit and vegetable intake in older age (60-79 years). The specific aims of this 
chapter are: 
i) To examine the relationship of an a priori defined dietary score and fruit and 
vegetable intake with childhood socioeconomic factors.  
ii) To examine the relationship of an a priori defined dietary score and fruit and 
vegetable intake with adult socioeconomic factors.  
iii) To examine the relationship of an a priori defined dietary score and fruit and 
vegetable intake with combined childhood and adult socioeconomic factors.  
iv) To examine the relationship of an a priori defined dietary score and fruit and 
vegetable intake with social interaction and family circumstances. 
 
7.4. Methods 
7.4.1. Subjects and methods of data collection 
Analyses described in this chapter were carried out on cross-sectional data from the 20 
year re-examination of participants in the BRHS in 1998-2000, when aged 60-79 years. 
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4252 men (77% of survivors) attended a physical examination, provided a fasting blood 
sample, and completed both a general questionnaire, answering questions on their 
lifestyle and medical history, and an FFQ264. In addition data on childhood and adult 
social circumstances were collected via postal questionnaire in 1978-80, 1992 and 1996.  
 
7.4.2. Dietary assessment and defining diet scores 
Dietary intake was measured in 1998-2000 via a self-completed postal FFQ, with 
participants reporting their usual frequency of consumption of 86 food and drink items, 
as described in detail in Chapter 3, section 3.3.2. Diet quality was examined using an a 
priori dietary score, the EDI, a Mediterranean style dietary score developed specifically 
to address adherence to nutritional recommendations for older adults233;354. The EDI 
was chosen as results in Chapter 6 demonstrated it was the a priori dietary score most 
strongly associated with CHD events, CVD mortality and all-cause mortality, compared 
to the HDI and the MDS. The EDI consisted of nine components (meat; fish and 
seafood; vegetables; cereals; fruit; legumes; olive oil; dairy; bread), each assigned a 
four-point scoring system based on the frequency of consumption, resulting in a total 
score range from 9 to 36. Score 4 was assigned for the highest consumption of fruits, 
vegetables, cereals and olive oil. However, for meat, fish/seafood, and legumes, score 4 
with achieved for moderate consumption (1-2 days/week). For bread intake, score 4 was 
assigned when someone consumed only whole grain bread and for dairy, score 4 was 
assigned for low fat milk and cheese intake only. Higher scores of the EDI indicated 
greater adherence to the EDI dietary pattern and hence a higher diet quality. Full detail 
of the scoring criteria used for the EDI can be found in Chapter 6 (Section 6.4.3 and 
Table 6.2).  
 
As an additional marker of diet quality, frequency of fruit and vegetable consumption 
was used in addition to the EDI. This has been consistently shown to be strongly related 
to a lower risk of CVD mortality369. Fruit and vegetable intake is also simpler to 
measure than the EDI and hence less prone to measurement error. In the FFQ, 
participants were asked how frequently they consumed fresh fruit and vegetables (1, 2, 
3, 4, 5, 6, or 7 days per week; monthly; rarely/never. Daily consumption was classified 
as intake of both fruit and vegetable on 7 days per week. 
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7.4.3. Measurement of socioeconomic position 
The measurement of all adult and childhood socioeconomic variables has been 
described in detail in Chapter 3 (Section 3.3.4). Adult occupation was recorded at study 
entry (aged 40-59 years), by a nurse-administered questionnaire in 1978-2000, and 
social class was based on the longest held occupation recorded using the Registrar 
General’s occupational classification285. The six occupational social class categories 
were: I (professional occupations e.g. barristers, physicians, engineers), II (intermediate 
occupations e.g. teachers, sales managers), III non-manual (skilled non-manual 
occupations e.g. clerks, shop assistants), III manual (skilled manual occupations e.g. 
bricklayers, coalminers), IV (partly skilled occupations e.g. bus conductors, postmen) 
and V (unskilled occupations e.g. porters, general labourers). Participants were 
classified as having either a manual (social classes III manual, IV, V) or non-manual 
(social classes I, II, III non-manual) occupational social class and men who were in the 
Armed Forces were excluded (n = 112). Additional socioeconomic measures available 
from the 1996 postal questionnaire were education (age at leaving full-time education) 
and pension (financial support the participant has or will have on retirement - state only 
or state plus private pension). The 20 years re-examination questionnaire in 1998-2000 
also provided data on car and house ownership, and whether participants had central 
heating at home. Adverse socioeconomic measures were combined to create a 
composite score in order to investigate the cumulative impact of low socioeconomic 
position, and to take a range of socioeconomic measures into account that may have a 
greater impact than occupation alone. One point was assigned for each of the following: 
manual adult social class; education ≤ 14 years; no car; not a house owner; state pension 
only; no central heating; to generate a total score between 0 and 6370. 
 
Childhood socioeconomic variables were collected via postal questionnaire in 1992. 
Childhood occupational social class was based on father’s longest held occupation and 
participants were classified as manual or non-manual using the Office of Population 
Censuses and Surveys Classification of Occupations social class coding manual371. Men 
whose father’s longest held occupation was in the Armed Forces were excluded from 
analysis (n = 81). Data were also available on childhood household amenities. 
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Participants were asked if their home had a bathroom, hot water supply or family car 
ownership, up to 10 years old. A cumulative adverse childhood socioeconomic score 
was created, as an overall marker of early life socioeconomic position. One point was 
assigned for each of the following: manual childhood social class; no bathroom; no hot 
water supply; no family car ownership, to generate a total score from 0 to 4370.  
 
To assess the combined effects of childhood and adult social occupational social class 
on diet quality, participants were categorised into four combined childhood and adult 
social class groups: childhood and adult non-manual; childhood non-manual and 
manual adult; manual childhood and adult non-manual; childhood and manual adult 
social class. Additionally, a combined adverse childhood and adulthood socioeconomic 
measures score was created by summing the adverse adult and childhood scores, to 
generate a total from 0 to 10.  
 
7.4.4. Social interaction and family circumstances variables 
The measurement of variables on social interactions and family circumstances has been 
described in detail in Chapter 3 (Section 3.3.4). In the 1998-2000 questionnaire, men 
were asked how often they saw or spoke to their children, siblings, friends and 
neighbours (every week; every month; every few months; every year; rarely/never; does 
not apply), whether they were living alone (living alone; living with a partner/spouse; 
living with other family members; living with other people), and what their marital 
status is (single; married; widowed; divorced/separated; other). A small number of men 
whose marital status was “other” were excluded from the analysis (n = 8).  
 
7.4.5. Cardiovascular risk factors 
Established and emerging cardiovascular risk factors were measured at the 20 year re-
examination in 1998-2000 as described in Chapter 3, section 3.3. Information on 
cigarette smoking, alcohol intake and physical activity were self-reported via 
questionnaire. Men were classified into four smoking groups (never smoked; long-term 
ex-smokers, >15 years; recent ex-smokers, ≤ 15 years; current smokers)282. Alcohol 
intake was classified into five groups based on the number and frequency of alcoholic 
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beverages consumed per week (none; occasional; light; moderate; heavy)91. Current 
physical activity was classified into six groups based on the frequency and intensity of 
exercise(inactive; occasional; light; moderate; moderately vigorous and vigorous)283. 
Height and weight were measured at physical examination in 1998-2000. Body mass 
index (BMI) was calculated and participants were classified into four BMI categories: 
(underweight, <18.5; normal weight, 18.5-24.99; overweight, 25-29.99; obese, ≥ 30 
kg/m2)105. 
 
7.4.6. Statistical methods 
Of the 4252 men attending the twenty year re-examination, data were available on fruit 
and vegetable intake for 4067 participants and 3924 of these men had adequate data to 
apply the EDI score. Participants were categorised into quartiles of the EDI using cut 
off points, which produced the nearest categorisation into equal sized groups that these 
integer data would allow. Descriptive characteristics of participants were presented by 
daily fruit and vegetable intake and by EDI quartiles. P values for difference between 
groups for daily fruit and vegetable intake were obtained using chi squared tests and p 
values for trend across EDI quartiles were obtained using regression analyses. Chi 
squared analysis was also used to assess the relationship between childhood and adult 
socioeconomic measures. Multivariable logistic regression assessed associations 
between childhood and adult socioeconomic measures, social interactions and family 
circumstances, with daily fruit and vegetable intake and EDI quartiles. Odds ratios for 
EDI were presented for being in the highest quartile compared to the reference group of 
the lower three quartiles combined. Logistic regression models were adjusted for age, 
energy intake (kcal/day), smoking status, alcohol intake, physical activity and BMI. In 
addition, childhood socioeconomic measures, social interactions and family 
circumstances were adjusted for adult occupational social class and conversely, adult 
socioeconomic measures were adjusted for childhood occupational social class. Age and 
energy intake were fitted continuously and smoking status, alcohol intake, physical 
activity, BMI, adult and childhood social class were fitted as categorical variables in the 
adjustments. A test for interaction between childhood and adult social class was also 
performed. 
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7.5. Results 
In this cohort of older men, less than one in five (17.9%) participants consumed fresh 
fruit and vegetables daily. The EDI score was normally distributed with a mean of 24.2 
(SD 3.3), ranging from 12 to 35. Table 7.1 presents the characteristics of the men by 
EDI quartiles and by daily fruit and vegetable intake. As described previously in 
Chapter 6, the EDI score was inversely associated with adverse cardiovascular risk 
factors. Men in the highest EDI quartile were younger on average and significantly less 
likely to be current smokers, heavy drinkers, physically inactive, of manual adult social 
class and of manual childhood social class, and had a slightly lower mean age and total 
energy intake. Men who consumed fruit and vegetables daily had a significantly lower 
energy intake and were significantly less likely to be current smokers, physically 
inactive, manual adult social class and manual childhood social class. Table 7.2 presents 
childhood socioeconomic measures in relation to adult socioeconomic measures, all of 
which were significantly associated with each other. 
 
7.5.1. Diet quality and childhood socioeconomic factors 
Table 7.3 presents odds ratios for being in the top EDI quartile and consuming fruit and 
vegetables daily according to childhood socioeconomic measures. Childhood 
occupational social class was the childhood socioeconomic measure most strongly 
associated with diet quality; men of manual childhood social class were significantly 
less likely to be in the top EDI quartile (OR: 0.73, 95% CI: 0.61-0.88) and to consume 
fresh fruit and vegetables daily (OR: 0.80, 95% CI: 0.66-0.97), which was independent 
of age, energy intake, smoking, physical activity, alcohol, BMI and adult social class. In 
sensitivity analysis, further adjusting for all other adult socioeconomic measures, the 
associations were weakened slightly between childhood social class and EDI (OR: 0.81, 
95% CI: 0.67-0.98) and daily fruit and vegetable consumption (OR: 0.82, 95% CI: 0.66-
1.02). Men without a family car in childhood were less likely to be in the highest 
quartile of EDI, with borderline statistical significance after adjustment for behavioural 
factors and adult social class. Family car ownership was not however significantly 
associated with fruit and vegetable intake. The presence of a bathroom or a hot water 
supply in the childhood home showed no significant associations with either EDI or 
daily fruit and vegetable consumption after adjustment. A significant trend was seen 
between the cumulative adverse childhood socioeconomic score and EDI, but no 
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significant trend was seen with daily fruit and vegetable consumption after adjustment 
for behavioural factors and adult social class. 
 
7.5.2. Diet quality and adult socioeconomic factors 
The odds ratios for being in the top EDI quartile and for consuming fruit and vegetable 
daily according to adult socioeconomic measures are presented in Table 7.4. Adult 
occupational social class was strongly associated with diet quality; men of manual 
social class were significantly less likely to be in the top EDI quartile (OR: 0.66, 95% 
CI: 0.55-0.79) and to consume fresh fruit and vegetables daily (OR: 0.65, 95% CI: 0.54-
0.79), independent of age, energy intake, smoking, physical activity, alcohol, BMI and 
childhood social class. These results suggest that occupational adult social class had a 
greater magnitude of effect on EDI and fruit and vegetable intake than occupational 
childhood social class. Additional sensitivity analysis, further adjusting for all other 
adult socioeconomic measures, showed that the associations between adult social class 
and EDI (OR: 0.86, 95% CI: 0.70-1.06) and daily fruit and vegetable consumption (OR: 
0.74, 95% CI: 0.59-0.93) were attenuated. When examining occupational social class as 
a continuous variable, for every unit decrease in social class the odds of being in the top 
EDI quartile (OR: 0.82, 95% CI: 0.77-0.88) and of consuming fruit and vegetables daily 
(OR: 0.81, 95% CI: 0.75-0.88) both decreased. Men with a state pension only or ≤ 14 
years of education were significantly less likely to be in the highest quartile of EDI and 
to consume fruit and vegetables daily. When examining education as a continuous 
variable, for every additional year of education, the odds of being in the top EDI 
quartile (OR: 1.03, 95% CI: 1.01-1.05) and of consuming fruit and vegetables daily 
(OR: 1.02, 95% CI: 1.01-1.04) both increased. In addition, men who did not own a car, 
did not own a house or did not have central heating were significantly less likely to be 
in the highest EDI quartile, but no associations were seen with daily fruit and vegetable 
consumption. A significant inverse trend was observed between the cumulative adverse 
adult socioeconomic score and both EDI and daily consumption of fruit and vegetables.  
 
7.5.3. Diet quality and combined childhood and adult socioeconomic factors 
Examining the combined effects of occupational social class in childhood and adulthood 
showed that diet quality was highest in men with both childhood and adult non-manual 
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social class and lowest in those with both childhood and manual adult social class 
(Table 7.5). Whether in childhood or adulthood, exposure to manual social class was 
associated with a poorer diet quality. A test for interaction between childhood and adult 
occupational social class showed evidence that the effect of childhood social class 
(manual/non-manual) was strengthened in those whose adult social class had also been 
manual (interaction test p = 0.02 for EDI quartiles). However, no such interaction was 
seen for daily fruit and vegetable intake (p = 0.44). A significant inverse trend was also 
seen between the combined childhood and adulthood adverse socioeconomic score with 
both EDI and daily consumption of fruit and vegetables. Additional sensitivity analyses, 
examining fruit intake and vegetable intake individually, showed significant inverse 
trends with the combined childhood and adulthood adverse socioeconomic score, with a 
stronger association for vegetables than for fruit. 
 
7.5.4.  Diet quality and social interaction and family circumstances variables 
Table 7.6 presents the odds ratios for of being in the top EDI quartile and for consuming 
fruit and vegetable daily according to social interactions and family circumstances. Men 
who were widowed or divorced/separated were significantly less likely to eat fruit and 
vegetables daily, compared to married men. Men living alone were significantly less 
likely to be in the highest quartile of EDI (OR: 0.71, 95% CI: 0.53-0.95) and to eat fruit 
and vegetables daily (OR: 0.61, 95% CI: 0.44-0.85) compared to those living with other 
people. However, social contact with children, siblings, friends or neighbours did not 
show any associations with EDI or daily fruit and vegetable consumption. Further 
sensitivity analysis, stratifying men in to those who were married and unmarried 
showed that social contact was still not significantly associated with diet quality in 
either subgroup. 
 
7.6. Discussion 
7.6.1. Summary of main findings 
This chapter examined associations between a range of childhood and adult 
socioeconomic factors, social interaction and family circumstances with diet quality, 
assessed by daily fruit and vegetable consumption and the EDI, in older British men 
aged 60-79 years. Both childhood and adult socioeconomic factors were independently 
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associated with diet quality, with adult factors appearing to be more influential than 
childhood factors. Diet quality was also influenced by marital status and living 
arrangements, but did not show an association with social contact. Results from this 
chapter add to the limited literature on the role of social and material conditions 
particularly in childhood and the use of multiple disaggregated socioeconomic measures 
on diet quality in the older age. The results show that childhood social class persists as a 
strong influence on diet quality in older ages. 
 
7.6.2. Comparison with previous studies 
Several adult socioeconomic measures showed strong associations with diet quality in 
older men, which were independent of age, energy intake, smoking, physical activity, 
alcohol and BMI and childhood social class. The strength of associations with EDI were 
strongest jointly for pension status and home ownership (which are two strong markers 
of material wealth), followed by education, car ownership, social class, and then central 
heating. In contrast, associations with daily fruit and vegetable intake were strongest for 
social class, followed by receipt of a pension, and then educational status. These 
observed socioeconomic gradients in diet quality are consistent with previous literature 
showing a healthier diet (characterised by a high intake of fruit, vegetables and other 
Mediterranean style food groups) in higher socioeconomic groups, measured by either 
occupation, education, income, house ownership or car access in both middle 
aged222;356-358;372 and older adult populations208;373-376. In a previous study using the EDI 
it was shown that being in the highest EDI tertile was associated with better financial 
status and a higher educational level233. Results in this chapter extend the previous 
findings by Kourlaba et al233 by including socioeconomic measures particularly relevant 
to older adults (pension status and central heating) and used a combination of different 
adverse adult socioeconomic factors, which showed a strong inverse trend with both the 
EDI score and daily fruit and vegetable intake. 
  
Childhood occupational social class was also strongly associated with diet quality, with 
men of manual childhood social class less likely to be in the top quartile of EDI and to 
consume fruit and vegetables daily, independent of behavioural factors and adult social 
class. In relation to childhood household amenities, there was a borderline significant 
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association between family car ownership and EDI, which may be due to car ownership 
being a strong marker of SEP or material wealth, particularly for the generation of this 
cohort. However, the presence of a bathroom and hot water supply in the house in 
childhood were not associated with diet quality in later life. These findings are 
consistent with previous studies showing that childhood social class is associated with 
dietary intake in middle-aged populations359;360;377. However, a previous study in early 
old age (61-80 years) showed that childhood social circumstances (social class and per 
capita household food expenditure) were not strongly related to adult diet quality, 
measured by the Healthy Diet Score373. To my knowledge, the results presented in this 
chapter are the first to confirm that the influences of childhood social class on diet 
quality in middle aged populations can persist at older ages. 
 
Analyses combining childhood and adult socioeconomic factors were consistent with 
the possibility of cumulative effects of adverse childhood and adult socioeconomic 
factors on diet quality in older age. Results also suggested there was a possibly 
interaction between childhood and adult social class, showing that the effect of 
childhood social class was strengthened in those whose adult social class had also been 
manual. This lends support to previous research in an adult British population 
suggesting that although adult dietary patterns are determined by childhood influences, 
diet can be modified by change in socioeconomic position in adulthood359. Previous 
studies have suggested that adult socioeconomic measures are more important than 
childhood socioeconomic measures (based on father’s occupation or mother’s 
education) in influencing adult diet quality360;373;378. Results in this chapter support this 
notion, but in an older adult population, as the magnitude of effect on diet quality 
observed for adult occupational social class was greater than that for occupational 
childhood social class. Examining the combined effects of occupational social class in 
both childhood and adulthood showed that diet quality was highest in men with both 
childhood and adult non-manual social class and lowest in those with both manual 
childhood and adult social class.  
 
A higher diet quality in older men was associated with not living alone and with being 
married. This finding is consistent with those of previous studies which have showed 
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that these measures of family circumstances are important determinants of diet in older 
adults362;363;374;379;380. Previous exploratory research has suggested that barriers to 
healthy eating in older men living alone include poor cooking skills and low motivation 
to change eating habits381. The literature has also shown that diet quality in older adults 
is affected by frequency of social contact362;363 but no such association was found here. 
This could be explained by the fact that men in this cohort were not socially isolated; 
the majority of participants had contact with their children, siblings, friends or 
neighbours once a week or more. More refined categories of social contact were not 
available in the study questionnaire but could potentially have helped to identify 
associations with diet quality. 
 
7.6.3. Strengths and limitations 
The major strength of the results presented in this chapter is that it is a moderately large 
population-based cohort, assessing a range of socioeconomic measures across the life 
course and including the assessment of several potentially important confounding 
factors, which have been taken into account in analyses. However, misclassification of 
childhood socioeconomic status is possible with participants, from lower socioeconomic 
positions in particular, being more likely to over-estimate the social class of their 
father382. This recall bias could have resulted in a weakened association between 
childhood socioeconomic measures and diet quality. The socioeconomic variables used 
were dichotomous in nature, which represents a coarse gradation, but even when 
socioeconomic variables were examined continuously (e.g. occupational adult social 
class and education) the results in relation to diet quality were very similar. Information 
on pension status was collected in 1996, so it is possible that if the men had not yet 
retired at this time point, pension status may have changed by the re-examination in 
1998-2000. However, this is unlikely as the vast majority of men (74%) had already 
retired by 1996. 
 
Dietary intakes were assessed using an 86-item FFQ. Assessment of dietary intake by 
self-reported measures can be prone to measurement error through misreporting, which 
can affect the estimation of energy intake and micronutrient intake321;322. The FFQ 
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method in particular can be more prone to measurement error than other measures such 
as weighted food records or 24-hour dietary recall198;200. In elderly populations non-
response to questions may have increased the chance of dietary underreporting190;312. 
The collection of dietary data may also have been subject to social desirability bias200 
and it is possible low socioeconomic groups could have been more affected by this, with 
previous studies showing that lower socioeconomic status and lower education are 
predictors of underreporting321. However, the FFQ used here has been validated 
previously against weighed food intakes in the British population273;274 and the dietary 
intake of participants was broadly comparable with those from the National Diet and 
Nutrition Survey339 (as discussed in section 6.6.2.1). In addition, to reduce the risk of 
bias in dietary assessment, established minimum and maximum cut-offs for total energy 
intake were applied to the data (<500 or > 8000 kcal279) to exclude under and over-
reporters, and all analyses were adjusted for total energy intake280. It is possible that 
some residual confounding remains in the assessment of dietary intake, but 
underreporting of food intake is only likely to have biased the relative risk estimates 
towards the null, leading to an underestimation of the associations between 
socioeconomic circumstances and diet quality.  
 
Observed associations between socioeconomic indicators and diet quality, were 
generally stronger based on the EDI score instead of daily fruit and vegetable intake. 
This may indicate that a high EDI score is a better marker of an overall healthy diet in 
this older population, than using the simpler measure of daily fruit and vegetable 
consumption.  
 
Results in this chapter are based on older men of predominantly of white European 
ethnic origin and may therefore be limited to this population. Although gender 
differences exist in dietary intake383;384, the social gradients in diet quality observed in 
this study are also likely to exist in older women. Some residual confounding is possible 
due to the self-reported nature of variables such as smoking status, alcohol intake and 
physical activity. Self-reported measures of physical activity can be a particular problem 
in older age groups due to the light intensities of activity and vast variability in duration 
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of activity in these age groups which make accurate recall especially difficult315-317 (as 
discussed in Chapter 4, Section 4.6.3). However, a validation study in older men within 
the BRHS has shown self-reported physical activity questions used within this cohort 
are associated with a graded increase in objectively measured physical activity318. This 
reduces the risk of measurement error and any possible misclassification of physical 
activity is only likely to have attenuated relative risk estimates between dietary scores 
and socioeconomic factors320. Lastly, it is possible additional confounders such as 
health status and dentition could also influence diet quality – these unmeasured 
confounders may have underestimated or exaggerated the measures of association 
observed. 
 
 
7.6.4. Conclusions 
The diet quality of older men is independently influenced by socioeconomic factors 
both in childhood and adulthood, with adult socioeconomic position being more 
influential than early life socioeconomic position in determining dietary patterns. In 
addition, diet quality seems to be influenced by marital status and adult living 
arrangements. Public health interventions aimed at improving diet quality of older 
people with low diet quality need to consider both early and later life socioeconomic 
factors and circumstances.  
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Table 7.1 Characteristics of men aged 60-79 years in 1998-2000 by diet quality (Elderly Dietary Index and daily fruit and vegetable 
intake) 
 
  EDI Quarters* 
p    Daily Fruit and Vegetable Intake† p  
  1st  2nd  3rd  4th  
  No Yes 
  (12-22 points) (23-24 points) (25-26 points) (27-35 points)           
n  
1074 982 901 967 
  
  3338 729   
Age (years), mean (SD) 
68.8 (5.5) 68.6 (5.5) 68.6 (5.6) 68.1 (5.3) 
0.007 
  68.6 (5.5) 68.8 (5.4) 0.54 
Energy intake (kcal/d), mean (SD) 
2142.5 (574.7) 2181.6 (535.3 2139.1 (530.2) 2032 (443.2) 
<0.001 
  2120.4 (537.3) 2100.6 (486.1) 0.001 
Current smokers, n (%) 
265 (24.7) 114 (11.7) 67 (7.4) 45 (4.7) 
<0.001 
  473 (14.2) 36 (5.0) 
<0.001 
Heavy drinkers, n (%) 
43 (4.2) 30 (3.1) 22 (2.5) 12 (1.3) 
<0.001 
  97 (3.0) 16 (2.2) 0.26 
Physically inactive, n (%) 
158 (15.4) 99 (10.4) 95 (10.8) 80 (8.6) 
<0.001 
  385 (12.0) 66 (9.3) 0.04 
Obese, BMI >30kg/m2, n (%)  
190 (17.8) 180 (18.4) 162 (18.1) 145 (15.1) 
0.110 
  575 (17.3) 125 (17.2) 0.95 
Manual adult social class, n (%) 
687 (66.0) 518 (54.1) 374 (42.6) 357 (38.2) 
<0.001 
  1757 (54.1) 279 (39.7) 
<0.001 
Manual childhood social class, n (%) 
745 (78.2) 637 (72.7) 565 (68.1) 545 (60.9) 
<0.001 
  2171 (72.2) 422 (63.3) 
<0.001 
 
BMI, body mass index; EDI, Elderly Dietary Index. 
*Data for EDI available for 3924 participants. P for trend across EDI quarters. 
†Data for fruit and vegetable intake available for 4067 participants. P for difference between groups
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Table 7.2 Childhood socioeconomic measures according to adult socioeconomic measures in men aged 60-79 years in 1998-2000 
 
Childhood 
socioeconomic 
measures 
  Adult socioeconomic measures 
  
Non-manual 
adult social class  
(%) 
Education  
>14 years 
 (%) 
Car ownership  
(%) 
House ownership 
 (%) 
State and private 
pension  
(%) 
Central heating 
(%) 
Childhood social 
class Manual 39.0 56.7 81.6 86.2 79.2 92.4 
  Non-Manual 73.2 82.0 91.2 94.1 90.3 95.4 
p value*   <0.001 <0.001 <0.001 <0.001 <0.001 0.005 
Bathroom Yes 58.3 73.8 87.7 90.3 85.4 94.3 
  No 38.2 53.6 80.1 85.6 78.8 92.1 
p value*   <0.001 <0.001 <0.001 <0.001 <0.001 0.006 
Hot water supply Yes 59.0 74.7 87.6 90.4 85.6 94.5 
  No 37.0 52.0 80.1 85.4 78.4 91.9 
p value*   <0.001 <0.001 <0.001 <0.001 <0.001 0.001 
Family car 
ownership Yes 71.7 84.8 92.5 92.7 86.7 95.9 
  No 43.7 59.8 82.3 87.0 81.2 92.7 
p value*   <0.001 <0.001 <0.001 <0.001 0.001 0.004 
 
*p value for difference between groups. 
  
 225 
 
Table 7.3 Odds ratios (95% CI) for the top quartile of the Elderly Dietary Index and daily fruit and vegetable intake by childhood 
socioeconomic measures in men aged 60-79 years in 1998-2000 
 
    EDI Quartiles *   Daily Fruit and Vegetable Intake
† 
   
n % Q4 
Unadjusted   Adjusted   
n % 
Unadjusted   Adjusted 
  OR (95% CI)  p   OR (95% CI)  p   OR (95% CI)  p   OR (95% CI)  p 
Childhood social 
class* 
  
Non-Manual 1062 33.0 1.00 
 
  1.00 
 
  1081 22.7 1.00 
 
  1.00 
 
Manual 2492 21.9 0.57 (0.49-0.67) <0.001   0.73 (0.61-0.88) 0.001   1593 16.3 0.66 (0.56-0.79) <0.001   0.80 (0.66-0.97) 0.03 
Childhood household 
amenities 
 
          
  
        
  
    
  
  
Bathroom Yes 1906 27.2 1.00    1.00    1960 19.1 1.00    1.00  
  No 1820 22.9 0.79 (0.68-0.92) 0.002   0.95 (0.81-1.12) 0.57   1895 17.0 0.87 (0.74-1.02) 0.09   0.95 (0.80-1.14) 0.61 
 
                                
Hot water supply Yes 1955 27.7 1.00    1.00    2013 20.0 1.00   1.00   
  No 1768 22.3 0.75 (0.64-0.87) <0.001   0.94 (0.80-1.12)  0.51   1838 16.0 0.76 (0.64-0.90)  0.001   0.85 (0.71-1.02)  0.08 
                                  
Family car ownership Yes 617 31.9 1.00    1.00    630 19.8 1.00    1.00   
 
No 3110 23.8 0.66 (0.55-0.80) <0.001   0.81 (0.66-1.00) 0.05   3227 17.7 0.87 (0.70-1.08) 0.20   1.01 (0.80-1.27) 0.95 
                                 
Adverse childhood 
amenities score‡ 0 
356 33.7 1.00 
<0.001 
  1.00 
0.03 
  361 19.1 1.00 
<0.001 
  1.00 
0.12 
  1 570 32.8 0.96 (0.73-1.27)   1.11 (0.82-1.51)   578 24.7 1.39 (1.01-1.92)   1.42 (1.01-1.99) 
  2 845 22.6 0.57 (0.44-0.75)   0.78 (0.57-1.05)   885 16.4 0.83 (0.60-1.14)   1.01 (0.72-1.42) 
  3 479 25.7 0.68 (0.50-0.92)   0.93 (0.67-1.29)   491 21.4 1.15 (0.82-1.62)   1.33 (0.92-1.91) 
  4 1281 21.1 0.53 (0.410.68)   0.78 (0.58-1.05)   1333 15.0 0.75 (0.55-1.01)   0.93 (0.66-1.29) 
EDI, Elderly Dietary Index. Analyses adjusted for age, energy intake, smoking, physical activity, alcohol, BMI, and adult social class. 
*Data for EDI available for 3924 participants. Odds ratio for quartile 4 vs. quartiles 1-3. 
†Data for fruit and vegetable intake available for 4067 participants.  
‡Score includes: manual childhood social class; no bathroom; no hot water supply; no family car ownership.  
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Table 7.4 Odds ratios (95% CI) for the top quartile of Elderly Dietary Index and daily fruit and vegetable intake by adult socioeconomic 
measures in men aged 60-79 years in 1998-2000 
 
    EDI Quartiles
*   Daily Fruit and Vegetable Intake† 
 
  
n % Q4 
Unadjusted   Adjusted   
n % 
Unadjusted   Adjusted 
  
OR (95% CI)  p   OR (95% CI)  p   OR (95% CI)  p   OR (95% CI)  p 
Adult social class Non-Manual 1875 30.8 1.00     1.00     1916 22.1 1.00     1.00   
  Manual 1936 18.4 0.51 (0.44-0.59) <0.001   0.66 (0.55-0.79) <0.001   2036 13.7 0.56 (0.47-0.66) <0.001   0.65 (0.54-0.79) <0.001 
                               
  
Education >14 years 2280 28.8 1.00     1.00     2336 20.0 1.00     1.00   
(age leaving full-time) ≤ 14 years 1209 18.4 0.56 (0.47-0.66) <0.001   0.61 (0.49-0.76) <0.001   1264 15.3 0.72 (0.60-0.87) 0.001   0.76 (0.60-0.96) 0.02 
                                  
Car ownership Yes 3271 26.6 1.00     1.00     3368 18.8 1.00     1.00   
  No 591 13.7 0.44 (0.34-0.56) <0.001   0.64 (0.48-0.85) 0.002   635 13.2 0.66 (0.51-0.84) 0.001   0.80 (0.60-1.07) 0.13 
                                  
House ownership Yes 3360 26.7 1.00     1.00     3464 18.9 1.00     1.00   
  No 457 11.4 0.35 (0.26-0.48) <0.001   0.53 (0.37-0.75) <0.001   494 12.2 0.60 (0.45-0.79) <0.001   0.77 (0.55-1.08) 0.14 
                                  
Pension State + private 2971 27.7 1.00     1.00     3053 19.7 1.00     1.00   
  State only 612 13.1 0.39 (0.31-0.50) <0.001   0.53 (0.40-0.71) <0.001   656 10.8 0.50 (0.38-0.64) <0.001   0.66 (0.49-0.88) 0.005 
                                  
Central heating Yes 3517 25.6 1.00     1.00     3632 18.5 1.00     1.00   
  No 253 14.6 0.50 (0.35-0.71) <0.001   0.67 (0.46-0.99) 0.04   266 13.5 0.69 (0.48-0.99) 0.05   0.85 (0.57-1.25) 0.40 
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Table 7.4 Continued. Odds ratios (95% CI) for the top quartile of Elderly Dietary Index and daily fruit and vegetable intake by adult 
socioeconomic measures in men aged 60-79 years in 1998-2000 
 
    EDI Quartiles
*   Daily Fruit and Vegetable Intake† 
 
  
n % Q4 
Unadjusted   Adjusted   
n % 
Unadjusted   Adjusted 
  
OR (95% CI)  p   OR (95% CI)  p   OR (95% CI)  p   OR (95% CI)  p 
Adverse SE score‡ 0 1123 35.4 1.00 
<0.001 
  1.00 
<0.001 
  1137 24.4 1.00 
<0.001 
  1.00 
<0.001 
  1 
834 25.9 0.64 (0.52-0.78)   0.74 (0.59-0.92)   857 18.2 0.69 (0.55-0.86)   0.74 (0.58-0.94) 
  2 
593 19.7 0.45 (0.35-0.57)   0.56 (0.42-0.74)   616 14.9 0.55 (0.42-0.71)   0.65 (0.48-0.88) 
  ≥ 3 
547 12.8 0.27 (0.20-0.35)   0.43 (0.31-0.59)   580 11.2 0.39 (0.29-0.52)   0.50 (0.35-0.71) 
 
EDI, Elderly Dietary Index; SE, socioeconomic. Analyses adjusted for age, energy intake, smoking, physical activity, alcohol, BMI and childhood social class. 
*Data for EDI available for 3924 participants. Odds ratio for quartile 4 vs. quartiles 1-3. 
†Data for fruit and vegetable intake available for 4067 participants.  
‡Score includes: manual social class; education ≤ 14 years; no car; not a house owner; state pension only; no central heating. 
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Table 7.5 Odds ratios (95% CI) for the top quartile of Elderly Dietary Index and daily fruit and vegetable intake by combined childhood 
and adult socioeconomic measures in men aged 60-79 years in 1998-2000 
 
    EDI Quartiles*   Daily Fruit and Vegetable Intake† 
        Unadjusted   Adjusted   
n % 
Unadjusted   Adjusted 
    
n % Q4 OR (95% CI) p 
 
OR (95% CI) p 
 
OR (95% CI) p 
 
OR (95% CI) p 
Childhood/adult 
social class 
Non-manual/ 
Non-manual 
764 34.2 1.00 
<0.001 
  1.00 
<0.001 
  775 23.7 1.00 
<0.001 
  1.00 
<0.001 
  
Manual/ 
Non-manual 
978 28.7 0.78 (0.63-0.95)   0.84 (0.68-1.05)   1002 20.8 0.84 (0.67-1.05)   0.84 (0.67-1.06) 
  
Non-manual/ 
Manual 
271 28.0 0.75 (0.55-1.02)   0.92 (0.66-1.27)   279 17.9 0.70 (0.50-0.99)   0.74 (0.51-1.07) 
  Manual/ 
Manual 
1454 17.1 0.40 (0.33-0.49)   0.49 (0.39-0.61)   1529 13.1 0.48 (0.39-0.60)   0.53 (0.42-0.67) 
Combined 
childhood & 
adult adverse SE 
score‡ 
0-2 788 35.4 1.00 
<0.001 
  1.00 
<0.001 
  801 23.5 1.00 
<0.001 
  1.00 
<0.001 
3-4 1024 27.5 0.69 (0.57-0.85)   0.74 (0.60-0.92)   1045 20.7 0.85 (0.68-1.06)   0.83 (0.66-1.05) 
5 851 20.9 0.48 (0.39-0.60)   0.57 (0.45-0.73)   884 14.3 0.54 (0.42-0.70)   0.57 (0.44-0.75) 
≥ 6 338 12.1 0.25 (0.18-0.36)   0.37 (0.25-0.54)   358 11.2 0.41 (0.28-0.59)   0.46 (0.31-0.68) 
 
EDI, Elderly Dietary Index; SE, socioeconomic. Analyses adjusted for age, energy intake, smoking, physical activity, alcohol and BMI. 
*Data for EDI available for 3924 participants. Odds ratio for quartile 4 vs. quartiles 1-3. 
†Data for fruit and vegetable intake available for 4067 participants. 
‡Score includes: childhood socioeconomic measures (manual childhood social class; no bathroom; no hot water supply; no family car ownership) and adult socioeconomic 
measures (manual social class; education ≤ 14 years; no car; not a house owner; state pension only; no central heating)  
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Table 7.6 Odds ratios (95% CI) for the top quartile of Elderly Dietary Index and daily fruit and vegetable intake by social interaction 
and family circumstances in men aged 60-79 years in 1998-2000 
 
      
EDI Quartiles* 
      Daily Fruit and Vegetable Intake† 
 
  
n % Q4 
Unadjusted   Adjusted   
n % 
Unadjusted   Adjusted 
  
OR (95% CI) p 
 
OR (95% CI) p 
 
OR (95% CI) p 
 
OR (95% CI) p 
Marital 
status Married 
3224 26.3 1.00     1.00     3332 19.2 1.00     1.00   
Single 131 16.0 0.53 (0.33-0.86) 0.01   0.69 (0.42-1.16) 0.16   142 13.4 0.65 (0.40-1.07) 0.09   0.66 (0.38-1.15) 0.14 
Widowed 280 16.8 0.57 (0.41-0.78) 0.001   0.70 (0.49-1.00) 0.05   292 9.6 0.45 (0.30-0.67) <0.001   0.53 (0.35-0.80) 0.003 
Divorced/Separated 157 16.6 0.56 (0.36-0.85) 0.007   0.65 (0.41-1.04) 0.07   166 10.2 0.48 (0.29-0.80) 0.005   0.42 (0.23-0.76) 0.004 
                                
Living 
alone No 
3386 25.9 1.00 
<0.001 
  1.00 
0.02 
  3497 18.8 1.00 
<0.001 
  1.00 
0.003 
Yes 423 17.0 0.59 (0.45-0.76)   0.71 (0.53-0.95)   450 12.0 0.59 (0.44-0.79)   0.61 (0.44-0.85) 
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Table 7.6 Continued. Odds ratios (95% CI) for the top quartile of Elderly Dietary Index and daily fruit and vegetable intake by social 
interaction and family circumstances in men aged 60-79 years in 1998-2000 
      EDI Quartiles*       Daily Fruit and Vegetable Intake† 
 
  
n 
% 
Q4 
Unadjusted   Adjusted   
n % 
Unadjusted   Adjusted 
  OR (95% CI) p  
OR (95% CI) p 
 
OR (95% CI) p 
 
OR (95% CI) p 
Social 
contact - 
Children 
Every week 3082 24.5 1.00 
0.78 
  1.00 
0.54 
  3184 17.5 1.00 
0.62 
  1.00 
0.80 
Every month 217 30.9 1.37 (1.02-1.85)   1.17 (0.84-1.63)   224 22.3 1.35 (0.97-1.88)   1.19 (0.83-1.70) 
Every few months to every year 95 29.5 1.29 (0.82-2.01)   1.49 (0.91-2.45)   100 13.0 0.70 (0.39-1.27)   0.71 (0.38-1.33) 
Rarely/Never/Does not apply 210 22.4 0.89 (0.63-1.24)   0.96 (0.66-1.39)   215 19.1 1.11 (0.78-1.58)   1.10 (0.75-1.62) 
                                 
Social 
contact - 
Siblings 
Every week 990 23.5 1.00 
0.16 
  1.00 
0.31 
  1036 17.7 1.00 
0.90 
  1.00 
0.80 
Every month 680 24.3 1.04 (0.83-1.31)   0.89 (0.70-1.14)     699 18.3 1.04 (0.81-1.34)   0.98 (0.75-1.27) 
Every few months to every year 787 26.4 1.17 (0.94-1.45)    1.07 (0.85-1.36)     810 17.4 0.98 (0.77-1.25)   0.92 (0.71-1.20) 
Rarely/Never/Does not apply 687 25.9 1.14 (0.91-1.42)   1.09 (0.85-1.40)   709 18.2 1.04 (0.81-1.32)   0.99 (0.76-1.30) 
                                  
Social 
contact - 
Friends 
Every week 3247 25.0 1.00 
0.70 
  1.00 
0.34 
  3357 17.9 1.00 
0.36 
  1.00 
0.33 
Every month 246 28.9 1.22 (0.91-1.62)    1.12 (0.82-1.52)    253 18.2 1.02 (0.73-1.42)   0.97 (0.68-1.38) 
Every few months to every year 79 30.4  1.31 (0.81-2.13)    1.43 (0.85-2.41)   84 19.1 1.08 (0.62-1.87)   1.20 (0.68-2.11) 
Rarely/Never/Does not apply 55 18.2 0.67 (0.33-1.33)      0.92 (0.43-1.96)    60 23.3 1.39 (0.76-2.55)   1.46 (0.73-2.92) 
                                  
Social 
contact - 
Neighbours 
Every week 3306 24.9 1.00 
0.58 
  1.00 
0.60 
  3425 18.1 1.00 
0.70 
  1.00 
0.35 
Every month 211 25.1 1.01 (0.73-1.40)   0.87 (0.62-1.23)    217 13.8 0.72 (0.49-1.08)   0.62 (0.41-0.95) 
Every few months to every year 57 36.8 1.76 (1.02-3.03)   1.76 (0.97-3.20)   59 23.7 1.40 (0.77-2.58)   1.25 (0.64-2.42) 
Rarely/Never/Does not apply 91 23.1 0.91 (0.55-1.48)   1.01 (0.59-1.73)   95 16.8 0.91 (0.53-1.58)   0.87 (0.47-1.60) 
EDI, Elderly Dietary Index. Analyses adjusted for age, energy intake, smoking, physical activity, alcohol, BMI, and adult social class. 
*Data for EDI available for 3924 participants. Odds ratio for quartile 4 vs. quartiles 1-3. 
†Data for fruit and vegetable intake available for 4067 participants. 
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CHAPTER 8 Associations between a principal component analysis of dietary 
patterns, cardiovascular risk factors and risk of cardiovascular disease and 
mortality in older British men 
8.1. Summary 
Diet is a major modifiable risk factor for morbidity and mortality, but few studies have 
examined the relationship between a posteriori defined dietary patterns (a data-driven, 
exploratory approach to define dietary patterns based on the available data) and the risk 
of cardiovascular disease (CVD) and mortality in older adults. This chapter examines 
prospective associations between a posteriori dietary patterns (defined using principal 
component analysis) and the risk of CVD and all-cause mortality in older British men. 
At the 20 year re-examination in 1998-2000, 4252 men from the British Regional Heart 
Study (BRHS), aged 60-79 years, attended a physical examination, provided a fasting 
blood sample and completed both a general lifestyle questionnaire and a food frequency 
questionnaire (FFQ), and were followed up until 2010 for CVD and mortality. 3226 
men, free from CVD at baseline and with available dietary data, were included in the 
analysis. Principal component analysis of 34 food groups, derived from the FFQ items, 
was used to identify dietary patterns. Cox proportional hazards regression was used to 
assess associations between quartiles of adherence to dietary patterns and risk of 
coronary heart disease (CHD) events, CVD events, CVD mortality and all-cause 
mortality. Principal component analysis identified three interpretable dietary patterns, 
which together explained 20.8% of the total variance in diet: ‘high fat/low fibre’ (high 
consumption of red meat, meat products, white bread, fried potato), ‘prudent’ (high 
consumption of poultry, fish, fruit, vegetables, pasta, rice, wholemeal bread) and ‘high 
sugar’ (high consumption of biscuits, puddings, chocolate, sweets) explaining 7.9%, 
7.1% and 5.8% of the variance respectively. There were 899 deaths, 316 CVD deaths, 
569 CVD events and 301 CHD events during a mean follow-up period of 11.3 years. 
The ‘high fat/low fibre’ dietary pattern was associated with an increased risk of all-
cause mortality only, even after adjustment for cardiovascular risk factors (highest vs. 
lowest quartile; hazard ratio [HR]: 1.44, 95% CI: 1.13-1.84). Adherence to a ‘high 
sugar’ diet was associated with a borderline significant trend for an increased risk of 
CVD events and CHD events in fully adjusted models. The ‘prudent’ diet did not show 
a significant relationship with any cardiovascular outcomes or mortality. Adopting a 
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diet which avoids ‘high fat/low fibre’ and ‘high sugar’ components may reduce the risk 
of cardiovascular events and all-cause mortality in older adults. 
 
8.2. Introduction 
Diet is an important and well-established major modifiable risk factor for cardiovascular 
mortality and morbidity6;8;23;202, as discussed in Chapter 2, section 2.5. Chapter 2 also 
introduced the two main approaches which have been used to assess dietary patterns: (1) 
A priori approaches, which are hypothesis oriented or theoretically defined, since they 
use available scientific evidence to generate predefined dietary scores or indexes based 
on dietary recommendations or guidelines; and (2) A posteriori approaches, which are 
data-driven or exploratory, since dietary patterns are derived from the available data 
based on methods such as principal component analysis, or cluster analysis29;30. 
Although the relationship between both a priori or a posteriori defined dietary patterns 
and the risk of CVD and mortality has been examined in middle-aged populations, few 
studies have been in older adults in particular208;257. The associations between a priori 
defined patterns and cardiovascular risk factors and the risk of CVD and mortality, and 
socioeconomic circumstances, in older aged men have already been examined in 
Chapter 6 and Chapter 7 respectively. However, using a posteriori methods to define 
dietary patterns in relation to disease outcomes has the advantage of not making any 
prior assumptions or hypotheses but uses the existing data to characterise total diet, so 
that patterns describe the eating behaviour of a population and can allow for biological 
interactions among nutrients30. Principal component analysis is one common method of 
deriving a posteriori dietary patterns and is a data-reduction technique, which identifies 
foods that are frequently consumed together and aggregates food items or groups on the 
basis of the degree of correlation with one another29;30. Principal component analysis is 
useful for describing the intercorrelation of foods consumed299. It has been suggested 
that principal component analysis may generate more meaningful and interpretable 
dietary patterns than cluster analysis (an alternative a posteriori method which separates 
individuals into mutually exclusive groups based on differences in dietary intake) as it 
has higher statistical power, and is less influenced by extreme values195;207. 
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Defining dietary patterns a posteriori has typically identified two major types of dietary 
patterns – healthy (‘prudent’) and unhealthy (‘Western’) diets207;385;386. Healthy/prudent 
dietary patterns have tended to show inverse associations with CVD and mortality risk, 
whereas unhealthy/Western patterns have either shown positive associations or no 
significant association at all385;386. In the elderly specifically, few studies have used a 
posteriori methods to define dietary patterns in relation to CVD, in particular, and 
mortality risk208, with a particular paucity of studies in older British populations257. 
 
The aim of this chapter is therefore to identify a posteriori dietary patterns, defined 
using principal component analysis, of older British men aged 60-79 years, and to 
examine the cross-sectional associations between these dietary patterns and 
cardiovascular risk factors, and the prospective associations with the risk of CHD 
events, CVD events, CVD mortality and all-cause mortality.  
 
8.3. Objectives 
To examine the associations of a posteriori dietary patterns with cardiovascular risk 
factors and the risk of CVD and mortality in older age (60-79 years). The specific aims 
of this chapter are: 
i) To identify typical patterns of diet using a posteriori derived dietary patterns 
(identified using principal component analysis) in older men. 
ii) To examine the relationship of a posteriori dietary patterns with established and 
emerging cardiovascular risk factors.  
iii) To examine the association between a posteriori derived dietary patterns and 
risk of CHD events, CVD events, CVD mortality and all-cause mortality. 
 
8.4. Methods 
8.4.1. Subjects and methods of data collection 
Data used in this chapter are based on the 20 year re-examination of British Regional 
Heart Study participants in 1998-2000, aged 60-79 years. 4252 men (77% of survivors) 
completed a questionnaire answering questions on their lifestyle and medical history, 
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completed a FFQ, attended a physical examination and provided a fasting blood 
sample264. Participants were prospectively followed for cardiovascular mortality and 
morbidity from re-examination (1998-2000) through to June 2010. Follow-up was 
achieved for 98% of the cohort35. Information on deaths was collected through the 
National Health Service Central Register (death certificates coded using International 
Classification of Diseases, ninth revision [ICD-9]). Evidence regarding non-fatal events 
was obtained by on-going reports from general practitioners and by biennial reviews of 
the patients’ medical records264. The four outcomes examined in this chapter were: 
CHD events (diagnosis of non-fatal myocardial infarction [MI] or fatal CHD [ICD-9 
codes 410-414]); CVD events (diagnosis of non-fatal MI, non-fatal stroke or fatal CVD 
[ICD-9 codes 390-459]); CVD mortality (ICD-9 codes 390-459) and all-cause 
mortality. Two additional outcomes were also considered in further exploratory 
analysis: non-CVD mortality (all deaths excluding ICD-9 codes 390-459) and cancer 
mortality (ICD-9 codes 140-209). Participants were censored at date of death or at the 
end of the study period (June 2010) if still alive. Of the 4252 men attending the physical 
examination, 723 men with prevalent heart failure, MI or stroke at baseline were 
excluded, leaving 3529 participants for inclusion in this study. 
 
8.4.2. Dietary assessment 
A self-administered postal FFQ, completed in 1998/2000, provided dietary intake data 
on the usual frequency of consumption of 86 food and drink items, as described in detail 
in Chapter 3, section 3.3.2 (see Appendix VI for a copy of the FFQ used). Nutrient 
intakes were derived using a validated computer program to calculate the total 
macronutrient and micronutrient composition of foods consumed301. The multivariate 
nutrient density model was used to adjust macronutrients for energy intake; 
carbohydrates, protein, total fat and saturated fat were expressed as percentages of 
energy (% kcal). Participants were also asked to indicate how often they consumed fresh 
fruit and vegetables (rarely/never, monthly, or 1, 2, 3, 4, 5, 6, or 7 days per week), with 
daily consumption classified as 7 days per week. Plasma vitamin C and E levels were 
also available from blood samples at the re-examination (1998-2000)301. The Healthy 
Diet Indictor (HDI) and the Elderly Dietary Index (EDI) dietary scores were generated 
as described previously in Chapter 6, section 6.4.3. 
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The 86 food items in the FFQ were aggregated into 34 mutually exclusive food groups, 
on the basis of the similarity of food types and nutrient composition; these were 
comparable to food groups used previously for a national representative dietary survey 
of British adults387. Individual food items were summed to generate a total score for 
each of the 34 food groups. The food groups were generated if at least one of the food 
items within the group was not missing. A list of these 34 food groups generated from 
the FFQ, together with their units of measurement and range, is shown in Table 8.1. Of 
the 3529 participants who attended the twenty year re-examination and were free from 
prevalent heart failure, MI or stroke, 303 participants with missing data on any of the 34 
food groups were excluded, leaving 3226 men for inclusion in the final analysis. 
 
8.4.3. Cardiovascular risk factors 
Established and emerging cardiovascular risk factors were measured at the re-
examination in 1998-2000. Socio-demographic and behavioural risk factors were 
assessed by self-report in the questionnaire and included smoking, physical activity and 
alcohol intake, as described in Chapter 3, section 3.3.3. Participants were classified into 
four cigarette smoking groups (never smoked; long-term ex-smokers, >15 years; recent 
ex-smokers, ≤ 15 years; current smokers)90. Current physical activity was classified into 
six groups based on intensity and frequency of exercise (inactive; occasional; light; 
moderate; moderately vigorous and vigorous)283. Alcohol intake was classified into five 
groups based on the number and frequency of alcoholic drinks consumed per week 
(none; occasional; light; moderate; heavy)282. Social class was measured using the 
baseline questionnaire in 1978-80, as described in Chapter 3, section 3.3.4. Social class 
was based on the longest held occupation coded using the Registrar General’s 
occupational classification285 and participants were classified as manual, non-manual or 
armed forces. Region of residence was categorised according to whether the town of 
each participant at the examination in 1998-2000 was in the southern England region or 
the rest of Britain. Systolic blood pressure (SBP) was assessed by physical examination, 
and plasma concentrations of metabolic risk factors (glucose, triglyceride and high 
density lipoprotein [HDL]) and inflammatory/hemostatic markers (C-reactive protein 
[CRP], tissue plasminogen activator [t-PA], D-dimer, von Willebrand Factor [vWF], 
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fibrinogen, interleukin 6 [IL-6] and homocysteine) were measured from fasting blood 
samples collected at re-examination in 1998-2000 as described in Chapter 3 (section 
3.3.5 and 3.3.6). In addition, at the 20th year examination, participants were classified as 
having prevalent diabetes if they had a previous diagnosis, according to self-report. 
Assessment of body composition also occurred at the 20th year re-examination and 
measures used within this chapter include body mass index (BMI), waist circumference 
(WC) and mid-arm muscle circumference (MAMC), the measurements of which were 
described in Chapter 3 (section 3.3.1). Participants were classified into four BMI 
categories using WHO cut-points (underweight, <18.5 kg/m2; normal weight, 18.5-
24.99 kg/m2; overweight, 25-29.99 kg/m2; obese, ≥ 30 kg/m2)105. 
 
8.4.4. Statistical methods 
Principal component analysis was conducted using orthogonal varimax rotation on the 
34 food groups generated from the FFQ, in order to identify dietary patterns. Principal 
component analysis was performed in Stata 13.1 (Stata Corp., College Station, Texas), 
using a correlation matrix which transformed the input variables (food groups) to z 
scores388, to account for the different scales of measurement of the food groups used. 
Three principal components were retained based on having an eigenvalue greater than 
one, the scree plot of eigenvalues and the interpretability of the rotated factors389. Food 
groups with factor loading of more than 0.20 or less than -0.20 were considered to be 
important contributors to the component/dietary pattern. The factors scores for each 
dietary pattern were calculated for each participant by summing the intakes of the food 
groups weighted by their factor loadings. The higher the score the closer the diet to the 
dietary pattern, and the lower the score the further the diet from the dietary pattern. 
Participants were then classified into quartiles of adherence to each of the three dietary 
patterns.  
 
Baseline cardiovascular risk factors of participants were presented by quartiles of the 
distribution of the three dietary patterns with continuous variables reported as means 
and standard deviations, and categorical variables as percentages. The distributions of 
CRP, D-dimer, IL-6 and homocysteine were highly skewed and were log transformed. 
Cox proportional hazards regression models were fitted to assess the association 
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between quartiles of adherence to dietary patterns and the risk of all-cause mortality, 
CVD mortality, CVD events and CHD events. All Cox models were tested for the 
proportional-hazards assumption, on the basis of Schoenfeld residuals, which was not 
found to be violated. Multivariable models were adjusted for potential confounders in a 
sequential manner, including age (model 1), energy intake, smoking status, alcohol 
intake, physical activity, social class and BMI (model 2), HDL, SBP and diabetes 
(model 3) and CRP and vWF (model 4). Age, energy intake, HDL, SBP, CRP and vWF 
were fitted as continuous variables. Smoking status, alcohol intake, physical activity, 
social class, BMI and diabetes were fitted as categorical variables.  
 
8.5. Results  
8.5.1.  A posteriori dietary patterns, derived by principal component analysis 
Analyses were based on 3226 men, aged 60-79 years, who attended the 20 year re-
examination, were free from prevalent heart failure, MI and stroke at baseline, and 
provided information on the 34 food groups. Table 8.2 shows the food group factor 
loadings for the three major dietary patterns identified by principal component analysis. 
From the 34 factors extracted, 12 had an eigenvalue greater than one, of which three 
factors were selected with meaningful interpretability. These three interpretable a 
posteriori dietary patterns identified by principal component analysis explained 20.8% 
of the total variance in diet. The dietary pattern defined by the first principal component 
was labeled ‘high fat/low fibre’ and explained 7.9% of the total variance. This dietary 
pattern was characterised by a high consumption of red meat, meat products, fried 
potato, white bread, eggs and beer (positive scoring coefficients) and a low intake of 
wholemeal bread (negative scoring coefficients). The strongest component of this 
pattern was meat products with a factor loading of 0.42. The second principal 
component reflected a ‘prudent’ diet, explaining 7.1% of the variance, and was 
characterised by a high consumption of poultry, fish, vegetables, legumes, fruit, pasta 
and rice, wholemeal bread, eggs, sauces, soups and olive oil (positive scoring 
coefficients). The strongest component of this pattern was fish with a factor loading of 
0.38. The third principal component reflected a ‘high sugar’ diet, and explained 5.8% of 
the total variance. This dietary pattern was characterised by a high consumption of 
breakfast cereal, full-fat cheese, biscuits, puddings, chocolate, sweets and sweet spreads 
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(positive scoring coefficients) and a low consumption of beer (negative scoring 
coefficients). The strongest component of this pattern was biscuits and puddings with a 
factor loading of 0.46.  
 
8.5.2.  A posteriori dietary patterns and cardiovascular risk factors 
8.5.2.1 ‘High fat/low fibre’ dietary pattern and cardiovascular risk factors 
Cardiovascular risk factor and dietary factors for each quartile of the ‘high fat/low fibre’ 
dietary pattern are presented in Table 8.3. In unadjusted analyses, adherence to the ‘high 
fat/low fibre’ dietary pattern showed a strong positive association with current smoking, 
heavy drinking, physical inactivity and manual social class and a strong inverse 
association with living in Southern England. Two measures of obesity (BMI and WC) 
were positively associated with this dietary pattern but muscle mass (MAMC) was not. 
As expected, many dietary variables were strongly associated with this dietary pattern, 
with strong positive associations seen with energy intake, percent of energy from fat 
and saturated fat, and inverse associations with percent of energy from carbohydrates, 
percent of energy from protein, fibre, vitamin C, iron, daily fruit and vegetable intake 
and plasma vitamin C and E. The ‘high fat/low fibre’ dietary pattern was also inversely 
associated with the HDI and the EDI (two a priori defined dietary scores introduced in 
Chapter 6). Among metabolic variables, triglyceride level was positively associated 
with this dietary pattern and HDL was inversely associated. The prevalence of diabetes 
was also inversely associated with the ‘high fat/low fibre’ dietary pattern, which was an 
unexpected finding and may be an example of dietary change, secondary to the 
development of illness. All inflammatory/hemostatic markers (CRP, t-PA, D-dimer, 
vWF, fibrinogen, IL-6 and homocysteine) were positively associated with adherence to 
this diet pattern. 
 
8.5.2.2 ‘Prudent’ dietary pattern and cardiovascular risk factors 
Table 8.4 presents cardiovascular risk factors and dietary factors by quartiles of the 
‘prudent’ dietary pattern. Unadjusted analysis showed that adherence to the ‘prudent’ 
pattern was strongly inversely associated with current smoking, physical inactivity and 
manual social class. However, heavy drinking and living in Southern England were not 
significantly associated with the ‘prudent’ dietary pattern. Measures of obesity (BMI 
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and WC) were not associated with this dietary pattern but MAMC showed a very 
modest positive association. Associations between dietary variables and the ‘prudent’ 
dietary pattern were generally in the opposite direction to the ‘high fat/low fibre’ dietary 
pattern. Participants with higher adherence to the ‘prudent’ dietary pattern had a 
significantly higher percent of energy from protein, higher intakes of fibre, iron, vitamin 
C and E, higher plasma vitamin C and E levels, a higher proportion of daily fruit and 
vegetable intake, and a higher EDI score and significant lower intakes of percent of 
energy from fat and saturated fat. However, as for the ‘high fat/low fibre’ dietary 
pattern, the ‘prudent’ dietary pattern was positively associated with total energy intake 
and inversely associated with the HDI score. Triglyceride level and all 
inflammatory/hemostatic markers were inversely associated, and HDL and diabetes 
were positively associated with the ‘prudent’ dietary pattern. 
 
8.5.2.3 ‘High sugar’ dietary pattern and cardiovascular risk factors 
Cardiovascular risk factors and dietary factors are presented by quartiles of the ‘high 
sugar’ dietary pattern in Table 8.5. Contrary to expectations, in unadjusted analyses 
manual social class, several behavioural variables (current smoking, heavy drinking and 
physical inactivity) and body composition variables (BMI and WC) were inversely 
associated with adherence to a ‘high sugar’ dietary pattern. The proportion of 
participants living in the southern region of England was positively associated with the 
‘high sugar’ diet, but no association was found with MAMC. Participants consuming a 
‘high sugar’ diet had a significantly higher intake of total energy, higher percent of 
energy from carbohydrates, fat and saturated fat, higher intakes of fibre, vitamin C and 
E, iron, higher plasma vitamin C, a higher proportion of people consuming fruit and 
vegetables daily and a higher EDI score, but a significantly lower percent of energy 
from protein. Prevalent diabetes, some metabolic variables (triglycerides, HDL and 
glucose) and some inflammatory/hemostatic markers (CRP, t-PA and IL-6) were 
inversely associated with a ‘high sugar’ diet, but D-dimer was positively associated with 
this dietary pattern. 
 
To test whether the observed inverse associations between a ‘high sugar diet and 
behavioural, body composition and cardiovascular risk factors could be explained by an 
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inverse association between a ‘high sugar’ diet and manual social class, analyses were 
stratified into manual and non-manual occupational social class but the inverse 
associations were still apparent within both groups. Men in the highest quartile of the 
‘high sugar’ diet also had the lowest proportion of obese individuals and it is therefore 
possible that obese men had made changes to their diet to reduce sugar intake. However, 
when analyses were stratified into obese and non-obese participants, inverse 
associations between a ‘high sugar’ diet and adverse behavioural risk and 
cardiovascular risk factors remained in both groups. 
 
8.5.3. A posteriori dietary patterns and risk of CVD/mortality  
There were a total of 899 deaths, 316 CVD deaths, 569 CVD events and 301 CHD 
events during a mean period of 11.3 years of follow-up. 
 
8.5.3.1 ‘High fat/low fibre’ dietary pattern and CVD/mortality 
Adjusted hazard ratios (HRs) for CHD events, CVD events, CVD mortality and all-
cause mortality by quartiles of adherence to a ‘high fat/low fibre’ dietary pattern are 
presented in Table 8.6. A ‘high fat/low fibre’ dietary pattern was associated with a 
graded increase in all-cause mortality risk. Although attenuated slightly, this association 
remained after adjustment for socio-demographic, behavioural and cardiovascular risk 
factors, with a 44% increase in risk in the highest compared to the lowest quartile of 
adherence to the ‘high fat/low fibre’ pattern (HR: 1.44, 95% CI: 1.13-1.84, p-trend: 
0.007). In age-adjusted analysis, participants in the highest quartile of the ‘high fat/low 
fibre’ dietary pattern had an increased risk of CVD mortality with a significant trend (p 
–trend: 0.002) and incident CVD events with a borderline significant trend (p-trend: 
0.06). However, these trends disappeared after adjustment for energy intake, smoking, 
alcohol, physical activity, social class and BMI. No significant trends were seen 
between the ‘high fat/low fibre’ dietary pattern and risk of incident CHD events. 
 
To investigate the factors underlying the significant association between adherence to 
the ‘high fat/low fibre’ and an increased risk of all-cause mortality, the risks of cause-
specific mortality were also examined in further exploratory analysis. Non-CVD 
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mortality was strongly associated with the ‘high fat/low fibre’ diet (highest vs. lowest 
quartile; HR: 1.47, 95% CI: 1.09-1.99, p-trend: 0.008) and in particular cancer mortality 
was strongly associated with this diet pattern in the fully adjusted model (highest vs. 
lowest quartile; HR: 1.62, 95% CI: 1.09-2.40, p-trend: 0.01). 
8.5.3.2 ‘Prudent’ dietary pattern and CVD/mortality 
Table 8.7 presents the adjusted HRs for the four outcomes by quartiles of adherence to a 
‘prudent’ dietary pattern. Adherence to the ‘prudent’ dietary pattern was associated with 
a significant graded decrease in risk of all-cause mortality across quartiles (p-trend: 
0.001). However, after adjustment for socio-demographic, behavioural and 
cardiovascular risk factors (model 4) HRs was attenuated slightly but men in the second 
quartile of the ‘prudent’ diet still had a significantly decreased risk of all-cause 
mortality (second vs. first quartile; HR: 0.77, 95% CI: 0.63-0.95), although the trend 
across quartiles was not significant (p-trend: 0.28). Similar associations were observed 
with CVD mortality; in the fully adjusted model, men in second quartile of adherence to 
a ‘prudent’ diet had a lower risk but the trend across quartiles was not significant 
(second vs. first quartile; HR: 0.68, 95% CI: 0.47-0.98, p-trend: 0.74). No significant 
associations were seen between quartiles of a ‘prudent’ diet and the risk of either 
incident CVD events or incident CHD events. 
 
8.5.3.3 ‘High sugar’ dietary pattern and CVD/mortality 
Adjusted HRs for the four outcomes examined by quartiles of adherence to a ‘high 
sugar’ dietary pattern are presented in Table 8.8. This dietary pattern was not 
significantly associated with all-cause-mortality after adjustment for cardiovascular risk 
factors (highest vs. lowest quartile; HR: 1.00, 95% CI: 0.77-1.29, p-trend: 0.71) [model 
4]. The risk of CVD mortality was increased in the top quartile of adherence to the ‘high 
sugar’ pattern but the trend was not significant (highest vs. lowest quartile; HR: 1.32, 
95% CI: 0.84-2.05, p-trend: 0.33) in the model adjusted for cardiovascular risk factors 
(model 4). A borderline significant trend was observed between adherence to a ‘high 
sugar’ diet and an increased risk of both incident CVD events (highest vs. lowest 
quartile; HR: 1.47, 95% CI: 1.06-2.04, p-trend: 0.06) and incident CHD events (highest 
vs. lowest quartile; HR: 1.57, 95% CI: 1.00-2.46, p-trend: 0.06) in fully adjusted 
models. 
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8.6. Discussion 
8.6.1. Summary of main findings 
In this chapter, principal component analysis has been used to apply a posteriori 
defined dietary patterns to a cohort of older men. This data-driven method identified 
three interpretable dietary patterns: ‘high fat/low fibre’, ‘prudent’ and ‘high sugar’ 
which reflect typical eating habits of older men in the BRHS. Adherence to a ‘high 
fat/low fibre’ pattern (a high intake of red meat, meat products, white bread, fried potato 
and eggs), characteristic of a traditional British diet, was associated with higher levels 
of adverse cardiovascular risk factors and an increased risk of all-cause mortality, with a 
44% higher risk in those in the highest compared to the lowest quartile of adherence. 
However, adherence to a ‘prudent’ diet (characterised by a high consumption of poultry, 
fish, fruit, vegetables, pasta, rice, and wholemeal bread) more closely resembled a 
Mediterranean-style diet and was associated with lower levels of cardiovascular risk 
factors in crude analysis, but did not show a significant trend with cardiovascular 
outcomes or mortality in adjusted analysis. The third dietary pattern identified was a 
‘high sugar’ pattern (characterised by a high consumption of biscuits, puddings, 
chocolate, sweets), which showed an inverse association with a number of 
cardiovascular risk factors. However, adherence to a ‘high sugar’ diet was associated 
with a borderline significant trend for an increased risk of CVD events and CHD events 
in fully adjusted models. 
 
8.6.2. Comparison with previous studies 
In this cohort of older British men, principal component analysis identified three dietary 
patterns: a ‘high fat/low fibre’ pattern which was characteristic of a typical British diet 
and could also have been referred to as a traditional or Western style diet; a ‘prudent’ 
pattern which more closely resembled a Mediterranean-style diet or healthy diet; and a 
‘high sugar’ pattern with a high consumption of sweet item and confectionary. These 
emerging dietary patterns are consistent with those reported in previous studies using 
principal component analysis, which have typically identified two major types of 
dietary patterns, an unhealthy/Western diet and a healthy/prudent diet207;385;386. One 
study in older British adults, aged 59 to 73 years, identified very similar dietary patterns 
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(prudent and traditional) to those identified in this chapter374. In this previous study, by 
Robinson et al374, the prudent diet (high in consumption of fruit, vegetables, oily fish 
and wholemeal cereals) is comparable to the ‘prudent’ diet observed in this cohort and 
adherence was also associated with non-manual social class and being a non-smoker. 
The traditional diet (high in consumption of vegetables, processed and red meat, fish 
and puddings) had similarities with the ‘high fat/low fibre’ diet in this cohort and was 
also associated with higher alcohol consumption. The three dietary patterns identified in 
this chapter together explained ~21% of the total variance in the dietary data. Although 
this proportion of variance seems low, this is actually greater than the variance 
explained by a comparable study in older British adults, aged 65 years and over, which 
identified four interpretable principal components from the National Diet and Nutrition 
Survey data, explaining 9.8% of the total variance257.  
 
Results in this chapter showed a significant graded association between adherence to a 
‘high fat/low fibre’ dietary pattern and an increased risk of all-cause mortality. This 
association was attenuated slightly after adjustment for BMI, HDL, SBP and diabetes 
suggesting physiological cardiovascular risk factors may in part be mediating the 
association between a ‘high fat/low fibre’ diet and an increased risk of all-cause 
mortality. Further adjustment for CRP and vWF attenuated the association slightly 
further suggesting a possible mechanism of inflammation, caused by a diet low in 
antioxidant components such as fruit and vegetables, potentially leading to an increased 
mortality risk. In particular, adherence to the ‘high fat/low fibre’ diet was associated 
with an increased risk of cancer mortality. These results for the so called ‘high fat/low 
fibre’ diet are consistent with studies showing that fibre intake and all-cause mortality 
are inversely associated390. These results are also support those from previous studies 
which have found that the consumption of red meat and processed meat (two 
components of the ‘high fat/low fibre’ dietary patterns with high factor loadings) is 
associated with an increased risk of all-cause and cancer mortality219;391. Adherence to a 
‘prudent’ diet was associated with a non-significantly reduced risk of all-cause 
mortality; there was also no significant trend between a ‘high sugar’ diet and the risk of 
all-cause mortality. None of the three dietary patterns described here were associated 
with CVD mortality. A comparable study of an older British population, aged 65 years 
and older, from the National Diet and Nutrition Survey, identified four interpretable diet 
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patterns using principal component analysis: ‘Mediterranean–style’, ‘health aware’, 
‘traditional’ and ‘sweet and fat’257. Only the Mediterranean–style dietary pattern was 
associated with a reduced risk of all-cause mortality, with an 18% reduction in risk in 
those in the highest compared to the lowest tertile257. However, in men only, the 
traditional diet was also a risk factor for mortality, similar to the ‘high fat/low fibre’ 
results observed in this cohort.   
 
A recent meta-analysis of 13 prospective studies involving 338,787 participants 
examined the association between dietary patterns defined by principal component 
analysis and risk of all-cause and CVD mortality385. Summary relative risk estimates 
(SRREs) showed a significant inverse association between a prudent/healthy dietary 
pattern and all-cause mortality (highest vs. lowest category of dietary pattern score; 
SRRE: 0.76, 95% CI: 0.68-0.86) and CVD mortality (SRRE: 0.81, 95% CI: 0.75-0.87) 
but non-significant associations between the Western/unhealthy dietary pattern and all-
cause mortality (SRRE: 1.07, 95% CI: 0.96-1.20) and CVD mortality (SRRE: 0.99, 
95% CI: 0.91-1.08). The risk estimates observed in the present study for the association 
between a prudent diet and a lower risk of all-cause mortality and CVD mortality were 
in the same direction as those in the meta-analysis but statistically non-significant. Also, 
a significant association was observed in the present study between an unhealthy diet 
(the ‘high fat/low fibre’ diet) and a higher risk of all-cause mortality which was not seen 
in the meta-analysis. These discrepancies may have been due to the much bigger sample 
size in the meta-analysis giving greater power to detect smaller effects or due to the 
differences in confounder adjustments; few studies included in this meta-analysis had 
such a comprehensive adjustment for established and emerging cardiovascular risk 
factors as were included in this chapter.  
  
In this chapter, there was no significant association between a ‘high fat/low fibre’ diet 
or a ‘prudent’ diet and the risk of CVD events or CHD events, but adherence to a ‘high 
sugar’ diet was associated with a borderline significant trend for an increased risk of 
CVD events and CHD events in fully adjusted models. These results are in keeping with 
the American Heart Association recommendation of reducing dietary intake of added 
sugars in order to lower the risk of cardiovascular disease392 and the recent suggestion 
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that sugar may be a more important risk factor than fat for cardiovascular disease393;394. 
A meta-analysis of 12 prospective studies involving 409,780 participants examined the 
association between principal component analysis defined dietary patterns and CHD 
risk. Summary relative risks showed an inverse association between the prudent/healthy 
diet and CHD risk, but no association with the Western/unhealthy diet386. The observed 
association between a healthy diet and CHD events in this meta-analysis but not in the 
current study may again possibly be explained by the much larger sample size in the 
meta-analysis giving greater power to detect smaller effects. This meta-analysis did not 
identify any studies from the UK specifically and did not mention high sugar/sweet 
dietary patterns, as observed in this cohort. Results from this chapter may therefore be 
the first study of principal component analysis defined dietary patterns and CHD risk in 
the UK, and this study has shown that a high sugar dietary pattern may increase CHD 
and CVD risk in older British men. 
 
8.6.3. Strengths and limitations 
A major strength of the results presented in this chapter is that data are from a 
moderately large prospective population-based study, with negligible loss to follow-up 
and the ascertainment of CVD and mortality outcomes was objective35;264. However, 
since the study comprised predominately of white European older male participants, the 
applicability of the findings to women and non-white ethnic groups is uncertain. 
Moreover, results may not be applicable to men with prevalent MI, stroke or heart 
failure since such participants were excluded from analyses. 
 
The FFQ measured dietary intake at baseline only, so whether dietary patterns of 
participants changed throughout follow-up was unknown. Also, as discussed in Chapter 
6, dietary intake was assessed using a FFQ, which can be prone to measurement error 
through misreporting and can affect the estimation of energy intake and micronutrient 
intake321;322. Misreporting of energy intake may therefore affect dietary pattern analysis, 
especially since underreporting can be more prevalent for some unhealthy food 
groups350;351. Also, in older populations non-response to FFQ questions could have 
increased the chance of dietary underreporting104;323. However, the FFQ used in this 
study has previously been validated against weighed food intakes in British 
populations273;274, and the dietary intake of BRHS participants was broadly comparable 
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with those from the National Diet and Nutrition Survey339, as discussed in section 
6.6.2.1. In addition, to reduce the risk of bias in dietary assessment, established 
minimum and maximum cut-offs for total energy intake were applied to the data (<500 
or > 8000 kcal279) to exclude under and over-reporters. It is possible that some residual 
confounding remains in the assessment of dietary patterns, but underreporting of food 
intake is only likely to have biased the relative risk estimates towards the null. 
 
All analyses were adjusted for total energy intake to reduce the risk of bias280. Total 
energy intake showed strong positive associations with all three dietary patterns. 
However, analyses in Chapter 6 already showed that energy intake was not significantly 
associated with all-cause mortality, CVD mortality, CVD events of CHD events after 
adjustment for cardiovascular risk factors (see section 6.5.3), and therefore the 
adjustment for energy intake in this chapter did not represent an over-adjustment338. A 
previous study also suggested that it is not necessary to adjust individual food items for 
energy intake before entry into a principal component analysis but that energy 
adjustment should be made when analysing the effects of the dietary patterns on the 
outcome of interest395, which supports the method of adjustment used here. 
 
A posteriori methods of defining dietary patterns have the advantage over using a priori 
methods, of making no prior assumptions about dietary patterns, instead using an 
empirical, data-driven approach to derive typical patterns of dietary intake30. The ‘high 
fat/low fibre’ dietary pattern was inversely associated with the EDI dietary score and the 
‘prudent’ dietary pattern and was positively associated with the EDI. Since strong 
inverse associations between the EDI and risk of CVD mortality and all-cause mortality 
were observed (Chapter 6), the observed associations between dietary patterns and the 
EDI support the validity of these principal component analysis-derived dietary patterns 
as measures of unhealthy/healthy diets. However, principal component analysis has 
some limitations. Firstly, data on the reproducibility and validity of this method in 
nutritional epidemiology is limited396-398. Secondly, subjectivity was introduced at 
various points in the analysis, such as the grouping of dietary variables and the choice 
of how many components to retain, which may have influenced the observed 
associations with disease risk30;389;399. However, as outlined in methods section above, 
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the food groups used were comparable to those used previously for a national 
representative dietary survey of British adults387 (section 8.4.2) and criteria for deciding 
how many components to retain was decided in advance of the analysis (section 8.4.4), 
both of which helped to reduce this bias. 
 
The ‘high sugar’ dietary pattern was inversely associated with several cardiovascular 
risk factors in crude cross-sectional analysis, including current smoking, heavy 
drinking, physical inactivity, BMI and WC, and these associations could not be 
explained by stratifying for social class or obesity status. These results for a ‘high sugar’ 
diet were contrary to expectations since a significant relationship between added sugar 
consumption and increased risk of CVD mortality was previously observed in American 
adults400 and an association between a high sugar intake and a higher risk of CHD 
events and CVD events was observed prospectively in this cohort. However, several 
items with a high factor loading in the ‘high sugar’ dietary pattern contained a mixture 
of types of food, which could not be separated due to the nature of the FFQ questions, 
and may possibly explain the unexpected directions of association. For example, the 
‘breakfast cereal’ food group included both high sugar and high fibre cereal types (e.g. 
porridge, muesli) and the ‘biscuits and puddings’ food group included both high sugar 
items and healthier items (e.g. tinned fruit, yoghurt).  
 
The self-reported nature of some of the cardiovascular risk factors, including smoking 
status, alcohol intake, and physical activity, may possibly have caused misclassification 
which could have led to over or under-estimates of hazard ratios. In particular, self-
reported measures of physical activity can be a problem in older age groups due to the 
light intensities of activity and very variable duration of activity in these age groups 
which make accurate recall especially difficult315-317 (as discussed in Chapter 4, Section 
4.6.3). However, a validation study in older men within the BRHS has shown self-
reported physical activity questions used within this cohort are associated with a graded 
increase in objectively measured physical activity318. This reduces the risk of 
measurement error and any possible misclassification of physical activity is likely to 
have been non-differential across participants of varying diet quality and is only likely 
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to have attenuated relative risk estimates between a posteriori dietary scores and 
outcomes320. 
 
Lastly, there may have been a healthy-adherer/healthy-user effect in people who 
adhered to a healthier diet. In particular, people with a high intake of fruit, vegetables, 
wholegrain bread, olive oil etc., may have been on average more health-conscious and 
more likely to have exhibited a series of healthier behaviours, including regular visits to 
their general practitioner, having more preventive tests, higher adherence to medicine 
etc352;353. Such confounding variables were unmeasured in this study and hence may 
have caused a slight over-estimation of the magnitude of effect of dietary patterns on 
CVD and mortality risk. 
 
8.6.4. Conclusion 
A posteriori, data-driven, methods can be used to identify typical dietary patterns of a 
population. In this cohort of older men, principal component analysis identified three 
interpretable dietary patterns: ‘high fat/low fibre’, ‘prudent’ and ‘high sugar’. Dietary 
patterns persist as an important risk factor for CVD and all-cause mortality in the 
elderly, with high adherence to a ‘high fat/low fibre’ dietary pattern being associated 
with an increased risk of all-cause mortality, and adherence to a ‘high sugar’ diet being 
associated with an modest increase in risk of CVD events and CHD events, which could 
not be explained by adjustment for cardiovascular risk factors. The ‘prudent’ diet was 
not significantly associated with cardiovascular outcomes or mortality. Adopting a diet 
which avoids ‘high fat/low fibre’ and ‘high sugar’ components may be beneficial to 
reduce the risk of cardiovascular events and all-cause mortality in older adults. 
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Table 8.1 List of 34 food groups derived from items in the food frequency questionnaire, used in men aged 60-79 years in 1998-2000 
 
Food group Food items Units Range 
Red meat Beef (including minced beef, beef burgers); lamb; pork, bacon, ham, salami days/week 0-7 
Poultry Chicken, turkey, other poultry days/week 0-7 
Meat products Tinned meat (all types, corned beef, etc.); pork sausages; beef sausages; meat 
pies, pasties; liver, kidney, heart 
days/week 
0-7 
Fish White fish (cod, haddock, hake, plaice, fish fingers, etc.); kippers, herrings, 
pilchards, tuna, sardines, salmon, mackerel (including tinned); shellfish 
days/week 
0-7 
Potatoes Boiled, baked, mashed days/week 0-7 
Fried potatoes Chips or fried (from shop); chips or fried (cooked at home); roast potatoes days/week 0-7 
Vegetables Green vegetables, salad; carrots; parsnips, swedes, turnips, beetroot, other 
root vegetables; onions; tomatoes 
days/week 
0-7 
Legumes Baked or butter beans, lentils, peas, chickpeas, sweetcorn days/week 0-7 
Fruit Apples; pears; oranges; bananas; other fruits pieces/week 0-60 
Pasta and rice Spaghetti and other pasta; rice (all types except pudding rice) days/week 0-7 
Breakfast cereal Grapenuts, porridge, Ready brek, Special K, Sugar Puffs, Rice Crispies; 
Cornflakes, muesli, Shredded Wheat, Sultana Bran, Weetabix; Bran Flakes, 
Puffed Wheat; All Bran, Wheat Bran; other cereal 
days/week 
0-7 
White bread White bread days/week 0-7 
Wholemeal bread Brown bread; wholemeal bread days/week 0-7 
Full-fat cheese e.g. cheddar, Leicester, stilton, brie, soft cheeses days/week 0-7 
Low-fat cheese e.g. edam, cottage cheese, reduced fat cheeses days/week 0-7 
Full-fat milk Full-fat milk None; ≤ 0.5 pint; 0.5-1 pint; >1 pint/day 
None; ≤ 0.5 pint; 0.5-1 pint; >1 pint/day 
None; ≤ 0.5 pint; 0.5-1 pint; >1 pint/day 
None; ≤ 0.5 pint; 0.5-1 pint; >1 pint/day 
1-4 
Semi-skimmed milk Semi-skimmed milk 1-4 
Skimmed milk Skimmed milk 1-4 
Other milk Condensed milk, evaporated milk etc. 1-4 
Biscuits and puddings Digestive biscuits, plain biscuits; sweet biscuits, sponge cakes, scones, buns; 
ice-cream, sweet yoghurts, trifle; fruit cake, fruit bread, plum pudding; fruit 
tart, jam tart, fruit crumble; milk puddings (rice, tapioca); tinned fruit, jellies; 
sweet sauces (chocolate, custard) 
days/week 
0-7 
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Table 8.1 Continued. List of 34 food groups derived from items in the food frequency questionnaire, used in men aged 60-79 years in 
1998-2000 
 
Food group Food items Units Range 
Chocolate and sweets Chocolate, chocolate bars, sweets (all types) days/week 0-7 
Eggs Eggs (boiled, poached, fried, scrambled); eggs in baked dishes (e.g. flans, 
quiches, soufflés, egg custard etc.) 
days/week 
0-7 
Fruit juice Natural fruit juices (including tomato juice) days/week 0-7 
Soft drinks Fizzy drinks, non-diet squashes; low calorie (diet) squashes and fizzy drinks days/week 0-7 
Tea and coffee Tea; coffee; other hot drinks (hot chocolate, malted milk, Horlicks) cups/day 0-34 
Nuts Nuts (e.g. salted or unsalted peanuts), nut butter days/week 0-7 
Savoury snacks Potato crisps, corn chips, crackers days/week 0-7 
Sweet spreads Jam, honey, marmalade, chocolate spread days/week 0-7 
Sauces and soups Chutney, brown sauce, tomato sauce; soups (all kinds, home-made, tinned, 
packet) 
days/week 
0-7 
Wine Wine single glasses/week 0-44 
Beer Beer, Lager, Shandy pints/week 0-70 
Spirits Spirits single glasses/week 0-84 
Olive oil Olive oil mls/week 0-500 
Butter Butter grams/week 0-1134 
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Table 8.2 Food group factor loadings for ‘high fat/low fibre’, ‘prudent’ and ‘high 
sugar’ dietary patterns, in men aged 60-79 years in 1998-2000 
 
Food groups 
‘High fat/low fibre’ 
dietary pattern 
‘Prudent’  
dietary pattern 
‘High sugar’  
dietary pattern 
        
Variance explained (%) 7.9 7.1 5.8 
        
Red meat 0.33 0.12 0.03 
Poultry 0.03 0.29 -0.09 
Meat products 0.42 0.08 -0.04 
Fish 0.07 0.38 -0.08 
Potatoes 0.05 0.12 0.12 
Fried potatoes 0.36 0.01 0.02 
Vegetables -0.01 0.26 0.09 
Legumes 0.14 0.26 0.01 
Fruit -0.13 0.23 0.04 
Pasta and rice 0.00 0.34 -0.06 
Breakfast cereal -0.19 0.06 0.28 
White bread 0.34 -0.19 0.04 
Wholemeal bread -0.30 0.25 0.07 
Full-fat cheese 0.04 0.05 0.25 
Low-fat cheese -0.03 0.17 -0.03 
Full-fat milk 0.04 -0.07 0.13 
Semi-skimmed milk 0.03 -0.01 0.13 
Skimmed milk -0.13 0.10 -0.17 
Other milk 0.07 0.03 -0.12 
Biscuits and puddings 0.06 -0.03 0.46 
Chocolate and sweets 0.06 -0.04 0.41 
Eggs 0.26 0.23 0.09 
Fruit juice -0.13 0.17 0.12 
Soft drinks 0.08 0.05 0.09 
Tea and coffee 0.09 -0.06 0.12 
Nuts 0.01 0.14 0.10 
Savoury snacks 0.16 0.03 0.15 
Sweet spreads -0.12 0.06 0.36 
Sauces and soups 0.17 0.26 0.18 
Wine -0.18 0.19 -0.04 
Beer 0.23 0.09 -0.31 
Spirits 0.01 0.10 -0.11 
Olive oil -0.08 0.23 -0.05 
Butter 0.09 0.02 0.04 
 
Factor loadings ≥ 0.20/≤ -0.20 are indicated in bold.
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Table 8.3 Cardiovascular risk factors and dietary factors by quartiles of a ‘high fat/low fibre’ dietary pattern, in men aged 60-79 years 
in 1998-2000 
    ‘High fat/low fibre’ dietary pattern (quartiles) 
P (trend) 
  
    Q1 Q2 Q3 Q4   
  n 807 806 807 806   
Socio-demographic/Behavioural variables           
  Age (years) 68.0 (5.4) 68.5 (5.3) 68.4 (5.5) 68.1 (5.4) 0.81 
  Current smokers (%) 4.3 7.6 13.7 24.7 <0.001 
  Heavy drinkers (%) 1.3 1.3 3.0 5.8 <0.001 
  Physically inactive (%) 7.9 9.6 8.2 11.9 0.02 
 
Manual social class (%) 32.5 41.8 53.4 69.4 <0.001 
  Living in southern England region (%) 37.3 37.8 34.2 27.4 <0.001 
Body composition         
   Obesity (BMI ≥ 30 kg/m2) (%) 14.5 15.4 15.9 18.8 0.02 
  Waist circumference (cm)  95.8 (10.6) 97.1 (9.6) 97.2 (9.9) 97.8 (11.1) <0.001 
  Mid-arm muscle circumference (cm) 26.6 (2.3) 26.7 (2.2) 26.6 (2.3) 26.4 (2.5) 0.06 
Dietary variables          
   Energy intake (kcal) 1861.8 (385.3) 2004.7 (420.2) 2175.2 (445.5) 2548.4 (591.3) <0.001 
  Carbohydrates (% kcal) 54.9 (6.7) 52.5 (6.7) 51.9 (6.8) 50.2 (6.5) <0.001 
  Protein (% kcal) 16.5 (2.3) 15.9 (2.3) 15.3 (2.2) 14.8 (2.0) <0.001 
  Fat (% kcal) 26.8 (5.8) 29.8 (5.9) 31.2 (5.6) 33.5 (5.4) <0.001 
  Saturated fat (% kcal) 10.5 (3.2) 12.2 (3.4) 13.0 (3.5) 14.1 (3.3) <0.001 
  Fibre (g/day) 29.7 (8.6) 26.6 (8.7) 24.9 (8.0) 23.9 (8.0) <0.001 
  Vitamin C (mg/day) 94.5 (38.8) 85.9 (36.2) 80.7 (35.9) 74.0 (34.5) <0.001 
  Vitamin E (mg/day) 8.4 (4.6) 8.4 (4.8) 8.3 (4.4) 8.9 (5.5) 0.05 
  Iron (mg/day) 14.9 (5.5) 14.3 (5.5) 13.5 (4.6) 14.3 (5.0) 0.004 
  Daily fruit intake (%) 61.6 46.2 38.9 21.4 <0.001 
  Daily vegetable intake (%) 45.1 35.9 28.8 23.5 <0.001 
  Plasma vitamin C (µmol/L) 35.2 (26.3) 33.4 (23.5) 28.5 (26.3) 26.1 (30.9) <0.001 
  Plasma vitamin E (µmol/L)  35.4 (12.4) 34.5 (11.7) 33.1 (12.2) 32.0 (11.5) <0.001 
  Healthy Diet Indicator  3.4 (1.1) 3.0 (1.2) 2.8 (1.3) 2.4 (1.2) <0.001 
  Elderly Dietary Index 26.6 (2.8) 24.6 (2.8) 23.6 (2.7) 22.1 (2.9) <0.001 
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Table 8.3 Continued. Cardiovascular risk factors and dietary factors by quartiles of a ‘high fat/low fibre’ dietary pattern, in men aged 
60-79 years in 1998-2000 
    ‘High fat/low fibre’ dietary pattern (quartiles) 
P (trend) 
 
    Q1 Q2 Q3 Q4  
Metabolic variables           
  SBP (mmHg) 149.9 (24.5) 149.5 (23.7) 150.7 (23.0) 150.5 (24.3) 0.40 
  Triglycerides (mmol/L) 1.7 (0.9) 1.7 (0.9) 1.9 (1.1) 1.9 (1.3) <0.001 
  HDL (mmol/L) 1.4 (0.4) 1.3 (0.3) 1.3 (0.3) 1.3 (0.4) 0.02 
  Glucose (mmol/L) 6.0 (1.9) 5.9 (1.6) 6.0 (1.9) 6.0 (1.8) 0.98 
  Diabetes (%) 8.2 6.9 5.2 5.4 0.01 
Inflammatory/hemostatic markers           
  CRP (mg/L)* 1.3 (0.6-2.7) 1.5 (0.7-2.7) 1.9 (0.9-3.8) 2.0 (1.0-4.0) <0.001 
  t-PA (ng/mL) 10.0 (4.0) 10.5 (4.1) 11.4 (4.3) 11.3 (4.6) <0.001 
  D-dimer (ng/mL)* 73.5 (45.0-105.0) 75.6 (46.0-114.0) 86.9 (51.0-127.0) 78.9 (48.0-119.0) 0.005 
  vWF (IU/dL) 132.7 (45.2) 135.5 (44.0) 139.2 (44.8) 139.3 (46.3) 0.001 
  Fibrinogen (g/L)  3.1 (0.7) 3.2 (0.7) 3.3 (0.8) 3.3 (0.7) <0.001 
  IL-6 (pg/mL)* 2.0 (1.4-2.8) 2.2 (1.4-2.9) 2.6 (1.7-3.7) 2.6 (1.6-3.8) <0.001 
  Homocysteine (µmol/L)* 11.4 (9.6-13.2) 12.1 (10.0-14.1) 12.8 (10.4-14.6) 13.6 (10.8-16.0) <0.001 
 
Values presented as mean (SD) unless otherwise stated.  
BMI, body mass index; CRP, C-reactive protein; HDL, high density lipoprotein; IL-6, interleukin 6; SBP, systolic blood pressure; t-PA, tissue plasminogen activator; vWF, 
von Willebrand factor. 
*Log transformed - geometric mean and interquartile range presented. 
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Table 8.4 Cardiovascular risk factors and dietary factors by quartiles of a ‘prudent’ dietary pattern, in men aged 60-79 years in 1998-
2000 
    ‘Prudent’ dietary pattern (quartiles) 
P (trend) 
    Q1 Q2 Q3 Q4 
  n 807 806 807 806   
Socio-demographic/Behavioural variables         
  Age (years) 68.8 (5.4) 68.4 (5.5) 67.9 (5.2) 68.0 (5.5) 0.001 
  Current smokers (%) 21.4 13.0 9.5 6.4 <0.001 
  Heavy drinkers (%) 3.0 3.0 1.8 3.5 0.85 
  Physically inactive (%) 14.4 9.5 7.0 6.8 <0.001 
 
Manual social class (%) 62.3 52.7 46.7 35.4 <0.001 
  Living in southern England region (%) 36.1 33.8 32.6 34.4 0.40 
Body composition           
  Obesity (BMI ≥ 30 kg/m2) (%) 15.5 16.5 16.9 15.8 0.82 
  Waist circumference (cm)  97.1 (10.4) 97.4 (10.2) 96.7 (10.6) 96.8 (10.2) 0.38 
  Mid-arm muscle circumference (cm) 26.4 (2.5) 26.5 (2.2)  26.6 (2.3) 26.7 (2.2) 0.002 
Dietary variables            
  Energy intake (kcal) 1944.4 (461.7) 2132.3 (495.9) 2174.9 (514.8) 2335.7 (578.5) <0.001 
  Carbohydrates (% kcal) 52.3 (7.0) 52.1 (7.0) 52.9 (6.7) 52.2 (6.9) 0.54 
  Protein (% kcal) 14.7 (2.2) 15.4 (2.2) 15.8 (2.1) 16.5 (2.3) <0.001 
  Fat (% kcal) 32.2 (6.1) 31.0 (6.0) 29.6 (5.8) 28.5 (6.2) <0.001 
  Saturated fat (% kcal) 13.7 (3.5) 12.9 (3.5) 11.9 (3.3) 11.3 (3.6) <0.001 
  Fibre (g/day) 19.2 (5.6) 24.8 (6.4) 28.5 (7.5) 32.6 (8.5) <0.001 
  Vitamin C (mg/day) 57.8 (24.3) 76.9 (30.6) 91.7 (36.2) 108.7 (35.8) <0.001 
  Vitamin E (mg/day) 7.3 (4.7) 8.3 (4.7) 8.9 (4.9) 9.5 (4.7) <0.001 
  Iron (mg/day) 11.0 (3.5) 13.4 (4.3) 15.0 (4.7) 17.6 (5.7) <0.001 
  Daily fruit intake (%) 22.4 34.8 49.8 60.9 <0.001 
  Daily vegetable intake (%) 17.5 29.9 36.4 49.5 <0.001 
  Plasma vitamin C (µmol/L) 26.6 (28.8) 28.8 (22.6) 32.7 (29.1) 35.1 (26.6) <0.001 
  Plasma vitamin E (µmol/L)  31.7 (11.7) 34.1 (12.4) 34.5 (11.8) 34.7 (12.0) <0.001 
  Healthy Diet Indicator  2.9 (1.3) 3.0 (1.3) 3.0 (1.2) 2.7 (1.3) 0.001 
  Elderly Dietary Index 21.7 (3.2) 23.6 (2.7) 25.0 (2.6) 26.3 (2.4) <0.001 
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Table 8.4 Continued. Cardiovascular risk factors and dietary factors by quartiles of a ‘prudent’ dietary pattern, in men aged 60-79 years 
in 1998-2000 
    ‘Prudent’ dietary pattern (quartiles) 
P (trend) 
    Q1 Q2 Q3 Q4 
Metabolic variables           
  SBP (mmHg) 149.7 (23.9) 150.5 (23.9) 149.4 (23.8) 150.9 (23.9) 0.50 
  Triglycerides (mmol/L) 1.9 (1.1) 1.9 (1.2) 1.8 (1.0) 1.8 (0.9) 0.004 
  HDL (mmol/L) 1.3 (0.3) 1.3 (0.3) 1.3 (0.3) 1.4 (0.3) <0.001 
  Glucose (mmol/L) 5.9 (1.9) 6.0 (1.7) 6.0 (1.7) 6.1 (2.0) 0.20 
  Diabetes (%) 5.2 5.0 7.7 7.8 0.007 
Inflammatory/hemostatic markers         
  CRP (mg/L)* 2.0 (0.9-4.0) 1.7 (0.8-3.6) 1.5 (0.7-3.0) 1.4 (0.7-2.6) <0.001 
  t-PA (ng/mL) 11.0 (4.3) 11.0 (4.5) 10.7 (4.2) 10.5 (4.1) 0.02 
  D-dimer (ng/mL)* 83.9 (49.0-127.0) 79.8 (50.0-115.0) 76.9 (45.0-113.0) 74.0 (44.0-112.0) 0.001 
  vWF (IU/dL) 140.7 (45.8) 140.2 (46.7) 134.7 (43.3) 131.0 (44.0) <0.001 
  Fibrinogen (g/L) 3.3 (0.7) 3.3 (0.7) 3.2 (0.7) 3.1 (0.7) <0.001 
  IL-6 (pg/mL)* 2.6 (1.7-3.9) 2.4 (1.5-3.4) 2.2 (1.5-3.1) 2.1 (1.4-3.0) <0.001 
  Homocysteine (µmol/L)* 13.6 (10.9-16.2) 12.7 (10.2-15.0) 12.0 (9.9-13.9) 11.5 (9.7-13.3) <0.001 
 
Values presented as mean (SD) unless otherwise stated.  
BMI, body mass index; CRP, C-reactive protein; HDL, high density lipoprotein; IL-6, interleukin 6; SBP, systolic blood pressure; t-PA, tissue plasminogen activator; vWF, 
von Willebrand factor. 
*Log transformed - geometric mean and interquartile range presented. 
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Table 8.5 Cardiovascular risk factors and dietary factors by quartiles of a ‘high sugar’ dietary pattern, in men aged 60-79 years in 1998-
2000 
    ‘High sugar’ dietary pattern (quartiles) 
P (trend) 
    Q1 Q2 Q3 Q4 
  n 807 806 807 806   
Socio-demographic/Behavioural variables      
  Age (years) 67.1 (5.1) 68.0 (5.2) 68.6 (5.4) 69.3 (5.7) <0.001 
  Current smokers (%) 17.6 12.2 10.4 10.1 <0.001 
  Heavy drinkers (%) 7.3 2.7 1.0 0.4 <0.001 
  Physically inactive (%) 10.5 10.6 9.7 6.8 0.01 
 
Manual social class (%) 56.4 51.6 47.2 42.0 <0.001 
  Living in southern England region (%) 29.7 33.6 34.5 39.0 <0.001 
Body composition           
  Obesity (BMI ≥ 30 kg/m2) (%) 21.2 17.2 15.4 10.8 <0.001 
  Waist circumference (cm)  98.4 (10.8) 97.9 (10.0) 96.4 (9.9) 95.3 (10.3) <0.001 
  Mid-arm muscle circumference (cm) 26.7 (2.4) 26.5 (2.3) 26.6 (2.3) 26.4 (2.3) 0.06 
Dietary variables            
  Energy intake (kcal) 1855.3 (461.8) 1995.1 (434.2) 2200.2 (456.4) 2535.1 (514.3) <0.001 
  Carbohydrates (% kcal) 50.3 (8.2) 52.3 (6.9) 53.0 (6.0) 53.7 (5.8) <0.001 
  Protein (% kcal) 16.5 (2.6) 15.9 (2.2) 15.5 (2.0) 14.5 (1.8) <0.001 
  Fat (% kcal) 29.2 (7.4) 30.1 (6.4) 30.6 (5.4) 31.5 (5.1) <0.001 
  Saturated fat (% kcal) 11.7 (4.2) 12.4 (3.8) 12.6 (3.1) 13.1 (3.0) <0.001 
  Fibre (g/day) 22.8 (8.6) 25.1 (8.2) 27.2 (7.9) 30.0 (8.2) <0.001 
  Vitamin C (mg/day) 73.9 (39.3) 79.4 (36.7) 85.5 (33.0) 96.2 (35.7) <0.001 
  Vitamin E (mg/day) 7.5 (4.8) 7.9 (4.1) 8.6 (4.8) 9.9 (5.2) <0.001 
  Iron (mg/day) 11.9 (4.4) 13.5 (4.8) 14.7 (4.8) 16.8 (5.4) <0.001 
  Daily fruit intake (%) 35.6 42.4 43.5 46.7 <0.001 
  Daily vegetable intake (%) 28.6 29.7 33.5 41.5 <0.001 
  Plasma vitamin C (µmol/L) 28.4 (22.3) 30.9 (23.7) 32.2 (30.0) 31.8 (31.0) 0.008 
  Plasma vitamin E (µmol/L)  33.6 (11.8) 34.2 (12.5) 34.4 (12.5) 32.8 (11.1) 0.26 
  Healthy Diet Indicator 2.9 (1.4) 2.9 (1.3) 2.9 (1.3) 3.0 (1.2) 0.16 
  Elderly Dietary Index 23.7 (3.8) 24.2 (3.3) 24.4 (3.0) 24.5 (2.8) <0.001 
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Table 8.5 Continued. Cardiovascular risk factors and dietary factors by quartiles of a ‘high sugar’ dietary pattern, in men aged 60-79 
years in 1998-2000 
    ‘High sugar’ dietary pattern (quartiles) 
P (trend) 
    Q1 Q2 Q3 Q4 
Metabolic variables           
  SBP (mmHg) 151.3 (22.8) 150.1 (23.9) 149.6 (24.3) 149.6 (24.6) 0.13 
  Triglycerides (mmol/L) 1.9 (1.0) 1.9 (1.1) 1.9 (1.2) 1.7 (0.9) 0.01 
  HDL (mmol/L) 1.4 (0.4) 1.3 (0.3) 1.3 (0.3) 1.3 (0.3) 0.004 
  Glucose (mmol/L) 6.1 (1.9) 6.0 (1.8) 5.9 (1.6) 5.9 (1.9) 0.04 
  Diabetes (%) 9.5 6.7 5.4 4.0 <0.001 
Inflammatory/hemostatic markers           
  CRP (mg/L)* 1.8 (0.9-3.7) 1.7 (0.9-3.4) 1.6 (0.7-3.2) 1.5 (0.7-2.9) <0.001 
  t-PA (ng/mL) 11.3 (4.6) 10.9 (4.1) 10.6 (4.0) 10.4 (4.4) <0.001 
  D-dimer (ng/mL)* 75.1 (46.0-111.0) 75.7 (46.0-109.0) 81.5 (49.0-121.0) 82.3 (49.0-125.5) 0.005 
  vWF (IU/dL) 135.9 (47.2) 137.9 (42.7) 136.0 (44.7) 136.8 (45.8) 0.91 
  Fibrinogen (g/L) 3.2 (0.7) 3.3 (0.7) 3.2 (0.7) 3.2 (0.7) 0.47 
  IL-6 (pg/mL)* 2.4 (1.6-3.5) 2.3 (1.5-3.3) 2.4 (1.5-3.3) 2.2 (1.4-3.1) 0.02 
  Homocysteine (µmol/L)* 12.7 (10.3-14.6) 12.2 (9.9-14.2) 12.5 (10.2-14.7) 12.4 (10.1-14.4) 0.41 
 
Values presented as mean (SD) unless otherwise stated.  
BMI, body mass index; CRP, C-reactive protein; HDL, high density lipoprotein; IL-6, interleukin 6; SBP, systolic blood pressure; t-PA, tissue plasminogen activator; vWF, 
von Willebrand factor. 
*Log transformed - geometric mean and interquartile range presented. 
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Table 8.6 Hazard ratios (95% CI) for CHD events, CVD events, CVD mortality and all-cause mortality by quartiles of a ‘high fat/low 
fibre’ dietary pattern in men aged 60-79 years in 1998-2000 
  
‘High fat/low 
fibre’ diet 
quartiles 
Cases (n) 
Rate (per 1,000 
person years) 
Model 1 Model 2 Model 3 Model 4 
All-cause mortality Q1 187 22.65 1.00 1.00 1.00 1.00 
  Q2 199 24.62 1.06 (0.87-1.30) 1.01 (0.82-1.25) 1.07 (0.85-1.33) 1.10 (0.88-1.38) 
  Q3 239 30.59 1.32 (1.09-1.60)* 1.16 (0.94-1.43) 1.12 (0.90-1.40) 1.11 (0.88-1.39) 
  Q4 274 35.69 1.63 (1.36-1.97)* 1.40 (1.11-1.76)* 1.43 (1.12-1.82)* 1.44 (1.13-1.84)* 
  p-trend     <0.001 0.002 0.005 0.007 
CVD mortality Q1 62 7.51 1.00 1.00 1.00 1.00 
  Q2 80 9.90 1.27 (0.91-1.78) 1.28 (0.89-1.83) 1.38 (0.94-2.01) 1.45 (0.99-2.12) 
  Q3 81 10.37 1.32 (0.95-1.84) 1.11 (0.76-1.61) 1.10 (0.74-1.63) 1.10 (0.74-1.64) 
  Q4 93 12.11 1.67 (1.21-2.30)* 1.40 (0.94-2.10) 1.36 (0.89-2.09) 1.39 (0.90-2.14) 
  p-trend     0.002 0.19 0.34 0.35 
CVD events Q1 133 16.95 1.00 1.00 1.00 1.00 
  Q2 139 17.84 1.02 (0.81-1.30) 1.00 (0.78-1.30) 1.00 (0.76-1.30) 1.02 (0.78-1.33) 
  Q3 146 19.51 1.12 (0.88-1.42) 1.01 (0.77-1.31) 0.95 (0.72-1.25) 0.95 (0.72-1.25) 
  Q4 151 20.55 1.23 (0.97-1.55) 1.04 (0.78-1.40) 0.95 (0.70-1.29) 0.95 (0.69-1.30) 
  p-trend     0.06 0.80 0.69 0.64 
CHD events Q1 70 8.66 1.00 1.00 1.00 1.00 
  Q2 72 9.05 1.02 (0.73-1.41) 1.00 (0.70-1.42) 1.00 (0.69-1.44) 1.02 (0.71-1.48) 
  Q3 77 10.04 1.13 (0.82-1.56) 1.01 (0.70-1.44) 0.94 (0.64-1.36) 0.92 (0.63-1.35) 
  Q4 82 10.97 1.28 (0.93-1.76) 1.09 (0.73-1.62) 0.97 (0.63-1.47) 0.95 (0.62-1.46) 
  p-trend     0.10 0.69 0.80 0.72 
 
CHD, coronary heart disease; CVD, cardiovascular disease.  
Model 1: Age adjusted. Model 2: Adjusted for model 1 + energy intake, smoking, alcohol, physical activity, social class and BMI. Model 3: Adjusted for model 2 + HDL, 
SBP and diabetes. Model 4. Adjusted for model 3 + CRP and vWF.  
*P <0.05 
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Table 8.7 Hazard ratios (95% CI) for CHD events, CVD events, CVD mortality and all-cause mortality by quartiles of a ‘prudent’ 
dietary pattern in men aged 60-79 years in 1998-2000 
  
‘Prudent’ diet 
quartiles 
Cases (n) 
Rate (per 1,000 
person years) 
Model 1 Model 2 Model 3 Model 4 
All-cause mortality Q1 280 36.66 1.00 1.00 1.00 1.00 
  Q2 214 26.64 0.72 (0.60-0.86)* 0.76 (0.63-0.93)* 0.76 (0.62-0.93)* 0.77 (0.63-0.95)* 
  Q3 202 25.15 0.76 (0.63-0.91)* 0.88 (0.72-1.07) 0.89 (0.72-1.10) 0.93 (0.75-1.14) 
  Q4 203 24.97 0.72 (0.60-0.86)* 0.81 (0.66-1.00)* 0.78 (0.62-0.98)* 0.83 (0.66-1.04) 
  p-trend     0.001 0.13 0.11 0.28 
CVD mortality Q1 95 12.44 1.00 1.00 1.00 1.00 
  Q2 66 8.22 0.66 (0.48-0.90)* 0.68 (0.48-0.95)* 0.66 (0.46-0.94)* 0.68 (0.47-0.98)* 
  Q3 78 9.71 0.91 (0.67-1.23) 0.99 (0.71-1.37) 0.98 (0.69-1.39) 1.03 (0.72-1.47) 
  Q4 77 9.47 0.81 (0.60-1.10) 0.92 (0.64-1.30) 0.87 (0.60-1.27) 0.94 (0.64-1.37) 
  p-trend     0.47 0.89 0.96 0.74 
CVD events Q1 158 21.64 1.00 1.00 1.00 1.00 
  Q2 140 18.39 0.85 (0.68-1.07) 0.92 (0.72-1.17) 0.90 (0.70-1.16) 0.93 (0.72-1.21) 
  Q3 133 17.21 0.87 (0.69-1.10) 0.92 (0.71-1.18) 0.91 (0.70-1.19) 0.93 (0.71-1.21) 
  Q4 138 17.63 0.85 (0.68-1.07) 0.93 (0.72-1.22) 0.90 (0.68-1.19) 0.94 (0.71-1.25) 
  p-trend     0.22 0.63 0.50 0.68 
CHD events Q1 87 11.65 1.00 1.00 1.00 1.00 
  Q2 79 10.12 0.87 (0.64-1.18) 0.97 (0.70-1.34) 0.95 (0.68-1.34) 0.99 (0.70-1.40) 
  Q3 70 8.87 0.83 (0.61-1.14) 0.90 (0.64-1.27) 0.89 (0.61-1.28) 0.92 (0.64-1.34) 
  Q4 65 8.10 0.73 (0.53-1.01) 0.82 (0.56-1.18) 0.81 (0.55-1.20) 0.86 (0.58-1.27) 
  p-trend     0.06 0.26 0.27 0.40 
 
CHD, coronary heart disease; CVD, cardiovascular disease.  
Model 1: Age adjusted. Model 2: Adjusted for model 1 + energy intake, smoking, alcohol, physical activity, social class and BMI. Model 3: Adjusted for model 2 + HDL, 
SBP and diabetes. Model 4. Adjusted for model 3 + CRP and vWF.  
*P <0.05
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Table 8.8 Hazard ratios (95% CI) for CHD events, CVD events, CVD mortality and all-cause mortality by quartiles of a ‘high 
sugar’ dietary pattern in men aged 60-79 years in 1998-2000 
 
‘High sugar’ diet 
quartiles 
Cases (n) 
Rate (per 1,000 
person years) 
Model 1 Model 2 Model 3 Model 4 
All-cause mortality Q1 219 27.32 1.00 1.00 1.00 1.00 
  Q2 222 28.00 0.94 (0.78-1.14) 1.00 (0.82-1.23) 1.04 (0.84-1.29) 1.06 (0.85-1.31) 
  Q3 214 26.56 0.81 (0.67-0.98)* 0.85 (0.68-1.05) 0.89 (0.71-1.12) 0.91 (0.72-1.15) 
  Q4 244 31.18 0.88 (0.73-1.05) 0.89 (0.70-1.13) 0.96 (0.75-1.24) 1.00 (0.77-1.29) 
  p-trend     0.08 0.18 0.53 0.71 
CVD mortality Q1 64 7.98 1.00 1.00 1.00 1.00 
  Q2 73 9.21 1.04 (0.74-1.45) 1.07 (0.75-1.53) 1.10 (0.75-1.63) 1.13 (0.76-1.66) 
  Q3 75 9.31 0.91 (0.66-1.29) 0.91 (0.62-1.33) 0.95 (0.63-1.43) 0.97 (0.64-1.47) 
  Q4 104 13.29 1.18 (0.86-1.61) 1.07 (0.71-1.61) 1.27 (0.82-1.96) 1.32 (0.84-2.05) 
  p-trend     0.39 0.94 0.40 0.33 
CVD events Q1 112 14.50 1.00 1.00 1.00 1.00 
  Q2 139 18.34 1.17 (0.91-1.50) 1.26 (0.97-1.65) 1.22 (0.92-1.62) 1.27 (0.95-1.68) 
  Q3 139 18.00 1.07 (0.83-1.37) 1.10 (0.83-1.46) 1.08 (0.80-1.46) 1.10 (0.81-1.50) 
  Q4 179 24.04 1.32 (1.04-1.67)* 1.33 (0.98-1.81) 1.40 (1.01-1.93)* 1.47 (1.06-2.04)* 
  p-trend     0.05 0.16 0.09 0.06 
CHD events Q1 59 7.48 1.00 1.00 1.00 1.00 
  Q2 67 8.61 1.08 (0.76-1.53) 1.11 (0.76-1.61) 1.13 (0.76-1.68) 1.15 (0.77-1.72) 
  Q3 79 10.00 1.18 (0.84-1.65) 1.24 (0.85-1.82) 1.21 (0.80-1.83) 1.20 (0.79-1.83) 
  Q4 96 12.60 1.40 (1.01-1.94)* 1.42 (0.93-2.16) 1.52 (0.97-2.38) 1.57 (1.00-2.46) 
  p-trend     0.04 0.09 0.07 0.06 
 
CHD, coronary heart disease; CVD, cardiovascular disease.  
Model 1: Age adjusted. Model 2: Adjusted for model 1 + energy intake, smoking, alcohol, physical activity, social class and BMI. Model 3: Adjusted for model 2 
+ HDL, SBP and diabetes. Model 4. Adjusted for model 3 + CRP and vWF.  
*P <0.05
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CHAPTER 9 Implications and conclusions  
9.1. Summary 
This chapter reviews the implications of the findings of this thesis in relation to public 
health and future epidemiological studies. Findings from analyses conducted for this thesis 
demonstrate that body composition (both obesity and low muscle mass) and poor diet 
quality are important risk factors for cardiovascular disease (CVD) and mortality in men, 
which persist in older age. The particular findings of potential public health importance are: 
i) that it is important to consider both adiposity and muscle mass as determinants of CVD 
and all-cause mortality in older adults; ii) that efforts are needed to maintain muscle mass 
and prevent sarcopenia in older age; iii) that further efforts are needed to prevent and 
reduce obesity in older age; and iv) that specific efforts are needed to improve diet quality 
in older age. These results have implications for future epidemiological studies, which 
include: 1) the need to carry out larger studies when examining the effects of sarcopenia 
and obesity on the risk of CVD and mortality, and to replicate findings in women and 
different ethnic groups; 2) to further explore the causal mechanistic pathways leading to 
sarcopenia; 3) the need for a universal consensus definition of sarcopenia and sarcopenic 
obesity to be adopted in order to make valid comparisons across studies; 4) the need to 
examine whether the effects of dietary patterns on the risk of CVD and mortality observed 
in this thesis are also beneficial in other older populations, including women and different 
ethnic groups; and 5) the need for further large studies on dietary patterns and the risk of 
CVD and mortality in older populations with prevalent CVD. 
 
9.2.  Introduction 
9.2.1.  Key findings  
The research in this thesis has addressed several important questions on the cross-sectional 
associations between measures of body composition (adiposity and muscle mass) and 
dietary patterns in relation to cardiovascular risk factors, and the prospective associations 
between measures of body composition and dietary patterns in relation to risk of CVD and 
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mortality, using a representative population based cohort of older men from the British 
Regional Heart Study (BRHS), aged 60-79 years, over 11 years of follow-up. 
 
Findings from Chapter 4 suggest that several established and emerging cardiovascular risk 
factors are related to low muscle mass based on consistent associations with both mid-arm 
muscle circumference (MAMC) and fat-free mass index (FFMI), and that sarcopenic 
obesity is associated with the highest levels of inflammatory and haemostatic markers. 
Chapter 5 showed that it is important to consider both muscle mass and adiposity as 
determinants of CVD mortality and all-cause mortality in older adults. Men who were 
sarcopenic, obese or sarcopenic obese had higher risks of all-cause mortality and CVD 
mortality compared to those who were non-sarcopenic, non-obese, with sarcopenic obese 
individuals having the highest risk of all-cause mortality. Using a combination of 
anthropometric measures of central adiposity (waist circumference [WC] or waist-to-hip 
ratio [WHR]) and muscle mass (MAMC) to define sarcopenic obesity appeared to be the 
strongest predictors of cardiovascular mortality and all-cause mortality in older men.  
 
Findings from Chapter 6 and Chapter 8 showed that diet quality is an important 
determinant of the risk of CVD and mortality in older adults. Chapter 6 specifically 
suggested that higher adherence to either the Healthy Diet Indicator (HDI) or the Elderly 
Dietary Index (EDI) was associated with the least adverse cardiovascular risk profile. Men 
with higher adherence to the EDI had a 25% lower risk of all-cause mortality, a 37% lower 
risk of CVD mortality and a 34% lower risk of coronary heart disease (CHD) events, which 
was independent of socio-demographic, behavioural and cardiovascular risk factors. 
However, the HDI score was not significantly associated with any of the outcome 
measures. Encouraging older adults to adhere to a dietary pattern close to that defined in the 
EDI criteria may therefore reduce the risk of all-cause mortality, CVD mortality and CHD 
events and hence have public health benefits. Chapter 7 showed that social inequalities in 
diet quality, as measured by the EDI, persist in older age and that diet quality is influenced 
by both childhood and adulthood socioeconomic factors, in addition to marital status and 
habitation. Findings from Chapter 8 suggested that encouraging older adults to adopt a diet 
which avoids ‘high fat /low fibre’ components (including red meat, meat products, fried 
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potato and white bread) and ‘high sugar’ components (including biscuits, puddings, 
chocolate, sweets and sweet spreads) may be beneficial to reduce the risk of cardiovascular 
events and all-cause mortality in older adults. 
 
9.2.2.  Novelty of the present findings 
Although there is already some evidence that sarcopenia is associated with established and 
emerging cardiovascular risk factors in older age137;153-159, whether sarcopenic obese 
individuals have the worst cardiovascular risk profile is uncertain154;155;160-173, as discussed 
in Chapter 2 (section 2.4.7). The results presented in Chapter 4 have provided additional 
evidence that low muscle mass (as measured by both MAMC and FFMI) is associated with 
physical inactivity, higher mean levels of insulin resistance and higher levels of 
inflammatory and hemostatic markers including C-reactive protein (CRP), fibrinogen and 
von Willebrand Factor (vWF). Findings also revealed that lower muscle mass was less 
likely in individuals with a high percentage of energy intake from carbohydrates, and to my 
knowledge this is the first study to show this. Results in Chapter 4 also showed that 
sarcopenic obese individuals had significantly higher levels of inflammatory and 
haemostatic markers (CRP, vWF and fibrinogen) compared to the sarcopenic only, obese 
only or non-sarcopenic, non-obese groups. 
 
There is a paucity of prospective evidence on the associations between sarcopenic obesity 
and the risk of CVD177 (Chapter 2, section 2.4.8) and mortality190-194 (Chapter 2, section 
2.4.9). To my knowledge, only one prospective study has examined the association between 
sarcopenic obesity groups and CVD177. The results reported in Chapter 5 add to the limited 
literature on the prospective associations between sarcopenia and sarcopenic obesity in 
relation to the risk of CVD and mortality, showing that sarcopenic obesity in older men 
(defined by WC and MAMC) is associated with an increased risk of all-cause mortality, an 
increased risk of CVD mortality, although non-significant, but is not associated with CVD 
events or CHD events. 
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Chapter 2 also highlighted the paucity of studies relating dietary patterns to the risk of CVD 
and mortality in older adults, especially in British populations. The examination of the 
associations between a priori dietary patterns and the risk of CVD and mortality in older 
adults has mainly focused on Mediterranean diet scores32, but whether this type of diet is 
applicable to an older UK population is questionable223 and there are limited studies in 
elderly populations on other a priori defined dietary patterns232 (Chapter 2, section 2.5.3). 
Results from Chapters 6 and 7 add to the limited literature on the relationships between a 
priori dietary patterns, cardiovascular risk factors and the risk of CVD and mortality in 
older British adults. Specifically, this thesis describes the first application of the EDI, a 
modified Mediterranean diet score233, to a non-Mediterranean population. The results 
emphasize that the EDI is applicable to an older British population and higher adherence is 
associated with the least adverse cardiovascular risk profile and a lower risk of all-cause 
mortality, CVD mortality and CHD events. Chapter 7 also highlights the influence of 
socioeconomic circumstances on diet quality, as measured by the EDI, in older age. To my 
knowledge, the findings in Chapter 7 are the first to confirm that the influences of 
childhood social class on diet quality can persist in older populations. 
 
 
There are also a limited number of studies that have used a posteriori methods to define 
dietary patterns in relation to CVD and mortality risk in older adults255;256, with a paucity of 
studies in British populations (Chapter 2, section 2.5.4). Only one study was identified in 
an older British population which has examined the association between dietary patterns, 
defined by principal component analysis, and risk of all-cause and CVD mortality257. 
Findings presented in Chapter 8 add to the limited literature on the associations between a 
posteriori dietary patterns and the risk of CVD and mortality in older adults, and to my 
knowledge no other study to date has analysed the association between dietary patterns 
defined by principal component analysis and the risk of CHD in an older British 
population. Findings therefore need to be replicated in other older British populations. 
 
The coherence of these findings in relation to existing research and the strengths and 
limitations of these findings were discussed in each of the results chapters. In the 
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subsequent sections of this chapter, the potential implications of the findings in terms of 
public health and future epidemiological research are discussed. 
 
9.3. Public health implications of findings 
9.3.1.  Considering both adiposity and muscle mass as determinants of CVD and all-
cause mortality in older age 
This thesis has shown that both obesity and sarcopenia are associated with CVD and all-
cause mortality in older age. The strength and temporality of these associations provide 
strong evidence of causality as highlighted in the Bradford Hill criteria401. The public health 
implications of these findings are that it is important that both these elements of body 
composition are measured in older age to assess the risk of CVD and mortality, and that 
prevention efforts should focus on both maintaining muscle mass and preventing obesity. 
 
It has been suggested previously that future research is needed to identify surrogate 
anthropometric indices of sarcopenic obesity18 and results from this thesis suggest that such 
indices may include combined measures of central adiposity (WC or WHR) and muscle 
mass (MAMC). Although anthropometric measurements such as WC, WHR and MAMC 
require training to locate the correct anatomical positions for measurement, they are still 
sufficiently valid as well as simpler, quicker and cheaper than more invasive and expensive 
as well as more accurate measurements of adiposity and muscle mass such as computerised 
tomography scanning, magnetic resonance imaging, or dual x-ray absorptiometry111. Such 
anthropometric measures may therefore be much more readily available in both clinical and 
non-clinical settings and represent a practical alternative approach to defining sarcopenic 
obesity, in order to predict the risk of cardiovascular mortality and all-cause mortality in 
older adults. A further discussion on the implications of defining sarcopenia and sarcopenic 
obesity for future research will be given in section 9.4.1. 
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9.3.2.  Potential strategies to maintain muscle mass and prevent sarcopenia in older 
age 
Sarcopenia is not well recognised as a major public health problem and this is supported by 
the fact that to date no International Classification of Disease (ICD) codes or standard 
treatment guidelines for sarcopenia exist145;402. Public health efforts are needed in the UK to 
maintain muscle mass and prevent sarcopenia to reduce the risk of CVD and mortality in 
older age groups. Sarcopenia has a multifactorial aetiology134;136;403 which may therefore 
present several opportunities for intervention. Findings from this thesis suggested that 
physical inactivity, a low percent of energy intake from carbohydrates and metabolic and 
inflammatory pathways were implicated in sarcopenia (Chapter 4). However, whether 
targeting these risk factors would provide opportunities for intervention is unclear from this 
thesis as associations observed were cross-sectional and hence causality cannot be 
established. Therefore, further understanding of the aetiology of sarcopenia and sarcopenic 
obesity in older age is needed (see section 9.4.1 for a further discussion). 
 
Evidence from existing literature suggests that increased physical activity and improved 
nutrition appear to be the fundamental components of interventions to prevent 
sarcopenia144;145;404;405 and hence to reduce the risk of CVD and mortality in older age. 
Physical activity, both aerobic and resistance, is a modifiable lifestyle behaviour, which can 
partially reverse age-associated skeletal dysfunction306. Evidence has shown that resistance 
training in particular is effective in increasing muscle strength, lean body mass and physical 
function in older adults406;407. The World Health Organization’s (WHO) globally 
recommended physical activity levels for adults aged 65 years and above are at least 150 
minutes of moderate-intensity aerobic physical activity per week or at least 75 minutes of 
vigorous-intensity aerobic physical activity per week, as well as muscle-strengthening 
activities, involving major muscle groups, on 2 or more days a week408. The National 
Service Framework for Older People included physical activity as a health promotion 
activity that is of specific benefit to older people, but a large proportion of people aged over 
50 are sedentary (take less than half an hour of moderate intensity physical activity a week) 
and few people take the WHO recommended levels of activity for improving health1;409. 
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This highlights the need for interventions and health promotion activities to increase 
physical activity, particularly resistance based activity, in older adults in the general 
population in order to reduce the risk of sarcopenia.  
 
It has also been suggested that optimizing diet and nutrition through the life course may be 
key to preventing sarcopenia132;145;410. Although findings from this thesis did not show an 
association between protein intake and low muscle mass (Chapter 4), possibly due to the 
limitations of the cross-sectional methodology used, other literature has shown that dietary 
protein is a key nutrient in older age which helps to maintain lean mass since amino acids 
are required for muscle protein synthesis133;410. Existing evidence from trials has also 
shown that supplementation of the diet with essential amino acids improves lean body 
mass, strength and physical function411 and that supplementing regular meals with leucine, 
in particular, may also improve muscle protein synthesis in older adults412. This has 
important public health implications for increasing protein intake in the elderly to reduce 
the risk of sarcopenia and hence to lower the risk of CVD and mortality. However, further 
studies are needed to define optimal intakes of protein in older ages410. A novel finding 
from this thesis showed that, cross-sectionally, lower muscle mass was less likely in 
individuals with a high percentage of energy intake from carbohydrates. However, the 
consensus in the literature on optimal carbohydrate intake is still very conflicting413, with 
some studies showing that a low-carbohydrate diet decreases body weight and improves 
cardiovascular risk factors414 and others showing that a low-carbohydrate diet is associated 
with a higher risk of all-cause mortality415. Further prospective studies are therefore needed 
to elucidate any causal associations between dietary carbohydrate intake and the risk of 
sarcopenia. Existing evidence from other studies also highlights the importance of older 
adults consuming a diet of adequate quality to ensure sufficient intakes of vitamin D, 
antioxidants and omega-3 polyunsaturated fatty acids which may help to preserve muscle 
mass and function132;133;410. Efforts to improve overall dietary quality in older age therefore 
have important public health implications for reducing the risk of sarcopenia, and policy 
efforts to improve diet quality in older age will be discussed below in section 9.3.4. 
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Several pharmacological agents have also been suggested in the treatment of sarcopenia402 
including: testosterone therapy, which may increase muscle strength and size but may also 
be associated with some adverse effects416; growth hormone, which stimulates the 
development of skeletal muscle and the breakdown of fat417; selective androgen receptor 
modulators; and myostatin inhibitors, a protein which inhibits muscle formation130. 
However, none of these interventions have proven to be as efficacious as exercise in 
combination with nutrition402, which highlights the public health importance of 
interventions in physical activity and improved diet quality to reduce the risk of sarcopenia. 
 
9.3.3.  Efforts to prevent and reduce obesity in older age 
Overweight and obesity are already well recognised as a major public health problem as 
they are well established as being strongly associated with cardiovascular morbidity and 
mortality in adult populations, and obesity prevalence in middle-aged and older adults is 
continuing to rise over time10;11. Therefore, public health prevention efforts to reduce the 
risk of obesity in the UK are already in place in both middle-aged and older adults1;418. The 
Department of Health announced ‘A call to action on obesity in England’ in 2011, with a 
national ambition of a downward trend in the level of excess weight averaged across all 
adults by 202011. Existing health promotion efforts include increasing physical activity and 
improving diet and nutrition, and these are recognised as having specific benefits to older 
people1;418. Detailed efforts to improve diet quality, and hence reduce excessive calorie 
consumption and obesity will be discussed in section 9.3.4. Continuing these population-
wide efforts to reduce levels of obesity in older age is therefore needed, especially since 
visceral obesity is also associated with sarcopenia and sarcopenic obesity18-21. Ongoing 
public health efforts to reduce obesity in combination with new efforts to reduce the risk of 
sarcopenia, as discussed above in section 9.3.2, would therefore reduce the risk of 
sarcopenic obesity in the population.  
  
9.3.4. Efforts to improve diet quality in older age 
This thesis has shown that poor diet quality is associated with CVD and all-cause mortality 
in older age. The strength and temporality of the associations between dietary patterns and 
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outcomes observed here provide strong evidence for causality as highlighted in the 
Bradford Hill criteria401. The public health implications of the findings from this thesis are 
therefore that efforts should be made to improve diet quality in older age in the UK in order 
to reduce the risk of CVD and mortality. Although socioeconomic position is not a 
modifiable lifestyle risk factor, amelioration of diet quality in population groups with lower 
diet quality would help to reduce social inequalities in diet.  
 
Much focus has recently been on public health policy efforts to improve the overall diet 
quality of the population in the UK419 and it has been suggested that the most powerful 
interventions are policies which effectively address affordability, availability and 
acceptability of diet420. One such policy is the NHS ‘Change4Life’ programme which is 
aimed at increasing the acceptability of a higher diet quality by giving people advice on a 
healthy diet421. This is England’s first ever social marketing campaign to reduce obesity by 
encouraging individuals to adhere to six healthy behaviours including cutting back on fat 
and swapping sugars. The Department of Health’s Public Health Responsibility Deal, 
which was launched in 2011, has also aimed to improve diet quality within England by 
encouraging businesses and organisations to sign up to voluntary pledges in order to help 
people eat more healthily422. These pledges include reformulation of food products and 
recipes to reduce total calories and harmful ingredients such as saturated fat and salt; 
encouraging people to eat more fruit and vegetable to help reach the 5-a-day target; and out 
of home food labelling and putting calorie information on menus. Also, new consistent 
front of pack nutritional labelling on food and drink was launched in the UK in 2013. The 
system combines red, amber and green colour-coding and nutritional information on how 
much total fat, saturated fat, salt, sugar and calories food products contain in order to help 
people make healthy choices about their diet423. 
 
The National Service Framework for Older People, included improved diet and nutrition as 
a health promotion activity which is of specific benefit to older people1, but the above 
public health policy efforts in the UK are aimed at the general population and do not target 
older adults specifically. One way of improving the diet of older adults and of reducing 
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social inequalities in diet in older age could be to introduce food subsidies for the most 
socioeconomically disadvantaged group of older adults, since subsidising healthier foods is 
shown to be effective in modifying dietary behaviour424. One such food subsidy already in 
existence in the UK is ‘Healthy Start’425. Women who are pregnant or families with a child 
under four years old and who are on certain benefits, and all pregnant women under 18 
years, qualify to receive weekly food vouchers to spend on milk, plain fresh and frozen 
fruit and vegetables, and infant formula milk. A food subsidy for older adults specifically is 
also in operation in the United States of America - the Senior Farmers' Market Nutrition 
Program provides low-income older adults with vouchers that can be exchanged for eligible 
foods (fruits, vegetables and fresh-cut herbs) at farmers' markets, roadside stands, and 
community-supported agriculture programs426. However, no such food subsidy exists for 
disadvantaged groups of older adults in the UK and future modelling and simulation studies 
may therefore provide evidence for policy makers on the potential benefits of such a food 
subsidy427. 
 
There has also been much recent debate surrounding the topic of food taxes on unhealthy 
foods, including a fat tax and a sugar-sweetened beverage tax, as public health measures to 
limit the consumption of unhealthy foods428-431. Such taxes could in theory have the 
potential to improve diet quality in older age and hence reduce the risk of CVD and 
mortality, and also to reduce social inequalities in diet quality in older age. Food taxes are 
currently already in place in some European countries, but the debate as to whether to 
introduce such taxes in the UK continues428-432. 
 
9.4. Implications for future epidemiological research 
This thesis has addressed several important questions on the role of body composition 
(adiposity and low muscle mass) and dietary patterns on the risk of CVD and mortality in 
older men aged 60 to 79 years from the BRHS. However this is a broad topic and therefore 
some unanswered questions remain, and in addition, some new questions have arisen as a 
result of the findings. In addition the findings from this thesis have some limitations, which 
were discussed in each of the preceding results chapters. In this section the implications for 
future epidemiological studies are summarised. 
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9.4.1.  Investigating sarcopenia and sarcopenic obesity with the risk of CVD and 
mortality in older age 
This thesis has examined the cross-sectional associations between measures of adiposity 
and muscle mass with cardiovascular risk factors (Chapter 4), and has also examined the 
prospective associations between combined measures of adiposity and muscle mass in 
relation to cardiovascular outcomes and mortality (Chapter 5). Although this study has the 
strengths of using data from a moderately large population-based, geographically and 
socioeconomically representative, cohort of older British men with very high follow-up 
rates35;264 and comparing a wide range of body composition measures (as discussed in 
Chapters 4 and 5), there are still some limitations and considerations which call for a need 
to extend these investigations to future epidemiological studies in other populations. 
 
At the initiation of the BRHS in the mid-1970s, the risk of CVD was lower in women in 
middle age, which would have required a very large number of female subjects in order to 
ensure adequate number of cardiovascular endpoints, which would have caused 
considerable logistic and financial problems. It was therefore decided that the study would 
include only men34. Also, towns were selected which did not have appreciable population 
movement and hence had a small proportion of non-white ethnic minority groups. 
Therefore, the data presented in this thesis are based on older men predominantly of white 
European ethnic origin264. There is considerable variation in body composition and the 
prevalence of sarcopenia with age, between genders and across different ethnic 
groups151;433. Future epidemiological studies are therefore important to replicate the 
findings from this thesis in other large populations including women, different ethnic 
groups and in younger people. Such studies would provide evidence of whether the 
associations observed between sarcopenic obesity and CVD and all-cause mortality were 
consistent in other populations and would also add to the sparse existing literature on the 
prospective associations between sarcopenic obesity and CVD and mortality. 
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The aetiology of sarcopenia is multifactorial and is not fully understood134;136;403. Chapter 4 
provided some evidence of associations between measures of sarcopenia and cardiovascular 
risk factors; findings suggested that physical inactivity, a high percent of energy intake 
from carbohydrates and metabolic and inflammatory pathways were implicated in 
sarcopenia. However, a major limitation of these findings is that analysis was cross-
sectional and hence causality could not be established. Therefore, there is a need for further 
exploration and understanding of the aetiological factors involved in sarcopenia and 
sarcopenic obesity in older age. In particular, studies analysing the prospective associations 
between changes in muscle mass and cardiovascular risk factors would be useful and would 
help to identify the reasons for the excess risk of CVD in sarcopenic older men and the 
excess risk of all-cause mortality in sarcopenic obese men, as observed in Chapter 5.  
A key challenge in future epidemiological studies on sarcopenia in older age is defining 
sarcopenia and sarcopenic obesity. It has been suggested that current research on both the 
plausible mechanisms leading to sarcopenia and the functional consequences of sarcopenia 
are hindered by a lack of consensus definition and standardised assessment 
methodology20;434. A consensus definition of sarcopenia is essential in order to make valid 
comparisons of findings across sarcopenia studies, but to date there is no universally 
adopted definition of sarcopenia. However, a number of consensus definitions have been 
proposed, as discussed in Chapter 2 (Section 2.4.6). In 2009, the European Working Group 
on Sarcopenia in Older People (EWGSOP) proposed a definition of sarcopenia which 
includes the presence of both low muscle mass and low muscle function (either low 
strength e.g. handgrip strength, and/or low physical performance e.g. gait speed)17. In 2011, 
a similar definition was proposed by the International Working Group on Sarcopenia 
(IWGS), who suggested that diagnosis is based on a low whole-body or appendicular fat-
free mass in combination with poor physical functioning134. For the purpose of this thesis 
data were only available on muscle mass and not muscle strength or physical performance 
so therefore the EWGSOP or IWGS definitions could not be applied. Since the onset of this 
thesis, another clinical definition of sarcopenia has also been suggested in 2014 by the 
Foundation for the National Institutes of Health (FNIH) Sarcopenia Project. This definition 
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has recommended specific cut points for muscle weakness (grip strength <26kg for men 
and <16kg for women) and for low lean mass (appendicular lean mass adjusted for body 
mass index <0.789 for men and <0.512 for women)435. Future epidemiological studies 
investigating the association between sarcopenic and risk of CVD and mortality should 
therefore use the proposed standardised consensus sarcopenia definitions (EGWSOP, 
IWGS and FNIH). Using all three proposed definitions within a study would allow for a 
comparison of which definition is most effective in predicting the risk of CVD and 
mortality over time. Future epidemiological studies should also examine both measures of 
muscle mass and muscle function to address the question of whether muscle mass or 
strength is most important in predicting the risk of CVD and mortality. 
 
Sarcopenia is the term used to refer to the age-associated loss of skeletal muscle mass and 
function140. However, at the initiation of this thesis data were unavailable on the decline in 
muscle mass over time so the assessment of sarcopenia was based on low muscle mass, 
measured at one time point only, as is the case for several previous studies17-19. Future 
epidemiological studies should therefore seek to examine the change in muscle mass over 
time in relation to the risk of CVD and mortality, providing a more accurate measure of 
sarcopenia than just using data from one time point.  
 
9.4.2.  Investigating diet quality and the risk of CVD and mortality in older age 
This thesis has examined the prospective associations between a priori dietary scores in 
relation to the risk of cardiovascular outcomes and mortality (Chapter 6), the cross-
sectional associations of social circumstances and a priori dietary scores (Chapter 7) and 
the prospective associations between a posteriori dietary patterns, derived by principal 
component analysis, in relation to the risk of cardiovascular outcomes and mortality 
(Chapter 8). This study has the strengths of using data from a moderately large population-
based, geographically and socioeconomically representative, cohort of older British men 
with very high follow-up rates35;264. The dietary intake of BRHS participants used in this 
thesis, collected via a food frequency questionnaire, is broadly comparable with the intake 
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in the National Diet and Nutrition Survey339 so results are therefore generalisable to older 
men in the UK. However, for reasons given in section 9.4.1, the BRHS does not include 
women34. Since gender differences exist in dietary intake383;384 it is therefore important to 
examine whether the dietary patterns explored in this thesis are also beneficial in large 
cohorts of older women in the UK. Similarly, the BRHS is comprised of men 
predominantly of white European ethnic origin, so results may not be applicable to non-
white ethnic groups and further studies are needed to examine whether the dietary patterns 
observed here are also beneficial in other ethnic groups.  
 
Results from this thesis have been the first to show that adherence to the EDI is associated 
with a lower risk of all-cause mortality, CVD mortality and CHD events and that this 
dietary score is applicable to older British men (Chapter 6). In order to provide further 
evidence on the effectiveness of adherence to the EDI on lowering the risk of CVD and 
mortality in a UK population, a nutritional intervention trial could be carried out in older 
adults, with the intervention group receiving education or encouragement to adhere to 
components of the EDI233 in comparison to a control group of existing dietary intake. This 
would help to inform policy efforts on the recommendation of dietary intake in older adults 
in the UK. 
 
Dietary intake can vary greatly by region and country223;436, so although results in this 
thesis are applicable to the UK, they may not be applicable to other parts of Europe or other 
countries outside of Europe. A priori methods of defining dietary patterns in particular have 
the limitation that they may be culturally or regionally specific and may not be universally 
applicable30;204. Future studies would therefore need to be carried out in other countries to 
assess whether the EDI is a valid measure of diet quality and related to the risk of CVD and 
mortality in other populations. A posteriori methods of defining dietary patterns have the 
advantage over a priori methods of making no prior assumptions about dietary patterns, 
instead using an empirical, data-driven approach to derive typical patterns of dietary 
intake30. However, the results observed in Chapter 8 are therefore geared specifically to the 
dataset from which they were derived, and likely to apply only to older British men. 
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Dietary patterns, identified by principal component analysis, are likely to differ according 
to different populations studied and further studies in other European populations are 
needed to see if patterns similar to those in this thesis are derived, and to compare these 
patterns with the associated risks of CVD and mortality. 
 
Results from this thesis were based on the assessment of diet at one time point at the twenty 
year re-examination in 1998-2000, so it is possible that dietary patterns may have changed 
over time. The recently completed re-examination of BRHS participants, in 2010 to 2012, 
has collected dietary data via a food frequency questionnaire and further exploratory 
analyses would allow assessments to be made about whether the overall diet quality of 
BRHS participants had improved or worsened over time. This would provide important 
information on whether diet is stable in older age groups over time.  
 
Analyses in this thesis related to the prospective associations between dietary patterns and 
risk of CVD and mortality excluded men with prevalent MI, stroke and heart failure since 
dietary changes may have occurred in these individuals following diagnosis and also no 
measure of the severity of CVD was available for these participants. Further large 
epidemiological studies are therefore needed in populations with controlled prevalent CVD 
(e.g. CHD, stroke or heart failure) in order to provide evidence of whether the dietary 
patterns studied in this thesis, such as the EDI, are effective in the secondary prevention of 
CVD. 
 
9.5. Concluding statement 
The population in the UK is ageing due to a steady increase in life expectancy over time. 
Since the 1930s, the number of people aged over 65 years in the UK has more than 
doubled1. CVD remains the main cause of mortality in the UK, accounting for nearly a 
third of all deaths in both men and women, and is a major contributor to morbidity and 
disability4. Results from this thesis have demonstrated that body composition and dietary 
patterns are two important and potentially modifiable risk factors for CVD and mortality, 
which persist in older age. Sarcopenic men and obese men have a significantly increased 
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risk of CVD mortality and all-cause mortality, and men with both sarcopenia and obesity 
have the highest all-cause mortality risk. Adherence to high quality dietary patterns, 
measured using both a priori dietary scores and a posteriori dietary patterns were 
associated with a decreased risk of CVD and all-cause mortality, emphasizing the 
importance of adopting a dietary pattern inherent in the Elderly Dietary Index criteria and 
avoiding ‘high fat /low fibre’ and ‘high sugar’ components. These results emphasize the 
potential of population-wide public health measures to prevent sarcopenia and obesity and 
also to improve overall diet quality in older adults in the UK, in order to decrease the risks 
of CVD and all-cause mortality in older age. 
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APPENDIX VII Baseline questionnaire in 1978-80 
Selected question used in this thesis on occupation: 
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APPENDIX VIII Postal questionnaire in 1996 
 
Selected question used in this thesis on education and pension status: 
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Selected question used in this thesis on father’s occupation and childhood amenities: 
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